

ACCESSION NUMBER:		0001078782-15-000536
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20141231
FILED AS OF DATE:		20150406
DATE AS OF CHANGE:		20150406
FILER:
	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zivo Bioscience
 Inc.
		CENTRAL INDEX KEY:			0001101026
		STANDARD INDUSTRIAL CLASSIFICATION:	FOOD & KINDRED PRODUCTS [2000]
		IRS NUMBER:				870699977
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231
	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30415
		FILM NUMBER:		15753451
	BUSINESS ADDRESS:	
		STREET 1:		7 WEST SQUARE LAKE RD
		CITY:			BLOOMFIELD HILLS
		STATE:			MI
		ZIP:			48302
		BUSINESS PHONE:		(248) 452 9866
	MAIL ADDRESS:	
		STREET 1:		7 WEST SQUARE LAKE RD
		CITY:			BLOOMFIELD HILLS
		STATE:			MI
		ZIP:			48302
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTH ENHANCEMENT PRODUCTS INC
		DATE OF NAME CHANGE:	20040202
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WESTERN GLORY HOLE INC
		DATE OF NAME CHANGE:	19991215






















 2014






Zivo Bioscience
 Inc. 














2804 Orchard Lake Rd.
 Suite 202
 Keego Harbor
 MI 48320













Common Stock
 par value $.001 per share



 as defined in Rule 405 of the Securities Act.




 and (2) has been subject to such filing requirements for the past 90 days.


 if any
 every Interactive Date File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).


 and will not be contained
 to the best of registrant&#146;s knowledge
 in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.&nbsp;


 an accelerated filer
 a non-accelerated filer
 or a smaller reporting company. &nbsp;See the definitions of &#147;large accelerated filer
&#148; &#147;accelerated filer
&#148; and &#147;smaller reporting company&#148; in Rule 12b-2 of the Exchange Act (Check one).
























 2014 by non-affiliates of the issuer was $20
364
868 based on the closing price of the registrant&#146;s common stock on such date.


 2015
 there were 129
743
859 shares of $.001 par value common stock issued and outstanding








ZIVO BIOSCIENCE
 INC. AND SUBSIDIARIES
(formerly Health Enhancement Products
 Inc. and Subsidiaries)


































&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Market for Registrant's Common Equity
 Related Stockholder Matters and Issuer Purchases of Equity Securities



































&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Directors
 Executive Officers and Corporate Governance.











&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain Relationships and Related Transactions
 and Director Independence.

































 as amended
 and Section 21E of the Securities Exchange Act of 1934
 as amended. These statements involve known and unknown risks
 uncertainties and other factors which may cause our or our industry&#146;s actual results
 performance or achievements to be materially different from any future results
 performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements include
 but are not limited to statements regarding:



















 you can identify forward-looking statements by terms such as &#147;may&#148;
 &#147;&nbsp;will&#148;
 &#147;should&#148;
 &#147;could&#148;
 &#147;would&#148;
 &#147;expects&#148;
 &#147;plans&#148;
 &#147;anticipates&#148;
 &#147;believes&#148;
 &#147;estimates&#148;
 &#147;projects&#148;
 &#147;predicts&#148;
 &#147;potential&#148; and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks
 uncertainties
 and other factors that may cause our actual results
 levels of activity
 performance
 or achievements to be materially different from any future results
 levels of activity
 performance
 or achievements expressed or implied by such forward-looking statements. Given these uncertainties
 you should not place undue reliance on these forward-looking statements. Also
 these forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as otherwise required by law
 we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained in this report to reflect any change in our expectations or any change in events
 conditions or circumstances on which any of our forward-looking statements are based. We qualify all of our forward-looking statements by these cautionary statements.















 1983
 under the name of &#147;L. Peck Enterprises
 Inc.&#148; On May 27
 1999
 we changed our name to &#147;Western Glory Hole
 Inc.&#148; &nbsp;From 1990 until October 2003
 we had no business operations; we were in the development stage and were seeking profitable business opportunities. &nbsp;On October 30
 2003
 we acquired 100% of the outstanding shares of Health Enhancement Corporation (&#147;HEC&#148;) in exchange for 9
000
000 of our shares
 making HEC our wholly-owned subsidiary. In connection with this transaction
 we changed our name to Health Enhancement Products
 Inc. &nbsp;On October 14
 2014
 at the annual meeting of the Shareholders&#146; of the Company
 a proposal was passed to change the name of the Company from Health Enhancement Products
 Inc. to Zivo Bioscience
 Inc. (&#147;ZIVO&#148;). &nbsp;On October 16
 2014
 the Amended Articles of Incorporation effecting the name change were filed with the State of Nevada. &nbsp;On October 30
 2014
 the Financial Industry Regulatory Authority (&#147;FINRA&#148;) approved the name Zivo Bioscience
 Inc. for trading purposes and the symbol change to ZIVO effective November 10
 2014.


 AZ produced and marketed a liquid dietary supplement with marginal success beginning in 2003 until sales were suspended in January of 2012. &nbsp;&nbsp;


 in place since December 2011
 determined the sole focus for the near term was to move forward with a research-based product development program. &nbsp;Over the course of 2012
 2013 and 2014
 we engaged fully in such activities
 all as more fully explained herein. &nbsp;We are implementing a business model in which we would derive future income from licensing and selling natural bioactive ingredients that may be derived from or are initially based on the algae cultures. We expect that these planned new products will likely be sold to much larger
 better-financed animal
 food
 dietary supplement and medical food manufacturers. &nbsp;The anticipated income streams are to be generated from a) royalties and advances for licensed natural bioactive ingredients
 and b) bulk sales of such ingredients. These bulk ingredients will likely be made by contracted ingredient manufacturers and then sold by us to animal food
 dietary supplement and medical food processors and/or name-brand marketers. Further
 we expect to license our bioactive molecules as lead compounds or templates for synthetic variants intended for therapeutic applications.


 we established HEPI Pharmaceuticals
 Inc. as our wholly owned subsidiary (&#147;HEPI Pharma&#148;). The purpose of HEPI Pharma was to develop potential pharmaceutical applications for the bioactive ingredients that may be derived from our algae cultures.


 we formed Zivo Biologic
 Inc.
 a Delaware corporation
 for the purpose of manufacturing and commercialization of proprietary ingredients for non-medicinal animal health applications. Zivo Biologic is 100% owned by Health Enhancement Products
 Inc.


 we acquired the assets
 consisting primarily of intellectual property rights
 of Wellness Indicators
 Inc. (&#147;Wellness&#148;)
 a Michigan corporation based in Illinois. &nbsp;Concurrently
 we formed WellMetris
 LLC (&#147;WellMetris&#148;) as a 100% owned entity of ZIVO. &nbsp;We acquired four patent applications as part of the transaction
 in addition to engineering drawings
 prototypes
 chemical formulae
 validation data
 laboratory equipment and IT equipment. &nbsp;We assigned all of the intellectual property acquired to WellMetris with a stated value of $1
391
281. The mission of WellMetris is to develop
 manufacture
 market and sell Wellness Tests. &nbsp;The Wellness Tests are intended to provide individuals the information and opportunity to optimize their health and identify future health risks or to provide insurers
 employers and healthcare providers timely information to intervene with wellness programs
 fitness regimes or other preventative measures. During the period of time since we have operated WellMetris
 we have filed / drafted an additional eight patent applications around the intellectual property acquired
 as noted in the section &#147;Patents and Proprietary Rights&#148;. &nbsp;In the summer of 2014
 we evaluated the circumstances related to the original four patent applications acquired and determined that that two of the existing patent applications could be improved and filed new patents applications to redefine and better protect our intellectual property than the original purchased patent applications. &nbsp;We have abandoned one of the initial four patent applications purchased
 released two of the four applications purchased and substituted them with two new patent applications
 and retained ownership of one of the four applications purchased
 which has now converted to a national phase application. &nbsp;We determined that with the additional filed / drafted eight patent applications around the intellectual property acquired
 we have protected our rights with regards to the original patent applications purchased
 however we determined should record a loss on abandonment of $1
391
281 for the year ended December 31
 2014 as the initial value of the acquired patent applications pending resides in the newly filed / drafted eight patent applications.











 we intend to approach potential customers or licensees in the following market verticals. &nbsp;The products described throughout this document are still in the development stage
 and subject to development risk. &nbsp;There can be no assurance that any of the products described below will prove to be effective
 or if found to be effective
 will be able to be produced in a commercially viable manner.




 or significantly reducing symptoms
 of bovine mastitis &#150; a condition that effectively stops milk production. According to the National Mastitis Council
 the condition affects 10% of the U.S. dairy herd at any one time
 costing producers approximately $1
100 per case. In the U.S. alone
&nbsp;causes a highly contagious and potentially fatal form of bovine mastitis (an infection of the mammary gland)
 for which there currently is no treatment. &nbsp;In the cow&#146;s udder
 mammary epithelial cells form an immunological barrier to protect the mammary gland. &nbsp;When bacteria or other pathogens break through this barrier
 an infection sets in
 affecting quality and quantity of milk produced. &nbsp;&nbsp;Our compounds showed promising early results for restoration of the immunological barrier in experiments conducted in vitro
 as conducted by the Principal Researcher at the University of Wisconsin - Madison
 Department of Dairy Science.


 2013
 we entered into a confidential Collaboration and Option Agreement (&#147;Agreement&#148;) with Zoetis
 a global animal health company
 in connection with the prevention
 treatment
 and management of bovine mastitis. &nbsp;In the Agreement
 we granted to the counterparty an exclusive option to negotiate an exclusive license with us. &nbsp;Specifically
 upon completion of a collaborative study (which is in process)
 the Agreement provides for a 90 day exclusivity period for evaluation of results and
 based on the counterparty&#146;s desire for an exclusive license thereto
 90 days to conclude an exclusive license agreement.


 we intend to move on three related fronts &#150; working to bring an algal feed ingredient to market in the United States by amplifying the algae culture; working to produce a bovine dietary supplement for global consumption outside the U.S.; and
 putting ourselves in a position to license the isolated bioactive molecules to a pharmaceutical or drug development company for synthetic development as a prescribed drug for production animal applications.

 study believes that the same autoimmune effect may be useful in combating bovine respiratory disease complex (&#147;BRDC&#148;)
 also known as &#147;shipping fever.&#148; BRDC typically occurs when beef cattle are shipped from the ranch to the feedlot prior to processing. According to the American Association of Beef Producers
 cattle ranchers and feedlot operators attribute a 30% loss in body weight to BRDC when it occurs &#150; a $10 billion problem in the U.S. alone. We are planning a field study to validate several dosing modalities before offering a licensing option.


 which if successful could allow a relatively rapid release to production and sales as a companion animal dietary supplement. According to the Nutrition Business Journal
 the canine joint-health dietary supplement market segment tops $360 million in the U.S. alone. Estimates for the world market may be substantially higher
 but such estimates are difficult to obtain. An in vitro tissue explant experiment conducted by the Comparative Orthopaedics Laboratory at University of Missouri found that direct stimulation of living canine joint tissue with our bioactive compounds protected cartilage from degradation by IL-1b
 and can be produced on an efficient basis
 we intend to sell or license our product as a supplement ingredient to larger
 well-established and profitable brand-names in the pet industry. &nbsp;We have conducted other laboratory studies simulating the effects of canine osteoarthritis with positive results.


 the isolated bioactive molecules found in the amplified algae product can be licensed to a pharmaceutical company for development as a synthetic prescription drug. We expect that the process of developing and testing such a drug could take years. &nbsp;Therefore
 as is common practice
 we intend to work toward negotiating a reasonable upfront licensing fee
 milestone payments upon each successful conclusion of a development phase
 followed by pre-market approval; and finally
 a steady stream of royalties in the future. The other revenue streams generated by feed and supplement sales may begin to be realized in 2015
 but no assurance can be provided in that regard. Much of the research and licensing progress is paced by the availability of capital funding and/or debt financing.









 functional foods
 or health foods
 represent an estimated $20 billion business in the U.S. and a $28 billion business in Europe. The Middle East
 although significantly smaller
 is growing at a rate of 12-14% annually
 followed closely by the newly-affluent in China and India. These foods typically are processed products that contain one or more staple foods augmented with a variety of performance-enhancing ingredients.






 dried kelp
 Omega-3 fish oil
 resveratrol
 saw palmetto and similar supplements attests to the American public&#146;s obsession with &#145;natural&#146; products. The dietary supplement business is a $24 billion industry in the U.S. alone
 and twice that the world over.


 we will endeavor to private-label the compound or finished product for larger
 established marketers and retailers. If we are able to accomplish this
 we believe this is a more efficient use of capital and resources while still retaining control of the intellectual property
 the manufacturing process and pricing decisions. We do not intend to be placed in a position where our premier product application is commoditized and we must compete on price.




 during or after various medical procedures
 including surgery
 chemotherapy
 radiation therapy and physical therapy. At times
 medicinal foods are used to augment the effects of prescription drugs. These medicinal foods are expensive and typically reimbursed by health insurers.


 but the standards are less stringent than pharmaceutical applications. &nbsp;Once again
 under our new business model
 if we are able to produce a commercial product in this area
 we will endeavor to enter into a private-label arrangement with a larger strategic partner to produce and distribute this product application.


 we developed an alternate use for extracted algal carrageenan
 which can be mixed with sugar and other ingredients to create a gelatin-like substance and then mixed with over-the-counter medications
 dietary supplements
 gluten-free proteins
 medical food ingredients such as electrolytes
 and our own
 proprietary algal compounds to create a novel delivery method for children and individuals who can&#146;t swallow pills or chew
 but are not candidates for intravenous feeding or medical intervention.


 remains inert with the majority of such active ingredients
 and remains stable and flavorful at room temperature for up to two (2) years. A provisional patent has been filed while various combinations of medicines and supplements are being evaluated as ingredient candidates. &nbsp;


 we will endeavor to license or private-label this new development to larger
 well-established brand names in their respective fields.




 the process for developing a new prescription drug is costly
 complex and time-consuming. It is an undertaking well beyond our current financial capabilities and one that may take years to achieve. If we pursue the development of a prescription drug
 we will likely seek a partnership with a co-developer that will share in the risk and expense of the initial development process
 and then share in any royalties resulting from the licensing or sale of any synthetic molecule and its homologs we are able to develop and license.


 licenses fees and royalty payments across animal and human applications.









 manufacturing
 marketing
 and selling tests that we believe will allow individuals and their care providers to optimize&nbsp;personal health and identify future health risks. &nbsp;The information obtained will also provide insurers
 employers and healthcare providers timely information to intervene with wellness programs
 fitness regimes or other preventative measures. &nbsp;We plan to develop and commercialize such tests in three phases:



 we plan to develop and commercialize a series of tests
 which are intended to measure indicators of good health and optimal metabolic function (collectively
 the &#147;Phase One Test&#148;). &nbsp;The Phase One Test is being designed to measure biomarkers related to oxidative stress
 inflammation
 and antioxidant status to establish a metabolic assessment from which intervention can commence
 and from which metabolic syndrome can be inferred.



 we plan to develop and commercialize a testing technology &nbsp;focused on &nbsp;the positive or negative metabolic effects of diet and dietary supplements in a self-administered format that integrates with smartphone operating systems.



 we plan to develop and commercialize tests intended to provide a complete metabolic profile for an individual utilizing the metabolites present in urine. &nbsp;&nbsp;The Company believes the Phase Three Tests will allow identification of healthy versus unhealthy bodily processes in real-time. This technology can also be applied to livestock and companion animals. As capital funding becomes available
 the Company will move forward with finalizing its transition cow syndrome test
 for which a provisional patent application has already been filed.


 diabetes
 autoimmune diseases and cancer. &nbsp;&nbsp;The Wellness Tests are intended to identify pre-conditions to such illnesses. &nbsp;Such identification may allow for early intervention and reduce incidence of such illnesses or forestall their onset. &nbsp;This is critically important to large employers
 insurers and governmental agencies who are payers for health claims and are facing massive increases in premiums or cash outlays.


 report
 record and manage wellness and health data for large groups such as large employers
 pension funds
 accountable care organizations
 state Medicaid agencies and their actuarial consultants
 underwriters
 re-insurers and wellness consultants. The software also contains tools to conduct meta-analysis of baseline health benchmarks and monitor the progress of pre-clinical intervention programs within large groups.










 Omega-3 and antioxidants are made and marketed in a fiercely competitive
 price-sensitive market environment. Recently
 several algae producers have made health claims for their proprietary algae strains
 ranging from diabetes to controlling HIV symptoms. Proprietary products offered by some marketers are often dogged by unsubstantiated claims of product efficacy or present potential product safety issues
 which in turn draw the attention of regulators. The optimal position for a supplement and ingredient maker is when pricing power can be exerted through well-protected intellectual property and further backed by well-documented safety and efficacy claims.


 Cognis
 ConAgra
 Cargill and Nestle
 each of which has active M&amp;A efforts
 a large scientific staff and a generous R&amp;D budget to develop supplements and ingredients for a wide range of applications. However
 we intend to approach these very same competitors as potential strategic partners
 in order to leverage their specific expertise in certain food and supplement categories where a mutually beneficial relationship can be struck. &nbsp;There can be no assurance that this strategy will be effective.


 the companion animal dietary supplement segment
 and specifically joint health
&nbsp;is made up almost exclusively of chondroitin/glutathione supplements
 which have dominated that segment for more than a decade. This $360 million segment represents a potentially lucrative opportunity to introduce a completely new product if we are able to demonstrate superior benefits and produce a product at a comparable price.







 the animal health market as it pertains to mastitis in dairy cows
 and specifically feed ingredients that exhibit beneficial properties
 has been largely in the realm of yeast-based products. Only recently has there been a focus on algae-based alternatives
 as promoted by Alltech with its $200 million expansion of an algae facility in Kentucky. In the U.S.
 feed ingredients cannot be promoted using any form of health claim
 and dietary supplements for production animals are non-existent. However
 outside the U.S.
 the use of dietary supplements is widespread
 and we intend to market our refined ingredients to a worldwide market in partnership with a global brand name.




 which changes markedly throughout the day. Blood-based wellness tests are even less reliable because the biomarkers for oxidative stress and inflammation are extremely dynamic and will often change before the blood can be tested
 casting doubt on the results.


 there is no guarantee that our products will be proven to be effective and commercially viable
 or that a larger
 better-financed competitor may not emerge once we begin promoting our products. &nbsp;






 including algae
 and these source materials are held in growing environments at our contract research facilities. We are using these materials for research and development purposes only. &nbsp;&nbsp;We have also contracted a well-known research facility where we have cryopreserved a broad sampling of our cultures. &nbsp;




 we will need two physical components to deliver our services. &nbsp;A dedicated
 custom reader device and a test strip comprised of eight (8) different chemistry tests on a single urine test strip housed in a proprietary cartridge.



 custom reader device is manufactured by a third party to our specifications. &nbsp;We do not believe that there is a risk of supply
 as there are several manufacturers available to produce the unit.



 as there are several manufacturers available to produce the units.




 we have readjusted the business model to focus in the near term on research and development in order to license our product and technology to third parties. &nbsp;At this time
 there are no customers providing any revenue.






 we are only manufacturing the product for purposes of research and development programs that are currently underway.




 we are using third parties to manufacture our custom reader device and test strips.









 we have secured a patent and federal trademark registrations in the U.S. Patent and Trademark Office (&#147;USPTO&#148;) as described below:



807
622 relates to our proprietary complex algal culture. &nbsp;The title of the patent is: Composition and use of phyto-percolate for treatment of disease. &nbsp;This invention relates generally to a method of preparation of a phyto-percolate that is derived from fresh water mixture including algae. The invention further relates to the potential use of the phyto-percolate in a variety of disease states. &nbsp;This patent was filed on November 30
 2006 and has a term of 20 years from the earliest claimed filing date (which can be extended via Patent Term Adjustment and Patent Term Extension). The initial term would expire on November 30
 2026. &nbsp;



586
053 relates to our proprietary algal culture. The title of the patent is: &#147;Composition and Use of Phytopercolate for Treatment of Disease.&#148; This invention relates generally to a method of preparation of a phyto-percolate that is derived from fresh water mixture including algae. The invention further relates to the use of the phyto-percolate in a variety of disease states. The phyto-percolate is believed to contain an activity that induces the reduction of soluble and insoluble fibrin. Further
 the phyto-percolate is believed to reduce oxidative stress in the body. The patent was filed on April 20
 2006 and has a term of 20 years from the earliest claimed filing date. The patent was issued on November 19
 2013 and expires in April of 2026.



791
060 relates to our proprietary culture. Title of the patent is the same: &#147;Composition and Use of Phytopercolate for Treatment of disease.&#148; This invention relates generally to a method of preparation of a phyto-percolate that is derived from fresh water mixture including algae. The invention further describes proteolytic activity. &nbsp;The patent was filed on October 4
 2010 and has a term of 20 years from the earliest claimed filing date. The patent was issued on July 29
 2014 and expires in July of 2030.


 trade names
 service marks
 and the like which will continue as long as we use those respective marks.


 await examination or are in process:









7
807
622









2
631
773






Response to Examination Report filed 10/01/12




8
791
060







 deadline for response 4/11/15




12/947
684





PCT/US2010/056862 Canadian App. No. 2
780
144
Annuity paid
 request for examination due 11/16/15











Office Action issued
 Extension &nbsp;to respond requested
 response due 5/11/15


















13/841
739





14/558
516




8
586
053


Composition for Affecting Cytokines
 Lactoferrin
 and Serum Amyloid A

61/834
842
Application Filed 6/13/2013
 non-provisional and PCT filed 6/13/14

Composition for Affecting Cytokines
 Lactoferrin and Serum Amyloid A







National Phase entered 8-22-12 (US
 JP
 MX)















SN 13/580
471














SN 61/835
282




SN 2
827
401





SN 61/871
665




SN 61/872
928




SN 13/812
220
Patent Counsel has POA
 pending review

Systems
 Methods and Program Products for Collecting and Organizing Health Data

SN 13/397
360




61/367
486









SN 62/116
766
Filed Feb 22
 2015



SN 62/025
 669
Filed July 17
 2014














SN 62
116
766
Filed Feb 16
 2015



SN 62 136
764
Filed March
 23
 2015




Filed Nov 20
 2014
















 our product(s) are subject to extensive governmental regulations. &nbsp;In the United States
 these laws
 regulations and other constraints exist at the federal
 state and local levels and at all levels of government in foreign jurisdictions. The majority of these regulations directly relate to (1) the formulation
 clinical testing
 manufacturing
 packaging
 labeling
 distribution
 sale and storage of our product(s) and (2) product claims and advertising
 including claims and advertising by us
 as well as claims and advertising by distributors for which we may be held responsible.




 the formulation
 testing
 manufacturing
 packaging
 storing
 labeling
 promotion
 advertising
 distribution and sale of our product(s) are subject to regulation by various governmental agencies
 primarily (1) the Food and Drug Administration (&#147;FDA&#148;) and (2) the Federal Trade Commission (&#147;FTC&#148;). &nbsp;Our activities also are regulated by various agencies of the states and localities and foreign countries in which our product(s) are manufactured
 promoted
 distributed and sold. The FDA
 in particular
 regulates the formulation
 manufacture and labeling of conventional foods
 dietary ingredients and dietary supplements (or nutraceuticals).


 drugs
 cosmetics and medical devices in the United States. &nbsp;To the extent that we manufacture finished product(s) for sale to consumers (and in certain other limited circumstances where we sell our product as an ingredient)
 FDA regulations require us to comply with current good manufacturing practice (&#147;cGMP&#148;) regulations for the preparation
 packing and storage of dietary supplements. &nbsp;This is a complex series of regulations that have posed significant compliance challenges to the supplement industry. &nbsp;&nbsp;To the extent that we supply our product(s) as ingredients for the use in foods or nutraceuticals
 we would be required to comply with cGMP regulations for foods
 as well as the provisions of the Food Safety Modernization Act of 2011 which require all companies involved in the production of food and food ingredients to develop and implement a Hazard Analysis and Critical Control Point (&#147;HACCP&#148;) program.


 Drug and Cosmetic Act (&#147;FFDCA&#148;) by recognizing &#147;dietary supplements&#148; as a distinct category of food and
 we believe
 is generally favorable to the dietary supplement industry. &nbsp;The legislation grandfathered
 with some limitations
 dietary ingredients that were on the market before October 15
 1994. &nbsp;A dietary supplement that contains a dietary ingredient that was not on the market before October 15
 1994 will require evidence of a history of use or other evidence of safety establishing that it is reasonably expected to be safe. &nbsp;To the extent that we offer for sale unique
 proprietary ingredients we will be required to file with FDA evidence supporting the conclusion that we have a &#147;reasonable expectation&#148; that they will be safe for human consumption when used as directed. &nbsp;The FDA recently published an &#147;Advance Notice of Proposed Rulemaking&#148; which the nutraceutical industry believes will substantially increase the level of evidence required to satisfy the &#147;reasonable expectation&#148; standard.


 truthful and non-misleading statements of nutritional support to be made in labeling
 such as statements describing general well-being from consumption of a nutraceutical ingredient or the role of a nutrient or dietary ingredient in affecting or maintaining structure or function of the body. &nbsp;A company making a statement of nutritional support must possess adequate substantiating scientific evidence for the statement
 disclose on the label that the FDA has not reviewed the statement and that the product is not intended to mitigate
 treat
 cure or prevent disease
 and notify the FDA of the statement within 30 days after its initial use. &nbsp;To the extent we produce finished product for use by consumers as nutraceuticals
 we will be required to comply with these provisions of DSHEA. &nbsp;




 this category of products is subject to the Nutrition
 Labeling and Education Act (&#147;NLEA&#148;) and regulations promulgated under the NLEA. The NLEA regulates health claims
 ingredient labeling and nutrient content claims characterizing the level of a nutrient in the product. The ingredients added to conventional foods must either be generally recognized as safe by experts (&#147;GRAS&#148;) or be approved as food additives under FDA regulations.







 which exercises jurisdiction over the advertising of our product
 has for years instituted enforcement actions against companies marketing supplements for alleged false
 misleading or unsubstantiated advertising of some of their products. &nbsp;The FTC has specific guides for advertising claim substantiation as well as for the use of testimonials. &nbsp;As a general matter
 companies making health related claims for their products or ingredients are required to possess well designed human clinical studies supporting such claims at the time they are made. &nbsp;Enforcement actions have often resulted in consent decrees and significant monetary payments by the companies involved. In addition
 the FTC has increased its scrutiny of the use of testimonials which we have and may in the future utilize.




 we may be required to obtain an approval
 license or certification from the relevant country's ministry of health or comparable agency. &nbsp;This would hold true for jurisdictions such as Canada
 the European Union
 Japan
 Australia and New Zealand. &nbsp;The approval process generally requires us to present each product and product ingredient to appropriate regulators for review of data supporting safety as well as substantiating any claims we may desire to make. &nbsp;&nbsp;We would also be required to comply with product labeling and packaging regulations that vary from country to country. Our failure to comply with these regulations could prevent our product(s) from being legally offered for sale. &nbsp;




 also known as Proposition 65
 provides that no person in the course of doing business shall knowingly discharge or release a chemical known to the state to cause cancer or reproductive toxicity into water or into land where such chemical passes or probably will pass into any source of drinking water
 without first giving clear and reasonable warning. &nbsp;Among other things
 the statute covers all consumer goods (including foods) sold in the State of California. &nbsp;Prop. 65 allows private enforcement actions (sometimes called &#147;bounty hunter&#148; actions). &nbsp;Reports indicate that over 100 such actions have been commenced annually over the past 3 years against companies in the nutraceutical industry (e.g.
 lead content of calcium
 lead content of ginseng
 PCB in fish oil) alleging that their products are contaminated with heavy metals or other compounds that would trigger the warning requirements of the Act. &nbsp;While we intend to take appropriate steps to ensure that any of our products that we may market will be in compliance with the Act
 given the nature of this statute and the extremely low tolerance limits it establishes (well below federal requirements)
 there is a risk that we
 our contracted producer or a licensee could be found liable for the presence of miniscule amounts of a prohibited chemical in our product. &nbsp;Such liability could be significant.




 we will produce research-only feedstock for chemical analysis
 safety studies and efficacy studies compliant with applicable state and federal regulations. However
 we will rely on our research partners to conduct their respective R&amp;D programs in a manner compliant with applicable regulation and law. Once a product concept has been fully developed
 we intend to manufacture that product
 either internally or on a contract basis. In either case
 we intend to adhere to all state and federal regulations relative to the safety and efficacy of the product application
 as well as relevant regulations covering the safe and consistent manufacture of that product.




 which are advising us as to the most time and cost-efficient path to classification and approvals.








 beginning in 2004. In spring of 2009
 we undertook a research and development process with a view to fractioning the existing product into much smaller
 concentrated groups of molecules with similar physical properties. These groups were then tested&nbsp;







 2014 on research and development
 as compared to $1 million in 2013. The resources were spent on external research
 mainly to independent facilities involved in the analysis and validation of our bioactive compounds in various applications and animal models. To date
 all of these amounts have been directly expensed as they have been incurred.


 the Company has moved forward with the following R&amp;D activities:



 a long-term study utilizing primary bovine mammary epithelial cells at the University of Wisconsin &#150; Madison allowed the Company to conduct more than one hundred individual experiments to test the bioactivity of different culturing
 concentration and isolation methods. This phase of the research has been concluded.



&nbsp;by the principal researcher at the University of Wisconsin and other research labs. &nbsp;The pre-pilot and pilot arms of this study have been completed and the results gained thus far may shorten the primary arm of this bovine study
 which is expected to commence upon available funding.



 using our natural bioactive compounds. The study will be repeated and expanded when capital funding is made available. 



 Company principals determined that a more definitive in vivo study would be more useful
 pending capital funding.








 but also testing the method of isolation and then validating that the isolated molecules retain their bioactivity across a select range of human and animal cell lines
studies. We must ensure that this does not occur occasionally
 it is required for every production process
 every safety validation process and every intended application
 such as a canine dietary supplement that is mixed with food
 as opposed to a canine dietary supplement that is administered in the form of a chewable caplet. Further
 as we now enter production scale-up
 we are required to provide cGMP protocols and QA protocols that show we can produce the algal biomass and/or the active ingredients safely
 consistently and in defined quantities
 and therefore rely on these same experiments and methods to substantiate our quality claims. These datasets form the basis for establishing the value of a license agreement. Therefore
 every single license that we hope to issue requires its own data set and safety validation for the specific application being licensed. These datasets represent the core of the intellectual property that is being licensed.




 the method was not commercially viable
 and the Company has expended considerable resources to develop a single-species
 high-volume and commercially viable production methodology.


 resulting in the creation of a product platform strategy whereby four different forms of the bioactive compound(s) could be formulated and developed for future marketing across several categories and applications: &nbsp;a) the raw algae biomass
 which would naturally contain the beneficial compound(s); b) a more refined extraction which could be introduced into animal feed or supplements; c) the isolated natural molecule(s) which could be more appropriate for human consumption in food or supplements; and d) the synthetic version of any such natural molecule(s) which could be licensed to drug development companies or joint-ventured in a risk-sharing arrangement.







 we contracted with several experts in the field to coordinate isolation of the different organisms present in the culture
 grow each of them separately and then subject them to the same life-cycle stressors as the original culture. The stated goal was to grow algae in bulk as a direct source of micro-nutrition and feed ingredient for production animals
 namely beef cattle and dairy cows
 as well as companion animal dietary supplementation. &nbsp;The production capability would be licensed to others. Per the business model
 we have no intention of fielding a finished product
 but rather empowering licensees to strike supply agreements with larger
 better-financed brand names or licensing directly with such brand names. There can be no assurance that commercially viable products will be developed
 or that they can be successfully and profitably manufactured and marketed.


 our contracted researchers have been able to successfully isolate one or more algal species
 scale up the production/output of the isolated species and still retain some of the key
 desirable bioactive properties associated with the earlier
 complex culture. At the close of 2014
 proof of concept growing techniques
 including both pond and bioreactor modes
 have shown that our target algal specie can be grown in commercially viable quantities
 and the harvest time has been compressed from several months to several days&#146; time. We are uncertain if we can grow biomass in sufficient tonnage for livestock feed
 but we believe that the current production methods will allow us to satisfy demand for a more refined extract introduced into animal supplements and
 as a more purified substance
 into human supplements. 


 we tested the algal biomass and isolates derived from the aforementioned prototype growing facilities in dairy cows with successful results.




 as it relates to autoimmune and anti-inflammatory response. These are very broad categories and work is still required to fully describe the 3D structure of such compounds
 as the actual structure is how the bioactivity exists and where the value is locked. One approach among several we&#146;ve taken is to create synthetic homologs
 and from them deduce the composition and 3D structure of the naturally bioactive compounds. This is an iterative process
 with equal potential for dead-ends and breakthroughs. Substantial time
 money
 and effort have been expended in this regard. &nbsp;In early 2014
 we determined that the synthetic approach was not yielding the hoped-for results and halted that particular effort. Further
 in spring of 2014 we commenced an intensive data integrity study to re-examine the analytics and isolation techniques to make sure we were approaching the characterization process in as expeditious and efficient manner as possible. &nbsp;We believe that we have made substantial progress towards achieving these hoped-for results
 but more confirmatory studies and scale-up experiments are still needed. &nbsp;&nbsp;&nbsp;&nbsp;Subject to the availability of sufficient funding
 we estimate that we will
 in fiscal 2015
 be required to expend in excess of $2
000
000 on research and subsequent product development in order to complete the initiatives discussed herein. &nbsp;In addition to the activity in 2014
 we will continue our research and development efforts&nbsp;in 2015 and beyond. &nbsp;These expenditures will need to be met from external funding sources. In the past
 we have had difficulty raising funds from external sources. Thus
 we may not be able to raise the funding required to continue our research and development activities. In the event that these sources are not available or adequate to meet our research needs
 we will be unable to pursue our research activities
 in which case our ability to substantiate the accumulated intellectual property with objective clinical support for its characterization
 method of action and efficacy will continue to be impeded
 thereby severely hindering our ability to generate licensing revenue (or otherwise commercialize our products) and adversely affect our operating results.


 we will continue our current research program with our research partners
 we will expand our investigations to include various experts and consultants on an as-needed basis and explore new product concepts and applications. Our current contracts with our research partners cover the following activities:



 experiments
 standards development
 FDA compliance
 cGMP and QA protocols


&nbsp;to substantiate efficacy and safety for each specific application or claim
 i.e.
 bovine mastitis
 bovine respiratory disease complex
 canine osteoarthritis
 canine joint health
 porcine respiratory/reproductive syndrome
 etc.
 to boost value for each specific license






 FDA safety compliance
 cGMP and QA protocols













 programmatic applications of its testing and reporting platform. We are interested in supporting the intervention by wellness consultants or medical professionals in the lifestyle choices made by individuals covered by traditional health insurance plans
 retiree medical benefits pools
 employer-sponsored health initiatives and taxpayer-sponsored programs like Medicaid and the ACA (Affordable Care Act). &nbsp;These interventions
 which are typically non-medical
 have been shown to be successful in delaying the onset of chronic diseases such as diabetes or cardiovascular problems. We believe that targeting asymptomatic individuals and focusing intervention efforts on these individuals may have a positive result for wellness programs
 and potentially lower premiums and health claims.


 the WellMetris product platform requires additional prototype analyzers and additional dry chemistry reagent strips and cartridges to conduct pilot programs for potential customers
 and to use the result of these pilot programs to help normalize data for the dry chemistry reagents as part of the FDA submission package. Such efforts are pending available capital funding.


 primarily focused on those individuals who purchase dietary supplements
 join health clubs or are otherwise actively pursuing a healthy lifestyle. This involves miniaturizing some aspects of our test cartridge concept and creating a mobile application
 thereby eliminating the need for the analyzer device. This is a significant undertaking
 which will not commence until we realize revenues from our Phase 1 product launch or attract additional capital funding.




 in all material respects
 in compliance with local
 state
 and federal environmental laws applicable to our production and waste disposal. The cost of this compliance activity to date has not been material
 and has been absorbed within our general operations overhead.




 2014 we had two full-time employees
 positioned in executive management. In addition
 we have three part-time people acting on a consulting basis as our Chief Science Officer
 Director
 Research &amp; Development and Lead Scientist &amp; Clinical Coordinator. We believe that our employee relations are good. No employee is represented by a union.



Information on our website is not incorporated by reference into this Form&nbsp;10-K and should not be considered part of this report or any other filing we make with the SEC. We file annual
 quarterly and current reports
 and other information with the Securities and Exchange Commission. &nbsp;&nbsp;Our filings with the SEC can be viewed at www.sec.gov.



Our independent registered public accounting firm has issued an opinion on our consolidated financial statements which states that the consolidated financial statements were prepared assuming we will continue as a going concern and further states that our recurring losses from operations
 stockholders&#146; deficit and inability to generate sufficient cash flow to meet our obligations and sustain our operations raise substantial doubt about our ability to continue as a going concern. &nbsp;

Unless and until we realize licensing and royalty revenues sufficient to cover our expenses
 we will be reliant upon external sources to fund our continued operations. There is no guarantee that this funding will continue. If we are unable to raise additional funds
 there will be a material adverse effect on our business
 financial condition and results of operations.






As of December 31
 2014
 we had 128
773
859 shares outstanding. &nbsp;We also had contractual commitments to issue 56
877
961 additional shares as of December 31
 2014
 consisting of 47
824
956 common shares issuable upon the conversion of convertible debentures and related accrued interest and 9
053
005 common shares issuable upon the exercise of outstanding warrants. &nbsp;This totals a potential 185
651
820 shares outstanding if all debentures were converted and warrants exercised. &nbsp;In order to increase the authorized shares to a higher number
 we would need to amend our articles of incorporation
 which would require shareholder approval. &nbsp;There is no guarantee that we will be able to obtain the shareholder approval necessary to amend our articles of incorporation to increase our authorized shares.

&nbsp;We do not have resources to pursue the development
 manufacturing and marketing of products on our own
 and we will need to rely on third parties for some of these activities. &nbsp;

The ability to market our product is dependent upon proven
 clinical research.&nbsp;
 there is no guarantee that the research will successfully achieve this goal. If our current research does not return the results we expect
 our business prospects will be materially and adversely affected.

Nutraceutical and animal supplement products
 although not subject to FDA approval
 must follow strict guidelines in terms of production and advertising claims. Our ability to produce and successfully market our products is dependent upon adhering to these requirements. &nbsp;If we fail to comply with applicable government regulations concerning the production and marketing of our product
 we could be subject to substantial fines and penalties
 which would have a material adverse effect on our business.

We have a history of losses
 we expect to continue to incur losses and we may not achieve or sustain profitability in the future. &nbsp;
 if and when we do become profitable
 we will sustain profitability. If we are ultimately unable to generate sufficient revenue to meet our financial targets
 become profitable and have sustainable positive cash flows
 investors could lose their investment.
We compete with a wide range of established companies in a variety of different markets
 all of whom have substantially greater name recognition and resources than we do. We face or will face other specialized competitors if we are able to expand into new vertical markets. These competitors may be more efficient and successful than we are. &nbsp;If we fail to compete successfully
 our operating results and financial condition will be materially adversely affected.

The future success of our business depends upon our ability to meet regulatory requirements for the sale of our products. Increased enforcement of existing laws and regulations
 as well as any laws
 regulations
 or changes that may be adopted or implemented in the future
 could limit our ability to market our products.

Our success depends in part upon the continued service of our senior management personnel. Our success will also depend on our future ability to attract and retain highly qualified technical
 managerial and marketing personnel. The market for qualified personnel has historically been
 and we expect that it will continue to be
 intensely competitive. We cannot assure you that we will continue to be successful in attracting or retaining such personnel. The loss of certain key employees or our inability to attract and retain other qualified employees could have a material adverse effect on our business.

In recent years
 there has been significant litigation in the U.S. and elsewhere involving patents and other intellectual property rights. Companies are increasingly bringing and becoming subject to suits alleging infringement
 misappropriation or other violations of patents
 copyrights
 trademarks
 trade secrets or other intellectual property rights. These risks have been amplified by an increase in the number of third parties whose sole or primary business is to assert such claims. &nbsp;We could incur substantial costs in prosecuting or defending any intellectual property litigation. Additionally
 the defense or prosecution of claims could be time-consuming and could divert our management's attention away from the execution of our business plan.









 any settlement or adverse judgment resulting from a claim could require us to pay substantial amounts or obtain a license to continue to use the technology that is the subject of the claim
 or otherwise restrict or prohibit our use of the technology. We cannot assure you that we would be able to obtain a license from the third patty asserting the claim on commercially reasonable terms
 that we would be able to develop alternative technology on a timely basis
 or that we would be able to obtain a license to use a suitable alternative technology to permit us to continue offering
 and our customers to continue using
 our affected products or technology. In addition
 we may be required to indemnify our customers for third-party intellectual property infringement claims
 which would increase the cost to us. &nbsp;An adverse determination could also prevent us from offering our products or services to others. Infringement claims asserted with or without merit against us may have an adverse effect on our business
 financial condition and results of operations.


 such payments or costs could have a material adverse effect upon our business and financial results. &nbsp;Even if we are not a party to any litigation between a customer and a third party
 an adverse outcome in any such litigation could make it more difficult for us to defend our technology in any subsequent litigation in which we are a named party. &nbsp;Moreover
 such infringement claims with or without merit may harm our relationships with our existing customers and may deter others from dealing with us.

Our ability to compete effectively is dependent in part upon our ability to protect our intellectual property rights. &nbsp;While we hold one issued patent and pending patent applications covering certain elements of our technology
 these patents
 and
 more generally
 existing patent laws
 may not provide adequate protection for portions of the technology that are important to our business. In addition
 our pending patent applications may not result in issued patents.


 copyright
 trademark and trade secret laws offer us only limited protection and the laws of some foreign countries do not protect proprietary rights to the same extent. Accordingly
 defense of our trademarks and proprietary technology may become an increasingly important issue as we seek to expand our product development into countries that provide a lower level of intellectual property protection than the U.S. Policing unauthorized use of our trademarks and technology is difficult and the steps we take may not prevent misappropriation of the trademarks or technology on which we rely. If competitors are able to use our trademarks or technology without recourse
 our ability to compete would be harmed and our business would be materially and adversely affected.


 the reduction or loss in intellectual property protection for our technology
 the diversion of our management's attention and harm to our reputation
 any of which could materially and adversely affect our business and results of operations.

We do not anticipate paying any cash dividends on our common stock in the foreseeable future. &nbsp;If we do not pay cash dividends
 you could receive a return on your investment in our common stock only if the market price of our common stock has increased when you sell your shares.

Sales of substantial amounts of our common stock in the public market
 or the perception that these sales could occur
 could cause the market price of our common stock to decline and impede our ability to raise capital through the issuance of additional equity securities. We have outstanding warrants and convertible debt that may result in substantially more outstanding shares
 which could cause the price of our common stock to decline.

We have not finished developing our products or sold any products. &nbsp;We have only begun test marketing. &nbsp;We cannot be assured that there is a sufficient market demand for our products. &nbsp;In addition
 while we are actively pursuing the relationships necessary to begin manufacturing and marketing the Wellness Tests
 we have not yet finalized agreements with potential business partners
 including third-party resellers
 labs or distributors of the Wellness Tests. &nbsp;Failure to secure these critical alliances on reasonable terms could negatively impact us
 our business and future plans. &nbsp;&nbsp;

We do not own or operate
 and currently do not plan to own or operate
 manufacturing facilities for production of tests or devices which are critical to the successful operation of the business. We plan to target manufacturers and to form alliances for the mass production of our products
 but we have no assurance that such alliances will be established. Furthermore
 once we enter into such relationships
 we may not have sufficient long-term agreements with any third-party manufacturers to ensure adequate supply and price controls. &nbsp;This may result in delays
 quality control issues
 additional expenses
 and failure to meet demand or other customer obligations or needs. &nbsp;






The success of our products is contingent upon one or more third parties manufacturing products according to design specifications. In practice
 this is difficult to enforce and guarantee. As a result
 we may never realize the expected efficiency
 quality or sensitivity of our products and
 as a result
 may be required to continue research and development with another manufacturer. &nbsp;If a joint venture partner or contractor fails to meet design specifications
 we will experience delays in commencing operations or delays in fulfilling orders in the future. Such delays could have a material adverse impact on our financial condition.








 Michigan and 2
000 square feet in Keego Harbor
 Michigan on a month to month basis to serve as the headquarters of our company. &nbsp;&nbsp;The monthly rent is $3
300.







Item 5. &nbsp;Market for Registrant&#146;s Common Equity
 Related Stockholder Matters and Issuer Purchases of Equity Securities.




 without retail mark-up
 mark-down or commission and may not represent actual transactions. &nbsp;


Year ended December 31
 2013









































Year ended December 31
 2014






































 2014 we had 145 shareholders of record.


 due to our need to retain all of our cash for operations. &nbsp;We do not anticipate paying any cash dividends on our common stock for the foreseeable future.




 2014
 we issued 500
000 shares of common stock for $100
000. Additionally
 we issued 1
650
000 shares of common stock from the exercise of warrants for net proceeds of $206
250. Finally
 we issued 2
917
000 shares of common stock through the conversion of $350
000 of 11% convertible debenture and we issued 950
000 shares of common stock through the conversion of $70
000 of 111% convertible debenture debt held by convertible noteholders.







 2014
 we issued 2
516
667 shares of common stock for $402
500 and 1
058
333 three year common stock warrants exercisable at $.15 per share and 250
000 three year common stock warrants exercisable at $.20 per share. Additionally
 we issued 1
088
000 shares of common stock through the conversion of $70
600 of debt held by convertible noteholders. Further
 we issued 416
667 shares of the Company&#146;s common stock in connection with a stock purchase consummated in December 2013. Finally
 we issued 390
000 shares of common stock from the exercise of warrants for net proceeds of $48
750.


 2014
 we issued 781
477 shares of the Company&#146;s common stock valued at $113
760 in connection with financings in the third quarter. &nbsp;Additionally
 we issued 500
000 shares of common stock valued at $65
000 to a non-related party for services to be rendered over a six month period.


 2014 we issued 95
288 shares of common stock valued at $7
623 in connection with financings in the fourth quarter and we issued 116
667 shares of common stock valued at $17
500 to a non-related party for services rendered during the three months ended December 31
 2014.


 as amended (&#147;the Act&#148;) or Section 4(2) under the Act
 based on the following facts: in each case
 there was no general solicitation
 there was a limited number of investors
 each of whom was an &#147;accredited investor&#148; (within the meaning of Regulation D under the &#147;1933 Act&#148;
 as amended) and/or was (either alone or with his/her purchaser representative) sophisticated about business and financial matters
 each such investor had the opportunity to ask questions of our management and to review our filings with the Securities and Exchange Commission
 and all shares issued were subject to restrictions on transfer
 so as to take reasonable steps to assure that the purchasers were not underwriters within the meaning of Section 2(11) under the 1933 Act.










 we acquired Health Enhancement Corporation
 and changed our name from Western Glory Hole
 Inc. to Health Enhancement Products
 Inc. Western Glory Hole
 Inc. was a development stage company and had no operations during the year ended December 31
 2002 or during the year ended December 31
 2003
 until its acquisition of Health Enhancement Corporation in November 2003.


 we have put in place a business model in which we would derive future income from licensing and selling natural bioactive ingredients that may be derived from or are initially based on the algae cultures. We expect that these planned new products will likely be sold to much larger
 better-financed animal
 food
 dietary supplement and medical food manufacturers. &nbsp;The anticipated income streams are to be generated from a) royalties and advances for licensed natural bioactive ingredients
 and b) bulk sales of such ingredients. These bulk ingredients will likely be made by contracted ingredient manufacturers and then sold by us to animal food
 dietary supplement and medical food processors and/or name-brand marketers. Further
 we expect to license our bioactive molecules as lead compounds or templates for synthetic variants intended for therapeutic applications.


 we are developing
 manufacturing
 marketing
 and selling tests that we believe will allow people to optimize their health and identify future health risks. &nbsp;We plan to develop and commercialize such tests in three phases:



 we plan to develop and commercialize a series of tests
 which are intended to measure indicators of good health and optimal metabolic function (collectively
 the &#147;Phase One Test&#148;). &nbsp;The Phase One Test is being designed to measure biomarkers related to oxidative stress
 inflammation
 and antioxidant status to establish a metabolic assessment from which intervention can commence
 and from which metabolic syndrome can be inferred.



 we plan to develop and commercialize a testing technology &nbsp;focused on &nbsp;the positive or negative metabolic effects of diet and dietary supplements in a self-administered format that integrates with smartphone operating systems.



 we plan to develop and commercialize tests intended to provide a complete metabolic profile for an individual utilizing the metabolites present in urine. &nbsp;&nbsp;The Company believes the Phase Three Tests will allow identification of healthy versus unhealthy bodily processes in real-time for both humans and animals.







 diabetes
 autoimmune diseases and cancer. &nbsp;&nbsp;The Wellness Tests are intended to identify pre-conditions to such illnesses. &nbsp;Such identification may allow for early intervention and reduce incidence of such illnesses or forestall their onset. &nbsp;This is critically important to large employers
 insurers and governmental agencies who are payers for health claims and are facing massive increases in premiums or cash outlays.


 report
 record and manage wellness and health data for large groups such as large employers
 pension funds
 accountable care organizations
 state Medicaid agencies and their actuarial consultants
 underwriters
 re-insurers and wellness consultants. The software also contains tools to conduct meta-analysis of baseline health benchmarks and monitor the progress of pre-clinical intervention programs within large groups.


 we have been incurring significant operating losses and negative cash flow. We experienced only nominal sales of our sole product
 which was pulled from the market in January of 2012
 and have relied primarily on the sale of company securities and shareholder loans to fund operations. &nbsp;&nbsp;We are also experiencing an ongoing and substantial working capital deficiency. We have from time to time had difficulty raising capital from third parties. In December of 2014 through March of 2015
 we successfully raised capital to fund operations and research for the first quarter of 2015. If we are unable to obtain additional funding in the near term
 we may be unable to continue as a going concern
 in which case you would suffer a total loss of your investment in our company.

Results of Operations for Years Ended December 31
 2014 and 2013




 2014&nbsp;and&nbsp;2013 were $0. &nbsp;&nbsp;We implemented a new business model starting in 2012.




 2014 and 2013. As noted above
 we ceased all sales activities as of January 2012.




000 in 2014 from $0 in 2013. &nbsp;The increase is attributed to work in both ZIVO and WellMetris. Expenses included hiring public relations firms
 developing our websites (www.zivobioscience.com and www.wellmetris.com) and developing the software tools within the WellMetris platform for managing the wellness consultants who will work in delivering our process to the end users. 




000 to approximately $907
000 in 2014
 compared to approximately $1
190
000 in 2013. The decrease in general and administrative expenses was due primarily to following: 1) $251
000 of the decrease was due to the awarding in 2013 of warrants to purchase 557
000 shares of common stock
 exercisable for five years at $.25 per share. The warrants were valued at $250
640 using the Black Scholes valuation method and 2) the remainder of the decrease ($32
000) was due to a reduction in staff. &nbsp;&nbsp;




000 to $685
000 in 2014 compared to $902
000 in 2013. &nbsp;Professional fees and consulting expense were decreased in 2014 due to the following: a reduction in legal fees of $95
000
 a reduction in the use in outside consultants of $84
000 and a reduction in accounting fees of $38
000. 




 2014
 we incurred approximately $1
971
000 in research and development expenses
 as compared to $1
018
000 for the comparable period in 2013. These expenses are comprised of costs associated with internal and external research (there was no internal research in 2014). Internal research and development was $0 in 2014
 compared to $41
000 in 2013. The decrease was due to the closure of the production research facility. &nbsp;External research and development increased approximately $994
000 in 2014 to $1
971
000
 compared to $977
000 in 2013. This increase was due primarily to the increase in costs associated with external clinical trials. We expect external research and development to increase in 2015 as we pursue additional external trials
 subject to the availability of sufficient funding
 which we do not currently have.









 2014
 we evaluated the circumstances related to the four Patent Applications Pending relating to the acquisition of asset of Wellness Indicators in August 2013. &nbsp;The Company has filed / drafted an additional eight patents applications around the intellectual property acquired. &nbsp;The Company has determined that the new patents applications redefine and protect its intellectual property better than the original purchased patent applications. &nbsp;As such
 the Company has abandoned the patent applications purchased and recorded a loss on abandonment of $1
391
281 for the year ended December 31
 2014.




 2014
 HEP Investments and ZIVO entered into the Fourth Amendment to Loan Agreement and the Fifth Amended and Restated Senior Secured Convertible Promissory Note amend the calculation of the conversion price for the convertible promissory note. Previously
 the outstanding principal and interest under the note had been convertible into shares of common stock at the lower of the stated price per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market. &nbsp;Following the amendment
 the convertible note is convertible into shares of common stock at a fixed price per share conversion rate (eliminating the lower of 25% discount off of the ten day trailing quoted price of the common stock). &nbsp;The result of this December 1
 2014 amendment with HEP Investments
 was to eliminate the derivative liability that had previously been recorded in connection with our Senior Secured Convertible Promissory Note.






 2014
 we incurred approximately $164
000 of finance costs (non-cash)
 as compared to $4
048
000 for the year ended December 31
 2013
 a $3
883
000 decrease. &nbsp;The decrease in finance charges paid with stocks and warrants was due primarily to a decrease in 2014 of $1
535
000 of convertible debentures issued. &nbsp;Amortization of bond discount increased approximately $337
000 from $1
465
000 in 2013 to $1
802
000 in 2014. The increase in bond amortization in 2014 was due increase of $879
100 11% convertible debentures.




 which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. For the reasons discussed herein
 there is a significant risk that we will be unable to continue as a going concern
 in which case
 you would suffer a total loss of your investment in our company.


 2015
 we had cash in the bank of $10
000. We have incurred significant net losses since inception
 including an operating loss of approximately $5
153
000 during the year ended December 31
 2014. We have
 since inception
 consistently incurred negative cash flow from operations. During the year ended December 31
 2014
 we incurred negative cash flows from operations of approximately $2
736
000. &nbsp;As of December 31
 2014
 we had a working capital deficiency of $6
200
876 and a stockholders&#146; deficiency of $6
369
168. Although we recently raised a limited amount of capital
 we have a near term need for significant additional capital.


 2014
 our operating activities used approximately $2
736
000 in cash
 compared with $2
986
000 in cash during the comparable prior period. &nbsp;The approximate $250
000 decrease in cash used by our operating activities was due primarily to the following (all of which are approximated): a $10
777
000 increase in net income (from a net loss)
 a $1
200
000 change (increase) in accounts payable
 a $263
000 change (increase) in deferred revenue and customer deposits
 a $236
000 change (increase) in miscellaneous receivables
 a $103
000 change (increase) in prepaid expenses
 a $331
000 change in accrued liabilities (increase)
&nbsp;and a $122
000 change in security deposits (decrease)
 offset by a $3
883
000 decrease in deferred finance costs (a non-cash expense item)
 a $10
093
000 decrease in fair value adjustment of derivative liability (a non-cash expense item)
 &nbsp;a $337
000 increase in amortization and depreciation (a non-cash expense item)
 a decrease of $285
000 in stocks and warrants issued for services rendered &nbsp;(a non-cash expense item)
 a $1
391
000 change (increase) in abandonment of patent applications pending (a non-cash expense item)
 and a change (decrease) in deferred rent.


 2014 and 2013
 our investing activities used $0 and $331
000 in cash
 respectively. &nbsp;The difference of $331
000 is due to the purchase of intangible assets related to the Wellness Indicators transaction in 2013
 which were subsequently abandoned in 2014.







 2014 and 2013
 our financing activities generated $2
244
000 and $3
764
000 in cash
 respectively. The difference of $1
520
000 was primarily related to a net decrease of proceeds of $1
534
000 from issuance of convertible debentures (with loans payable converted into convertible debentures) and a decrease of $102
000 from the proceeds of sales of common stocks and the exercise of warrants
 offset by an increase of $141
000 in loans from related parties.


 we entered into an agreement with HEP Investments
 LLC (&#147;HEP&#148;) under which HEP agreed to purchase convertible notes in the aggregate principal amount of $2
000
000. &nbsp;During the course of 2014
 we amended this agreement to provide for funding up to $6
000
000. &nbsp;As of the date of this filing
 HEP had advanced $5
782
200 pursuant to this arrangement. &nbsp;HEP&#146;s convertible notes are secured by all our assets.


 we continue to experience a shortage of capital
 which is materially and adversely affecting our ability to run our business. As noted above
 we have been largely dependent upon external sources for funding. We have in the past had difficulty in raising capital from external sources. &nbsp;We are still heavily reliant upon external financing for the continuation of our research and development program. &nbsp;


000
000 in cash over the next 12 months in order to fund our normal operations and to fund our research and development initiatives. Based on this cash requirement
 we have a near term need for additional funding. Historically
 we have had great difficulty raising funds from external sources; however
 we recently were able to raise a limited amount of capital from outside sources. If we are unable to raise the required capital
 we will be forced to curtail our business operations
 including our research and development activities.




 anticipated income streams are to be generated from the following:






 isolated natural compounds and synthetic variants thereof
 &nbsp;and b) bulk sales of such ingredients;





 the primary selling season is November through April of any given year.


















 the Reports thereon
 and the Notes thereto
 commencing on page F-1 of this report
 which Consolidated Financial Statements
 Reports
 Notes and data are incorporated herein by reference.












&nbsp;Based on their evaluation as of December&nbsp;31
 2014
 our Chief Financial Officer has concluded that our disclosure controls and procedures
 as defined in Rules&nbsp;13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934
 as amended (the &#147;Exchange Act&#148;)
 were effective as of the end of the period covered by this report to ensure that the information required to be disclosed by us in this Annual Report on Form&nbsp;10-K was recorded
 processed
 summarized and reported within the time periods specified in the SEC&#146;s rules and instructions for Form&nbsp;10-K. Our disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management
 including our Chief Financial Officer
 to allow timely decisions regarding required disclosure.

&nbsp;Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting as defined by Rules&nbsp;13a-15(f) and 15d-15(f) under the Exchange Act. Because of its inherent limitations
 internal control over financial reporting may not prevent or detect misstatements. Therefore
 even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Also
 projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions
 or that the degree of compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of the Company&#146;s internal control over financial reporting as of December&nbsp;31
 2014. In making this assessment
. Based on our assessment of those criteria
 management believes that the Company maintained effective internal control over financial reporting as of December&nbsp;31
 2014.



This Management&#146;s report is not deemed filed for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section
 unless we specifically state in a future filing that such report is to be considered filed.

There were no changes in our internal control over financial reporting (as such term is defined in Exchange Act Rules&nbsp;13a-15(f) and 15d-15(f)) during the year ended December&nbsp;31
 2014 that have materially affected
 or are reasonably likely to materially affect
 our internal control over financial reporting.







&nbsp;&nbsp;Directors
 Executive Officers and Corporate Governance.








 directors and employees. The Code is incorporated by reference as an exhibit to this Annual Report on Form 10-K. We will upon request and without charge provide a copy of our Code of Ethics. Requests should be directed to Principal Accounting Officer
 Health Enhancement Products
 Inc.
 2804 Orchard Lake Road
 Suite 202
 Keego Harbor
 MI 48320.














Item 13. &nbsp;Certain Relationships and Related Transactions
 and Director Independence.




















 or hereby incorporated by reference into
 this Form&nbsp;10-K.










 the Registrant has duly caused this report to be signed on its behalf by the undersigned
 thereunto duly authorized.



HEALTH ENHANCEMENT PRODUCTS
 INC.




Date: &nbsp;April 6
 2015









 this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.




 Principal


 President

 2015



 Director

 Director

 2015



 Director


 2015



 Director


 2015



 Director


 2015



 Director


 2015











ZIVO BIOSCIENCE
 INC. AND SUBSIDIARIES


 Inc. (formerly Health Enhancement Products
 Inc.) and Subsidiaries (the &#147;Company&#148;) as of December 31
 2014 and 2013 and the related consolidated statements of operations
 stockholders&#146; deficiency and cash flows for each of the two years in the period ended December 31
 2014. These consolidated financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.


 nor were we engaged to perform
 an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances
 but not for the purpose of expressing an opinion on the effectiveness of the Company&#146;s internal control over financial reporting. Accordingly
 we express no such opinion. Also
 an audit includes examining
 on a test basis
 evidence supporting the amounts and disclosures in the financial statements
 assessing the accounting principles used and significant estimates made by management
 as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.


 the consolidated financial statements referred to above present fairly
 in all material respects
 the consolidated financial position of Zivo Bioscience
 Inc. and Subsidiaries at December 31
 2014 and 2013
 and the results of their operations and their cash flows for each of the two years in the period ended December 31
 2014
 in conformity with accounting principles generally accepted in the United States of America.


 the Company has incurred significant operating losses for the years ended December 31
 2014 and 2013 and
 as of December 31
 2014
 has a significant working capital and stockholders&#146; deficiency. These factors raise substantial doubt about the Company&#146;s ability to continue as a going concern. Management&#146;s plans regarding those matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.


/s/ WOLINETZ
 LAFAZAN &amp; COMPANY
 P.C.

 LAFAZAN &amp; COMPANY
 P.C.





 New York

 2015









ZIVO BIOSCIENCE
 INC. AND SUBSIDIARIES

 Inc. and Subsidiaries)











December 31



December 31

















493
104

1
383


72
122
31
724


118
467



4
834



688
527
33
107

PROPERTY AND EQUIPMENT
 NET
93
750
68
750




1
391
281







1
392
126




2
174
403

101
857









483
208

1
225
589

&nbsp;&nbsp;&nbsp;&nbsp;Loans Payable
 Related Parties

141
014

&nbsp;&nbsp;&nbsp;&nbsp;Convertible Debentures Payable
111
280 and &nbsp;

314 at December 31
 2013 and 2014
 respectively
1
619
319
3
628
386


8
036
239



738
686
1
238
994


10
877
452
6
233
983



&nbsp;&nbsp;&nbsp;&nbsp;Convertible Debenture Payable
2
159
189 and &nbsp;

047
958 at December 31
 2013 and 2014
 respectively
890
811
237
042


890
811
237
042


11
768
263
6
471
025







&nbsp;&nbsp;&nbsp;&nbsp;Common stock
 $.001 par value
 200
000
000 shares authorized;&nbsp;&nbsp;&nbsp;116
852
128
773
859 issued and outstanding at December 31
 2013 and 2014
 respectively
116
852
128
774


32
895
380
35
427
339


(42
606
092)
(41
925
281)


(9
593
860)
(6
369
168)





2
174
403

101
857













ZIVO BIOSCIENCE
 INC. AND SUBSIDIARIES

 Inc. and Subsidiaries)

















December 31
 2013

December 31
 2014



















198
632


1
189
812
907
156


902
362
684
893


1
018
023
1
971
175



1
391
281


3
110
197
5
153
137




(3
110
197)
(5
153
137)






262
837



409
371
93
683



(118
466)


(1
674
135)
8
418
982


(1
464
516)
(1
801
735)


(30
122)
(4
835)


(2
821
630)



(1
226
009)
(164
108)


(441
477)
(589
573)




(6
985
681)
5
833
948





(10
095
878)

680
811











112
214
131
125
327
071








112
214
131
182
205
032














ZIVO BIOSCIENCE
 INC. AND SUBSIDIARIES

 Inc. and Subsidiaries)



FOR THE PERIOD JANUARY 1
 2013 THROUGH DECEMBER 31
 2014

















































Balance
 January 1
 2013
105
317
816

105
318

28
448
707

(32
510
214)

(3
956
189)






38
226

38
226




434
749

434
749



2
910
606
2
911
704
089

707
000


1
441
889
1
442
(1
442)





1
800
000
1
800
103
200

105
000



1
250
000
1
250
148
750
150
000


2
577
565
2
577
1
157
327

1
159
904


765
000

96
735

97
500




479
405

479
405




1
021
311

1
021
311


789
217

264
323

265
112





(10
095
878)
(10
095
878)



Balance
 December 31
 2013
116
852
093
116
852
32
895
380
(42
606
092)
(9
593
860)






49
600

49
600




56
779

56
779


616
667

81
883

82
500



3
433
334
3
433
499
067

502
500


2
038
000
2
038
138
562

140
600


2
917
000
2
917
347
083

350
000


2
040
000
2
040
252
960

255
000




40
537

40
537




830
891

830
891




114
091

114
091


876
765

120
506

121
383





680
811
680
811



Balance
 December 31
 2014
128
773
859

128
774

35
427
339

(41
925
281)

(6
369
168)














ZIVO BIOSCIENCE
 INC. AND SUBSIDIARIES

 Inc. and Subsidiaries)



















December 31



December 31











(10
095
878)

680
811




434
750
139
279


38
226
49
600


1
226
009
164
107


30
122
4
835


2
821
630



1
464
515
1
801
735


6
234



19
453
25
000



1
391
281


1
674
135
(8
418
982)


(19
110)





(63
421)
40
398


(118
467)
118
467


122
917



(455
432)
744
273


(27
837)



(235
000)



190
941
522
307


(2
986
213)
(2
736
046)




(331
377)



(331
377)




&nbsp;&nbsp;Proceeds from (payment of) loans payable
 related parties

141
015



(1
890)


2
904
408
1
369
700


859
500
735
500


3
763
547
2
244
325


445
957
(491
721)


47
147
493
104





493
104

1
383






























 INC. AND SUBSIDIARIES 

 Inc. and Subsidiaries)




For the Year Ended December 31
 2013


 2013
 the Company issued 21
111 shares of its common stock in return for a cashless exercise of 35
000 common stock warrants.


 2013
 the Company recorded $377
088 in discounts on 11% convertible debentures.


 2013
 $15
000 in Loans Payable - Related Party was transferred to Loans Payable - Other (HEP Investments
 LLC) pursuant to a Participation Agreement entered into by the two parties on March 18
 2013 (See Note 7 - Convertible Debt).


 2013
 the Company issued 1
191
182 shares of its common stock in return for the cashless exercise of 1
900
000 common stock warrants.


 2013
 the Company recorded $1
000
000 in discounts on 11% convertible debentures.


 2013
 the Company issued 600
000 shares of its common stock valued at $72
000 as consideration for payment of obligations to issue common stock.


 2013
 the Company issued 2
577
565 shares of its common stock valued at $1
159
904 for the purchase of patent applications pending from Essex Angel Capital (see Note 12).


 2013
 the Company recorded $968
000 in discounts on 11% convertible debentures.


 2013
 a significant shareholder converted $50
000 of 1% convertible debentures into 1
000
000 shares of the Company&#146;s common stock.


 2013
 $289
592 in Loans Payable &#150; Other (HEP Investments LLC and Venture Group
 LLC - See Note 7 - Convertible Debt) were converted to 11% convertible debentures.


 2013
 the Company issued 229
597 shares of its common stock in return for cashless exercises of 450
000 common stock warrants.


 2013
 a significant shareholder converted $55
000 of 1% convertible debentures into 800
000 shares of the Company&#146;s common stock.


 2013
 the Venture Group converted $150
000 of 11% convertible debentures into 1
250
000 shares of the Company&#146;s common stock.


 2013
 the Company recorded 648
663 in discounts on 11% convertible debentures.


 2013
 the Company established additional derivative liabilities of $5
335
976 consisting of unamortized debt discounts of $2
825
752 and finance costs valued at $2
510
224.

For the Year Ended December 31
 2014


 2014
 holders of 1% and 11% Convertible Debentures converted $420
000 into 3
867
000 shares of the Company&#146;s common stock. In addition
 as part of an exercise of common stock warrants
 a 1% convertible debenture holder applied $22
000 of accrued interest to the purchase price of 300
000 shares of the Company&#146;s common stock.


 2014
 holders of 1% Convertible Debentures converted $70
600 into 1
088
000 shares of the Company&#146;s common stock.







 2014
 the Company issued 416
667 shares of the Company&#146;s common stock in connection with a stock purchase consummated in December 2013.


 2014
 the Company issued 781
477 shares of the Company&#146;s common stock valued at $113
760 in connection with financings in the third quarter.


 2014
 the Company recorded $1
285
000 in discounts on 11% convertible debentures.


 2014
 the Company recorded $40
537 in discounts on 11% convertible debentures.


 2014
 the Company issued 95
288 shares of the Company&#146;s common stock valued at $7
623 in connection with financings in the fourth quarter.













 INC. AND SUBSIDIARIES 

 Inc. and Subsidiaries)





 Inc. (formerly known as Health Enhancement Products
 Inc.) and Subsidiaries (Health Enhancement Corporation
 HEPI Pharmaceuticals
 Inc.
 WellMetris
 LLC
 and Zivo Biologic
 Inc.) (collectively the &#147;Company&#148;) business models are as follows: 1) to derive future income from licensing and selling natural bioactive ingredients derived from their proprietary algae cultures to animal
 human and dietary supplement and medical food manufacturers (currently
 the Company's focus is on research and identification of its bioactive ingredients and is not currently selling its product commercially)
 and 2) developing
 manufacturing
 marketing
 and selling tests that the Company believes will allow people to optimize their health and identify future health risks.


 2014
 at the annual meeting of the Shareholders&#146; of the Company
 a proposal was passed to change the name of the Company from Health Enhancement Products
 Inc. to Zivo Bioscience
 Inc. &nbsp;On October 16
 2014
 the Amended Articles were filed with the State of Nevada. &nbsp;On November 7
 2014
 FINRA (Financial Industry Regulatory Authority) approved the name Zivo Bioscience
 Inc. for trading purposes. &nbsp;Effective November 10
 2014
 the Company began trading on the OTCQB under the symbol: ZIVO.






153
137 and $3
110
197 during the years ended December 31
 2014 and 2013
 respectively. In addition
 the Company had a working capital deficiency of $6
200
876 and a stockholders&#146; deficiency of $6
369
168 at December 31
 2014. These factors raise substantial doubt about the Company's ability to continue as a going concern.


 therefore
 have a material adverse effect on its business. Furthermore
 there can be no assurance that any such required funds
 if available
 will be available on attractive terms or that they will not have a significant dilutive effect on the Company&#146;s existing stockholders.




 either in the form of debt or equity or some combination thereof. &nbsp;There can be no assurances that the Company will be able to raise the additional funds it requires.


 2014
 the Company received:



500 from the sale of common stock and exercise of common stock warrants; and


369
700 from the issuance of convertible debt.


014 from loans from to related party loans.



&nbsp;The consolidated financial statements include the accounts of Zivo Bioscience
 Inc. and its wholly-owned Subsidiaries
 Health Enhancement Corporation
 HEPI Pharmaceuticals
 Inc.
 WellMetris
 LLC
 and Zivo Biologic
 Inc. All significant intercompany transactions and accounts have been eliminated in consolidation.






The Company&#146;s consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America
 which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
 at the date of the financial statements and reported amount of revenues and expenses during the reporting period. &nbsp;Actual results could differ from those estimates. &nbsp;Management uses its best judgment in valuing these estimates and may
 as warranted
 solicit external professional advice and other assumptions believed to be reasonable. &nbsp;&nbsp;

&nbsp;For the purpose of the statements of cash flows
 cash equivalents include time deposits
 certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. The Company maintains cash and cash equivalents balances at financial institutions and are insured by the Federal Deposit Insurance Corporation up to $250
000. At times
 balances in certain bank accounts may exceed the FDIC insured limits. Cash equivalents consist of highly liquid investments with an original maturity of three months or less when purchased. At December 31
 2014
 the Company did not have any cash equivalents.

Property and equipment consists of furniture and office equipment
 and are carried at cost less allowances for depreciation and amortization. Depreciation and amortization is determined by using the straight-line method over the estimated useful lives of the related assets
 generally five to seven years. &nbsp;Repair and maintenance costs that do not improve service potential or extend the economic life of an existing fixed asset are expensed as incurred.



The authoritative guidance for fair value measurements defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Market participants are buyers and sellers in the principal market that are (i)&nbsp;independent
 (ii)&nbsp;knowledgeable
 (iii)&nbsp;able to transact
 and (iv) willing to transact. The guidance describes a fair value hierarchy based on the levels of inputs
 of which the first two are considered observable and the last unobservable
 that may be used to measure fair value which are the following:



Level 2 &#150; Inputs other than Level&nbsp;1 that are observable
 either directly or indirectly
 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or corroborated by observable market data or substantially the full term of the assets or liabilities.




 accounts payable
 accrued expenses and loans payable - related parties. &nbsp;All of these items were determined to be Level 1 fair value measurements.


 prepaid expenses
 accounts payable
 accrued expenses
 loans payable - related parties and the current portion of convertible debt all approximate fair value because of the short maturity of these instruments. &nbsp;The recorded value of long-term convertible debt approximate fair value as the terms and rates approximate market rates.






835 and $30
122 for the years ended December 31
 2014 and 2013
 respectively.









 the Company recognizes revenue in accordance with Staff Accounting Bulletin No. 104
 &#147;Revenue Recognition&#148; (&#147;SAB No. 104&#148;)
 which superseded Staff Accounting Bulletin No. 101
 &#147;Revenue Recognition in Financial Statements&#148; (&#147;SAB No. 101&#148;). SAB No. 104 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&#146;s judgment regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers
 estimated returns and allowances
 and other adjustments will be provided for in the same period the related sales are recorded




 2014 and 2013 no shipping and handling costs were incurred.







 consisting of salaries and equipment and related expenses incurred for product research studies conducted primarily within the Company and by Company personnel. Research expenses were approximately $0 and $41
000 for the years ended December 31
 2014 and 2013
 respectively;



 consisting of fees
 charges
 and related expenses incurred in the conduct of clinical studies conducted with Company products by independent external entities. External clinical studies expenses were approximately $1
971
000 and $977
000 for the years ended December 31
 2014 and 2013
 respectively.






 2014 and 2013 were primarily attributable to net operating loss carry forwards. Since the Company has a history of losses
 and it is more likely than not that some portion or all of the deferred tax assets will not be realized
 a full valuation allowance has been established. In addition
 utilization of net operating loss carry-forwards are subject to a substantial annual limitation due to the &#147;change in ownership&#148; provisions of the Internal Revenue Code. The annual limitation may result in the expiration of net operating loss carry-forwards before utilization.




Under the provisions of FASB ASC 718
 stock-based compensation cost is estimated at the grant date based on the award&#146;s fair value and is recognized as expense over the requisite service period. &nbsp;The Company generally issues grants to its employees
 consultants and board members. &nbsp;At the date of grant
 the Company determines the fair value of the stock option award and recognizes compensation expense over the requisite service period. &nbsp;The fair value of the stock option or warrant award is calculated using the Black Scholes option pricing model.


 warrants were granted to employees
 directors and consultants of the Company. &nbsp;As a result of these grants
 the Company recorded compensation expense of $188
880 and $472
975 during the years ended December 31
 2014 and 2013 respectively.











Year Ended December 31






























 option-pricing models require the input of highly subjective assumptions
 including the expected stock price volatility. Because the Company&#146;s employee warrants have characteristics significantly different from those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimate
 in management&#146;s opinion the existing models may not necessarily provide a reliable single measure of the fair value of its employee options.




 2014
 consisted of 47
824
956 common shares from convertible debentures and related accrued interest and 9
053
005 common shares from outstanding warrants. Potentially dilutive securities as of December 31
 2013
 consisted of 36
290
424 common shares from convertible debentures and related accrued interest and 17
100
539 common shares from outstanding warrants. &nbsp;&nbsp;For 2013
 diluted and basic weighted average shares were the same
 as potentially dilutive shares are anti-dilutive.



Advertising/Public Relations costs are charged to operations when incurred. These expenses were approximately $116
000 and $27
000 for the years ended December 31
 2014 and 2013
 respectively.




000 at times during the year. &nbsp;








 the Financial Accounting Standards Board (&#147;FASB&#148;) issued Accounting Standards Update No. 2014-09 (ASU 2014-09)
ASU 2014-09 superseded the revenue recognition requirements in &#147;Revenue Recognition (Topic 605)&#148;
 and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflect the consideration to which the entity expects to be entitled to in exchange for those goods or services. &nbsp;ASU 2014-09 is effective for annual reporting periods beginning after December 15
 2016
 including interim periods within that reporting period. &nbsp;Early adoption is not permitted. ASU 2014-09 is not expected to have a material impact on the Company&#146;s financial position or results of operations.


 but not yet effective
 accounting standards been adopted in the current period










 2014 and 2013 consist of the following:




December 31



December 31











20
000

20
000



80
000

80
000









100
000

100
000&nbsp;



(31
250)

(6
250)









68
750

93
750




000 and $19
453 for the years ended December 31
 2014 and 2013
 respectively.




 2014
 the Company evaluated the circumstances related to the four Patent Applications Pending relating to the acquisition of asset of Wellness Indicators in August 2013. &nbsp;The Company has filed / drafted an additional eight patents applications around the intellectual property acquired. &nbsp;The Company has determined that the new patents applications redefine and protect its intellectual property better than the original purchased patent applications. &nbsp;As such
 the Company has abandoned the patent applications purchased and recorded a loss on abandonment of $1
391
281 for the year ended December 31
 2014.

NOTE 6 &#150; LOAN PAYABLE
 RELATED PARTIES


 2013
 Mr. Maggiore
 a significant shareholder
 advanced the Company a total of $462
000. &nbsp;As discussed in Note 7
 this amount was reclassified into convertible debt attributed to HEP Investments
 LLC
 of which Mr. Maggiore is a member. As of December 31
 2013
 there was no balance due to Mr. Maggiore.


 2014
 Mr. Maggiore advanced the Company $134
670. &nbsp;This amount remained unpaid as of December 31
 2014.


 Officers
 advanced the Company $6
344. &nbsp;These amounts remained unpaid as of December 31
 2014.



HEP Investments
 LLC &#150; Related Party


 2011
 the Company and HEP Investments
 LLC
 a Michigan limited liability company (&#147;Lender&#148;)
 entered into the following documents
 effective as of December 1
 2011
 as amended through December 1
 2014: (i) a Loan Agreement under which the Lender has agreed to advance up to $6
000
000 to the Company
 subject to certain conditions
 (ii) a Convertible Secured Promissory Note in the principal amount of $6
000
000 (&#147;Note&#148;) (of which $5
419
700 has been advanced as of December 31
 2014) &nbsp;and (iii) a Security Agreement
 under which the Company granted the Lender a security interest in all of its assets and (iv) an Intellectual Property security agreement under which the Company and its subsidiaries granted the Lender a security interest in all their respective intellectual properties
 including patents
 in each case order to secure their respective obligations to the Lender under the Note and related documents. &nbsp;In addition
 the Company&#146;s subsidiaries have guaranteed the Company&#146;s obligations under the Note. &nbsp;The Company has also made certain agreements with the Lender which shall remain in effect as long as any amount is outstanding under the Loan. &nbsp;These agreements include an agreement not to make any change in the Company&#146;s senior management
 without the prior written consent of the Lender. Two representatives of the Lender will have the right to attend Board of Director meetings as non-voting observers.







 2014 advanced under the Note (i) are convertible into the Company&#146;s restricted common stock according to the following schedule: (A) $84
700 at $.10 per share
 (B) $2
660
000 at $.12 per share
 (C) $1
285
000 at $.15 per share
 (D) $640
000 at $.22 per share
 and (E) $750
000 at $.30 per share
 (ii) bear interest at the rate of 11% per annum and (iii) must be repaid as follows: &nbsp;accrued interest must be paid on the first and second anniversary of the Note and unpaid principal not previously converted into common stock must be repaid on the second anniversary of the Note
 with the provision that the first Note of $500
000 due on December 1
 2013 was initially extended to June 1
 2014. &nbsp;As of December 31
 2014
 a total of $1
000
000 in $.12 convertible debt has become due. &nbsp;In July 2014
 the Lender agreed to rolling 30 day extensions until notice is given to the Company to the contrary. &nbsp;The Lender has not converted any of the debt through the date of this report. &nbsp;The Note may be prepaid upon sixty days written notice
 provided that the Company shall be required to pay a prepayment premium equal to 5% of the amount repaid. &nbsp;The Company determined that the modification of these Notes was not a substantial modification in accordance with ASC 470-50
 &#147;Modifications and Extinguishments.&#148;


 2013 advanced under the Note are convertible into the Company&#146;s restricted common stock according to the following schedule: (A) $2
660
000 at the lesser of $.12 per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market
 (B) $640
000 at the lesser of $.22 per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market
 and (C) $750
000 at the lesser of $.30 per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market.


 2014
 as discussed in Note 8 &#150; Derivative Liability
 in connection with the HEP Investments December 1
 2014 Fourth Amendment to Loan Agreement and the Fifth Amended and Restated Senior Secured Convertible Promissory Note amend the calculation of the conversion price for the convertible promissory note. Previously
 the outstanding principal and interest under the note had been convertible into shares of common stock at the lower of the stated price per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market. &nbsp;Following the amendment
 the convertible note is convertible into shares of common stock at the stated price per share conversion rate (eliminating the lower of 25% discount off of the ten day trailing quoted price of the common stock).


 2011
 the Lender had advanced the Company $600
000
 consisting of $500
000 in cash and $100
000 previously advanced by the Lender in connection with a transaction previously disclosed in a Current Report on Form 8-K dated September 12
 2011. &nbsp;&nbsp;The Lender has agreed to advance the remaining $1
400
000 in $250
000 increments (final increment of $150
000) upon request of the Company&#146;s CEO
 subject to satisfaction of certain conditions. &nbsp;In addition
 the Company has agreed to (i) issue the Lender warrants to purchase 1
666
667 shares of common stock at an exercise price of $.12 per share (including a cashless exercise provision)
 expiring September 30
 2016 and (ii) enter into a Registration Rights Agreement with respect to all the shares of common stock issuable to the Lender in connection with the Loan transaction
 in each case subject to completion of funding of the full $2
000
000 called for by the Loan Agreement.


000 against this transaction. &nbsp;In addition
 the Company recorded a derivative liability of $552
988. &nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. &nbsp;We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;volatility 151.45%
 annual rate of dividends 0% and a risk free interest rate of .27%. &nbsp;In addition
 the Company has recognized other income of $24
422 representing the change in fair value of this derivative liability. &nbsp;&nbsp;&nbsp;&nbsp;


 HEP Investments advanced the Company an additional $500
000 on which the Company recorded a debt discount in the amount of $500
000. This represents the future value of the stock to be issued under the terms of the convertible debt. We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: volatility of 140.93%-143.36%
 annual rate of dividends 0% and a risk free interest rate of .25%. In connection with the $500
000 in convertible notes
 the Company recorded non-cash finance charges of $16
575 during 2012.


 HEP Investments advanced the Company an additional $120
592. &nbsp;According to the terms of the agreement
 a threshold of $250
000 must be reached. &nbsp;Until this threshold is reached
 the differential of $184
592 is classified as Loan Payable &#150; Related Party (Note 6).


 2013
 the Company was advised of a Participation Agreement between HEP Investments and Christopher Maggiore
 a significant shareholder of the Company
 whereby Mr. Maggiore has become a member of HEP Investments
 LLC. Accordingly
 loans made by Mr. Maggiore to the Company aggregating $462
000 ($15
000 at December 31
 2012 and $447
000 during the period January 1
 2013 through March 5
 2013) have been reclassified as loans payable to HEP Investments pursuant to the previously disclosed agreement entered into on December 2
 2011 to invest up to $2
000
000 in convertible notes. Upon this reclassification
 HEP Investments reached a $500
000 threshold and these advances were converted to convertible debt. &nbsp;The Company recorded a debt discount in the amount of $377
088. This represents the future value of the stock to be issued under the terms of the convertible debt. We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: volatility of 160.96%
 annual rate of dividends 0% and a risk free interest rate of .25.







000
000 the Company was obligated pursuant to the terms of the Note to issue 1
666
667 of its common stock warrants
 exercisable at $.12 per share and expiring on September 30
 2016&nbsp;as well as 600
000 shares of its common stock. The common stock was valued at $192
000 based on a closing share price on April 15
 2013 of $.32 per share. The Company valued the 1
666
667 common stock warrants at $481
110 using the Black Scholes method of valuation using the following assumptions: &nbsp;exercise price of $.12
 a market value of $.32
 a remaining term of 3.46 years
 volatility of 148.44%
 annual rate of dividends of 0% and a risk free interest rate of 0.25%


 2013
 the Company and Lender
 entered into the following documents
 effective as of April 15
 2013: (i) First Amendment to Loan Agreement and (ii) an Amended and Restated Senior Secured Convertible Promissory Note. These agreements modified the term of agreements the Company entered into with HEP Investments on December 2
 2011 as discussed above. Pursuant to the terms of the modified agreements the Lender has agreed to advance up to a total of $3
750
000 and extend the due date of each Note
 based on a $250
000 tranche
 to two years from the date it was issued. The Company determined that the modification of the HEP Investments Loan Agreement was not a substantial modification in accordance with ASC 470-50
 &#147;Modifications and Extinguishments&#148;.


 2013
 the Lender had advanced the Company $2
707
592. &nbsp;&nbsp;Amounts advanced under the Note are (i) secured by all the Company&#146;s assets
 (ii) convertible into the Company&#146;s restricted common stock at the lesser of $.12 per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market and (iii) bear interest at the rate of 11% per annum.


 the Lender agreed to fund the remainder of the notes according to the following time lines:


 2013) in order for the Tranche to be convertible into the Company&#146;s restricted common stock at the lesser of $.12 per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market. &nbsp;&nbsp;If any amount less than $3 million is unfunded &nbsp;within &nbsp;the 20 day period
 then the Tranche in excess of $2 million is convertible into the Company&#146;s restricted common stock at the lesser of $.22 per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market. &nbsp;On August 1
 2013
 the Board of Directors authorized the Company to accept $281
000 received through May 10
 2013 of funding from HEP Investments with the conversion rate at $.12. &nbsp;


 2013 through September 30
 2013
 HEP Investments funded an additional $592
408. &nbsp;On August 1
 2013 and September 16
 2013 the Board of Directors authorized the Company to accept an additional $592
408 of funding from HEP Investments with the conversion rate at $.22. &nbsp;


 2013 and December 19
 2013 the Board of Directors authorized the Company to accept an additional $750
000 of funding from HEP Investments with the conversion rate at $.30. &nbsp;As of December 31
 2013
 HEP Investments has funded a total of $4.05 million ($2
707
592 to be converted at $.12
 $592
408 to be converted at $.22 and $750
000 to be converted at $.30).


 2013
 the Company and Lender
 entered into the Second Amendment to Loan Agreement effective as of December 16
 2013: This agreement modified the term of agreements the Company entered into with HEP Investments on December 2
 2011 as discussed above. Pursuant to the terms of the modified agreements the Lender has agreed to advance up to a total of $4
050
000. The Company determined that the modification of the HEP Investments Loan Agreement was not a substantial modification in accordance with ASC 470-50
 &#147;Modifications and Extinguishments&#148;.


 (ii) bear interest at the rate of 11% per annum and (iii) must be repaid as follows: accrued interest must be paid on the first and second anniversary of the $250
000 tranche and unpaid principal not previously converted into common stock must be repaid on the second anniversary of the Tranche (the Tranche of September 30
 2013 is funded at $300
000 with the same terms as described above). As of December 31
 2013
 there was accrued but unpaid interest due HEP Investments of $212
000 relating to $1
000
000 in investments that reached their first anniversaries between the fourth quarter of 2012 and the fourth quarter of 2013.







 2013
 HEP Investments advanced the Company an additional $971
000. &nbsp;HEP Investments has reached a $1
000
000 threshold (including monies advanced during the three months ended March 31
 2013) and these advances have been converted into convertible debt. &nbsp;The Company recorded a debt discount in the amount of $1
000
000. &nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. This stock was valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 151.37%-153.70%
 annual rate of dividends 0% and a risk free interest rates of 0.20-0.24%.


 2013
 HEP Investments advanced the Company an additional $592
408. &nbsp;HEP Investments has reached a $3
300
000 threshold (including monies advanced since September 2011) and these advances have been converted into convertible debt. &nbsp;The Company recorded a debt discount in the amount of $800
000 during the quarter ended September 30
 2013. &nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. This stock was valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 139.26%-147.03%
 annual rate of dividends 0% and a risk free interest rates of 0.33-0.34%.


 2013
 HEP Investments advanced the Company an additional $750
000. &nbsp;HEP Investments has reached a $4
050
000 threshold and these advances have been converted into convertible debt. &nbsp;The Company recorded a debt discount in the amount of $648
663 during the quarter ended December 31
 2013. &nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. This stock was valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 133.07%-134.91%
 annual rate of dividends 0% and a risk free interest rates of 0.33-0.4%.


 2013
 the first tranche of $500
000 11% Convertible Debenture became due. &nbsp;HEP Investments opted not to convert the debt into common stock and requested the Company extend the Tranche terms an additional 6 months. &nbsp;On March 17
 2014
 the Company and HEP Investments agreed to extend the terms of the 11% Convertible Debenture to June 1
 2014. &nbsp;The Company determined that the modification of the HEP Investments loan Agreement was not a substantial modification in accordance with ASC 470-50 &#147;Modifications and Extinguishments&#148;.


 2014
 HEP Investments advanced the Company an additional $1
285
000. &nbsp;HEP Investments has reached a $5
335
000 threshold (including monies advanced since September 2011) and these advances have been converted into convertible debt. &nbsp;The Company recorded a debt discount in the amount of $1
285
000 during the quarter ended September 30
 2014. &nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. This stock was valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 127.83%-135.08%
 annual rate of dividends 0% and a risk free interest rates of 0.48-0.59%.


 2014
 HEP Investments advanced the Company an additional $84
700. &nbsp;HEP Investments has reached a $5
419
700 balance (including monies advanced since September 2011) and these advances have been converted into convertible debt. &nbsp;The Company recorded a debt discount in the amount of $40
537 during the quarter ended December 31
 2014. &nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. This stock was valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 128.69%
 annual rate of dividends 0% and a risk free interest rates of 0.64%.

The Venture Group
 LLC


 2012
 the Company and The Venture Group
 LLC
 a Maryland limited liability company (&#147;Venture Group&#148;)
 entered into the following agreements
 effective as of January 26
 2012: (i) a Subscription Agreement under which the Lender has agreed to advance $500
000 to the Company
 as follows: &nbsp;$332
000 on January 26
 2012
 which advance has been made
 and $168
000 by February 3
 2012 (completed on July 22
 2013)
 (ii) a Subordinated Convertible Promissory Note in the principal amount of $500
000 (&#147;Note&#148;); and (iii) (a) a Security Agreement
 under which the Company granted the Lender a subordinated security interest in all of its assets and (b) an IP security agreement under which the Company granted the Lender a subordinated security interest in all its intellectual properties
 including patents
 to secure its obligations to the Lender under the Note and related documents. &nbsp;&nbsp;Amounts advanced under the Note are (i) secured on a subordinated basis by all the Company&#146;s assets
 (ii) convertible into the Company&#146;s restricted common stock at $.12 per share
 (iii) bear interest at the rate of 11% per annum (payable on the first and second anniversary of the Note (unless earlier paid off)
 in cash or stock
 at the Company&#146;s option)
 and (iv) unpaid principal not previously converted into common stock must be repaid on the second anniversary of the Note (January 27
 2014).







 the Company has agreed to issue the Lender warrants to purchase an aggregate of 833
333 shares of common stock at an exercise price of $.12 per share
 for a term of three years from January 27
 2012. &nbsp;The Warrants are issuable to the Lender pro rata based on the amount invested in relation to the total investment amount (about 166
667 warrants per $100
000 invested). Accordingly
 1) for the year ended December 31
 2012
 the Company recorded finance charges of $293
282 related to 553
112 warrants valued at $111
125 and excess finance charges of $182
157 relating to the $332
000 advanced as of that date; 2) for the year ended December 31
 2013
 the Company recorded finance charges of $108
390 related to 200
000 warrants. &nbsp;In addition
 the Company recorded excess finance charges of $311
405 relating to the issuance of 11% Convertible Debentures in the principal amount of $168
000. &nbsp;Amounts advanced under the Note are (i) secured on a subordinated basis by all the Company&#146;s assets
 (ii) convertible into the Company&#146;s restricted common stock at $.12 per share
 (iii) bear interest at the rate of 11% per annum (payable on the first and second anniversary of the Note (unless earlier paid off)
 in cash or stock
 at the Company&#146;s option)
 and (iv) unpaid principal not previously converted into common stock must be repaid on the second anniversary of the Note (January 27
 2014). 


 the Company has issued an additional 280
000
 3 year common stock warrants exercisable at $.12 per share valued at $108
390. &nbsp;The warrants were valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 150.98%
 annual rate of dividends 0% and a risk free interest rate of 0.32%
 pursuant to the terms of the Subscription Agreement and Subordinated Convertible Promissory Note dated January 26
 2012.


 2013
 the Venture Group converted $150
000 of the $500
000 convertible debenture into 1
250
000 shares of the Company&#146;s common stock. &nbsp;


 2014
 Venture Group converted the remaining $350
000 of the convertible debenture into 2
917
000 shares of the Company&#146;s common stock.




 2014
 the holders of $70
000 of 1% convertible debentures converted their debentures into 950
000 shares of the Company&#146;s common stock. &nbsp;On April 27
 2014
 the holders of $70
600 of 1% convertible debentures converted their debentures into 1
088
000 shares of the Company&#146;s common stock. &nbsp;


 2014
 the Company and the Note Holder and significant shareholder of the Company extended the remaining notes due for an additional six months. &nbsp;In September 2014
 the Lender agreed to rolling 30 day extensions until notice is given to the Company to the contrary. &nbsp;The Company determined that the modification of these Notes was not a substantial modification in accordance with ASC 470-50
 &#147;Modifications and Extinguishments.&#148;










December 31



December 31









1% Convertible notes payable
 net of unamortized discount of $0 &nbsp;and $5
546 respectively
 due at various dates ranging to April 2015 

240
000

375
054







11% Convertible note payable &#150; HEP Investments
 LLC
 a related party
 net of unamortized discount of $1
794
272 &nbsp;and $2
235
217 
 respectively
 due at various dates ranging from April 2015 to December 2016

3
625
428

1
814
783







11% Convertible note payable
 net of unamortized discount of $29
707 as of December 31
 2013



320
293



3
865
428

2
510
130



3
628
386

1
619
319









237
042

890
811




801
735 and $1
464
515 for the years ended December 31
 2014 and 2013
 respectively.









 2011 with HEP Investments
 LLC
 the Company recorded a derivative liability of $552
988. &nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. &nbsp;This derivative liability was valued utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.17
 expected volatility of 151.45% over the two year contractual life of the note
 an annual rate of dividends 0% and a risk free interest rate of .27%. &nbsp;In addition
 the Company has recognized other income of $24
422 representing the change in fair value of this derivative liability as of December 31
 2011. &nbsp;The derivative liability was marked to fair value at December 31
 2011 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.25
 a volatility of 151.49% over the remaining 1.92 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .25%.


 2012
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $496
375 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.29
 an expected volatility of 143.36% over the remaining 1.66 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .25%.


 2012
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $507
916 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.29
 an expected volatility of 140.93% over the remaining 1.57 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .25%.


 2012
 the Company valued the derivative liability at $1
026
128 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.19
 an expected volatility of 151.75% over the remaining 0.92 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .26%. The fair value of the derivative decreased by $506
729 which has been recorded in the statement of operations for the year ended December 31
 2012.


 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $377
088 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.22
 an expected volatility of 160.96% over the remaining 0.71 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .25%.


 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $616
040 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.35
 an expected volatility of 151.37% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .24%.


 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $518
756 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.30
 an expected volatility of 151.72% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .24%.


 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $856
410 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.47
 an expected volatility of 153.70% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .20%.


 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $916
028 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.50 an expected volatility of 153.46% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .22%.







 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $504
699 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.32 an expected volatility of 146.56% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .34%.


 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $418
790 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.46 an expected volatility of 147.03% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .32%.


 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $479
502 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.45 an expected volatility of 139.26% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .33%.


 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $214
525 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.37 an expected volatility of 134.91% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .33%.


 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $185
438 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.33 an expected volatility of 134.11% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .34%.


 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $248
701 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.42 an expected volatility of 133.07% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .39%.


 2013
 the Company valued the derivative liability at $8
036
239 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.39
 an expected volatility of 133.09% over the remaining contractual lives of the note ranging from 0.90-1.93 years
 an annual rate of dividends of 0%
 and a risk free rate of .38%. The fair value of the derivative increased by $1
674
135 which has been recorded in the statement of operations for the twelve months ended December 31
 2013.


 2014
 the Company valued the derivative liability at $2
671
529 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.17
 an expected volatility of 145.45% over the remaining 1.27 years contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .44%. The fair value of the derivative decreased by $6
135
458 which has been recorded in the statement of operations for the three months ended March 31
 2014. 


 2014
 the Company valued the derivative liability at $2
079
118 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.16
 an expected volatility of 135.6% over the remaining 1.04 years contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .47%. The fair value of the derivative decreased by $5
957
121 which has been recorded in the statement of operations for the six months ended June 30
 2014.


 2014
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $970
766 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.15 an expected volatility of 135.1% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .48%.







 2014
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $242
868 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.13 an expected volatility of 127.8% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .59%.


 2014
 the Company valued the derivative liability at $4
768
396 utilizing the Black-Scholes method of valuation using the following assumptions: &nbsp;closing stock price of $.13
 an expected volatility of 126.7% over the remaining 2.00 years contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .58%. The fair value of the derivative decreased by $4
481
478 which has been recorded in the statement of operations for the nine months ended September 30
 2014.


 2014
 as discussed in Note 7 &#150; Convertible Debt
 in connection with the HEP Investments December 1
 2014 Fourth Amendment to Loan Agreement and the Fifth Amended and Restated Senior Secured Convertible Promissory Note amend the calculation of the conversion price for the convertible promissory note. Previously
 the outstanding principal and interest under the note had been convertible into shares of common stock at the lower of the stated price per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market. &nbsp;Following the amendment
 the convertible note is convertible into shares of common stock at the fixed price per share conversion rate (eliminating the lower of 25% discount off of the ten day trailing quoted price of the common stock). &nbsp;The derivative was marked to market at December 1
 2014 and the balance of $830
891 was reclassified to Additional Paid-In Capital. &nbsp;




 &#147;Fair Value Measurements and Disclosures&#148;
 the following table represents the Company&#146;s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of December 31
 2014 and December 31
 2013:









December 31
 2014













December 31
 2013








8
036
239


8
036
239





&#148;
 2012.


 2014 and 2013.




December 31
 2014


December 31
 2013








8
036
239


1
026
128









1
213
634


5
335
976



(8
418
982)


1
674
135


(830
891)







8
036
239




 the December 1
 2014 amendment with HEP Investments eliminated the derivative liability.











 the Company granted warrants to purchase 50
000 shares of common stock to Philip M. Rice (CFO and a Director) in January
 2013
 at an exercise price of $.12 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter). &nbsp;The warrants were valued at $10
381 using the Black Scholes pricing model relying on the following assumptions: volatility 131.97%; annual rate of dividends 0%; discount rate 0.27%. &nbsp;In addition
 Mr. Rice will receive $10
000 for each annual term served
 paid quarterly.


 the Company granted warrants to purchase 50
000 shares of common stock to Thomas K. Cox in June
 2013
 at an exercise price of $.40 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter). &nbsp;The warrants were valued at $15
873 using the Black Scholes pricing model relying on the following assumptions: volatility 145.67%; annual rate of dividends 0%; discount rate 0.25%. &nbsp;In addition
 Mr. Cox will receive $10
000 for each annual term served
 paid quarterly.


 the Company granted warrants to purchase 50
000 shares of common stock to John B. Payne in July
 2013
 at an exercise price of $.38 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter). &nbsp;The warrants were valued at $17
187 using the Black Scholes pricing model relying on the following assumptions: volatility 143.37%; annual rate of dividends 0%; discount rate 0.25%. &nbsp;In addition
 Mr. Payne will receive $10
000 for each annual term served
 paid quarterly.


 the Company granted warrants to purchase 50
000 shares of common stock to John Gorman in November
 2013
 at an exercise price of $.36 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter). &nbsp;The warrants were valued at $14
053 using the Black Scholes pricing model relying on the following assumptions: volatility 141.53%; annual rate of dividends 0%; discount rate 0.33%. &nbsp;In addition
 Mr. Gorman will receive $10
000 for each annual term served
 paid quarterly. &nbsp;On August 19
 2014
 Mr. Gorman resigned from the board of directors.


 the Company granted warrants to purchase 50
000 shares of common stock to Philip M. Rice (CFO and a Director) in January
 2014
 at an exercise price of $.38 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter). &nbsp;The warrants were valued at $13
460 using the Black Scholes pricing model relying on the following assumptions: volatility 121.33%; annual rate of dividends 0%; discount rate 0.44%. &nbsp;In addition
 Mr. Rice will receive $10
000 for each annual term served
 paid quarterly.


 the Company granted warrants to purchase 50
000 shares of common stock to Thomas K. Cox in June
 2014
 at an exercise price of $.19 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter). &nbsp;The warrants were valued at $7
311 using the Black Scholes pricing model relying on the following assumptions: volatility 138.05%; annual rate of dividends 0%; discount rate 0.41%. &nbsp;In addition
 Mr. Cox will receive $10
000 for each annual term served
 paid quarterly.


 the Company granted warrants to purchase 50
000 shares of common stock to John B. Payne in July
 2014
 at an exercise price of $.14 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter). &nbsp;The warrants were valued at $4
876 using the Black Scholes pricing model relying on the following assumptions: volatility 118.27%; annual rate of dividends 0%; discount rate 0. 51%. &nbsp;In addition
 Mr. Payne will receive $10
000 for each annual term served
 paid quarterly.


 the Company granted warrants to purchase 50
000 shares of common stock to Nola E. Masterson in September
 2014
 at an exercise price of $.12 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter). &nbsp;The warrants were valued at $4
074 using the Black Scholes pricing model relying on the following assumptions: volatility 113.93%; annual rate of dividends 0%; discount rate 0.59%. &nbsp;In addition
 Ms. Masterson will receive $10
000 for each annual term served
 paid quarterly.







180 during the twelve months ended December 31
 2014
 representing the fees expensed and the value of the vested warrants described above.




 2013
 an investor received 21
111 shares as part of a cashless exercise of 35
000 common stock warrants that had an exercise price of $.10.


 2013
 investors received 1
191
181 shares as part of cashless exercises of 1
900
000 common stock warrants that had exercise prices at $.15. In addition the Company received proceeds of $85
000 from the exercise of 682
000 common stock warrants.


 2013
 upon completion of funding on a $2
000
000
 11% convertible debenture
 the Company issued 600
000 shares of its common stock valued at $192
000 and 1
666
667 common stock warrants valued at $481
110 using the Black Scholes method of valuation (see Note 8 &#150; Convertible Debt).


 2013
 the Company Board of Directors awarded its Chief Financial Officer 557
000
 5 year common stock warrants
 exercisable at $.25 per share. These warrants were valued at $250
640 using the Black Scholes valuation method of valuation using the following assumptions: &nbsp;closing stock price of $.46 an expected volatility of 194.14% a five year term
 an annual rate of dividends of 0%
 and a risk free rate of .25%. &nbsp;The Board of Directors resolution included quarterly 50
000
 5 year common stock warrants
 exercisable at $.25 per share. &nbsp;The Company issued 150
000 warrants for the 2nd
 3rd and 4th quarters of 2013. &nbsp;These warrants were valued at $46
115 using the Black Scholes valuation method of valuation using the following assumptions: &nbsp;closing stock price of $.25 to .46 an expected volatility of 138.68 to 194.11% a five year term
 an annual rate of dividends of 0%
 and a risk free rate of .23% to .31%.


 2013
 the Company Board of Directors granted a consultant to the Company 250
000
 5 year common stock warrants
 exercisable at $.33 per share. These warrants were valued at $87
510 using the Black Scholes valuation method of valuation using the following assumptions: &nbsp;closing stock price of $.36 an expected volatility of 190.15% a five year term
 an annual rate of dividends of 0%
 and a risk free rate of .25%.


 2013
 the company issued 280
000
 3 year common stock warrants
 exercisable at $.12 per share. These warrants were valued at $108
390 using the Black Scholes valuation method of valuation using the following assumptions: &nbsp;closing stock price of $.43 an expected volatility of 146.36% a three year term
 an annual rate of dividends of 0%
 and a risk free rate of .32%.


 2013
 the Company received proceeds of $548
000 from the issuance of 2
077
273 shares of common stock and the exercise of 50
000 common stock warrants.


 2013
 the Company issued 1
000
000 shares of its common stock upon conversion of $50
000 of 1% convertible debentures at $.05 per share.


 2013
 the Company issued 99
217 shares of its common stock valued at $40
802 and 858
936 common stock warrants valued at $356
304 using the Black Scholes method of valuation (see Note 7 &#150; Convertible Debt). We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 139.26%-147.03%
 annual rate of dividends 0% and a risk free interest rates of 0.33-0.34%.


 2013
 the Company issued 2
577
565 shares of its common stock valued at $1
159
904 for the purchase of assets from Essex Angel Capital (see below).


 2013
 the Company granted a consultant to the Company 56
256
 5 year common stock warrants
 exercisable at $.39 per share. These warrants were valued at $64
941 using the Black Scholes valuation method of valuation using the following assumptions: &nbsp;closing stock price of $.28 an expected volatility of 166.98% a five year term
 an annual rate of dividends of 0%
 and a risk free rate of .34%.


 2013
 the Company issued 229
597 shares of its common stock in return for cashless exercises of 450
000 common stock warrants that had exercise prices of $.15 and $.225.


 2013
 the Company issued 800
000 shares of its common stock upon conversion of $55
000 of 1% convertible debentures at $.05 to $.125 per share.







 2013
 the Company issued 1
250
000 shares of its common stock upon conversion of $150
000 of 11% convertible debentures at $.12 per share.


 2013
 the Company issued 90
000 shares of its common stock valued at $32
310 and 250
000 common stock warrants valued at $75
507 using the Black Scholes method of valuation (see Note 7 &#150; Convertible Debt). We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 142.88%-143.44%
 annual rate of dividends 0% and a risk free interest rates of 0.32-0.39%.


 2013
 the Company received proceeds of $256
500 from the issuance of 833
333 shares of common stock and the exercise of 33
000 common stock warrants.


 2014 Company issued 4
955
000 shares of common stock upon conversion of $490
600 of 1% and 11% convertible debentures. &nbsp;


 2014
 the Company received proceeds of $100
000 from the issuance of 500
000 shares of common stock and $255
000 from the exercise of 2
040
000 common stock warrants.


 2014 the Company issued 1
088
000 shares of common stock upon conversion of $70
600 of 1% convertible debentures. &nbsp;


 2014
 the Company received proceeds of $402
500 from the issuance of 2
516
667 shares of common stock and $48
750 from the exercise of 390
000 common stock warrants. The Company issued 416
667 shares of common stock to a non-related party shareholder relating to a stock purchase in December 2013.


 2014 the Company issued 500
000 shares of common stock valued at $64
500 to a non-related party for services rendered.


 2014 the Company issued 781
477 shares of its common stock valued at $113
760 and 856
667 common stock warrants valued at $108
212 using the Black Scholes method of valuation (see Note 7 &#150; Convertible Debt). We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 127.64%-134.94%
 annual rate of dividends 0% and a risk free interest rates of 0.48-0.49%.


 2014 the Company issued 116
667 shares of common stock valued at $17
500 and 500
000 common stock warrants valued at $34
302 using the Black Scholes method of valuation to a non-related party for services rendered. We valued the common stock warrants utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 117.65%
 annual rate of dividends 0% and a risk free interest rates of 0.49%. 


 2014 the Company issued 95
288 shares of its common stock valued at $7
623 and 84
700 common stock warrants valued at $5
879 using the Black Scholes method of valuation (see Note 7 &#150; Convertible Debt). We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 138.88%
 annual rate of dividends 0% and a risk free interest rates of 0.64%.




 2013
 the Company and Essex Angel Capital Inc. (&#147;Essex&#148;) entered into an Asset Purchase Agreement (previously disclosed in a Current Report on Form 8-K dated April 19
 2013). &nbsp;Essex held $1
350
000 in senior secured convertible debentures and secured convertible debentures in Wellness Indicators
 Inc. (&#147;Wellness&#148;)
 an Illinois based company. &nbsp;Essex
 along with other secured lenders held a total of $2
000
000 of secured debt. &nbsp;Essex foreclosed on certain assets
 consisting principally of intellectual property (the &#147;Assets&#148;)
 that secured Wellness&#146; obligation under the debentures. &nbsp;Upon the foreclosure and acquisition of all right
 title and interest in and to the Assets &nbsp;pursuant to its 1st perfected security interest in the Assets
 the Company purchased the Assets from Essex for $1
100
000
 paid in the common stock of the Company with each such share being issued at the lesser of (i) $0.31 per share; or (ii) a price equal to the weighted average price of said shares on the OTCBB for 20 consecutive trading days ending on the date of Closing (date of such closing being the &#147;Closing Date&#148;) plus a 20% premium amount.


 2013 (previously disclosed in a Current Report on Form 8-K dated August 20
 2013)
 the Company completed the acquisition from Essex of certain assets
 consisting principally of pending patents (the &#147;Assets&#148;) of Wellness. &nbsp;Essex held senior secured convertible debentures and secured convertible debentures in Wellness. &nbsp;Essex foreclosed and acquired all rights
 title and interest in and to the Assets pursuant to its 1st perfected security interest in the Assets.







100
000. &nbsp;$801
507 was paid in common stock with the remainder of $298
493 paid in cash. &nbsp;There were 2
577
565 shares of common stock issued
 valued at $0.31 per share. &nbsp;Based on the current market price of the stock at the time of issuance
 the Company recorded the 2
577
565 shares of common stock issued at $1
159
904. &nbsp;The Company also incurred an additional $32
884 in transaction costs
 for a total transaction cost of $1
491
281. &nbsp;The Company acquired both furniture and equipment
 along with 4 pending patents. &nbsp;The Company valued the furniture and equipment at $100
000 and the patent applications pending at $1
391
281. &nbsp;


 2014
 the Company evaluated the circumstances related to the four Patent Applications Pending relating to the acquisition of asset of Wellness Indicators in August 2013. &nbsp;The Company has filed / drafted an additional eight patents applications around the intellectual property acquired. &nbsp;The Company has determined that the new patents applications redefine and protect its intellectual property better than the original purchased patent applications. &nbsp;As such
 the Company has abandoned the patent applications purchased and recorded a loss on abandonment of $1
391
281 for the year ended December 31
 2014.




 the Company
 quarterly
 will issue warrants to purchase 50
000 shares of common stock to Philip M. Rice at the prevailing market price with a term of 5 years
 provided that the preceding quarterly and annual filings were submitted in a timely and compliant manner
 at which time such warrants would vest. &nbsp;On March 31
 2014 the Company issued warrants to purchase 50
000 shares of common stock at $.17. &nbsp;The warrants were valued at $13
460 using the Black Scholes pricing model relying on the following assumptions: volatility 128.35%; annual rate of dividends 0%; discount rate 0.44%. &nbsp;On May 14
 2014
 the Company issued warrants to purchase 50
000 shares of common stock at $.19. &nbsp;The warrants were valued at $6
756 using the Black Scholes pricing model relying on the following assumptions: volatility 121.96%; annual rate of dividends 0%; discount rate 0.47%. &nbsp;On August 14
 2014
 the Company issued warrants to purchase 50
000 shares of common stock at $.19. &nbsp;The warrants were valued at $4
828 using the Black Scholes pricing model relying on the following assumptions: volatility 116.72%; annual rate of dividends 0%; discount rate 0.42%. On November 14
 2014
 the Company issued warrants to purchase 50
000 shares of common stock at $.09. &nbsp;The warrants were valued at $3
664 using the Black Scholes pricing model relying on the following assumptions: volatility 117.69%; annual rate of dividends 0%; discount rate 0.54%. 








December 31
 2014

December 31
 2013























Outstanding
 beginning of year

16
900
539


16
365
209





3
149
700



4
820
330





(2
040
000)



(2
785
000)




(110
137)






(8
847
097)



(1
500
000)













Outstanding
 end of period

9
053
005


16
900
539












 2014 were as follows:











































































50
000





50
000





84
700




84
700




3
489
439




3
464
439






440
000





440
000






50
000





50
000






2
665
000





2
640
000






50
000





50
000






100
000





87
500






250
000





250
000






477
004





477
004






707
000





707
000






250
000





250
000






250
000





250
000






39
863





39
863






100
000





100
000






50
000





50
000



















9
053
005





8
990
505








 2013
 the Company entered into a Settlement Agreement and Mutual Release of all Claims (the &#147;Settlement Agreement&#148;) with Ceptazyme
 LLC (&#147;Ceptazyme&#148;) and Zus Health
 LLC (&#147;Zus Health&#148;) resolving claims the parties brought against one another in connection with a license agreement between the Company and Zus Health dated September 2
 2010 (the &#147;License Agreement&#148;). &nbsp;Under the terms of the Settlement Agreement
 the parties agreed to terminate the License Agreement and that no party would have any further obligations thereunder. &nbsp;No monetary consideration was exchanged in connection with the Settlement Agreement. &nbsp;As a result of this settlement
 the deferred revenue of $235
000 and customer deposits of $27
837 were recognized as other income.


 2014
 the Company settled a dispute with one of its vendors. &nbsp;The settlement agreement calls for the Company to make 10 payments of $6
250. &nbsp;If the payments are not made timely
 a total liability of $97
463 out of the gross amount recorded on the Company&#146;s books of $191
146 will be due. &nbsp;As a result of this settlement
 the difference of $93
683 is recognized as other income for the period ending September 30
 2014.


 2013
 the Company
 through its legal counsel
 sent a notice to the landlord at 7740 E. Evans
 Scottsdale
 AZ that it expected a timely return of the $118
466 security deposit. &nbsp;On June 14
 2013
 the landlord filed a Complaint in the State Court of Arizona that the Company owed the landlord in excess of $210
000 in damages in addition to the $118
466 security deposit related to the property at 7740 E. Evans
 Scottsdale
 AZ. The security deposit has been classified as a Miscellaneous Receivable since the second quarter of 2013. &nbsp;On July 24
 2014
 the Company settled the outstanding complaints and the $118
466 Miscellaneous Receivable was written off as other expense for the period ending September 30
 2014.












 Andrew Dahl
 is serving under the terms of an employment agreement dated
 December 16
 2011. Under the agreement Mr. Dahl serves as CEO for one year terms
 subject to automatic renewal
 unless either party terminates the Agreement on sixty days&#146;&#146; notice prior to the expiration of the term of the agreement. &nbsp;Mr. Dahl will be compensated as follows: &nbsp;he will receive an annual base salary of $240
000. &nbsp;In addition
 Mr. Dahl is entitled to monthly bonus compensation equal to 2% of the Company&#146;s revenue
 but only to the extent that such bonus amount exceeds his base salary for the month in question. &nbsp;In addition
 Mr. Dahl will be entitled to warrants having an exercise price of $.25 per share
 upon the attainment of specified milestones as follows: 1) Warrants for 500
000 shares upon identification of bio-active agents in the Company&#146;s product and filing of a patent with respect thereto
 2) Warrants for 500
000 shares upon entering into a business contract under which the Company receives at least $500
000 in cash payments
 3) Warrants for 1
000
000 shares upon the Company entering into a co-development agreement with a research company to develop &nbsp;medicinal or pharmaceutical applications (where the partner provides at least $2 million in cash or in-kind outlays)
 4) Warrants for 1
000
000 shares upon the Company entering into a co-development agreement for nutraceutical or dietary supplement applications (where the partner provides at least $2 million in cash or in-kind outlays)
 5) Warrants for 1
000
000 shares upon the Company entering into a pharmaceutical development agreement. &nbsp;As of December 30
 2014
 none of the milestones referred to had been achieved and there has been no notice of contract termination.




 which covers on the job injury.



WellMetris
 LLC


 2013
 the Company formed WellMetris
 LLC
 a Delaware Limited Liability Company for the purpose of developing
 manufacturing and marketing a non-invasive urinary wellness test. WellMetris is 100% owned by Zivo Bioscience
 Inc. &nbsp;As discussed in Note 11 &#150; Stockholder&#146;s Deficiency
 Purchase of Assets
 the Company bought the Assets of Wellness from Essex. &nbsp;Concurrently
 the Company transferred the Intellectual Property (patent applications pending) to WellMetris. &nbsp;As of December 31
 2014
 the Company evaluated the circumstances related to the Patent Applications Pending relating to the acquisition of asset of Wellness Indicators in August 2013. &nbsp;The Company has filed / drafted an additional eight patents applications around the intellectual property acquired. &nbsp;The Company has determined that the new patents applications redefine and protect its intellectual property better than the original purchased patent applications. &nbsp;As such
 the Company has abandoned the patent applications purchased and recorded a loss on abandonment of $1
391
281 for the year ended December 31
 2014.

Zivo Biologic
 Inc.


 2013
 the Company formed Zivo Biologic
 Inc.
 a Delaware Corporation
 for the purpose of manufacturing and commercialization of proprietary ingredients for non-medicinal animal health applications. Zivo Biologic is 100% owned by Zivo Bioscience
 Inc.






















uring the quarter ended September 30
 2013
 Mr. Maggiore a significant shareholder
 member of the Board of Directors of the Company and membership interest in HEP Investments
 subscribed to and paid for the acquisition for 454

 each Unit comprised of one share of common stock
 $.001 par value of the Company and warrants to purchase one-tenth (1/10) of one share of Common Stock (or 45
455 warrants total)
 at a per unit price of $.22 for an aggregate purchase price of $100
000.




 2014 the Company had available net-operating loss carry-forwards for Federal tax purposes of approximately $33
600
000
 which may be applied against future taxable income
 if any
 at various dates from 2014 through 2034. Certain significant changes in ownership of the Company may restrict the future utilization of these tax loss carry-forwards.


 2014 the Company had a deferred tax asset of approximately $13
400
000 representing the benefit of its net operating loss carry-forwards. The Company has not recognized the tax benefit because realization of the tax benefit is uncertain and thus a valuation allowance has been fully provided against the deferred tax asset. &nbsp;The difference between the Federal and State Statutory Rate of 40% and the Company&#146;s effective tax rate of 0% is due to a decrease in the valuation allowance of approximately $6
400
000 in 2014.




 2015 the Board of Directors reappointed Philip M. Rice II
 the Company&#146;s Chief Financial Officer
 as a director for a 1 year term. &nbsp;Mr. Rice received warrants to purchase 50
000 shares of common stock at an exercise price of $.09 per share for a term of three years
 vested at 12
500 per quarter. &nbsp;The terms of the appointment also includes a cash payment of $10
000. &nbsp;




 2014
 the Company received proceeds of $48
500 from the issuance of 970
000 shares of common stock.

CONVERTIBLE DEBT: HEP Investments
 LLC

During the period January 1
 2015 through April 3
 2015
 HEP Investments
 LLC
 a related party
 advanced the Company an additional $387
500.&nbsp; HEP Investments has reached a $5
807
200 balance (including monies advanced since September 2011) and these advances have been converted into convertible debt.&nbsp; The Company recorded a debt discount in the amount of $224
283 for the $387
500 transaction.&nbsp; This represents the future value of the stock to be issued under the terms of the convertible debt. This stock was valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 138.27%-139.02%
 annual rate of dividends 0% and a risk free interest rates of 0.55% to 0.63%.






















Articles of Incorporation of Health Enhancement Products
 Inc.
 as amended



Amendment to Articles of Incorporation of the Company
 dated July 24
 2012



Amended Articles of Incorporation dated October 16
 2014 for name change











Security Agreement with HEP Investments
 LLC ($100K loan) dated September 8
 2011



Senior Secured Note with HEP Investments
 LLC ($100K loan) dated September 8
 2011



Loan Agreement with HEP Investments
 LLC ($2M loan) dated December 2
 2011



Senior Secured Note with HEP Investments
 LLC ($2M loan) dated December 2
 2011



Security Agreement with HEP Investments
 LLC ($2M loan) dated December 2
 2011



IP Security Agreement with HEP Investments
 LLC ($2M loan) dated December 2
 2011



Investor Rights Agreement with Venture Group
 LLC ($500K loan) dated November 8
 2011



Subscription Agreement with Venture Group
 LLC ($500K loan) dated January 26
 2012



Subordinated Convertible Note with Venture Group
 LLC ($500K loan) dated January 27
 2012



Warrant Agreement with Venture Group
 LLC ($500K loan) dated January 26
 2012



Security Agreement with Venture Group
 LLC ($500K loan) dated January 26
 2012



Termination Agreement with Venture Group
 LLC ($500K loan) dated January 26
 2012 (terminating agreements with Venture Group
 LLC dated November 8
 2011)



Termination Agreement with Oxford Holdings
 LLC
 dated January 26
 2012



License Agreement between Zus Health LLC and the Company dated September 2
 2010



Lease Agreement between the Company and BCO
 LLC dated February 28
 2011



Employment Agreement with Andrew Dahl
 the Registrant&#146;s CEO



Employment Agreement with John Gorman
 the Registrant&#146;s EVP &#150; Operations



Amended and Restated Senior Secured Convertible Promissory Note and the First Amendment to Loan Agreement with HEP Investments
 LLC dated April 15
 2013



Asset Purchase Agreement with Essex Angel Capital Inc. dated April 15
 2013



Second Amendment to Loan Agreement with HEP Investments
 LLC dated December 16
 2013



Third Amendment to Loan Agreement with HEP Investments
 LLC dated March 17
 2014



Third Amendment to Loan Agreement with HEP Investments
 LLC dated July 1
 2014



Fourth Amended and Restated Senior Secured Convertible Promissory Note with HEP Investments
 LLC dated July 1
 2014



Change of Control Agreement dated August 10
 2014



Fourth Amendment to Loan Agreement with HEP Investments
 LLC dated December 1
 2014



Fifth Amended and Restated Senior Secured Convertible Promissory Note with HEP Investments
 LLC dated December 1
 2014











Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
 as amended



Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
 as amended















 2010 and incorporated herein by this reference.

 2013 and incorporated by this reference.







 2014 and incorporated by this reference.

 2010 and incorporated by this reference.

 2012 and incorporated by this reference.

 2012 and incorporated by this reference.

 2012 and incorporated by this reference.

 2012 and incorporated by this reference.

 2012 and incorporated by this reference.

 2012 and incorporated by this reference.

 2012 and incorporated by this reference.

 2012 and incorporated by this reference. 

 2012 and incorporated by this reference.

 2012 and incorporated by this reference.

 2012 and incorporated by this reference.

 2012 and incorporated by this reference.

 2012 and incorporated by this reference.

 2011 and incorporated by this reference.

 2011 and incorporated by this reference.

 2012 and incorporated by this reference.

 2012 and incorporated by this reference.

 2013 and incorporated by this reference.

 2013 and incorporated by this reference.

 2014 and incorporated by this reference.

 2014 and incorporated by this reference.

 2014 and incorporated by this reference.

 2014 and incorporated by this reference.

 2014 and incorporated by this reference.

 2014 and incorporated by this reference.

 2014 and incorporated by this reference.






























of the Securities Exchange Act of 1934
 as amended


 Andrew D. Dahl
 certify that:



 Inc. (the &#147;Company&#148;);



 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
 in light of the circumstances under which such statements were made
 not misleading with respect to the period covered by this report;



 the financial statements
 and other financial information included in this report
 fairly present in all material respects the financial condition
 results of operations and cash flows of the registrant as of
 and for
 the periods presented in this report;






 or caused such disclosure controls and procedures to be designed under our supervision
 to ensure the material information relating to the registrant
 including its consolidated subsidiaries
 is made known to us by others within those entities
 particularly through the period in which this report is being prepared;



 or caused such internal control over financial reporting to be designed under our supervision
 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;



 as of the end of the period covered by this report based on such evaluations
 and



 or is reasonably likely to materially affect
 the registrant&#146;s internal control over financial reporting; and



 based on our most recent evaluation of internal control over financial reporting
 to the registrant&#146;s auditors and the audit committee of registrant&#146;s board of directors (or persons performing the equivalent function):



 process
 summarize and report financial information; and



 whether or not material
 that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting.


 2015





























of the Securities Exchange Act of 1934
 as amended


 Philip M. Rice II certify that:


 Inc. (the &#147;Company&#148;);


 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
 in light of the circumstances under which such statements were made
 not misleading with respect to the period covered by this report;


 the financial statements
 and other financial information included in this report
 fairly present in all material respects the financial condition
 results of operations and cash flows of the registrant as of
 and for
 the periods presented in this report;





 or caused such disclosure controls and procedures to be designed under our supervision
 to ensure the material information relating to the registrant
 including its consolidated subsidiaries
 is made known to us by others within those entities
 particularly through the period in which this report is being prepared;



 or caused such internal control over financial reporting to be designed under our supervision
 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;



 as of the end of the period covered by this report based on such evaluations
 and



 or is reasonably likely to materially affect
 the registrant&#146;s internal control over financial reporting; and


 based on our most recent evaluation of internal control over financial reporting
 to the registrant&#146;s auditors and the audit committee of registrant&#146;s board of directors (or persons performing the equivalent function):



 process
 summarize and report financial information; and



 whether or not material
 that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting.



 2015






























(Subsections (a) and (b) of Section 1350

Chapter 63 of Title 18
 United States Code)


 Inc.
 a Nevada corporation (the &#147;Company&#148;)
 on Form 10-K for the year ended December 31
 2014 as filed with the Securities and Exchange Commission (the &#147;Report&#148;)
 I
 Andrew D. Dahl
 Chief Administrative Officer of the Company
 certify
 pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 18 U.S.C. Section 1350)
 that to the best of my knowledge and belief:






 in all material respects
 the financial condition and result of operations of the Company.


 2015






 INC. AND WILL BE RETAINED ZIVO BIOSCIENCE
 INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.




























(Subsections (a) and (b) of Section 1350

Chapter 63 of Title 18
 United States Code)


 Inc.
 a Nevada corporation (the &#147;Company&#148;)
 on Form 10-K for the period ended December 31
 2014 as filed with the Securities and Exchange Commission (the &#147;Report&#148;)
 I
 Philip M. Rice II
 Chief Accounting Officer of the Company
 certify
 pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 18 U.S.C. Section 1350)
 that to the best of my knowledge and belief:






 in all material respects
 the financial condition and result of operations of the Company.


 2015






 INC. AND WILL BE RETAINED BY ZIVO BIOSCIENCE
 INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.





















		xmlns:xsi=http://www.w3.org/2001/XMLSchema-instance
		xsi:schemaLocation=http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd
		xmlns:fil=http://www.heponline.com/20141231
		xmlns:link=http://www.xbrl.org/2003/linkbase
		xmlns:xlink=http://www.w3.org/1999/xlink
		xmlns:xbrldt=http://xbrl.org/2005/xbrldt








































		xmlns:xsi=http://www.w3.org/2001/XMLSchema-instance
		xsi:schemaLocation=http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd
		xmlns:fil=http://www.heponline.com/20141231
		xmlns:link=http://www.xbrl.org/2003/linkbase
		xmlns:xlink=http://www.w3.org/1999/xlink
		xmlns:xbrldt=http://xbrl.org/2005/xbrldt





















































































































































































































































































































































	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	


	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	

153
137 and $3
110
197 during the years ended December 31
 2014 and 2013
 respectively. In addition
 the Company had a working capital deficiency of $6
200
876 and a stockholders&amp;#146; deficiency of $6
369
168 at December 31
 2014. These factors raise substantial doubt about the Company&apos;s ability to continue as a going concern.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;There can be no assurance that sufficient funds required during the next year or thereafter will be generated from operations or that funds will be available from external sources such as debt or equity financings or other potential sources. The lack of additional capital resulting from the inability to generate cash flow from operations or to raise capital from external sources would force the Company to substantially curtail or cease operations and would
 therefore
 have a material adverse effect on its business. Furthermore
 there can be no assurance that any such required funds
 if available
 will be available on attractive terms or that they will not have a significant dilutive effect on the Company&amp;#146;s existing stockholders.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The Company is attempting to address its lack of liquidity by raising additional funds
 either in the form of debt or equity or some combination thereof. &amp;nbsp;There can be no assurances that the Company will be able to raise the additional funds it requires.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the year ended December 31
 2014
 the Company received:&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;ul type=&quot;disc&quot; style=&apos;margin-top:0cm&apos;&gt; &lt;li style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;received proceeds of $735
500 from&amp;nbsp;the sale of common stock and exercise of common stock warrants; and&lt;/font&gt;&lt;/li&gt; &lt;li style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;received proceeds of $1
369
700 from the issuance of convertible debt.&lt;/font&gt;&lt;/li&gt; &lt;li style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;received proceeds of $141


 Inc. and its wholly-owned Subsidiaries
 Health Enhancement Corporation
 HEPI Pharmaceuticals
 Inc.
 WellMetris
 LLC
 and Zivo Biologic
 Inc. All significant intercompany transactions and accounts have been eliminated in consolidation.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Accounting Estimates&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;-&amp;nbsp;&lt;/font&gt;&lt;/b&gt;&lt;font lang=&quot;EN-US&quot;&gt;The Company&amp;#146;s consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America
 which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
 at the date of the financial statements and reported amount of revenues and expenses during the reporting period. &amp;nbsp;Actual results could differ from those estimates. &amp;nbsp;Management uses its best judgment in valuing these estimates and may
 as warranted
 solicit external professional advice and other assumptions believed to be reasonable. &amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;-&lt;/font&gt;&lt;/b&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;For the purpose of the statements of cash flows
 cash equivalents include time deposits
 certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. The Company maintains cash and cash equivalents balances at financial institutions and are insured by the Federal Deposit Insurance Corporation up to $250
000. At times
 balances in certain bank accounts may exceed the FDIC insured limits. Cash equivalents consist of highly liquid investments with an original maturity of three months or less when purchased. At December 31
 2014
 the Company did not have any cash equivalents.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Property and Equipment&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&amp;#150;&amp;nbsp;&lt;/font&gt;&lt;/b&gt;&lt;font lang=&quot;EN-US&quot;&gt;Property and equipment consists of furniture and office equipment
 and are carried at cost less allowances for depreciation and amortization. Depreciation and amortization is determined by using the straight-line method over the estimated useful lives of the related assets
 generally five to seven years. &amp;nbsp;Repair and maintenance costs that do not improve service potential or extend the economic life of an existing fixed asset are expensed as incurred.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Fair Value Measurements&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot; style=&apos;background:white&apos;&gt;The authoritative guidance for fair value measurements defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Market participants are buyers and sellers in the principal market that are (i)&amp;nbsp;independent
 (ii)&amp;nbsp;knowledgeable
 (iii)&amp;nbsp;able to transact
 and (iv) willing to transact. The guidance describes a fair value hierarchy based on the levels of inputs
 of which the first two are considered observable and the last unobservable
 that may be used to measure fair value which are the following:&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot; style=&apos;background:white&apos;&gt;Level 1 &amp;#150; Quoted prices in active markets for identical assets or liabilities.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot; style=&apos;background:white&apos;&gt;Level 2 &amp;#150; Inputs other than Level&amp;nbsp;1 that are observable
 either directly or indirectly
 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or corroborated by observable market data or substantially the full term of the assets or liabilities.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot; style=&apos;background:white&apos;&gt;Level&amp;nbsp;3 &amp;#150; Unobservable inputs that are supported by little or no market activity and that are significant to the value of the assets or liabilities.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The Company&amp;#146;s financial instruments include cash and cash equivalents
 accounts payable
 accrued expenses and loans payable - related parties. &amp;nbsp;All of these items were determined to be Level 1 fair value measurements.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The carrying amounts of cash
 prepaid expenses
&amp;nbsp;accounts payable
 accrued expenses
 loans payable - related parties and the current portion of convertible debt all approximate fair value because of the short maturity of these instruments.&amp;nbsp; The recorded value of long-term convertible debt approximate fair value as the terms and rates approximate market rates.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The Company considers derivative liabilities to be a Level 3 fair value measurement.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Deferred Financing Costs&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The Company follows authoritative guidance for accounting for financing costs as it relates to convertible debt issuance cost. &amp;nbsp;These costs are deferred and amortized over the term of the debt period or until redemption of the convertible debentures. &amp;nbsp;Amortization of deferred financing costs amounted to $4
835 and $30
122 for the years ended December 31
 2014 and 2013
 respectively.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Revenue Recognition&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;For revenue from product sales
 the Company recognize revenue in accordance with Staff Accounting Bulletin No. 104
 &amp;#147;Revenue Recognition&amp;#148; (&amp;#147;SAB No. 104&amp;#148;)
 which superseded Staff Accounting Bulletin No. 101
 &amp;#147;Revenue Recognition in Financial Statements&amp;#148; (&amp;#147;SAB No. 101&amp;#148;). SAB No. 104 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&amp;#146;s judgment regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers
 estimated returns and allowances
 and other adjustments will be provided for in the same period the related sales are recorded&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Shipping and Handling Costs&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Shipping and handling costs are expensed as incurred. For the years ended December 31
 2014 and 2013 no shipping and handling costs were incurred.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;Research and Development&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Research and development costs are expensed as incurred. The Company accounts for research and development expenses under two main categories:&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;ul type=&quot;disc&quot; style=&apos;margin-top:0cm&apos;&gt; &lt;li style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Research Expenses
 consisting of salaries and equipment and related expenses incurred for product research studies conducted primarily within the Company and by Company personnel. Research expenses were approximately $0 and $41
000 for the years ended December 31
 2014 and 2013
 respectively;&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;ul type=&quot;disc&quot; style=&apos;margin-top:0cm&apos;&gt; &lt;li style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Clinical Studies Expenses
 consisting of fees
 charges
 and related expenses incurred in the conduct of clinical studies conducted with Company products by independent external entities. External clinical studies expenses were approximately $1
971
000 and $977
000 for the years ended December 31
 2014 and 2013
 respectively.&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Income Taxes&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The Company follows the authoritative guidance for accounting for income taxes. Deferred income taxes are determined using the asset and liability method. &amp;nbsp;Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The tax effects of temporary differences that gave rise to the deferred tax assets and deferred tax liabilities at December 31
 2014 and 2013 were primarily attributable to net operating loss carry forwards. Since the Company has a history of losses
 and it is more likely than not that some portion or all of the deferred tax assets will not be realized
 a full valuation allowance has been established. In addition
 utilization of net operating loss carry-forwards are subject to a substantial annual limitation due to the &amp;#147;change in ownership&amp;#148; provisions of the Internal Revenue Code. The annual limitation may result in the expiration of net operating loss carry-forwards before utilization.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Stock Based Compensation&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;We account for stock-based compensation in accordance with FASB ASC 718
&amp;nbsp;&lt;i&gt;Compensation &amp;#150; Stock Compensation. &amp;nbsp;&lt;/i&gt;Under the provisions of FASB ASC 718
 stock-based compensation cost is estimated at the grant date based on the award&amp;#146;s fair value and is recognized as expense over the requisite service period. &amp;nbsp;The Company generally issues grants to its employees
 consultants and board members. &amp;nbsp;At the date of grant
 the Company determines the fair value of the stock option award and recognizes compensation expense over the requisite service period. &amp;nbsp;The fair value of the stock option or warrant award is calculated using the Black Scholes option pricing model.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During 2014 and 2013
 warrants were granted to employees
 directors and consultants of the Company. &amp;nbsp;As a result of these grants
 the Company recorded compensation expense of $188
880 and $472
975 during the years ended December 31
 2014 and 2013 respectively.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The fair value of warrants was estimated on the date of grant using the Black-Scholes option-pricing model based on the following weighted average assumptions:&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;163&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:122.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;258&quot; colspan=&quot;3&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:193.5pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Year Ended December 31
&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;163&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:122.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;126&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:94.5pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;117&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:87.75pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;163&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:122.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Expected volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;126&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:94.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;113.93% to 138.05%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;117&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:87.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;131.97% to 194.14%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;163&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:122.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Expected dividends&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;126&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:94.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;117&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:87.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;163&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:122.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Expected term&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;126&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:94.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3 to 5 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;117&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:87.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3 to 5 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;163&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:122.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Risk free rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;126&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:94.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;.41% to .59%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;117&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:87.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;.25% to .34%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The Black-Scholes option-pricing model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition
 option-pricing models require the input of highly subjective assumptions
 including the expected stock price volatility. Because the Company&amp;#146;s employee warrants have characteristics significantly different from those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimate
 in management&amp;#146;s opinion the existing models may not necessarily provide a reliable single measure of the fair value of its employee options.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Income (Loss) Per Share&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Basic income (loss) per share is computed by dividing the Company&amp;#146;s net income (loss) by the weighted average number of common shares outstanding during the period presented. Diluted income (loss) per share is based on the treasury stock method and includes the effect from potential issuance of common stock such as shares issuable pursuant to the exercise of warrants and conversions of debentures. &amp;nbsp;Potentially dilutive securities as of December 31
 2014
 consisted of 47
824
956 common shares from convertible debentures and related accrued interest and 9
053
005 common shares from outstanding warrants. Potentially dilutive securities as of December 31
 2013
 consisted of 36
290
424 common shares from convertible debentures and related accrued interest and 17
100
539 common shares from outstanding warrants. &amp;nbsp;&amp;nbsp;For 2013
 diluted and basic weighted average shares were the same
 as potentially dilutive shares are anti-dilutive.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Advertising / Public Relations Costs&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Advertising/Public Relatio&lt;/font&gt;&lt;font lang=&quot;EN-US&quot;&gt;ns costs are charged to operations when incurred. These expenses were approximately $116
000 and $27
000 for the years ended December 31
 2014 and 2013
 respectively.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Concentrations of Credit Risk&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. &amp;nbsp;The Company has historically maintained cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation (&amp;#147;FDIC&amp;#148;) limit of $250
000 at times during the year. &amp;nbsp;&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Reclassifications&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Certain items in these consolidated financial statements have been reclassified to conform to the current period presentation.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;u&gt;&lt;font lang=&quot;EN-US&quot;&gt;Future Impact of Recently Issued Accounting Standards&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;In May 2014
 the Financial Accounting Standards Board (&amp;#147;FASB&amp;#148;) issued Accounting Standards Update No. 2014-09 (ASU 2014-09)
 &amp;#147;&lt;i&gt;Revenue from Contracts with Customers.&lt;/i&gt;&amp;#148;&lt;i&gt;&amp;nbsp;&lt;/i&gt;ASU 2014-09 superseded the revenue recognition requirements in &amp;#147;Revenue Recognition (Topic 605)&amp;#148;
 and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflect the consideration to which the entity expects to be entitled to in exchange for those goods or services.&amp;nbsp; ASU 2014-09 is effective for annual reporting periods beginning after December 15
 2016
 including interim periods within that reporting period.&amp;nbsp; Early adoption is not permitted. ASU 2014-09 is not expected to have a material impact on the Company&amp;#146;s financial position or results of operations.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Management does not believe there would have been a material effect on the accompanying financial statements had any other recently issued
 but not yet effective


 2014 and 2013 consist of the following:&lt;/font&gt;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt; &lt;tr&gt; &lt;td width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt;&lt;/td&gt; &lt;td width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt;&lt;/td&gt; &lt;td width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;108&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;108&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Furniture &amp;amp; fixtures&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;20
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;20
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;80
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;80
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;100
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;100
000&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Less accumulated depreciation and amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(31
250)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(6
250)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;68
750&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;93
750&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Depreciation and amortization was $25
000 and $19
453 for the years ended December 31
 2014 and 2013


 LLC &amp;#150; Related Party&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On December 2
 2011
 the Company and HEP Investments
 LLC
 a Michigan limited liability company (&amp;#147;Lender&amp;#148;)
 entered into the following documents
 effective as of December 1
 2011
 as amended through December 1
 2014: (i) a Loan Agreement under which the Lender has agreed to advance up to $6
000
000 to the Company
 subject to certain conditions
 (ii) a Convertible Secured Promissory Note in the principal amount of $6
000
000 (&amp;#147;Note&amp;#148;) (of which $5
419
700 has been advanced as of December 31
 2014) &amp;nbsp;and (iii) a Security Agreement
 under which the Company granted the Lender a security interest in all of its assets and (iv) an Intellectual Property security agreement under which the Company and its subsidiaries granted the Lender a security interest in all their respective intellectual properties
 including patents
 in each case order to secure their respective obligations to the Lender under the Note and related documents. &amp;nbsp;In addition
 the Company&amp;#146;s subsidiaries have guaranteed the Company&amp;#146;s obligations under the Note.&amp;nbsp; The Company has also made certain agreements with the Lender which shall remain in effect as long as any amount is outstanding under the Loan.&amp;nbsp; These agreements include an agreement not to make any change in the Company&amp;#146;s senior management
 without the prior written consent of the Lender. Two representatives of the Lender will have the right to attend Board of Director meetings as non-voting observers.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Amounts as of December 31
 2014 advanced under the Note (i) are convertible into the Company&amp;#146;s restricted common stock according to the following schedule: (A) $84
700 at $.10 per share
 (B) $2
660
000 at $.12 per share
 (C) $1
285
000 at $.15 per share
 (D) $640
000 at $.22 per share
 and (E) $750
000 at $.30 per share
 (ii) bear interest at the rate of 11% per annum and (iii) must be repaid as follows:&amp;nbsp; accrued interest must be paid on the first and second anniversary of the Note and unpaid principal not previously converted into common stock must be repaid on the second anniversary of the Note
 with the provision that the first Note of $500
000 due on December 1
 2013 was initially extended to June 1
 2014.&amp;nbsp; As of December 31
 2014
 a total of $1
000
000 in $.12 convertible debt has become due.&amp;nbsp; In July 2014
 the Lender agreed to rolling 30 day extensions until notice is given to the Company to the contrary.&amp;nbsp; The Lender has not converted any of the debt through the date of this report.&amp;nbsp; The Note may be prepaid upon sixty days written notice
 provided that the Company shall be required to pay a prepayment premium equal to 5% of the amount repaid.&amp;nbsp; The Company determined that the modification of these Notes was not a substantial modification in accordance with ASC 470-50
 &amp;#147;Modifications and Extinguishments.&amp;#148;&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Amounts as of December 31
 2013 advanced under the Note are convertible into the Company&amp;#146;s restricted common stock according to the following schedule: (A) $2
660
000 at the lesser of $.12 per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market
 (B) $640
000 at the lesser of $.22 per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market
 and (C) $750
000 at the lesser of $.30 per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On December 1
 2014
 as discussed in Note 8 &amp;#150; Derivative Liability
 in connection with the HEP Investments December 1
 2014 Fourth Amendment to Loan Agreement and the Fifth Amended and Restated Senior Secured Convertible Promissory Note amend the calculation of the conversion price for the convertible promissory note. Previously
 the outstanding principal and interest under the note had been convertible into shares of common stock at the lower of the stated price per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market.&amp;nbsp; Following the amendment
 the convertible note is convertible into shares of common stock at the stated price per share conversion rate (eliminating the lower of 25% discount off of the ten day trailing quoted price of the common stock).&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;As of December 5
 2011
 the Lender had advanced the Company $600
000
 consisting of $500
000 in cash and $100
000 previously advanced by the Lender in connection with a transaction previously disclosed in a Current Report on Form 8-K dated September 12
 2011. &amp;nbsp;&amp;nbsp;The Lender has agreed to advance the remaining $1
400
000 in $250
000 increments (final increment of $150
000) upon request of the Company&amp;#146;s CEO
 subject to satisfaction of certain conditions. &amp;nbsp;In addition
 the Company has agreed to (i) issue the Lender warrants to purchase 1
666
667 shares of common stock at an exercise price of $.12 per share (including a cashless exercise provision)
 expiring September 30
 2016 and (ii) enter into a Registration Rights Agreement with respect to all the shares of common stock issuable to the Lender in connection with the Loan transaction
 in each case subject to completion of funding of the full $2
000
000 called for by the Loan Agreement.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The Company recorded a debt discount of $500
000 against this transaction. &amp;nbsp;In addition
 the Company recorded a derivative liability of $552
988. &amp;nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. &amp;nbsp;We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;volatility 151.45%
 annual rate of dividends 0% and a risk free interest rate of .27%. &amp;nbsp;In addition
 the Company has recognized other income of $24
422 representing the change in fair value of this derivative liability. &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During 2012
 HEP Investments advanced the Company an additional $500
000 on which the Company recorded a debt discount in the amount of $500
000. This represents the future value of the stock to be issued under the terms of the convertible debt. We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: volatility of 140.93%-143.36%
 annual rate of dividends 0% and a risk free interest rate of .25%. In connection with the $500
000 in convertible notes
 the Company recorded non-cash finance charges of $16
575 during 2012.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the fourth quarter of 2012
 HEP Investments advanced the Company an additional $120
592. &amp;nbsp;According to the terms of the agreement
 a threshold of $250
000 must be reached. &amp;nbsp;Until this threshold is reached
 the differential of $184
592 is classified as Loan Payable &amp;#150; Related Party (Note 6).&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On March 18
 2013
 the Company was advised of a Participation Agreement between HEP Investments and Christopher Maggiore
 a significant shareholder of the Company
 whereby Mr. Maggiore has become a member of HEP Investments
 LLC. Accordingly
 loans made by Mr. Maggiore to the Company aggregating $462
000 ($15
000 at December 31
 2012 and $447
000 during the period January 1
 2013 through March 5
 2013) have been reclassified as loans payable to HEP Investments pursuant to the previously disclosed agreement entered into on December 2
 2011 to invest up to $2
000
000 in convertible notes. Upon this reclassification
 HEP Investments reached a $500
000 threshold and these advances were converted to convertible debt. &amp;nbsp;The Company recorded a debt discount in the amount of $377
088. This represents the future value of the stock to be issued under the terms of the convertible debt. We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: volatility of 160.96%
 annual rate of dividends 0% and a risk free interest rate of .25.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Upon reaching a funding level of $2
000
000 the Company was obligated pursuant to the terms of the Note to issue 1
666
667 of its common stock warrants
 exercisable at $.12 per share and expiring on September 30
 2016&amp;nbsp;as well as 600
000 shares of its common stock. The common stock was valued at $192
000 based on a closing share price on April 15
 2013 of $.32 per share. The Company valued the 1
666
667 common stock warrants at $481
110 using the Black Scholes method of valuation using the following assumptions: &amp;nbsp;exercise price of $.12
 a market value of $.32
 a remaining term of 3.46 years
 volatility of 148.44%
 annual rate of dividends of 0% and a risk free interest rate of 0.25%&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On April 16
 2013
 the Company and Lender
 entered into the following documents
 effective as of April 15
 2013: (i) First Amendment to Loan Agreement and (ii) an Amended and Restated Senior Secured Convertible Promissory Note. These agreements modified the term of agreements the Company entered into with HEP Investments on December 2
 2011 as discussed above. Pursuant to the terms of the modified agreements the Lender has agreed to advance up to a total of $3
750
000 and extend the due date of each Note
 based on a $250
000 tranche
 to two years from the date it was issued. The Company determined that the modification of the HEP Investments Loan Agreement was not a substantial modification in accordance with ASC 470-50
 &amp;#147;Modifications and Extinguishments&amp;#148;.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;As of April 16
 2013
 the Lender had advanced the Company $2
707
592. &amp;nbsp;&amp;nbsp;Amounts advanced under the Note are (i) secured by all the Company&amp;#146;s assets
 (ii) convertible into the Company&amp;#146;s restricted common stock at the lesser of $.12 per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market and (iii) bear interest at the rate of 11% per annum.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Under the terms of the First Amendment to Loan Agreement and the Amended and Restated Senior Secured Convertible Promissory Note
 the Lender agreed to fund the remainder of the notes according to the following time lines:&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The tranche between $2 million and $3 million must be funded within 20 days of the execution of the Note (April 15
 2013) in order for the Tranche to be convertible into the Company&amp;#146;s restricted common stock at the lesser of $.12 per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market. &amp;nbsp;&amp;nbsp;If any amount less than $3 million is unfunded &amp;nbsp;within &amp;nbsp;the 20 day period
 then the Tranche in excess of $2 million is convertible into the Company&amp;#146;s restricted common stock at the lesser of $.22 per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market. &amp;nbsp;On August 1
 2013
 the Board of Directors authorized the Company to accept $281
000 received through May 10
 2013 of funding from HEP Investments with the conversion rate at $.12. &amp;nbsp;&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The tranche between $3 million and $3.75 million must be funded within 90 days of the execution of the Note and is convertible into the Company&amp;#146;s restricted common stock at the lesser of $.22 per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market. &amp;nbsp;From the period July 1
 2013 through September 30
 2013
 HEP Investments funded an additional $592
408. &amp;nbsp;On August 1
 2013 and September 16
 2013 the Board of Directors authorized the Company to accept an additional $592
408 of funding from HEP Investments with the conversion rate at $.22. &amp;nbsp;&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On October 25
 2013 and December 19
 2013 the Board of Directors authorized the Company to accept an additional $750
000 of funding from HEP Investments with the conversion rate at $.30. &amp;nbsp;As of December 31
 2013
 HEP Investments has funded a total of $4.05 million ($2
707
592 to be converted at $.12
 $592
408 to be converted at $.22 and $750
000 to be converted at $.30).&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On December 16
 2013
 the Company and Lender
 entered into the Second Amendment to Loan Agreement effective as of December 16
 2013: This agreement modified the term of agreements the Company entered into with HEP Investments on December 2
 2011 as discussed above. Pursuant to the terms of the modified agreements the Lender has agreed to advance up to a total of $4
050
000. The Company determined that the modification of the HEP Investments Loan Agreement was not a substantial modification in accordance with ASC 470-50
 &amp;#147;Modifications and Extinguishments&amp;#148;.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Amounts advanced under the Note continue to be &amp;nbsp;(i) secured by all the Company&amp;#146;s assets
 (ii) bear interest at the rate of 11% per annum and (iii) must be repaid as follows: accrued interest must be paid on the first and second anniversary of the $250
000 tranche and unpaid principal not previously converted into common stock must be repaid on the second anniversary of the Tranche (the Tranche of September 30
 2013 is funded at $300
000 with the same terms as described above). As of December 31
 2013
 there was accrued but unpaid interest due HEP Investments of $212
000 relating to $1
000
000 in investments that reached their first anniversaries between the fourth quarter of 2012 and the fourth quarter of 2013.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended June 30
 2013
 HEP Investments advanced the Company an additional $971
000. &amp;nbsp;HEP Investments has reached a $1
000
000 threshold (including monies advanced during the three months ended March 31
 2013) and these advances have been converted into convertible debt. &amp;nbsp;The Company recorded a debt discount in the amount of $1
000
000. &amp;nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. This stock was valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 151.37%-153.70%
 annual rate of dividends 0% and a risk free interest rates of 0.20-0.24%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended September 30
 2013
 HEP Investments advanced the Company an additional $592
408. &amp;nbsp;HEP Investments has reached a $3
300
000 threshold (including monies advanced since September 2011) and these advances have been converted into convertible debt. &amp;nbsp;The Company recorded a debt discount in the amount of $800
000 during the quarter ended September 30
 2013. &amp;nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. This stock was valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 139.26%-147.03%
 annual rate of dividends 0% and a risk free interest rates of 0.33-0.34%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended December 31
 2013
 HEP Investments advanced the Company an additional $750
000. &amp;nbsp;HEP Investments has reached a $4
050
000 threshold and these advances have been converted into convertible debt. &amp;nbsp;The Company recorded a debt discount in the amount of $648
663 during the quarter ended December 31
 2013. &amp;nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. This stock was valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 133.07%-134.91%
 annual rate of dividends 0% and a risk free interest rates of 0.33-0.4%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;As of December 1
 2013
 the first tranche of $500
000 11% Convertible Debenture became due. &amp;nbsp;HEP Investments opted not to convert the debt into common stock and requested the Company extend the Tranche terms an additional 6 months. &amp;nbsp;On March 17
 2014
 the Company and HEP Investments agreed to extend the terms of the 11% Convertible Debenture to June 1
 2014. &amp;nbsp;The Company determined that the modification of the HEP Investments loan Agreement was not a substantial modification in accordance with ASC 470-50 &amp;#147;Modifications and Extinguishments&amp;#148;.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended September 30
 2014
 HEP Investments advanced the Company an additional $1
285
000. &amp;nbsp;HEP Investments has reached a $5
335
000 threshold (including monies advanced since September 2011) and these advances have been converted into convertible debt. &amp;nbsp;The Company recorded a debt discount in the amount of $1
285
000 during the quarter ended September 30
 2014. &amp;nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. This stock was valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 127.83%-135.08%
 annual rate of dividends 0% and a risk free interest rates of 0.48-0.59%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended December 31
 2014
 HEP Investments advanced the Company an additional $84
700. &amp;nbsp;HEP Investments has reached a $5
419
700 balance (including monies advanced since September 2011) and these advances have been converted into convertible debt. &amp;nbsp;The Company recorded a debt discount in the amount of $40
537 during the quarter ended December 31
 2014. &amp;nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. This stock was valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 128.69%
 annual rate of dividends 0% and a risk free interest rates of 0.64%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;The Venture Group
 LLC&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On January 27
 2012
 the Company and The Venture Group
 LLC
 a Maryland limited liability company (&amp;#147;Venture Group&amp;#148;)
 entered into the following agreements
 effective as of January 26
 2012: (i) a Subscription Agreement under which the Lender has agreed to advance $500
000 to the Company
 as follows:&amp;nbsp; $332
000 on January 26
 2012
 which advance has been made
 and $168
000 by February 3
 2012 (completed on July 22
 2013)
 (ii) a Subordinated Convertible Promissory Note in the principal amount of $500
000 (&amp;#147;Note&amp;#148;); and (iii) (a) a Security Agreement
 under which the Company granted the Lender a subordinated security interest in all of its assets and (b) an IP security agreement under which the Company granted the Lender a subordinated security interest in all its intellectual properties
 including patents
 to secure its obligations to the Lender under the Note and related documents. &amp;nbsp;&amp;nbsp;Amounts advanced under the Note are (i) secured on a subordinated basis by all the Company&amp;#146;s assets
 (ii) convertible into the Company&amp;#146;s restricted common stock at $.12 per share
 (iii) bear interest at the rate of 11% per annum (payable on the first and second anniversary of the Note (unless earlier paid off)
 in cash or stock
 at the Company&amp;#146;s option)
 and (iv) unpaid principal not previously converted into common stock must be repaid on the second anniversary of the Note (January 27
 2014).&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;In addition
 the Company has agreed to issue the Lender warrants to purchase an aggregate of 833
333 shares of common stock at an exercise price of $.12 per share
 for a term of three years from January 27
 2012.&amp;nbsp; The Warrants are issuable to the Lender pro rata based on the amount invested in relation to the total investment amount (about 166
667 warrants per $100
000 invested). Accordingly
 1) for the year ended December 31
 2012
 the Company recorded finance charges of $293
282 related to 553
112 warrants valued at $111
125 and excess finance charges of $182
157 relating to the $332
000 advanced as of that date; 2) for the year ended December 31
 2013
 the Company recorded finance charges of $108
390 related to 200
000 warrants.&amp;nbsp; In addition
 the Company recorded excess finance charges of $311
405 relating to the issuance of 11% Convertible Debentures in the principal amount of $168
000.&amp;nbsp; Amounts advanced under the Note are (i) secured on a subordinated basis by all the Company&amp;#146;s assets
 (ii) convertible into the Company&amp;#146;s restricted common stock at $.12 per share
 (iii) bear interest at the rate of 11% per annum (payable on the first and second anniversary of the Note (unless earlier paid off)
 in cash or stock
 at the Company&amp;#146;s option)
 and (iv) unpaid principal not previously converted into common stock must be repaid on the second anniversary of the Note (January 27
 2014). &lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;As a result of the completed funding in 2013
 the Company has issued an additional 280
000
 3 year common stock warrants exercisable at $.12 per share valued at $108
390.&amp;nbsp; The warrants were valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 150.98%
 annual rate of dividends 0% and a risk free interest rate of 0.32%
 pursuant to the terms of the Subscription Agreement and Subordinated Convertible Promissory Note dated January 26
 2012.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;text-indent:36pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On October 30
 2013
 the Venture Group converted $150
000 of the $500
000 convertible debenture into 1
250
000 shares of the Company&amp;#146;s common stock.&amp;nbsp; &lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;text-indent:36pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On February 18
 2014
 Venture Group converted the remaining $350
000 of the convertible debenture into 2
917
000 shares of the Company&amp;#146;s common stock.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;Other Debt&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;text-indent:36pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On February 7
 2014
 the holders of $70
000 of 1% convertible debentures converted their debentures into 950
000 shares of the Company&amp;#146;s common stock.&amp;nbsp; On April 27
 2014
 the holders of $70
600 of 1% convertible debentures converted their debentures into 1
088
000 shares of the Company&amp;#146;s common stock.&amp;nbsp; &lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;text-indent:36pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the six months ended June 30
 2014
 the Company and the Note Holder and significant shareholder of the Company extended the remaining notes due for an additional six months.&amp;nbsp; In September 2014
 the Lender agreed to rolling 30 day extensions until notice is given to the Company to the contrary.&amp;nbsp; The Company determined that the modification of these Notes was not a substantial modification in accordance with ASC 470-50
 &amp;#147;Modifications and Extinguishments.&amp;#148;&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:268.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Convertible debt consists of the following:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:268.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:268.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:268.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1% Convertible notes payable
 net of unamortized discount of $0 &amp;nbsp;and $5
546 respectively
 due at various dates ranging to April 2015 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;240
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;375
054&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:268.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:268.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;11% Convertible note payable &amp;#150; HEP Investments
 LLC
 a related party
 net of unamortized discount of $1
794
272 &amp;nbsp;and $2
235
217 
 respectively
 due at various dates ranging from April 2015 to December 2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3
625
428&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1
814
783&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:268.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:268.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;11% Convertible note payable
 net of unamortized discount of $29
707 as of December 31
 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;320
293&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:268.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3
865
428&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2
510
130&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:268.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Less: &amp;nbsp;Current portion&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3
628
386&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1
619
319&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:268.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:268.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Long term portion&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;237
042&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:84pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;890
811&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Amortization of the debt discount on all convertible debt was $1
801
735 and $1
464
515 for the years ended December 31
 2014 and 2013


 2011 with HEP Investments
 LLC
 the Company recorded a derivative liability of $552
988. &amp;nbsp;This represents the future value of the stock to be issued under the terms of the convertible debt. &amp;nbsp;This derivative liability was valued utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.17
 expected volatility of 151.45% over the two year contractual life of the note
 an annual rate of dividends 0% and a risk free interest rate of .27%. &amp;nbsp;In addition
 the Company has recognized other income of $24
422 representing the change in fair value of this derivative liability as of December 31
 2011. &amp;nbsp;The derivative liability was marked to fair value at December 31
 2011 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.25
 a volatility of 151.49% over the remaining 1.92 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .25%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On April 4
 2012
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $496
375 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.29
 an expected volatility of 143.36% over the remaining 1.66 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .25%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On May 8
 2012
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $507
916 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.29
 an expected volatility of 140.93% over the remaining 1.57 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .25%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On December 31
 2012
 the Company valued the derivative liability at $1
026
128 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.19
 an expected volatility of 151.75% over the remaining 0.92 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .26%. The fair value of the derivative decreased by $506
729 which has been recorded in the statement of operations for the year ended December 31
 2012.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On March 18
 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $377
088 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.22
 an expected volatility of 160.96% over the remaining 0.71 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .25%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On April 10
 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $616
040 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.35
 an expected volatility of 151.37% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .24%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On April 16
 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $518
756 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.30
 an expected volatility of 151.72% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .24%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On April 29
 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $856
410 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.47
 an expected volatility of 153.70% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .20%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On May 7
 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $916
028 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.50 an expected volatility of 153.46% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .22%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On July 15
 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $504
699 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.32 an expected volatility of 146.56% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .34%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On July 25
 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $418
790 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.46 an expected volatility of 147.03% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .32%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On September 30
 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $479
502 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.45 an expected volatility of 139.26% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .33%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On October 28
 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $214
525 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.37 an expected volatility of 134.91% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .33%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On December 18
 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $185
438 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.33 an expected volatility of 134.11% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .34%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On December 30
 2013
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $248
701 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.42 an expected volatility of 133.07% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .39%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On December 31
 2013
 the Company valued the derivative liability at $8
036
239 utilizing the Black-Scholes method of valuation using the following assumptions: &amp;nbsp;closing stock price of $.39
 an expected volatility of 133.09% over the remaining contractual lives of the note ranging from 0.90-1.93 years
 an annual rate of dividends of 0%
 and a risk free rate of .38%. The fair value of the derivative increased by $1
674
135 which has been recorded in the statement of operations for the twelve months ended December 31
 2013.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On March 31
 2014
 the Company valued the derivative liability at $2
671
529 utilizing the Black-Scholes method of valuation using the following assumptions:&amp;nbsp; closing stock price of $.17
 an expected volatility of 145.45% over the remaining 1.27 years contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .44%. The fair value of the derivative decreased by $6
135
458 which has been recorded in the statement of operations for the three months ended March 31
 2014. &lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On June 30
 2014
 the Company valued the derivative liability at $2
079
118 utilizing the Black-Scholes method of valuation using the following assumptions:&amp;nbsp; closing stock price of $.16
 an expected volatility of 135.6% over the remaining 1.04 years contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .47%. The fair value of the derivative decreased by $5
957
121 which has been recorded in the statement of operations for the six months ended June 30
 2014.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On July 14
 2014
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $970
766 utilizing the Black-Scholes method of valuation using the following assumptions:&amp;nbsp; closing stock price of $.15 an expected volatility of 135.1% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .48%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On September 19
 2014
 in connection with the HEP Investments agreement
 as a result of reaching certain funding thresholds which entitled HEP Investments to additional shares of common stock
 the Company was required to record an additional derivative liability of $242
868 utilizing the Black-Scholes method of valuation using the following assumptions:&amp;nbsp; closing stock price of $.13 an expected volatility of 127.8% over the remaining 2.00 year contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .59%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On September 30
 2014
 the Company valued the derivative liability at $4
768
396 utilizing the Black-Scholes method of valuation using the following assumptions:&amp;nbsp; closing stock price of $.13
 an expected volatility of 126.7% over the remaining 2.00 years contractual life of the note
 an annual rate of dividends of 0%
 and a risk free rate of .58%. The fair value of the derivative decreased by $4
481
478 which has been recorded in the statement of operations for the nine months ended September 30
 2014.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On December 1
 2014
 as discussed in Note 7 &amp;#150; Convertible Debt
 in connection with the HEP Investments December 1
 2014 Fourth Amendment to Loan Agreement and the Fifth Amended and Restated Senior Secured Convertible Promissory Note amend the calculation of the conversion price for the convertible promissory note. Previously
 the outstanding principal and interest under the note had been convertible into shares of common stock at the lower of the stated price per share or a 25% discount off of the ten day trailing quoted price of the common stock in the over the counter (OTC) market.&amp;nbsp; Following the amendment
 the convertible note is convertible into shares of common stock at the fixed price per share conversion rate (eliminating the lower of 25% discount off of the ten day trailing quoted price of the common stock).&amp;nbsp; The derivative was marked to market at December 1
 2014 and the balance of&amp;nbsp;830


 &amp;#147;Fair Value Measurements and Disclosures&amp;#148;
 the following table represents the Company&amp;#146;s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of December 31
 2014 and December 31
 2013:&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;234&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:175.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:55.5pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:55.5pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;234&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:175.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
 2014&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:55.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:55.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;234&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:175.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;Derivative Instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:55.5pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:55.5pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;234&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:175.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
 2013&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:55.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:55.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;234&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:175.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;Derivative Instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:55.5pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;8
036
239&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:55.5pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;8
036
239&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Level 3 financial instruments consist of certain embedded conversion features. &amp;nbsp;The fair value of these imbedded conversion features are estimated using the Black-Scholes valuation model. &amp;nbsp;The Company adopted the disclosure requirements of ASU 2011-04
&amp;nbsp;&lt;i&gt;&amp;#147;Fair Value Measurements
&amp;#148;&lt;/i&gt;&amp;nbsp;during the quarter ended March 31
 2012.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The following table summarizes the changes in fair value of the Company&amp;#146;s Level 3 financial instruments for the year ended December 31
 2014 and 2013.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;378&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:10cm;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td rowspan=&quot;2&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
 2014&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td rowspan=&quot;2&quot; width=&quot;96&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
 2013&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;378&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:10cm;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;378&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:10cm;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;Beginning Balance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;8
036
239&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;96&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1
026
128&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; rowspan=&quot;2&quot; width=&quot;378&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:10cm;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;Initial recognition - Derivative liability of embedded conversion feature of the Convertible Notes&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;96&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1
213
634&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;96&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;5
335
976&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;378&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:10cm;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;Change in fair value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(8
418
982)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;96&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1
674
135&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;378&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:10cm;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Reclassification to additional paid-in capital&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(830
891)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;96&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;378&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:10cm;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;Ending Balance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:18.75pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;96&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;8
036
239&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Changes in the unobservable input values would likely cause material changes in the fair value of the Company&amp;#146;s Level 3 financial instruments. &amp;nbsp;The significant unobservable input used in the fair value measurement is the estimation of the likelihood of the occurrence of a change to the conversion price based on the contractual terms of the financial instruments. &amp;nbsp;A significant increase (decrease) in this likelihood would result in a higher (lower) fair value measurement.&amp;nbsp; As noted in Note 7 &amp;#150; Convertible Debt and Note 8 &amp;#150; Derivative Liability
 the December 1


 the Company granted warrants to purchase 50
000 shares of common stock to Philip M. Rice (CFO and a Director) in January
 2013
 at an exercise price of $.12 per share. &amp;nbsp;The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter). &amp;nbsp;The warrants were valued at $10
381 using the Black Scholes pricing model relying on the following assumptions: volatility 131.97%; annual rate of dividends 0%; discount rate 0.27%. &amp;nbsp;In addition
 Mr. Rice will receive $10
000 for each annual term served
 paid quarterly.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;As compensation for serving as a member of the board of directors
 the Company granted warrants to purchase 50
000 shares of common stock to Thomas K. Cox in June
 2013
 at an exercise price of $.40 per share. &amp;nbsp;The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter). &amp;nbsp;The warrants were valued at $15
873 using the Black Scholes pricing model relying on the following assumptions: volatility 145.67%; annual rate of dividends 0%; discount rate 0.25%. &amp;nbsp;In addition
 Mr. Cox will receive $10
000 for each annual term served
 paid quarterly.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;As compensation for serving as a member of the board of directors
 the Company granted warrants to purchase 50
000 shares of common stock to John B. Payne in July
 2013
 at an exercise price of $.38 per share. &amp;nbsp;The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter). &amp;nbsp;The warrants were valued at $17
187 using the Black Scholes pricing model relying on the following assumptions: volatility 143.37%; annual rate of dividends 0%; discount rate 0.25%. &amp;nbsp;In addition
 Mr. Payne will receive $10
000 for each annual term served
 paid quarterly.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;As compensation for serving as a member of the board of directors
 the Company granted warrants to purchase 50
000 shares of common stock to John Gorman in November
 2013
 at an exercise price of $.36 per share. &amp;nbsp;The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter). &amp;nbsp;The warrants were valued at $14
053 using the Black Scholes pricing model relying on the following assumptions: volatility 141.53%; annual rate of dividends 0%; discount rate 0.33%. &amp;nbsp;In addition
 Mr. Gorman will receive $10
000 for each annual term served
 paid quarterly.&amp;nbsp; On August 19
 2014
 Mr. Gorman resigned from the board of directors.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;As compensation for serving as a member of the board of directors
 the Company granted warrants to purchase 50
000 shares of common stock to Philip M. Rice (CFO and a Director) in January
 2014
 at an exercise price of $.38 per share.&amp;nbsp; The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter).&amp;nbsp; The warrants were valued at $13
460 using the Black Scholes pricing model relying on the following assumptions: volatility 121.33%; annual rate of dividends 0%; discount rate 0.44%.&amp;nbsp; In addition
 Mr. Rice will receive $10
000 for each annual term served
 paid quarterly.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;As compensation for serving as a member of the board of directors
 the Company granted warrants to purchase 50
000 shares of common stock to Thomas K. Cox in June
 2014
 at an exercise price of $.19 per share.&amp;nbsp; The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter).&amp;nbsp; The warrants were valued at $7
311 using the Black Scholes pricing model relying on the following assumptions: volatility 138.05%; annual rate of dividends 0%; discount rate 0.41%.&amp;nbsp; In addition
 Mr. Cox will receive $10
000 for each annual term served
 paid quarterly.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;As compensation for serving as a member of the board of directors
 the Company granted warrants to purchase 50
000 shares of common stock to John B. Payne in July
 2014
 at an exercise price of $.14 per share.&amp;nbsp; The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter).&amp;nbsp; The warrants were valued at $4
876 using the Black Scholes pricing model relying on the following assumptions: volatility 118.27%; annual rate of dividends 0%; discount rate 0. 51%.&amp;nbsp; In addition
 Mr. Payne will receive $10
000 for each annual term served
 paid quarterly.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;As compensation for serving as a member of the board of directors
 the Company granted warrants to purchase 50
000 shares of common stock to Nola E. Masterson in September
 2014
 at an exercise price of $.12 per share.&amp;nbsp; The warrants have a term of three years and vested or will vest as follows: 12
500 vested on the grant date and the remaining 37
500 shall vest quarterly (12
500 per quarter).&amp;nbsp; The warrants were valued at $4
074 using the Black Scholes pricing model relying on the following assumptions: volatility 113.93%; annual rate of dividends 0%; discount rate 0.59%.&amp;nbsp; In addition
 Ms. Masterson will receive $10
000 for each annual term served
 paid quarterly.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The company recorded directors fees of $86
180 during the twelve months ended December 31
 2014
 representing the fees expensed and the value of the vested warrants described above.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;Stock Issuances&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended March 31
 2013
 an investor received 21
111 shares as part of a cashless exercise of 35
000 common stock warrants that had an exercise price of $.10.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended June 30
 2013
 investors received 1
191
181 shares as part of cashless exercises of 1
900
000 common stock warrants that had exercise prices at $.15. In addition the Company received proceeds of $85
000 from the exercise of 682
000 common stock warrants.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On April 15
 2013
 upon completion of funding on a $2
000
000
 11% convertible debenture
 the Company issued 600
000 shares of its common stock valued at $192
000 and 1
666
667 common stock warrants valued at $481
110 using the Black Scholes method of valuation (see Note 8 &amp;#150; Convertible Debt).&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On April 30
 2013
 the Company Board of Directors awarded its Chief Financial Officer 557
000
 5 year common stock warrants
 exercisable at $.25 per share. These warrants were valued at $250
640 using the Black Scholes valuation method of valuation using the following assumptions:&amp;nbsp; closing stock price of $.46 an expected volatility of 194.14% a five year term
 an annual rate of dividends of 0%
 and a risk free rate of .25%.&amp;nbsp; The Board of Directors resolution included quarterly 50
000
 5 year common stock warrants
 exercisable at $.25 per share.&amp;nbsp; The Company issued 150
000 warrants for the 2nd
 3rd and 4th quarters of 2013.&amp;nbsp; These warrants were valued at $46
115 using the Black Scholes valuation method of valuation using the following assumptions:&amp;nbsp; closing stock price of $.25 to .46 an expected volatility of 138.68 to 194.11% a five year term
 an annual rate of dividends of 0%
 and a risk free rate of .23% to .31%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On July 1
 2013
 the Company Board of Directors granted a consultant to the Company 250
000
 5 year common stock warrants
 exercisable at $.33 per share. These warrants were valued at $87
510 using the Black Scholes valuation method of valuation using the following assumptions:&amp;nbsp; closing stock price of $.36 an expected volatility of 190.15% a five year term
 an annual rate of dividends of 0%
 and a risk free rate of .25%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On July 22
 2013
 the company issued 280
000
 3 year common stock warrants
 exercisable at $.12 per share. These warrants were valued at $108
390 using the Black Scholes valuation method of valuation using the following assumptions:&amp;nbsp; closing stock price of $.43 an expected volatility of 146.36% a three year term
 an annual rate of dividends of 0%
 and a risk free rate of .32%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended September 30
 2013
 the Company received proceeds of $548
000 from the issuance of 2
077
273 shares of common stock and the exercise of 50
000 common stock warrants.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended September 30
 2013
 the Company issued 1
000
000 shares of its common stock upon conversion of $50
000 of 1% convertible debentures at $.05 per share.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended September 30
 2013
 the Company issued 99
217 shares of its common stock valued at $40
802 and 858
936 common stock warrants valued at $356
304 using the Black Scholes method of valuation (see Note 7 &amp;#150; Convertible Debt). We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 139.26%-147.03%
 annual rate of dividends 0% and a risk free interest rates of 0.33-0.34%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended September 30
 2013
 the Company issued 2
577
565 shares of its common stock valued at $1
159
904 for the purchase of assets from Essex Angel Capital (see below).&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On November 11
 2013
 the Company granted a consultant to the Company 56
256
 5 year common stock warrants
 exercisable at $.39 per share. These warrants were valued at $64
941 using the Black Scholes valuation method of valuation using the following assumptions:&amp;nbsp; closing stock price of $.28 an expected volatility of 166.98% a five year term
 an annual rate of dividends of 0%
 and a risk free rate of .34%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended December 31
 2013
 the Company issued 229
597 shares of its common stock in return for cashless exercises of 450
000 common stock warrants that had exercise prices of $.15 and $.225.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended December 31
 2013
 the Company issued 800
000 shares of its common stock upon conversion of $55
000 of 1% convertible debentures at $.05 to $.125 per share.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended December 31
 2013
 the Company issued 1
250
000 shares of its common stock upon conversion of $150
000 of 11% convertible debentures at $.12 per share.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended December 31
 2013
 the Company issued 90
000 shares of its common stock valued at $32
310 and 250
000 common stock warrants valued at $75
507 using the Black Scholes method of valuation (see Note 7 &amp;#150; Convertible Debt). We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 142.88%-143.44%
 annual rate of dividends 0% and a risk free interest rates of 0.32-0.39%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended December 31
 2013
 the Company received proceeds of $256
500 from the issuance of 833
333 shares of common stock and the exercise of 33
000 common stock warrants.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended March 31
 2014 Company issued 4
955
000 shares of common stock upon conversion of $490
600 of 1% and 11% convertible debentures.&amp;nbsp; &lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended March 31
 2014
 the Company received proceeds of $100
000 from the issuance of 500
000 shares of common stock and $255
000 from the exercise of 2
040
000 common stock warrants.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended June 30
 2014 the Company issued 1
088
000 shares of common stock upon conversion of $70
600 of 1% convertible debentures.&amp;nbsp; &lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended June 30
 2014
 the Company received proceeds of $402
500 from the issuance of 2
516
667 shares of common stock and $48
750 from the exercise of 390
000 common stock warrants. The Company issued 416
667 shares of common stock to a non-related party shareholder relating to a stock purchase in December 2013.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended September 30
 2014 the Company issued 500
000 shares of common stock valued at $64
500 to a non-related party for services rendered.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended September 30
 2014 the Company issued 781
477 shares of its common stock valued at $113
760 and 856
667 common stock warrants valued at $108
212 using the Black Scholes method of valuation (see Note 7 &amp;#150; Convertible Debt). We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 127.64%-134.94%
 annual rate of dividends 0% and a risk free interest rates of 0.48-0.49%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended December 31
 2014 the Company issued 116
667 shares of common stock valued at $17
500 and 500
000 common stock warrants valued at $34
302 using the Black Scholes method of valuation to a non-related party for services rendered. We valued the common stock warrants utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 117.65%
 annual rate of dividends 0% and a risk free interest rates of 0.49%. &lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During the three months ended December 31
 2014 the Company issued 95
288 shares of its common stock valued at $7
623 and 84
700 common stock warrants valued at $5
879 using the Black Scholes method of valuation (see Note 7 &amp;#150; Convertible Debt). We valued this stock utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 138.88%
 annual rate of dividends 0% and a risk free interest rates of 0.64%.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Purchase of Assets&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On April 15
 2013
 the Company and Essex Angel Capital Inc. (&amp;#147;Essex&amp;#148;) entered into an Asset Purchase Agreement (previously disclosed in a Current Report on Form 8-K dated April 19
 2013).&amp;nbsp; Essex held $1
350
000 in senior secured convertible debentures and secured convertible debentures in Wellness Indicators
 Inc. (&amp;#147;Wellness&amp;#148;)
 an Illinois based company.&amp;nbsp; Essex
 along with other secured lenders held a total of $2
000
000 of secured debt.&amp;nbsp; Essex foreclosed on certain assets
 consisting principally of intellectual property (the &amp;#147;Assets&amp;#148;)
 that secured Wellness&amp;#146; obligation under the debentures.&amp;nbsp; Upon the foreclosure and acquisition of all right
 title and interest in and to the Assets&amp;nbsp; pursuant to its 1st perfected security interest in the Assets
 the Company purchased the Assets from Essex for $1
100
000
 paid in the common stock of the Company with each such share being issued at the lesser of (i) $0.31 per share; or (ii) a price equal to the weighted average price of said shares on the OTCBB for 20 consecutive trading days ending on the date of Closing (date of such closing being the &amp;#147;Closing Date&amp;#148;) plus a 20% premium amount.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On August 19
 2013 (previously disclosed in a Current Report on Form 8-K dated August 20
 2013)
 the Company completed the acquisition from Essex of certain assets
 consisting principally of pending patents (the &amp;#147;Assets&amp;#148;) of Wellness.&amp;nbsp; Essex held senior secured convertible debentures and secured convertible debentures in Wellness.&amp;nbsp; Essex foreclosed and acquired all rights
 title and interest in and to the Assets pursuant to its 1st perfected security interest in the Assets.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The Company purchased the Assets from Essex for $1
100
000.&amp;nbsp; $801
507 was paid in common stock with the remainder of $298
493 paid in cash.&amp;nbsp; There were 2
577
565 shares of common stock issued
 valued at $0.31 per share.&amp;nbsp; Based on the current market price of the stock at the time of issuance
 the Company recorded the 2
577
565 shares of common stock issued at $1
159
904.&amp;nbsp; The Company also incurred an additional $32
884 in transaction costs
 for a total transaction cost of $1
491
281.&amp;nbsp; The Company acquired both furniture and equipment
 along with 4 pending patents.&amp;nbsp; The Company valued the furniture and equipment at $100
000 and the patent applications pending at $1
391
281.&amp;nbsp; &lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;As of December 31
 2014
 the Company evaluated the circumstances related to the four Patent Applications Pending relating to the acquisition of asset of Wellness Indicators in August 2013.&amp;nbsp; The Company has filed / drafted an additional eight patents applications around the intellectual property acquired.&amp;nbsp; The Company has determined that the new patents applications redefine and protect its intellectual property better than the original purchased patent applications.&amp;nbsp; As such
 the Company has abandoned the patent applications purchased and recorded a loss on abandonment of $1
391
281 for the year ended December 31
 2014&lt;/font&gt;&lt;font lang=&quot;EN-US&quot;&gt;.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0cm 0cm 0pt&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;Executive Compensation&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;As compensation for serving as Chief Financial Officer
 the Company
 quarterly
 will issue warrants to purchase 50
000 shares of common stock to Philip M. Rice at the prevailing market price with a term of 5 years
 provided that the preceding quarterly and annual filings were submitted in a timely and compliant manner
 at which time such warrants would vest.&amp;nbsp; On March 31
 2014 the Company issued warrants to purchase 50
000 shares of common stock at $.17.&amp;nbsp; The warrants were valued at $13
460 using the Black Scholes pricing model relying on the following assumptions: volatility 128.35%; annual rate of dividends 0%; discount rate 0.44%.&lt;/font&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp; On May 14
 2014
 the Company issued warrants to purchase 50
000 shares of common stock at $.19.&amp;nbsp; The warrants were valued at $6
756 using the Black Scholes pricing model relying on the following assumptions: volatility 121.96%; annual rate of dividends 0%; discount rate 0.47%.&amp;nbsp; On August 14
 2014
 the Company issued warrants to purchase 50
000 shares of common stock at $.19.&amp;nbsp; The warrants were valued at $4
828 using the Black Scholes pricing model relying on the following assumptions: volatility 116.72%; annual rate of dividends 0%; discount rate 0.42%.&amp;nbsp; %.&amp;nbsp; On November 14
 2014
 the Company issued warrants to purchase 50
000 shares of common stock at $.09.&amp;nbsp; The warrants were valued at $3
664 using the Black Scholes pricing model relying on the following assumptions: volatility 117.69%; annual rate of dividends discount rate 0.54%. &lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;Common Stock Warrants&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;A summary of the status of the Company&amp;#146;s warrants is presented below.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:141pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;201&quot; colspan=&quot;3&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:150.75pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
 2014&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;208&quot; colspan=&quot;3&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:156pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
 2013&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:141pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Number of&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:74.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Number of&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:79.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:141pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:74.25pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:79.5pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:141pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Outstanding
 beginning of year&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;16
900
539&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:74.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;16
365
209&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:79.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:141pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Issued&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3
149
700&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:74.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;4
820
330&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:79.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.18&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:141pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(2
040
000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:74.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.13&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(2
785
000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:79.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:141pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(110
137)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:74.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.31&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:79.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:141pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Expired&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(8
847
097)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:74.25pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(1
500
000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:79.5pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.32&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:141pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:74.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:79.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:141pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Outstanding
 end of period&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;9
053
005&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:74.25pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;16
900
539&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:79.5pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Warrants outstanding and exercisable by price range as of December 31
 2014 were as follows:&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;284&quot; colspan=&quot;5&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:213pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;Outstanding Warrants&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; colspan=&quot;5&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:184.5pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;Exercisable Warrants&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Contractual Life in Years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;50
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;4.87&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;50
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.10&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;84
700&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;4.94&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.10&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;84
700&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.10&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.12&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3
489
439&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;.96&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.12&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3
464
439&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;.12&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.125&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;440
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.125&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;440
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.125&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.14&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;50
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;4.62&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.14&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;50
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.14&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.15&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2
665
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2.58&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.15&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2
640
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.15&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;50
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;4.25&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;50
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.19&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;100
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3.12&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.19&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;87
500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.19&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.20&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;250
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2.33&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.20&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;250
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.20&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.22&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;477
004&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1.61&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.22&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;477
004&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.22&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.25&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;707
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3.52&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.25&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;707
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.25&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.30&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;250
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3.91&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.30&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;250
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.30&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.33&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;250
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3.50&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.33&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;250
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.33&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.36&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;39
863&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1.84&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.36&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;39
863&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.36&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.38&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;100
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1.78&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.38&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;100
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.38&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.40&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;50
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1.94&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.40&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;50
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:black 1pt solid;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.40&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;9
053
005&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1.72&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 2.25pt double;padding-bottom:0cm;padding-top:0cm;padding-left:0cm;border-left:#f0f0f0;padding-right:0cm;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;8
990


 2013
 the Company entered into a Settlement Agreement and Mutual Release of all Claims (the &amp;#147;Settlement Agreement&amp;#148;) with Ceptazyme
 LLC (&amp;#147;Ceptazyme&amp;#148;) and Zus Health
 LLC (&amp;#147;Zus Health&amp;#148;) resolving claims the parties brought against one another in connection with a license agreement between the Company and Zus Health dated September 2
 2010 (the &amp;#147;License Agreement&amp;#148;). &amp;nbsp;Under the terms of the Settlement Agreement
 the parties agreed to terminate the License Agreement and that no party would have any further obligations thereunder. &amp;nbsp;No monetary consideration was exchanged in connection with the Settlement Agreement.&amp;nbsp; As a result of this settlement
 the deferred revenue of $235
000 and customer deposits of $27
837 were recognized as other income.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On July 15
 2014
 the Company settled a dispute with one of its vendors.&amp;nbsp; The settlement agreement calls for the Company to make 10 payments of $6
250.&amp;nbsp; If the payments are not made timely
 a total liability of $97
463 out of the gross amount recorded on the Company&amp;#146;s books of $191
146 will be due.&amp;nbsp; &lt;/font&gt;&lt;font lang=&quot;EN-US&quot;&gt;As a result of this settlement
 the difference of $93
683 is recognized as other income for the period ending September 30
 2014.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-indent:36pt;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On May 1
 2013
 the Company
 through its legal counsel
 sent a notice to the landlord at 7740 E. Evans
 Scottsdale
 AZ that it expected a timely return of the $118
466 security deposit. &amp;nbsp;On June 14
 2013
 the landlord filed a Complaint in the State Court of Arizona that the Company owed the landlord in excess of $210
000 in damages in addition to the $118
466 security deposit related to the property at 7740 E. Evans
 Scottsdale
 AZ. The security deposit has been classified as a Miscellaneous Receivable since the second quarter of 2013. &amp;nbsp;On July 24
 2014
 the Company settled the outstanding complaints and the $118
466 Miscellaneous Receivable was written off as other expense for the period ending September 30


 Andrew Dahl
 is serving under the terms of an employment agreement dated
 December 16
 2011. Under the agreement Mr. Dahl serves as CEO for one year terms
 subject to automatic renewal
 unless either party terminates the Agreement on sixty days&amp;#146;&amp;#146; notice prior to the expiration of the term of the agreement. &amp;nbsp;Mr. Dahl will be compensated as follows: &amp;nbsp;he will receive an annual base salary of $240
000. &amp;nbsp;In addition
 Mr. Dahl is entitled to monthly bonus compensation equal to 2% of the Company&amp;#146;s revenue
 but only to the extent that such bonus amount exceeds his base salary for the month in question. &amp;nbsp;In addition
 Mr. Dahl will be entitled to warrants having an exercise price of $.25 per share
 upon the attainment of specified milestones as follows: 1) Warrants for 500
000 shares upon identification of bio-active agents in the Company&amp;#146;s product and filing of a patent with respect thereto
 2) Warrants for 500
000 shares upon entering into a business contract under which the Company receives at least $500
000 in cash payments
 3) Warrants for 1
000
000 shares upon the Company entering into a co-development agreement with a research company to develop &amp;nbsp;medicinal or pharmaceutical applications (where the partner provides at least $2 million in cash or in-kind outlays)
 4) Warrants for 1
000
000 shares upon the Company entering into a co-development agreement for nutraceutical or dietary supplement applications (where the partner provides at least $2 million in cash or in-kind outlays)
 5) Warrants for 1
000
000 shares upon the Company entering into a pharmaceutical development agreement. &amp;nbsp;As of December 30
 2014
 none of the milestones referred to had been achieved and there has been no notice of contract termination.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;Workers&amp;#146; Compensation&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The Company does not carry workers&amp;#146; compensation insurance


 2013
 Mr. Maggiore a significant shareholder
 subscribed to and paid for&amp;nbsp;the acquisition for 454
545&amp;nbsp;Units
 each Unit comprised of one share of common stock
 $.001 par value of the Company and warrants to purchase one-tenth (1/10) of one share of Common Stock (or 45
455 warrants total)
 at a per unit price of $.22 for an aggregate purchase price of $100


 2014 the Company had available net-operating loss carry-forwards for Federal tax purposes of approximately $33&lt;/font&gt;&lt;font lang=&quot;EN-US&quot;&gt;
600
000&lt;/font&gt;&lt;font lang=&quot;EN-US&quot;&gt;
 which may be applied against future taxable income
 if any
 at various dates from 2014 through 2034. Certain significant changes in ownership of the Company may restrict the future utilization of these tax loss carry-forwards.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;At December 31
 2014 the Company had a deferred tax asset of approximately $20
100
000&lt;/font&gt;&lt;font lang=&quot;EN-US&quot;&gt; representing the benefit of its net operating loss carry-forwards. The Company has not recognized the tax benefit because realization of the tax benefit is uncertain and thus a valuation allowance has been fully provided against the deferred tax asset. &amp;nbsp;The difference between the Federal and State Statutory Rate of 40% and the Company&amp;#146;s effective tax rate of 0% is due to a decrease in the valuation allowance of approximately $6&lt;/font&gt;&lt;font lang=&quot;EN-US&quot;&gt;
400


 2015 the Board of Directors reappointed Philip M. Rice II
 the Company&amp;#146;s Chief Financial Officer
 as a director for a 1 year term. &amp;nbsp;Mr. Rice received warrants to purchase 50
000 shares of common stock at an exercise price of $.09 per share for a term of three years
 vested at 12
500 per quarter. &amp;nbsp;The terms of the appointment also includes a cash payment of $10
000. &amp;nbsp;&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;Stock Issuances&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Subsequent to December 31
 2014
 the Company received proceeds of $48
500 from the issuance of 970
000 shares of common stock.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0cm 0cm 0pt;line-height:normal&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;Loan Payable &amp;#150; Related Party&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt 0.5in&apos;&gt;&lt;font style=&apos;background:white&apos;&gt;During the period January 1
 2015 through April 3
 2015
 HEP Investments
 LLC
 a related party
 advanced the Company an additional $387
500.  HEP Investments has reached a $5
807
200 balance (including monies advanced since September 2011) and these advances have been converted into convertible debt.  The Company recorded a debt discount in the amount of $224
283 for the $387
500 transaction.  This represents the future value of the stock to be issued under the terms of the convertible debt. This stock was valued utilizing the Black-Scholes method of valuation using the following assumptions: expected volatilities of 138.27%-139.02%


 Inc. (formerly known as Health Enhancement Products
 Inc.) and Subsidiaries (Health Enhancement Corporation
 HEPI Pharmaceuticals
 Inc.
 WellMetris
 LLC
 and Zivo Biologic
 Inc.) (collectively the &amp;#147;Company&amp;#148;) business models are as follows: 1) to derive future income from licensing and selling natural bioactive ingredients derived from their proprietary algae cultures to animal
 human and dietary supplement and medical food manufacturers (currently
 the Company&apos;s focus is on research and identification of its bioactive ingredients and is not currently selling its product commercially)
 and 2) developing
 manufacturing
 marketing
 and selling tests that the Company believes will allow people to optimize their health and identify future health risks.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;On October 14
 2014
 at the annual meeting of the Shareholders&amp;#146; of the Company
 a proposal was passed to change the name of the Company from Health Enhancement Products
 Inc. to Zivo Bioscience
 Inc.&amp;nbsp; On October 16
 2014
 the Amended Articles were filed with the State of Nevada.&amp;nbsp; On November 7
 2014
 FINRA (Financial Industry Regulatory Authority) approved the name Zivo Bioscience
 Inc. for trading purposes.&amp;nbsp; Effective November 10
 2014


 Inc. and its wholly-owned Subsidiaries
 Health Enhancement Corporation
 HEPI Pharmaceuticals
 Inc.
 WellMetris
 LLC
 and Zivo Biologic


 which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
 at the date of the financial statements and reported amount of revenues and expenses during the reporting period. &amp;nbsp;Actual results could differ from those estimates. &amp;nbsp;Management uses its best judgment in valuing these estimates and may
 as warranted


 cash equivalents include time deposits
 certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. The Company maintains cash and cash equivalents balances at financial institutions and are insured by the Federal Deposit Insurance Corporation up to $250
000. At times
 balances in certain bank accounts may exceed the FDIC insured limits. Cash equivalents consist of highly liquid investments with an original maturity of three months or less when purchased. At December 31
 2014


 and are carried at cost less allowances for depreciation and amortization. Depreciation and amortization is determined by using the straight-line method over the estimated useful lives of the related assets


 (ii)&amp;nbsp;knowledgeable
 (iii)&amp;nbsp;able to transact
 and (iv) willing to transact. The guidance describes a fair value hierarchy based on the levels of inputs
 of which the first two are considered observable and the last unobservable
 that may be used to measure fair value which are the following:&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot; style=&apos;background:white&apos;&gt;Level 1 &amp;#150; Quoted prices in active markets for identical assets or liabilities.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot; style=&apos;background:white&apos;&gt;Level 2 &amp;#150; Inputs other than Level&amp;nbsp;1 that are observable
 either directly or indirectly
 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or corroborated by observable market data or substantially the full term of the assets or liabilities.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot; style=&apos;background:white&apos;&gt;Level&amp;nbsp;3 &amp;#150; Unobservable inputs that are supported by little or no market activity and that are significant to the value of the assets or liabilities.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The Company&amp;#146;s financial instruments include cash and cash equivalents
 accounts payable
 accrued expenses and loans payable - related parties. &amp;nbsp;All of these items were determined to be Level 1 fair value measurements.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The carrying amounts of cash
 accounts payable
 accrued expenses


835 and $30
122 for the years ended December 31
 2014 and 2013


 the Company recognize revenue in accordance with Staff Accounting Bulletin No. 104
 &amp;#147;Revenue Recognition&amp;#148; (&amp;#147;SAB No. 104&amp;#148;)
 which superseded Staff Accounting Bulletin No. 101
 &amp;#147;Revenue Recognition in Financial Statements&amp;#148; (&amp;#147;SAB No. 101&amp;#148;). SAB No. 104 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&amp;#146;s judgment regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers
 estimated returns and allowances




 consisting of salaries and equipment and related expenses incurred for product research studies conducted primarily within the Company and by Company personnel. Research expenses were approximately $0 and $41
000 for the years ended December 31
 2014 and 2013
 respectively;&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;ul type=&quot;disc&quot; style=&apos;margin-top:0cm&apos;&gt; &lt;li style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Clinical Studies Expenses
 consisting of fees
 charges
 and related expenses incurred in the conduct of clinical studies conducted with Company products by independent external entities. External clinical studies expenses were approximately $1
971
000 and $977
000 for the years ended December 31
 2014 and 2013


 2014 and 2013 were primarily attributable to net operating loss carry forwards. Since the Company has a history of losses
 and it is more likely than not that some portion or all of the deferred tax assets will not be realized
 a full valuation allowance has been established. In addition


&amp;nbsp;&lt;i&gt;Compensation &amp;#150; Stock Compensation. &amp;nbsp;&lt;/i&gt;Under the provisions of FASB ASC 718
 stock-based compensation cost is estimated at the grant date based on the award&amp;#146;s fair value and is recognized as expense over the requisite service period. &amp;nbsp;The Company generally issues grants to its employees
 consultants and board members. &amp;nbsp;At the date of grant
 the Company determines the fair value of the stock option award and recognizes compensation expense over the requisite service period. &amp;nbsp;The fair value of the stock option or warrant award is calculated using the Black Scholes option pricing model.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;During 2014 and 2013
 warrants were granted to employees
 directors and consultants of the Company. &amp;nbsp;As a result of these grants
 the Company recorded compensation expense of $188
880 and $472
975 during the years ended December 31
 2014 and 2013 respectively.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The fair value of warrants was estimated on the date of grant using the Black-Scholes option-pricing model based on the following weighted average assumptions:&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;163&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:122.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;258&quot; colspan=&quot;3&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:193.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Year Ended December 31
&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;163&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:122.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;126&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:94.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:11.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;117&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:87.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;163&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:122.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Expected volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;126&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:94.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;113.93% to 138.05%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:11.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;117&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:87.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;131.97% to 194.14%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;163&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:122.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Expected dividends&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;126&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:94.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:11.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;117&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:87.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;163&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:122.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Expected term&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;126&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:94.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3 to 5 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:11.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;117&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:87.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3 to 5 years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;163&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:122.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Risk free rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;126&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:94.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;.41% to .59%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:11.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;117&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:87.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;.25% to .34%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;The Black-Scholes option-pricing model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition
 option-pricing models require the input of highly subjective assumptions
 including the expected stock price volatility. Because the Company&amp;#146;s employee warrants have characteristics significantly different from those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimate


 2014
 consisted of 47
807
881 common shares from convertible debentures and related accrued interest and 9
053
005 common shares from outstanding warrants. Potentially dilutive securities as of December 31
 2013
 consisted of 36
290
424 common shares from convertible debentures and related accrued interest and 17
100
539 common shares from outstanding warrants. &amp;nbsp;&amp;nbsp;For 2013
 diluted and basic weighted average shares were the same


000 and $27
000 for the years ended December 31
 2014 and 2013



	

 the Financial Accounting Standards Board (&amp;#147;FASB&amp;#148;) issued Accounting Standards Update No. 2014-09 (ASU 2014-09)
 &amp;#147;&lt;i&gt;Revenue from Contracts with Customers.&lt;/i&gt;&amp;#148;&lt;i&gt;&amp;nbsp;&lt;/i&gt;ASU 2014-09 superseded the revenue recognition requirements in &amp;#147;Revenue Recognition (Topic 605)&amp;#148;
 and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflect the consideration to which the entity expects to be entitled to in exchange for those goods or services.&amp;nbsp; ASU 2014-09 is effective for annual reporting periods beginning after December 15
 2016
 including interim periods within that reporting period.&amp;nbsp; Early adoption is not permitted. ASU 2014-00 is not expected to have a material impact on the Company&amp;#146;s financial position or results of operations.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Management does not believe there would have been a material effect on the accompanying financial statements had any other recently issued
 but not yet effective


 2014 and 2013 consist of the following:&lt;/font&gt;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt; &lt;tr&gt; &lt;td width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt;&lt;/td&gt; &lt;td width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt;&lt;/td&gt; &lt;td width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt;&lt;/td&gt; &lt;td width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;108&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;108&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Furniture &amp;amp; fixtures&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;20
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;20
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;80
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;80
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;100
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;100
000&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Less accumulated depreciation and amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(31
250)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(6
250)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:184.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;68
750&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;108&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:81pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;93


 &amp;#147;Modifications and Extinguishments.&amp;#148;&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:268.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Convertible debt consists of the following:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:268.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:268.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:268.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1% Convertible notes payable
 net of unamortized discount of $0 &amp;nbsp;and $5
546 respectively
 due at various dates ranging to April 2015 &lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;240
000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;375
054&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:268.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:268.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;11% Convertible note payable &amp;#150; HEP Investments
 LLC
 a related party
 net of unamortized discount of $1
794
272 &amp;nbsp;and $2
235
217 
 respectively
 due at various dates ranging from April 2015 to December 2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3
625
428&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1
814
783&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:268.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:268.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;11% Convertible note payable
 net of unamortized discount of $29
707 as of December 31
 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;320
293&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:268.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3
865
428&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;2
510
130&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:268.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Less: &amp;nbsp;Current portion&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3
628
386&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1
619
319&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:268.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;358&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:268.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Long term portion&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;237
042&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;112&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:84pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;890


 2014 and December 31
 2013:&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;234&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:175.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:55.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:12pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:55.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;234&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:175.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
 2014&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:55.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:12pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:55.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;234&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:175.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;Derivative Instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:55.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:12pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:55.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;234&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:175.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
 2013&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:55.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:12pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:55.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;234&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:175.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;Derivative Instruments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:55.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;8
036
239&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:12pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;74&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:55.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;8
036


 2014 and 2013.&lt;/font&gt;&lt;/p&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;378&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:10cm;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td rowspan=&quot;2&quot; width=&quot;95&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:71.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
 2014&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:12pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td rowspan=&quot;2&quot; width=&quot;96&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:72pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
 2013&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;378&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:10cm;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:12pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;378&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:10cm;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;Beginning Balance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:71.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;8
036
239&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:12pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;96&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:72pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1
026
128&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; rowspan=&quot;2&quot; width=&quot;378&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:10cm;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;Initial recognition - Derivative liability of embedded conversion feature of the Convertible Notes&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:71.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:12pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;96&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:72pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:71.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1
213
634&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:12pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;96&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:72pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;5
335
976&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;378&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:10cm;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;Change in fair value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:71.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(8
418
982)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:12pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;96&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:72pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;1
674
135&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;378&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:10cm;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Reclassification to additional paid-in capital&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:71.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(830
891)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:12pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;96&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:72pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;378&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:10cm;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;Ending Balance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:71.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:12pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;25&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:18.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;96&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:72pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;8
036


 2014&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;208&quot; colspan=&quot;3&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:156pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;b&gt;&lt;font lang=&quot;EN-US&quot;&gt;December 31
 2013&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:141pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Number of&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:74.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Number of&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:79.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:141pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:74.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:79.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:141pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Outstanding
 beginning of year&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;16
900
539&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:74.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;16
365
209&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:79.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:141pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Issued&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;3
149
700&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:74.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;4
820
330&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:79.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.18&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:141pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(2
040
000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:74.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.13&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(2
785
000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:79.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:141pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Cancelled&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(110
137)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:74.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.31&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:79.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:141pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Expired&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(8
847
097)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:74.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;(1
500
000)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-bottom:black 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:79.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.32&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:141pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:74.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;106&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:79.5pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;188&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:141pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;Outstanding
 end of period&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p style=&apos;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;9
053
005&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;99&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:74.25pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;0.16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:15.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;81&quot; style=&apos;border-bottom:black 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:0cm;width:60.75pt;padding-right:0cm;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;line-height:normal;margin:0cm 0cm 0pt&apos;&gt;&lt;font lang=&quot;EN-US&quot;&gt;16
900


 2014 were as follows:&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr style=&apos;height:14.85pt&apos;&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;height:14.85pt;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;284&quot; colspan=&quot;5&quot; style=&apos;border-top:#f0f0f0;height:14.85pt;border-right:#f0f0f0;width:213pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt;line-height:normal&apos;&gt;&lt;b&gt;Outstanding Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;height:14.85pt;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;246&quot; colspan=&quot;5&quot; style=&apos;border-top:#f0f0f0;height:14.85pt;border-right:#f0f0f0;width:184.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt;line-height:normal&apos;&gt;&lt;b&gt;Exercisable Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt;line-height:normal&apos;&gt;Average&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt;line-height:normal&apos;&gt;Weighted&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt;line-height:normal&apos;&gt;Weighted&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt;line-height:normal&apos;&gt;Remaining&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt;line-height:normal&apos;&gt;Average&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt;line-height:normal&apos;&gt;Range of&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt;line-height:normal&apos;&gt;Number&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt;line-height:normal&apos;&gt;Contractual Life in Years&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt;line-height:normal&apos;&gt;Exercise Price&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt;line-height:normal&apos;&gt;Number&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt;line-height:normal&apos;&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.09&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;50
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;4.87&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.09&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;50
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.09&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.10&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;84
700&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;4.94&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.10&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;84
700&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.12&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;3
489
439&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;.96&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.12&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;3
464
439&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;.12&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.125&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;440
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;.77&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.125&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;440
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.125&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.14&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;50
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;4.62&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.14&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;50
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.14&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.15&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;2
665
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;2.58&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.15&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;2
640
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.15&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.17&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;50
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;4.25&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.17&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;50
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.17&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.19&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;100
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;3.12&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.19&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;87
500&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.19&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.20&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;250
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;2.33&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.20&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;250
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.20&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.22&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;477
004&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;1.61&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.22&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;477
004&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.22&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.25&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;707
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;3.52&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.25&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;707
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.25&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.30&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;250
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;3.91&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.30&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;250
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.30&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.33&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;250
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;3.50&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.33&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;250
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.33&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.36&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;39
863&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;1.84&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.36&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;39
863&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.36&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.38&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;100
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;1.78&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.38&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;100
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.38&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.40&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;50
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;1.94&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.40&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;50
000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;0.40&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;21&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;9
053
005&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;15&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:11.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;95&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:71.25pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;1.72&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;26&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:19.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;66&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:49.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;17&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;75&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt;line-height:normal&apos;&gt;8
990

	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	

 2014
 the Company evaluated the circumstances related to the four Patent Applications Pending relating to the acquisition of asset of Wellness Indicators in August 2013.&amp;nbsp; The Company has filed / drafted an additional eight patents applications around the intellectual property acquired.&amp;nbsp; The Company has determined that the new patents applications redefine and protect its intellectual property better than the original purchased patent applications.&amp;nbsp; As such
 the Company has abandoned the patent applications purchased and recorded a loss on abandonment of $1
391
281 for the year ended December 31


 2013
 Mr. Maggiore
 a significant shareholder
 advanced the Company a total of $462
000. &amp;nbsp;As discussed in Note 7
 this amount was reclassified into convertible debt attributed to HEP Investments
 LLC
 of which Mr. Maggiore is a member. As of December 31
 2013
 there was no balance due to Mr. Maggiore.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;line-height:normal&apos;&gt;During the year ended December 31
 2014
 Mr. Maggiore advanced the Company $134
670.&amp;nbsp; This amount remained unpaid as of December 31
 2014.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;line-height:normal&apos;&gt;During the fourth quarter of 2014
 Officers
 advanced the Company $6
344.&amp;nbsp; These amounts remained unpaid as of December 31


 LLC&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;line-height:normal&apos;&gt;During the year ended December 31
 2013
 the Company formed WellMetris
 LLC
 a Delaware Limited Liability Company for the purpose of developing
 manufacturing and marketing a non-invasive urinary wellness test. WellMetris is 100% owned by Zivo Bioscience
 Inc.&amp;nbsp; As discussed in Note 11 &amp;#150; Stockholder&amp;#146;s Deficiency
 Purchase of Assets
 the Company bought the Assets of Wellness from Essex.&amp;nbsp; Concurrently
 the Company transferred the Intellectual Property (patent applications pending) to WellMetris.&amp;nbsp; As of December 31
 2014
 the Company evaluated the circumstances related to the Patent Applications Pending relating to the acquisition of asset of Wellness Indicators in August 2013.&amp;nbsp; The Company has filed / drafted an additional eight patents applications around the intellectual property acquired. &amp;nbsp;The Company has determined that the new patents applications redefine and protect its intellectual property better than the original purchased patent applications.&amp;nbsp; As such
 the Company has abandoned the patent applications purchased and recorded a loss on abandonment of $1
391
281 for the year ended December 31
 2014.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;line-height:normal&apos;&gt;&lt;b&gt;Zivo Biologic
 Inc.&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;line-height:normal&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;line-height:normal&apos;&gt;During the year ended December 31
 2013
 the Company formed Zivo Biologic
 Inc.
 a Delaware Corporation
 for the purpose of manufacturing and commercialization of proprietary ingredients for non-medicinal animal health applications. Zivo Biologic is 100% owned by Zivo Bioscience



	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	


	
	
	
	
	
	
	
	
	
	


			


			
			




			


			




			


			




			


			




			


			




			


			
			




			


			




			
			


			




			
			


			




			
			


			




			
			


			




			
			


			
			




			
			


			
			




			
			


			
			




			
			


			
			




			
			


			




			
			


			




			
			


			




			
			


			




			
			


			
			




			
			


			
			




			
			


			
			




			
			


			
			




			
			


			




			
			


			




			
			


			




			
			


			




			


			
			




			
			


			
			




			
			


			
			




			
			


			




			
			


			




			
			


			




			
			


			




			
			


			
			




			
			


			
			




			
			


			




			
			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			
			




			


			
			




			


			
			




			


			
			




			


			
			




			


			
			




			


			
			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			


			




			
			


			




			
			


			
			




			
			


			
			




			
			


			
			




			
			


			
			




			
			


			
			




			
			


			
			




			
			


			




			
			


			




			
			


			




			
			


			




			
			


			




			
			


			



		


		




				


				




		















		xmlns:xsi=http://www.w3.org/2001/XMLSchema-instance
		xsi:schemaLocation=http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd
		xmlns:fil=http://www.heponline.com/20141231
		xmlns:link=http://www.xbrl.org/2003/linkbase
		xmlns:xlink=http://www.w3.org/1999/xlink
		xmlns:xbrldt=http://xbrl.org/2005/xbrldt








		


		


		
		


		
		


		

 repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners



		
		


		
		


		
		


		
		


		
		


		

 net of income taxes



		


		


		
		
		


		
		


		
		


		


		
		


		
		


		


		
		




		


		


		
		


		


		




		
		


		
		


		
		


		
		


		
		


		
		


		
		


		




		
		


		
		


		
		


		
		


		
		


		
		


		


		


		


		


		


		
		


		
		


		


		


		
		


		


		


		


		
		


		




		
		


		
		


		
		


		
		


		

 repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners



		


		
		


		

 carrying value as of the balance sheet date of a written promise to pay a note
 initially due after one year or beyond the operating cycle if longer
 which can be exchanged for a specified amount of one or more securities (typically common stock)



		
		


		
		


		
		


		
		


		
		


		


		
		


		
		
		


		
		


		


		


		




		


		
		


		
		


		


		
		
		
		


		
		


		
		


		
		





 carrying value as of the balance sheet date of a written promise to pay a note
 initially due after one year or beyond the operating cycle if longer
 which can be exchanged for a specified amount of one or more securities (typically common stock)



		
		


		
		


		




		

 physical assets not used in production
 and which are not intended for resale



		
		


		


		
		


		


		
		


		

 net of income taxes



		
		


		


		


		
		






		


		
		


		
		


		
		


		
		
		
		


		
		
		
		


		






		
		


		
		


		


		
		


		
		


		
		


		
		


		
		


		
		


		


		


		
		


		
		


		
		


		
		


		








		
		


		


		
		


		
		


		
		


		

 use the element additional paid in capital
 common stock. For additional paid-in capital associated with only preferred stock
 use the element additional paid in capital



		
		


		
		


		
		


		

 net of accumulated depreciation
 depletion and amortization
 of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include
 but are not limited to
 land
 buildings
 machinery and equipment
 office equipment
 furniture and fixtures



		
		


		
		


		






		


		


		
		


		
		


		


		
		
		


		


		
		


		


		
		


		


		
		

 repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners



		




		
		


		


		


		
		


		


		


		
		


		
		


		

 typically cash
 provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement



		
		


		
		


		
		
		
		


		
		
		


		

 carrying value as of the balance sheet date of a written promise to pay a note
 initially due after one year or beyond the operating cycle if longer
 which can be exchanged for a specified amount of one or more securities (typically common stock)



		
		


		
		




		


		

 at the balance sheet date
 of long-lived
 depreciable assets commonly used in offices and stores. Examples include desks
 chairs



		

 typically the entity&apos;s common stock




 Plant



		


		


		


		


		
		


		
		
		


		



 $.001 par value
 200
000
000 shares authorized; 116
852
093 and 128
773
859 issued and outstanding at December 31
 2013 and 2014



		


		
		


		
		


		
		


		
		


		
		
		
		


		
		
		
		


		

 repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners



		
		


		

 carrying value as of the balance sheet date of a written promise to pay a note
 initially due after one year or beyond the operating cycle if longer
 which can be exchanged for a specified amount of one or more securities (typically common stock)



		
		


		
		


		
		


		
		


		


		


		


		


		


		
		


		
		


		

 repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners















		
		


		
		








		


		


		
		


		

 repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners



		


		
		


		
		


		
		


		


		
		


		
		


		
		


		


		
		


		
		


		
		


		












		


		






		

 security price
 commodity price
 foreign exchange rate



		

 repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners



		
		


		


		



 less discount of $111
280 and $746
314 at December 31



		
		


		
		


		
		


		
		
		
		


		
		


		
		


		

 which are expected to be converted into cash or otherwise disposed of within a year or the normal operating cycle







		

 carrying value as of the balance sheet date of a written promise to pay a note
 initially due after one year or beyond the operating cycle if longer
 which can be exchanged for a specified amount of one or more securities (typically common stock)



		
		


		
		


		
		


		
		


		
		
		


		

 owners or officers and their immediate families
 pension trusts



		


		
		


		
		


		
		


		


		


		
		


		
		


		


		
		


		
		


		
		




		


		
		


		


		
		






		
		



 Dec.31
 2012 and March 31


 Dec.31
 2012 and March 31



		
		


		
		


		
		


		
		


		
		


		


		


		


		
		


		




		


		
		


		


		



 less discount of $2
159
189 and $1
047
958 at December 31



		


		


		


		


		


		
		


		
		


		
		


		
		


		
		


		


		
		


		
		


		


		





 carrying value as of the balance sheet date of a written promise to pay a note
 initially due after one year or beyond the operating cycle if longer
 which can be exchanged for a specified amount of one or more securities (typically common stock)



		
		


		
		


		

 repairs
 rentals



		






		


		


		


		


		


		


		


		
		


		
		

 repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners



		
		


		


		
		


		


		


		


		
		
		


		
		


		
		
		
		


		

 repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners



		
		


		
		


		

 carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity&apos;s common stock) as of the balance sheet date



		


		
		


		


		


		


		


		
		


		


		
		


		
		


		




		


		


		


		


		
		


		
		


		


		


		


		
		


		

 typically cash
 provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement



		
		


		
		


		
		


		
		


		


		
		


		
		


		
		


		
		


		
		


		

 net of receivables from officers
 directors
 owners
 and affiliates of the entity



		


		


		


		


		
		


		
		


		


		
		
		


		


		


		






		
		


		


		
		


		
		


		
		


		

 repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners



		

 which are expected to be converted into cash or otherwise disposed of within a year or the normal operating cycle



		
		


		

 carrying value as of the balance sheet date of a written promise to pay a note
 initially due after one year or beyond the operating cycle if longer
 which can be exchanged for a specified amount of one or more securities (typically common stock)



		
		


		
		


		
		


		
		


		


		


		
		


		


		
		


		

 repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners



		
		


		




		


		
		


		
		


		


		








		
		


		
		


		
		


		
		


		
		


		
		


		
		


		
		


		


		


		
		


		


		


		

 net of income taxes



		


		
		


		
		


		


		


		
		


		
		


		


		


		
		


		
		


		
		


		
		


		


		
		


		

 repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners









		


		
		


		
		


		

 at the balance sheet date
 of long-lived physical assets used in the normal conduct of business and not intended for resale. This can include land
 buildings
 machinery and equipment
 and other types of furniture and equipment including
 but not limited to
 office equipment
 furniture and fixtures



		
		


		
		


		
		


		


		


		
		
		


		


		
		


		
















		xmlns:xsi=http://www.w3.org/2001/XMLSchema-instance
		xsi:schemaLocation=http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd
		xmlns:fil=http://www.heponline.com/20141231
		xmlns:link=http://www.xbrl.org/2003/linkbase
		xmlns:xlink=http://www.w3.org/1999/xlink
		xmlns:xbrldt=http://xbrl.org/2005/xbrldt





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Plant

				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				




				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				




				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				




				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				




				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				


				
				
				
				

































































































































































































































































































































    
    
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}
  
      

          











        
        
        


        
        
$ 5
546


11% Convertible notes payable unamortized discount HEP Investments
 LLC
1
794
272
2
235
217


        
        
$ 29
707




        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 carrying value as of the balance sheet date of a written promise to pay a note
 initially due after one year or beyond the operating cycle if longer
 which can be exchanged for a specified amount of one or more securities (typically common stock)
 at the option of the issuer or the holder.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
    
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}
  
      

          







        
        


        
$ 33
600
000


        
20
100
000


        
$ 6
400
000




        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
    
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}
  
      

Warrants Issued for the year ended December 31
 2014 (Details)


          


          



Warrants Outstanding at Dec. 31
 2013
16
900
539
        


        
3
149
700
        


        
(2
040
000)
        


        
(110
137)
        


        
(8
847
097)
        


Warrants Outstanding at Dec. 31
 2014
9
053
005
        




        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    


















begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(0`CE+5F
`(``.XA```3``@6T-O;G1E;G1?5'EP97-=
M+GAM;"B!`(HH``````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#

M+_O'25H!.:3ML8W4]`&V]H`M[%UK=Y/VW=M$E1%!(2*U.\`GMG/BSTN\S





OF_3U+HFG-K#L;G?CT&O.3-^W36EB2LJ?;/6JR^2Y0YY.

=ABMO-W@^]ST]&M]4E-T;'[^9+L7@FY;_=G[]R[EU?KS(

M


M(*($`BB@``(`````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````(R2ST[#
`S&[TB\0^3[ZFY(*&E
MNTQ(NR%4'L`D[A^UC:,D0/?VA`.2F/;T?;GSS];WN[F:50?'&(O3L.Z*$&Q
M
V)[UVIXK9]6#Z!B(F=I%




`


8CWU7*;U:JR)T=;\[=H=*?7_Z




M(76CNS64X]AR')+#7BNX5.P^AFVLV436D
C)K)`(FLVD34DLK)+)#(AMW)

S.

(LRBX)


\+Z_^%+']`P``



M=R([=(/8]3WE8+:*7

0A$Z$9%A*B8[&9CVN[L?N





I&B/KXA
MBW!!J3

SIVXDVBS5H?P9&G]!A?Z
A%T=(Z+KLX(XKC<KTM&_54QQK*)SK.46<N<+Y+)-6A
(\UF*U[

KBE.A1F'


*
P)-!]C*1+4CN]CMBIS539'\9/665X)1/Q3FL08SCIIL
MC73L




HR@(V2E.+_CK
\SF#@6BJ7D]S*3M.8E&$$'9V%
MS+&Z$C+84@+U2NV)[%6&,FQ2AA%T=-[V^N_R9;G#V!&YFR#4DV2:U*&$71T



M_\*PBPON3C#G&7?46IQ1F5:$70FI7:U;%3=JID%;DW:NRX-ZNN3I(\H3`C
MZ.@LVLNQNKFJE8_V][5

M)QK


`4$L#!!0`!@`(````(0!G






M:/^LWG^5Q6[?0KD#F)&:V&+SXU$V.3@*-'


$J1




A(':Y%UX1&)L;PM38*
M.)
@Y%S.B+&(2$\-A
L$B+M


]C(

M2R;1&+IDM`XD0.MXR

M#@&^&WN#IF5JO*L)L'$7H$
G&J-7%D2J'Y)D236$VFL*(YU@HGGCEB!H2V##

?.;UX6?J)'WAB^08-P31$^OB#@-_!JG*HL'@NKXFQ@_]
M@/4NFP+OZ@MLW!A$3ZP%#G-_YHNQ.@/@N8SW!AO:..D+M\WKT&;LBCXP49O&





M`P!02P

2EH3:?.6



B:`5




M9&


MT
G$3V:([1B!([SP\3L[41]H'QX7NFBN


!S:Z[\```#__P

M`\&]0265-H?MCF;?=V;.
@BC:$`$DMO=?S\IB:7J25TV/1R


3_]$V

MV$Y_Y
SO@]4IC


:[=4VF
AE\66[JX6;FW[!EE.#/S_U*M7U*=7/QY;/1+RI.+
MVZH^%YMJ-A?2



MFH((CXN


MAB+!U+CEPN@9B02769H.3HY%@F-:G
$M)B+!)!]
2
=4)%ATPX69B+!L&W-
M`1_F(L'4+!N?+@N98--Y&0M10)W+4
8)E+ATR9
*GSUE$K86/`P*FL9QTT+
M7JLP&+5U-=P`&`JD3LN@4PN-:680-*HR/#'&JO*\
&+*P'
-R[+\

M&!8VE&$#7!O)

N:`@JV9S*L@V-S&680\84
ZXXK?:`KEI]E


0;43Q<9G(%/O1S#!48?&:XN+A+8`V!S6]-_

8M.E*KT6')':V6L.56HP


%-E%@

M`!N\N@ILJ

IIRIP+D*



M0][G79ZC@IRZ?$4O4.&CHSO4)#:G=X1W-'N1O;'9Z@M8QS/F/B#N.XD:IG
MC-O180

A

37G%@%#

M_YTH;5W@;!SEMW&6`!RMN+%+X2@Q8AMCE?P=0(D3U9.D1Y(
U!_7TRB=Y$D^

MYY-T1K80(3MB'L\Q[Q+XB[GH2`OEXD6!^*_+LX!P83&/7BLN2-UQMX#)B1

M1Y4#G^:1Q

YC^':Y3SC0T-W=$U
M_TKU6K0&-;R

MAWK^!P``__\#`%!+`P04``8`````$`




C4U0JU2X=




M9[WJ\O.'T:


AV5`F78`=YT]:^ICK)=CL7.Q^Z`KP0U@Y

(2

M1Y:K



S'$.L[X4*



[9J*O9T2ZM*6AD_Z)GK
M05L


`4$L#!!0`!@`(








R/M
$SSB()WP$<?B=:)'G`7/B1]Q[#M'

8W;K`4W5#C_P\`

!'@KP2(#'




/?9VW*M`@[\J3Y=QOO97@'LW!?@@0`/!7@DP..O



M^`A301'&*




'[G!C_//




M^PF2]*)D$`__@]$_


'[G(&B&




M&3=1G*I)U6W2)DW3/JX)QC&J

MQ4

WQ4BR
MV9=-KS1==Y#W4Y)3MO?VBS-[*9A61C4V`CL20
]SGI(I`:?%O!:0@2L[TKRI


*
M0I_\_T[4MJUP-HF*
LX2D*







5EO#(MZ%H.
&Y3JK*
M


#T<?`51)+N#``30:]`-I:0H`/A<0H]PO%'%622SAT(W&(C0!
M
U24]

^XN7-HL0NFK/Y
M5D9CH9E`BQ:?:Y^5TF-#L*[=_@WA^%Z&U%DNI;-[5ZW([)+!&:AUJS@6DMJ1

991PRHN8*8UV.#M^0'
MYEM:Z\D!6SD*%O66XN(.9!LD:_!C=
PL5!?]W!19'`JR(*0%PP)@\/ZHK3
M73V7_P$``/__`P!02P


MUON`[]X'B1X&F?=.X%L[^=XJ`AF1+MAI)K+#KF4W#[8ZK)E?




236:PV0ILS1/BEH06:U#38I-B5S82C`?&#.@_3S21

M``#__P

M;!R'6
1Q9)O;W_?8AHA+U:4\A-B9



MBSMZ*9A61I4V`CH2A-Y['I
Q`:;II!#@P


TCB=D!Q&R$V9VC^E=
M(^;WB#1..@P!@9U*\/[_*ET1N

MKT5C4



F1*<]EF./0C%A+

OS





LD\F(4`1UNFS3VWE!C1G392_'&@T(H:2*(#=P/)&'BQ5$R7[R'979@B4\L

M63(

M=$4^!L0IC

M&C6L!
K`FX
;3)


MK*0UD3YO:0/_%%S41
&CV`2R%93D)JBN@B@

M31ME202MB`+_LF2MW+/5V35T-1'/V_8FXW4+%&M6
?5F2)%79XMOFX8+LJX@

M[*MU^^^TK9IE30[A@RTHDM\K='*C.H*-#XD;&1\0H
P+M7



-


V$'TOT'\P]+ZV
7A]6JVQZJ4]DMFTMUAB?[ICV5/?S:OJZZ



WLH+-M8/3T.!OU3




M9I9'JA(LU]
4
I7@.FMU`0U.YH(PC;)0`.03M#2J3Q]OQ9Q
_2''72@XTYLC



MLAS8O3[V:8BB1I'E$DK2-(A(0V*)*^8N=9G.D$4)W!YNCC;%%&X!&5DB%*



MH0@3F.U[Q/)8





M&:IA0G14J3BPS9.EEF&+;KV2;IBW/M-86*8+]X*WJ_7Z*!Q7Z1481
Z7*'
M)1%I2*PAB8:D&I))1
R$Y?H^=)OXR
VUH$)%L`6\RR06W+`7B=X46T!&$3*E


4:1GMLB#25I6N.1AL0:
MDFA(*A%IP=Q6JL7D&E*H'9@I@'^O`BLF0;8H@VP)*D.B+`)B35.HB&I1*X=
M'=U?




B:`54:!?EJR5`UN=74)7$_%\
M:&\R7K=`L6


MO/YC0&Y/94B\G@3N/8F[L`

M7@E^M*#U0+ELB6YD=PG

MG
-X4\SV'
8?





SD-0O%VVYX
M[+BB=D]EO#I#!9L`W@@G
U+/1L'W^YZ[\```#__P
`4$L#!!0`!@`(````

M76^;
!2&[R?M/R#?%VP@$**0JDW5;=(F3=


M



^+[6L-H+:
CTM2J?

MQ4%IT?YQ(C)8.9-P


FB9)U\`CY%X/F]BU-
M.M5LW](L1TT`B,G1/:2\_]\1IPC.+[@RT9?V\.MTR26GB09QHMH)MDZ26PE
MV=G^@D9I'8YF1'/R&(\(W




%S&U8FUA7=_\TG7I@O%TS?`4P2AG6NO7


M.69EN`YQC7=7


54&2KI3J2
:
M_UW99A3JMN7PKFRWO6W8Q

7R%O6N0K^KT-Y;
M7Z%7Y?+%U^5%*88JK1L2VVN;SCM:V7A/*&
#-6?DIC2]MX0-:-R'0;W.'#I)
M?A!+0GC4F0P


S6KZ1$0;?785;3
M0IV96\V(9HJBPRU769O8G
O!Y+EJ
)A;$SH;!/T06+D)QW[-&LX[F)&QMKOU




MA.




MH6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N'38-36;_7
2\
M/5CLJG:]69[MO45%]
2BS:IG60'

M#MI@TJ2L:=/625LMVZPON-/-^9XPMI;L+/X^I['SYLQEY^3B11H[M;!C:SNV
MTM3@V9

MS=*MOP```/__`P!02P
$%``&``@````A`
X5/F[P@``26````T```!X;]S
M='EL97

8


V-/0J.]H=
'354_545;^XW7OWW2;PM2]N

7V

M=9A

`\;N?UE'R[6_27^_^\.Y=]]_??/O/O[KS




Y5@D`1JP2!(E:'DBOP4#FK!($B




MI!

?AH62;.9;+M)TD(6
/L$6C&K&M&`#



7B9(!
\I^LT:

%-*@/X9&)`;7.0(@004


M:#!4E4B*056-+*DP5)5(`D%5A:1
JJ1%(.J&DFH4%4B03PB)(*29E052(I

W&&D$@8L[JC%@6JC&@'QG&*2'H:0TA4XRAR@<G;+#Y9QN:HQ5

)HHF+&PDN
M'2!4?]Z_R\@27*[D!QS3;%VTL4


M8MO#!#JPRLSP0+3IS8Z1WVCR*/ZC
DNJ\:85\I3EC/X`N6`IR8I@U=W7'Y


M






[U1*R13((Q:9\($(ZZF4@J
^

M'(H-YVUKX)?40WP
XX2GC9@B%WCWX(

M1



='+UQ_Q
!O(8GBN


MP]$.N1&=5?%_`-S_#P``__\#`%!+`P04``8`````$`F@U:_)-R``!.OP$`


1$$T0





KE&&Q8L]/SG??1%64%_=7N#&






1#A%AKM3=V6NWM'2=%N[6ZOM7:V=C^-&+X+EZ
M

-9(?[

M@FD:]`8-*^R\
L]Y/1[V\3H0Z9Y'Z[PRABRD;WTAC[+UI[LRV]\?G!_M[;XX

M'*I5'P/8('1BLE4*U8-/-63L
4^[I#WFR400&X^GOOCL')?LNG=RF
DA[9X?


DG^%M7/4





M
]'TY!8D94AH5P$'H44^;0`'L35@@.47L+?A94K_/9768V_&HQY9K&S$F[[9


O)


M

8IWGK\^.SH^.#NK#Z'(C9#M
M

MPC(7AB92DT^A



WY*Q9L^R'EF?154B[_^VO_R=^'%;-RR8!8ZPHL;5L.J%C

'3\:C=;#C:=

MS*=:Q
'EI6M]5JRE[4T?\$MCEO)RA4K%(=``?7EROO=OSVE;05'M[ZEU7'R5


M/M]]TQT
52SWYQF=E;/YZ1C0BUY.YZI=R*U`X;0DH@L+B-^PKS%TDNQVK
M1T4R\;B3,2=C^+?9'Q?!_YBT,(U9/HK7!E7'C9CS(OY2Y7;0K\@3&O#BL



M`S68(/PIWC;?36)0YD-_;KIW0C((+C5\DZF$

U(`VUI90@ABDN--44ZB:BU3^%K*



8K:(I5

E($7W_HX1$.*
^W*^NR198)!##O%/
M

M\G\K6`LT0X4=3F

]HCG54)D/%^NM
;V
MD*[[PALUA8@37=


?%N%\):OPEDH^Z06)'H











'1;\+G]AI
MN2+:THN5GABR6-&%F=5!1'%2RECX'HB-B%QO0HDR\:#L%PV+ZI%H?6+5FN*N


M86]CCOW8FGGHF17PE9W


M_LD*%BY5




\G0'@YM1M3;V2)6MA





MNAD%D`/-ZUI9V8/Y..4/0\9T1=UU;R@F*K$B6Q/;P8/)S2\*&P

MXB1'R6
:7_U1%KLZE`YYP:)=&X^J-BID@.5Z9Z8F1.R
9W:$H:;I
MDFKS6.=3+1(MT;'Y:1K[H$3I)7G0LN;%#::4N1M\7;.$ZM5@`UQ`OTM^_72

1Y&

MG$!0;]IV;;N?:&'_D-]\%[3OQ7F:I#



1C]W#%R%9GBLQ)Z

R(J2P\(HIDB[

MDX^E20#MD=CD'



=0!F&]%0(-Y#HL[L5#;(X`




V5+K=7SFN!T[


MBN4*HXDA#ES(!82
O%9HH;[5:#$)V$;$H!(




!AJ!ZDJ1JC&??'D2`
M]F:




29
MN1
8IPJH)A'^)U:0@W5




M#U)B^4Q)Q91L.^$GAX
74L9E2G8=L#IX9A-@AQLJOJN#;S
_BO1E%JYM?J6Z








;/_@'.H)@B8H/GUTLSTX0

0ZL._6:((^(1$C5LFO4C87#A2!$FI^@]
M0R$_2)V6GUT@-5J5-
ME'(UHK[NS8

[A;2+IXP




!-`*V.C*Q@@UEJ

MI/=EK5^N(C;5HKKBOP2@0*_M3?L;@VN[,!=4&093'



?T?\4G`122XM/&.Y



F!O`9?B:?I$S-XGDI]Y-H

M9B(

:

.9R47;X;LPTM^


O*CZEVJI\%`?UC$ZV



^.$
MWN/NAFN&I_M+H_9#TH]!XY7VN&6=2+F2KK7T;
W8_T9CB^62;
R4MHU\MGS

-.+@







/I'.(2)\
OJW3*[5SDHA#F1BU.6PKN`3\9N+?]9





X34UQ?86J8?Y\5

M
XW1SFNA7=UJKW





MIO6*7K]0ZWZEP'):)FZ\U0*[I'*W]J9(7+R\QUJ)+M:`RJ-Z['Z1M&^54$LD




M^3$L45AC5/O4XSUSE\F!M_(L;%$05HXN=GM_Q3QOBF;NK+W17EG?^`+HX3^
Q1)09Q(34_K
M.DRH'#<;IGIJ;9+&WU(RT5(5#!.J_#_^Z96DP]E`I0/8UD'2(7U%HVC]*$/


MQEC3S5Z6S?*\T02EH:!^EB]Z3/%J[U&R_+.F@1XMYZ%JUB.(B]JF1-N,N46
M*2XT-C4*V;`R*T066QWV']Z_MC2'Z8UN/_5WS*C9(TZKXC&?H-#`[9)\[$H
MY462VB7*;

MW[6Z
D?8R


].\M

%%#0F7_'
MH$.[:=



4#

M)HE;%+2(/I;6

:T'/9;Z`KVM6?2YR0+BO'ND=WL8*


W4+-*U7--6^%




3VA(*T*!+
M5D*L@='BVE7[R2!
D.)\+M#W`+*P%B%+[ID5(CY%ML`9:]_5



_YK_8M/E-RFG?@\\0WPY!'BVVE%
MT_




M\L-%]FY$D9YWKJ8$-L
M`%H

M798.?54`QN?6Z!1$T;2^_)+S2/.DBSJ#[S

!L^!6(W2!N1'Q5+E3Z[(J#
M@8NDJ88S-UJ=CG?'E(;M`9SYW\I1%_N\WQ8V2?I/8PS7ME:VU4/8V5A9W?X5




M48LHEZ3$/D$[DF+GR-3DR4!0BD;B;7N=EL_#_&)B79@DHD3Z;+GG)RC`-QK=
MCBY[_V


MV^)[0!ZU`DVO53WV'A!$Q#M$;.&__)Z/3V]



V


[R]0%

MRU=L^__8.[/E.*XSS[]*AH
*4Q$`A%JPC3V
`$'0PI@D
``DM7U70!7(LH`J
MN!92]

M%APA;JT8NMLB9K:]97#L`U;J9FWMMM=:6SO^4I0FYBXE



SJ;52FA2D:#=J`^/[*PK
(8;\BX*=&


*`*R=C=YEX[3
;A
MNDAQHVJES.1JX0R!Q).MQZYX8B%.M=MYR(BG7WZ..;#6^:]8Z@=!HAH0934[
M?:F4O)]Q2-'3^^$QOYRI@.+U\,HT4%W].HC.Q3_3QH^57
1-G7/_ZK%51HH




X2PT;ZL4/_V&V/#\LQ1D;%1'LDL@A67H%$'*^T-;(L/S5AJ
MXI&BL)IG:GZ)=&4+




]ODAPV=E;


P-

C:Q&(GCRZ[
MWDM?]J

MPE



4<D4S/\

J*K5
[S$TF+IJ*R5HN3]SZ8*5RC1]9
S$\;2`N;2W-W867_9#

M-LOA]Q:(3Z6'0NB]1S((FZ4_4GR!4C^7`Z(6?_EY%]S=W4/TM-#M0F=`HK_W




MRQ^CK=?@.JP6[%V]OJM&*1HEAD(G/!7.\ED)#ES8SO[9=])Y6NNXT4
[$JY
M_W_/X;?//OC]!\*[OV?OVNU?L=_78ZOH6W


ZTJ6Z&H_%$?_S&5ID]:X;I-8#8O51A6X^QI5]^
M[E

AY^1_LV?G?)1B'8VI(4IDB+H:VI?OR//D



MJ6-`(D%#5%+N'JQ:;2.=3'N30RB^D,HR&P\F9:SY4*5NUC-!?*M;TJ]2A8

XXV)E'$MDVESK[.)


2'&0;=\=2


-I10YJ[$M(&&'4O]P5`Z9_&DQOX.C#ZAE@F

M]60C\TN@+[@:





+36BJ.T<!;;P:S=\XSIX^<Y^7I=.#K4CO7

M=79\=87394)S#ZN&OI9MA4H\!2=-.*S*C1KRF`O5((B4R8*-$#*%[S0
SU(5
M3M7AMU65J.&\FNINZK\J]PO7W1C0)(;$RX6IW'O=3=:W:\`LNY**P2D?P1

]'IGSF7W:8_BU`UQX1`A5



#0Y5V!8A



9L)TM1QMRH:P$E'48V`7L\T9Q9CYK

MBB;CKND:03[)A?]*5[VEST2A@/R5Z@7_N[].::NK/$YWTP53Q[O5D7+=:XL*




L.E0(_![/L[L(L:2B5/O-]F$N$])@56K1=!N*U&.&*



M3@\LD7&6G0[4DU

+B^'@VF4USI_2&)K)8?%R\A_*I[
(_B



P1
]?JS
=&0R5OH&T!
M4[F]
3D2F`3+F7Z0;-&B!`#'N.)0W(;MF`10P28PRF]
DW]?EF2#









F+?=&7T^S3D2]^\7A(]

%[F27MO=ZU+0=;X#1%F
MFI#M0+PL]J7.X5&:VB'W6E&.*:.T)GP.DS:JK3VX=/Z9:U
+'2/=UW!.OSF%
MTU
*RH_8#T&K+L


MLRO
/]4#%1)E3H

P^3
N+D/)Y7-CFE/(1[T_G%S7`F8BV)`$GA

HS%50`K\I6R!+#
*SZ?CM

MV5MZ
[0D5?^Z!M5/D&:`IRI+T/[5D0@,VQO^ZXQXETJ(CB84F
!%DC5_#/
TN1Q\.E@1FR-#/A5\9);9
M6W1%4G



W9X=?I]-9


M)QS\A)D4]#1IDI]+%ZI+JSN-&!RRN8IF6ETS`
9RVP
G9/'0415!MZGYCAR/BC^JAB9PS%=]

;H5GD30[0:_C4!N`AU.



.!^M*CI:S5;B

M;V373DZ)UR
?`6U=8




MD-T:3P0ME??)*(%E*8-O%^
1R!IW(/MF]+ZHE[W;?Q$B/
M'JQ'G&C%'O`*Y
M!#@OA






M2!4!7Y1:NIJ(3LH/?QAC]Y^(\AN:-G@YGIT7\*4_!E=8!M280)T_Y#
(8L


Z
J



MU\5HQN1LC*-H=V.BDHQ9!D\ID[CK+I['OZIDNO(KZI)Z%^`2Y-D=M^;KZ(5U




M/*J2B_K2`(

&PK[GV753JVX:8L]O(90$[1K!Q?^!&)B/\^&MXKD1=@NM
MD[Q#[WS_/ZJ-#P$QT1VWOMI






^5
M

(ZN^P*(Y4;;6LJ3KEYEII*D$N5=F
M3]'K/JY3@E0-[@*A$2_-NX\^Z:BBVN;F1CJG$22PC!Z+\`?LPI0XHO84APL]


_%@
/QK+@



MPS16^\M$-::\FQH*8TV#DT+&*VH9K#I9A]@5U-Z&K22'/`L4*O+#8OC(
M%'PFY)B^4R(C]X6=%


FLN9X#%LU4;=T&N)9IHS*.T:8-;&



89D2^A%VA)6GQ^Y8==<'#-),7_:I&5#G%`A.'`^(+<'1:3;HA8A-HF%SMW


M?]XC
7X((8+E@];!M


YT0K

MW;L:H1%D:4AG;.Y3P*6E3O[J[$`HT$8!;)+_!]9J?NC)H)/M/%\P$30G
TX.+/4LWSY/3XY%^5



M7(=_BS.]+BS@A.'#GX0M%%AY9X1G(]+IW(17@(`7@.E[Y#&@%OEA-ID[:M5T



=




=\M_:2X
,M!I<++/4[Z/-ULX8I*
MRSO'8'+2]<KG#W;6ZE+W..WZP:<=M_+YPQVWLM1]COOBTX[[HB+/=QY*ULM
K0O8S!(SYK<4D/44J6*Q%OQQ<
M;&14:#!3:CKI\25Q/Z&K;/HCH5)X/7;LRW;Z8VDK*


G/O=B&U(
MT-7%!Z8V'.%F4/4#Y
6EDLR=ITSWU/JJ!


MY]&^+W*'29YE'?0C:%Q=7/&=[:&$_4:N74$3^[&U5X\F=#9&&'#!\I4O*77+


R^6575P3

&

8

K^1OPA7?'`
M[D8`F%]-.@;3DX34ACW'5**0\T-&'AZ=Y9*,4:<F6FJ*5=./U$:.Q+UG8K3
MUOR(OM9$HFU-VA[4TM*&8Z9W%9W`H5-R




M';57+*9PF`BN/(EG!;`OBA`5^%PT=64;SO7H0S
Q#
CEK(MVR6@$+LG-ZFN4

M.4[*QN;RI7S6W:Y^)P[G&TOIUW282T_U?8C`FYI=W3]#4VW^%29D\[EK(0Z
M@5)5+(N++_KH4TZW^DWJ]9%0Z4-0&55&/(I[H?\^T_4Q7Q+I-2!B\1IOLH2
M;?@


MA!\NE

MS

M^`:QHX

RF6M'$7H+W6:N+]#JT@2MQLN-JN%\=I/ZC?MAQ*G-8@81MD[WYAP
M-91RO*'`#=@T&H8P(F)[?473Q[UYE[Z5/&\Z=*O[UY9

.&^E\GK6!MQ'1!.[Q!1(#5G%<.]/Z36M
M*DXK6#V





'_J4L[D!=EUKM
MOYE.9\_^OP````#__P
`4$L#!!0`!@`(````(0`C638(U0(``/L'```8````




MV?VFY8*L:\C[4](?N`VBS/ZAN62UXJ%^@\*_0\YZDW]8!I.2\89*!M=P0M

.K
0_'DY
TA)Q]SH(!
*


M_2-@('#R/P)UT$C@Z/S

I3E\I'C1XW\/+Q=/@

MCSP-'LE+AD=G%F+E03






M

S;_
M

/&([FQ47Z-^J

M;8?#VO;11Y'@&X]5SVPU/%0MI6\=H/;?T?@GA&8Q`J@GC`7HS3!8T#$H1?
M1W&0$4_P


\+

29&2

W4\HH3*]S5:T
KWJ\7`!BU#CA0A/J=EE###
:1

M


/V





M`G-UBCA7



M3RHPJ.%#Z(4)E-#04



`4$L#!!0`!@`(````(0!%#T#D

MG[3_@'BOL1/;::(X5:LJ6Z5-FJ9]/!.


HGC

MC6B%/7I2C1;/-6=TG33@N]#DE)VYO:+*WHIF%9&538.A(2O?8\)W

MD``\D11N


&'#&ZT)X





B7`M)@7
M`ARXV)'F98Z?DMERA
EB[O/Y+?C1])Z1J=3QBQ;%-]%P!O&Y`:P46KGH,^%
M^PN*R4WUV@_@1:.EW1?VQ_J^)6+;65AVB

U2``


M`V;H)]IO!%7]1L[J\+]#O%AU13D&RE[#\57#@!G[(`:#+'97!_G'Z_!6POVT


6`6


MW]=YS5NF/=GS#IZ44K7
P%)5ONX59\40U#;^)`@2OV6BH\BP4.=PR+(4.;^1


M_=5RJ
\?P;?ZZ)KH6FZ_*%%\$QV'8L






%``!/



$
I
0J&]*`TS?L=^/+8G


M
D4NC\OGE\NWI


T4-JN=QF


M
T=5GM*J#C
II2K)2U47^7]H-%H);#QK&\.S:RP


Q'(^M^SE%[IBMRKPO(UG\765
M1:LSUM?)@](PREN,L:/ZWB[+HNK`LL0)K.ZQ')1&RL0EJEBP6`?IPKDB&SS
M0S9JFH)W!?G]NK4M:ZV]0DXFK8_[R&=.?;Q'/C;U\1_Y+*A/\,AG27W1SX.



6





4#=MX
M70.=.C2LZUYK1S;6`BH?5AGX1
3Q1,,6<1`F*77_9YZF`/AB-$PPJ4CJP;I]/!
M*I/285GO&K0496:O-7^VK/HIG#N4J=OUP4+$(X&B`9[2-'(VG$Z&JPT*1JV
M*%QYEP



M+V`^0Y2D:@+=*FW2-.WCV0$GL0H88;=I__VN;9J`$[7)7D(XG'LX]]C8GMV^



M:TP;6RM



\`(2!1G'


M-6?@T00R#20J13^(/
\8KWQ0
?(



M\2R+#
\38Y8N-6?@60/:D8]@93`J
K

M.9ND6F&RDYI\B(R=RVWFZBD)Z/3O(T-;-F3]-*;!O'$_!9[PK&U[`219S#Y
M)L71QO612N_W+=Z2[[C;TH9;%=G`1N$Y:PUG3Y0Z1O!6K6OKYF`@Y#ZNX.#
M+X$MS7.`O&%


2YX;6R455UOHS`0?#_I
M_H/E]V(@@80HI&I5]:[2G52=[N/9

SN[
MFV5Y^=34Z)$K+62;XR@(

M%K4PSXX4HX8M[C:M5'1=@^^G:$K9@=L=7M$W@BFI96DH

Y(18%HM






&PO=V]R:W-H965T<R]S:&5E
M=#4R+GAM;)14RV[;,!\%^@_$+Q'M&1;C@W+05+#;8`&*(H^SC2UDHB(HD#2

`]#DFI9-AKE3''9T8BP

B
M?%J#%6@HPB19H%TBP3P2I3TDX&&\&.X'V3IFH*.\V0Z&XU3#=;L&XC/20E





M#G[3AQ_PZ@\```#__P




M=-_9[VK\S$736JAV#@&YN!;5RY8;!@D%3)3FCL14!P;@%TGA.@
20I_]_R@J
MVY9X-H_RZWB6@!SMN+'WPB$Q8GMCE?P=1



T
M+GAM;)Q476_:
!1]G[3_8/F]



-KJTD5(
MQT*AEYHSEC%D6BX*B0I\VXF!

MK-/J=P#%1ZI`DAQ)\'TDB6^C-)E
):?H=E1A<3S[99I-%VR//15'S'W`X'/`Q`.835#

M@H#I[?A*5_H_7U03E'4T+4TR]XD#)AIW_=XG,7)[&UG@[/#X!68CY!TU@B
M]



M%(;O)^T_(.[+-RE$2:J&KENE39JF?5P[8()5P
AVFO;?[Q@3@IUT2W*1@/WZ
M]7/.
9PL[EZ;VGK!C!/:+FW?\6P+MSDM2+M=VK]^/MXDML4%:@M4TQ8O[3?
M[;O5QP^+/67/O
)86.#0\J5=='-79?G%6X0=VB'6Y@I*6N0@%NV=7G',KZ

U$L#/*]+Q@UN37V+7(/:\

M-.;435UP6BT*`A'(M%L

MACK)FPH?9;2IT(.P6+W9/5C7X'OSIPB7:U^$'W7S#95@+*'4-$
K!Y\?:`






SV'
ML


?ZU6?P$``/__
M`P!02P

M+W-H965T

P$'U?:?\!^;T0+D4A53I5MVMMNM5GMY=HP!


'0Z)[4Q?19%FM6\I3J4

M0PWDKVO1ZP-;R\ZA:ZFZW_473+8]4&Q%(\R3)25!R[*[JI.*;AOP_1BGE!VX


MXZ*J#1SW#!RAL:QXNN&:046!)DQFR
1D`PG`-6@%M@94A#[:^UX4ILY)L@R3







_-


MD

M.^)XM/Y\/.UW__4Q?B0W1NG'P)]^C&IQ
:^G53%@D



M++L(NT/8854*=`I
!:HJ\+L_X3RK*CV+*ZA.XZ$-69U-!%=%U4G0*3`1$
M#=CIXAKR!T\W`S;X9HS_OS$#+J9LC]U6X411403
3$1&6
?CS

MAQOU.*2LQ_%'293$8?U
\&$4W$Q$24AX




M71`R`LF:K)=%-;TCO7



MM!X7[2!6^1G.:@



M5ZR^8U2`8J09&8%D38

=*

M&V
H1=)U8^7<F&J%YY1IJ1$4B6-,AD*S99C^*=GI%BI!D9@62:
M/\=D*S99CQ+ETX5LB`K*]^[<(<U11B!9TB3K=AD/<*AWR6P9*08:49&()EF
MSF3/6

C$`R
MS8S)+H9[;


@+)-#

9



M;

W(

XMM




@+)
MD@8Y;


GI7)`DYS



GCZ\*&H_DY*7+[!`5)L]U


M/S20D0
A5+DVPU?9G@4OPC)2#'2C(Q`,OW,
M9<89MU<:ON[P2YX+H.*?EY=QVAUHT+'[B#4C(Q`LJ1!5PSXZ`@=3PY%.2U]




RAE^(?9U0=<)/&
M[^S9+


M

:#$1-8A2'
MTO[[G9E\%#LV)'D!






++C#2HG(8`#PZN0I



\XL#N6I#ES2?`U$

MJ$O:ZWH(K;%A`0@9%&F60

M'[0A5='HFB4([^);0A@Z)IIL#ZKM&+A6%OF]1-,H76-\8VE!?43#-&2A-
M/:MM2%5D^T$'U/!=%R!:8VM!D4F9[AMW$'?&=J0JLC2.P2CG('0FB*K
P33
MG('2-`Z#
X2^I4W`.1NQ1GUGH`(P`

:37.&H.\
;4A=(TNK$(QR!D)K\V?M

0C'(&0FMLUIXAG.8


X2CG('0

SW.Y4*4WC
#D#L_0
X2AG
M(+3&9G6&R.0


($)N/ZODM(T#J




O





X@VY(EGX*DL

Z!J1_^A5'
M$-B*AT_EZ(_(V&^E7_&;2C_XO&^E



1C?V2

1XP5

VT$+
M
V
6#(79AR!V3!<*!T<6-3ET#67LLC6&L')OKW4F7

ML&C#9''$_9-4!NE-M$Q9V;1F?/BA?:6@OY:7GQ6TEGDBCGXX`]0:MQ)2N2?3
MT*K5G7+2DH^A&$
40\R`3('\`+\B\*8=RP\WJ[05]$X!,?WD!:^6T!S/UP



6OHW05:73M_
MAETY[B0$C5ME)Y*03H)2#BU$Q]C-XHA9C)-PGRF/6_6)G:K(GD'6UX\@@D
M9)9U_S2Q1WNK7JYPE'(?YF


M[@-K8N+Y7]P_%\*60Q4@YR:]#

MJD$F$L*ZVC//9B)C^&8\]'0R@6_:K8Q\X/'P!H!7#
/MDD]\^!L85\%GZ)MM
M0)9;D57K.7`7^=@6@(5OX8ZR'2=M/(!P#3Q[^*'M#^.@;^]9+&)(:#(8&(


MP0^Y_@A:\*$L&_4'1
_K[K4W_P(``/__`P!02P
$%``&``@````A`&M-*R^J

MGQ8[(1]4S9A&X-I'-=:]W-5%&SEJI`]*R#F4K(EFH8R@U1O62TM$%M0^(P




U4_J.&TN



MMS.#E$S




!E]-

XKLAP

MO727HAMHT=O;82TT7&;VL89O%X
#%@8@KH30AX&Y=E^^ALM_````__\#`%!+

M4=SAT=3



K%@7LXG-$K*8RV
MNG(1TK$@]+SF6W;+D*F8EQ(K\+83`U5.%TFVG%%6S`=_?DK8V:-W8AN]^V1D


MEYZ2$K&U3JM?`90

B0^:`L.H\D\B49TG

&GR
F&1$
U8R24
:QI+?M.63V8)_9




M-P```/__`P!02P

M)'6=(HN^[TM1I4]'\/LM&*59QRU_$/HBSRI1BUTS`#I/&4I]GGMS#YA6BVT.



M'GC4NP65\#^XA2SH5F?0N@

1
MPV1H/=WD+]8_LDA?NK2O%1)?5Z\&_I6L?1G5I

7Z!_=5]N%PP*


ZC.@


MTQ'30AQ)]UNH!IAAH8+
^KB$0PT?W/HA.2'L%UH568&..ZEIFPG?MW;1I).X

ZJ6L\IO
:2;9`VTTH;;3..E0MI$1)9(0AF(Z:%..WNMU#-1B/L
MM(MM)$83RQ8B:HV`HPQ7*G=*G5L56JK*

@$R7/O6=


M.!9\7V#_P?#[Q)%\#Y(











MMQEM$2
!FP!$&:-%4A[CPLD/^59G5PB#^Z3./J=LKKA&QDHA1B$V18@GQJ;D
MZ2[-G@/$U8(A!C%.C!?5**3DZ2Y4+Q+ZB17B$T1:@R(IXTY+;9+;CBWOW3O
MD;+L1DBE$*,0FR+$9L9LW+4WPQ#H*:VKA6EZI$27)CHNA(Y=4MLZHQ;(L1\
MSLQ/Z^B2F:!'4AT58A1B4X38N&6`G

P_OL*Z:IAGAX10BZ%D%U2)Z1;(H0
M]253/RVD2V:'DF%5(A1B$T18E-`M)^A9%
/
PT0:[FX%%K&K$Y


L6YJJF&3A#&5K)R6DR%IC&KTU1#
MEB#FW\NDW')8S/L!2J[T2D-&0Y8@YN1





D

SJ--60)8CY]S*IB3:I`*6::LAHR!+$G)PC





-C73-A6@5%0-&0U9@IA3QJ;<(K7G

MN3)M5FR[;2$J6
35.C5F+BSN=&.:;#:R%J+&%'(9VV8MFOZ(7)H1:=IHTH@6

25B6T_2

*6=2



D%U-G
MW#)IJF&/I`8IV+57\6L5DC(4L0\^_E44OM40%*-=60T9`EB#EE/.J
XVU+
M[5$!$N




8^




MDTRD


MJ-Y_KLO=;^6Y@&Q#G50%7JKJLX+^NE

M^7IHH=PN
%+$UKMO2=%L(:
09BE=%6E;'6$!\/_L5*K6@(SD7[O/]W+7'C9S
MVUNZOF4+@

31

I_!/H(J-)=<[4JQALC76F-E^NI_K_A0=17DDXJRF<
`


MWR7
#J1DR4JY0_9]!T()QHM):9J*`G

$ERU!8GL7R'S/$





X

MT`Z\(1#-AM(;1C;ND_

MEF0=.223;A09@\)*/7#.N]?

M_


`M'A-*5`5N/.L%4B\;U+#S;





M/I8'&-G4S;[HX&OS
F^/35FL^TG[W5R&83S?%]4AP`@/S2TQZLVF6I6?ZM7K

M]_\A2-A0&$3:(/!I@P@YDVDDHOB.*


MW`=
11AF49JD`X:0@YW@I\4TD;ZXQTZ%

5YZO`N$07S.0(%6
MO-\J9A)/4\P8(;&GE:93%QG]!1S'Z53J)PB$`8)I3A^\P
F#-+AKB8&\0@
M



-*[LCA&W4$Y3+4$$
M\?ST@[GPK6(J




QDDGI;B1*[



MFNG^4B+H`C





]M/)&



P)NZ[DY?S

M``#__P


M35$2$5$42#I._KZ[HN)(L9$Z%SU6LS


B4IJ
M[B+3R@:^%

42L@;([9:-CZ0

;%


MW+G!

D4F8&@J`*]$*)P
:PI^Z^T[EOLHHP
A&


MKPQJIRLC&)6QI5C*=0@
99+C



M:&5E='


M/)O$@-4DCFQ3VK_?&3N$W(#P$L@P/L=G;IW.'][3Q'EC4G&1+5PR\%V'99&(

^.VHG#5\GC[SQC$&W($V9@+<0KNK[$:(+#7NOTL\G`3^G$
M;$/WB?XE#M\8W^XTI'L,BE#8+/YX8BJB`+
(!@C4B02N``\G91C:4!$Z+OY
M//!8[Q9N



M

8WL\D'(^
M5



#0Z
M0Y4Q;8JQIA431/NR90V\*:02Q
C*K%N%2-Y=TC4.`J.1:$-\@QI.H:#ED4
T.E:(%BQVMN7CM2Y`F:/I:-
M5&17@^^7,'TR-T]3.@%ITIJ61@?Z+!+=.IYA5<8F#;KG(



!%2$O


'0@*1NB1W!

-20JX8N/&_B

M'9*?&G28I)N74S_)1X0L&$H.+BXH]:!Q.LEYFS`!UU?3@COUH9Q]I!NX49?F

M971S+W-H965T





MO'M_N[]__]?7VV]/_20/MU]NGK3^CY_OOC\.LWU]_S/3?;UY^/.O[[^]O__Z



M4G\.Z_J3OW+G





4@

2[`4SZKB+MAH@A91^#
M+`9Y#(H8E#&H8E#'H(E!&X
N`$8[=9_1+KTW'CK.1;\YU;]?Z+@^9G4X&!P:










MX[EZN^\C+MPC)JZ$A;`N5$!5%)5!'51`U12]099(5UI^*AL#_HPO[

MGLS[+@3:+X$RHIRH(J)*J*:J%JB3J#C%BZCFG%.K(+#_-8=^)1=%ZXB[IP



MNN,1CLRT=D]_Q`O^$%;GV448L1&6,RHD*HI*H(JJ)&J*6J#/(BN5.^T.Q
MW+[PF[L[8/I0N\H=*R9//(FO@VR&J.&+7Y/E!'E1`512501U40-44O4&62%
M=:XA%/8'7=B;#*
??

H8E1
0$6N=<B='[`L/\]BS:X_<J5.P+XSO

M$=5$#5%+U!EDQ7+F(-QDW;[0:3OSO'#=FXQP6_8HZL+XWLD4-74A#$O&J)RH

MSB`K5LJ=;(_H0KJ3==*=Q/=.IJBI\?$`66,RHD*HI*H(JJ)&J*6J#/(CO/

5*N9-C]H5T)VOO.^P1.;YW
M

G:[H3CTP7TITP*B/*B0JBDJ@B
MJHD:HI:H

(]U

AVX7E\[V2*FKJPGRN0
M/V-43E00E40544W4$+5$G4%6V'GN9$-WXE$@PS71GB@CRHD*HI*H(JJ)&J*6


LF(Y)Q`?D8_9%_:.PAR11Y


MG7@4=B'1GB@CRHD*HI*H(JJ)&J*6J#/(BO6+W
DYW8E'41?&]TZFJ*D+Z4X8
ME1



M5!

[YU
45
7CHD#RAB5$Q5$)5%%5!
U


M;.E./(JZ
+YW







J)J*2J*JB1JBEJ@SR`H[

M2J**J9JB%JBSB`K5LJ=''&]\(+NQ*/HB!S?.YFBIBZD.V%43E00E40544W4
M$+5$G4%6V'GNY(+NQ/3A7U4@/:

MNR;:$V5$.5%!5!)51#510]02=089L2Y_D3LYS&/=B4=1%\;W3J:HL0N)



M2[H3CTP7TITP*B/*B0JBDJ@BJHD:HI:H

ZN*6KJ




[^!-46
7$F5$.5%!



V9#U#17[I'[]D60&-VJ*KC$<ICKQ2560]2T
MQ/I'2[3ZQ0;D!_K19^QZ9/0#V@]14]]E`YI6/?<H$BNZHU(PL1S0-'TUH&GZ
M^D?36V5B!]&_R';N)DACL?-H6M=KHOV`%!ST3719/QNBIKGR`=G$:
KAJ@I


BU]O



MY'CT549DZ;.




R*8?+/GZ
M.N?MSC;\4FWO3S3;G:V



M&J1/

MX@*V3S`U*7+5I&!2$DQ*@DDW

MNIX%
JEMP20=F*0#DW1@D@Y
TH%).C!)!R;IP0=F*0+622=7(1[LCO?RP7
M;J)8TYY)TVGK75]&VZ9D'L.&\TK)#:9P20SF&0&D\Q@DAE,,H-)9C#)#:9
M0Q;)/
]&+1?T40.S'=K'!4S2@4DZ

MT2Y;:B)5:H))33I28UP:2F9\^M2B2P
P-S!/:&P@@
DR&!P20PF`0&D\!@
M$M@S\ZLNH^M*$ABI$AA

MO94:._0NAQVL=/=
Q]1IL]Y%UU%4J2J%,G4R/NK.DA5=9*IDZ\\K)RJ@U15
M)Y5Z$156!4.JI9*W44KK!HB535

?HK?%\D9GNE*K
M8O4LV#.I

/2:ZW*8/&JC

M[I:78U

M?T47^E3#


M9;WELEN99Z8V/9MJ$^W251QDJ3@^J_^QZ\WE;A/?@%)YD*CR1(O;\01JC!A$



)7$+&QS%N]451)DJ20FBP]-




MUO/KJ)(@3R5Y?FE129PCG5.2WL':DGAF2A(YW6@_HHH@217Q2?VO7:7W6LA3


=NPJ+!7$9SW_:[6)($\%,4O3)F*/M*H'DE0/DZ1ZL#(4D%\
MUO.KJ((@3P5Y?FE119SOG%




28Z[*7:8)K+R`PMW9IYI

*T8TM;]TYQ+76*.]V7
<L=WH,45X^(&9:L#'J@!@*@!8GF!2''%E
M@DECQ$E6,,D*)AW!I&/((NF<0RE.[*_O;\
]T0J&TPXF11%G!3MF1K0M73R
MV5%)C$1)[!/[;4$[G\@?2'!D27`P0XFP?WL_6I=[K1B\2.MJD`?Y,Z+QAO;
MN)VFHOBY?O@\J?XFU\LE^LGG20_SQ/L@;SFGOZ]YO?1QNCXXW+E0C1G&H&I

:8
XRMUQK3@A)CN^65^VO-



7TEKO
M@$Z-2&N]\#@U(JWUQM[$R%8Y^H1+:D0Y^@9):D1:ZX
;J1%IK2]&I$:DM3Z/
MD!J1UGJ_?V+D7#GZX%MJ1#GZ8EEJ1%KK\URI$6FM[TNE1J2U/J:4&-E*:[V!
M


M]3JI]49:;Y):;Z2U_FI^8@TVTEI_13TQLE:.3LM2(\K1N4%J1%JGCS5K:;U.
M:KV6UNNDUFMIO4YJO5*.+K

EXR



M#Q@:G9+*F#8)`IU53%#MRY8U\*602E`#0U4&NE6
YG:2J(


#DX







O


%R:C7UJV^O*

\5OK2
I





PCU-E+`0+K$.)#J0ZD`F`8HH:&Q9U/CB$C6B
MQK,E!K-U&!#9N-U:[LK060@L8$D!I(:28CB@988[*&+S8@98$6AD1)'3C7





MBMLL%:





R$D;2!PN'/#;B/BQ\=['4YJ)$N`T;E4`&HHQ#OORM






M.:Y)47(S\*^5I_7^A09`_^_MMBHU2)'5G_7GK^W#Z?FV'XP'UY-AX)%Y[_OF

M-YP%%_@8&1_T:7QXPXNG


M`9(#4@!2`E*U$4==NO(ZZIY/1V5=B\A37VBDG7R`A(!$@

)(TR$!
M%4*L@;)V-=!(.W,`34R:F]:*O3<

M#*+E'T1S1%

JF/*6\\&PZO
MY9D2L5%[._J!.
]B:Z7.IN'`D]EH#.RJIDSAZ


G[ITN

M+L?&D\Z2KBN'-K!RI\:Q=Y=#&2?BIZSJR:Z36M7?U5[G]/_]_T;?OA?3U3


4()0BE&4(Y0@5)4.5`KEBR
_G2





(=/K+'-.;

MT!(X%7.:M7DWJKM2ES6G]+6!;`\







U%X5;=1L9&J(3`B@]=L/=N3@`G
0BUFHKC#68B3`J4C
.P

;#BP4=P%48W;YR\%(]WGM2\%!FHK+YO!$&PB0&)`

K


NH;IP;MV4

MWFQ^3Q'Q-_3L%G%F7;_QAW/U(`]RZ





MZO?]B?YN`I5F]&XZ_9V




%-

MW[!

D+98.=8T#G

M9




KVXFNR8S11SQ;!R%O$$_K4


MZ4U3I
E


[_6$]Z`9A]7A


$%``&``@````A

$;HMP*7X+!S<_IIR

M'D\]I#N$B#P5?'VR&4.C@+-PAMDY*(`?!IU266!CB2O0[_+V71GU+;CQ9A
M[/H

/F=Q2-$0X&/6

?*CCC[W`0ZD-X4VA![%O
M*!


D3EG0S$G^R\T(-DTQ2X8PHRE+^)NS0IZH





)F)IDC)KY_W%]?$T88V&:UDPU/R
MPC6Y67[\L-A*]:A+SHT##(U.26E



575?@^SF(*-MQ=P\']+5@2FJ9&Q?H/)OH





K;1Z867AF0J_=((7@JU4


M_P








A


/-4H4!/.+D87
M50RD



M3R4JA
E-HE)8

MZ(4$KXC1NGBB0
FH/.Z*%$:RR&B


M\Z735LKWCFK&M$X1@^:G9P:2&TAA(*6
J!'2N2E%^-\4


WPZ#59-
MGNF%`PRT[?HL]N0%,7B.D3_996DTVE1P[-5DEW#BU4KV6PMC1[N&]YF$:#
5(_@4.:B3\$R0.4POPA#1(X]ES!PP2.&X`[EXC@_N5<




M1#C`4/&=FPM1AY['TYR4F


M'


MS:TC
@6?RD*^R;)






2_VH?O[U]/=PG64ID5

U&PT'UCRKW??/RP/@KYK%+&
MM`

A0K=5.MRY?LJ2EE.E2=*5L`_B9`YU?`H][XJ):.Q691G_G@TFODYY85K


M8-H=R9+0W9+5`YF[_F9M$O2'LZ-J_'94*HZ?)8^_\8)!MJ%.6(&=$
\(_1IC



PS3]!&TA[)$)=-KUC.(B2#VXN:)8@=K;FO1G




M!)=P#Q`:SG[S


2YX

MKX7E4%@9
Y

MDH#OK-/JCT?%`Y=G2086N`\LLT4X/X]F


R]^F/BS
&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;*Q8VX[B1A!]CY1_L/P^^(H9+&%L9VLM)&B:)
\&].`

M:%EM?B15UD[HB=3PESUMJJR#K\W!:D\-R7;
J2HMU[8#J\J*VN0
8?
(!]WO



MYPOK';J=]S:1;N/(%IO!`EN+M+$*)J0H`%&8UI@0;^A[20!=
:`HH&X)JG
MJ^0P6`PNL0HD*I`*@)0#2%#
X?8Q&#J`QB!XL0-36XXMXC8N.X6LP!L-B34D
MT9!41*2(0?UBQ@F#\;`DV)%I`CE.6JIJFBE8@;N:*1ZRE&F]%H[(:&)!J2
MBHB4'IQ1
;W[#4%CEL7P[(@C_JBFC0K$*IH0H`4FAP=!\/#8WET#1DHR$Q


//P7@



_=$'KD`N(?O%.`[/4%+;NY684'!]4]K'8?@36P0VZ:W
M$J!8AQ(=PMLE.ZB
BX?/;XO\RE*1YD`VIQ;(Z=GO`G)%PM1IA?4Z
@C&88

TT[=_O#84DC1-
M7DB8')_C,S/V9'G[4A;.,U=:RHBGCLB#J]BF8@JB\B?WP\W
^)HPZJ$%;+B

N[+F%?R22E4R`Z\JH[I6




4_B_):+LOBMRSPV;*,0W<R'8V]CTFHW5%C\)X9MEHJN7.@:T!2UPQ[
MT%L`\6E'8`6Q:P1'!+H:]JJA#,^KP)\LZ3.D+FXQ=Q8#SP[C=0@*HITRJ%VN
MC&!4QMSB5NYLH_CGY897R.#X(C`L]O\L4&+9J&Z?L)KA%

\8P0/
M;Z\%

&=Q)`7[_)^O



M+8J4R#J'D[2
?IE
%P^I.L4C%G7SQY]_.SS?_+H[G??'E[M1\6$RNMF];(_W
CWW?GT<^?_ORGC]^.IR_GI]WN<H
1

MS



O'\KJLVV&[O]AQK^

M[W[W[9S\_\WYZ?CM+Z?]_=_W+SNHC7ER

_3




X3??-Z=+[_LW9CF^W7\^5X^)\/*ARI
M?I`R#(*_89!R&@=YH^
T=

6R;
/Y^
)/;`PWAW(VB0%(;0L`XQ8-('%8NE$+H/ZI56B$T1
MR@6%+7
I(-309-PP
IDI\ZQ##=SRT%-']0GHQ;(I3
/)/


M;-R&0JR&B^'2NE&4M#
AK0\2THISNNF#NO2
0FR*4#*WG
S;TKI@EM8CJ;0*
M

:I+
MTVC($L0).$=*$GA'5!?-=5MXB$15D-%1EB#FY)PEX73M+LD;%'+OI*F+X%FL


M59`I%&0)(DYN[4PY.4TK%/I`WVJ'X9
J0%`K74\70M
8U0EH-&0)8OZ#3*K4

?Y!'
MN5V(I*D

Z@0T&K($
7]G'LFY

5ESBE]K


DLX*
CK($

N[E*'[B+G/;NUNE0!TB4
MKKS:B5%=1Z

MX83OE(DVO*GRK49#1D.6(.8DW
W)?$V9:-N;]K87E2]NQ;ZHB5&=@$9#EB#F
M+YSP'4U[P^N.5D^#2
AHR%+$'&JA)4Y3:^XV&B'88\+D#CU1#4W
:K+

_809:B.(%!9C;39A8@
M$C686=P;&AUE6).PLQ<[3J;&;B@S;REI=?E`1(+FKP&BU&=@$9#EB#F+XSO

M).997IC&J$YYHR%+$/
?9%PS;5P!HGD.QI5L!'64)8@XN8VTODWTP=TYOCSM
MMU_J(TXFK+J9FISB?4#_EF`[+M6@*IX:=(%@7_V2XGXD+5Q*A.8TL0D\^:
MUE#RO65U1ZSG'DK)AZ!%^PXD]C1B736JBPT('NJZUR;1)?H;)S'(IN;:I@*$

M4LNI(&K`K+AHL0QY*%TQYPHR&K($

$-M0(9;()D9U

M!BC=K6C(:


M1#4QJN-O-&0)XI0&.:C;*PO;5B::
AHR%+$'

1J(C9\

4:XS!AA50D!ZQ`E2C?N

K=!3X2EAX7


M6BSVS+D6



M#NXN9UHJ

!3&-VRKN:K-=9UW8*G\NB3Y5:!&YYIY_J`&QX6YUK`#8]L
RTS



4?;+Y3)$/WM/

O9

M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````````````)R104_#(!B&[R;^AX9[





M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````

MK[Q1?]&#[`@OMDJ8_63LC?JO'BE8Q7UP/%FQ2G-O]/;!N^?
%BUE0NF)MS.W
8RY


5^^`N0ZX\P

^RC.*?(]Y-%G#LA:0:%R/)'




M(L


+66NA(1`$=4?I)19P


MB/4(XF









M970T

M971S+W-H965T-#










M`BT`%``&``@````A`!](2B0N`P``GPH``!D`````````````````QSX``'AL


M`'S

O
&UL4$L!`BT`%``&``@````A`-9-@C5`@``


M;%!+`0(M`!0`!@`(````(0#G!C(\:`4``(L5```8`````````````````!C7


M=#4U+GAM;%!+`0(M`!0`!@`(````(0!5+



%``!/&0``&0``





2YX

MKA8[A`(``




Q+GAM;%!+`0(M`!0`!@`(````(0`B*!$US@(```4(```9




O

BYX;6Q02P$+0`4``8`````$`!\Z=X'8``#R!0``&0``````







A+8&


]E-@F;`@``T08``!@`````````````````


MK%U3@P
``(@

M971S+W-H965T



C@N



M:&5E=#
P+GAM;%!+`0(M`!0`!@`(````(0#+WM.5UP(``#8(```9````````




M
2YX;6Q02P$+0`4``8`````$`;?_F-

M``8`````$`V5@\PC(!``!``@``$0````````````````!?LP$`9&]C4')O

O8V]R92YX;6Q02P$+0`4``8`````$`C?38]P$``!%#0``$```````


<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_SubsequentTransactionsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_MrRiceReceivedWarrantsToPurchaseSharesOfCommonStockOnReappointment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_TheTermsOfTheAppointmentAlsoIncludesACashPayment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_VestedOptionsPerQuarterForATermOfThreeYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ExercisePricePerShareOfWarrantsToPurchaseSharesOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_StockIssuancesTransactionsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_SharesIssuedAsPartOfACashlessExerciseOfCommonStockWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CashlessExerciseOfCommonStockWarrants1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ExercisePriceOfCommonStockWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanyIssuedSharesOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanyReceivedProceedsFromTheIssuanceOfSharesOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ExerciseOfCommonStockWarrants2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanyIssuedSharesOfItsCommonStockUponConversionOf1ConvertibleDebentures'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_N1ConvertibleDebenturesConvertedForCommonStock1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_PerShareValueOfSharesOfItsCommonStockUponConversionOf1ConvertibleDebentures'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanyIssuedSharesOfItsCommonStockValuedUsingTheBlackScholesMethodOfValuation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ValueOfStockIssuedUsingTheBlackScholesMethodOfValuation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CommonStockWarrantsIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ValueOfCommonStockWarrantsIssuedUsingTheBlackScholesMethodOfValuation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanyIssuedSharesOfItsCommonStockForThePurchaseOfAssetsFromEssexAngelCapital'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ValueOfSharesIssuedForThePurchaseOfAssetsFromEssexAngelCapital'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanyIssuedSharesOfItsCommonStockUponConversionOf11ConvertibleDebentures'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_N11ConvertibleDebenturesConvertedForCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_PerShareValueOfSharesOfItsCommonStockUponConversionOf11ConvertibleDebentures'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanyIssuedSharesOfCommonStockToANonRelatedParty'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ValueOfSharesOfCommonStockIssuedToANonRelatedParty'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_PropertyAndEquipmentDepreciationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DepreciationAndAmortizationExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_PropertyPlantAndEquipment1Abstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanyEnteredIntoASettlementAgreementAndMutualReleaseOfAllClaimsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ResultOfThisSettlementTheDeferredRevenue1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ResultOfThisSettlementCustomerDeposit1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_TheSettlementAgreementCallsForTheCompanyToMake10PaymentsOfAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_TotalLiabilityOfTheCompany1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_GrossAmountRecordedOnTheCompanySBooksDue1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ExpectedATimelyReturnOfTheSecurityDeposit1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_TheCompanyOwedTheLandlordInExcess1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DamagesInAdditionToTheSecurityDepositRelatedToTheProperty1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DifferenceOfamountIsRecognizedAsOtherIncomeForThePeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AdditionalDerivativeLiabilityRelatedToHepInvestmentsLlcParentheticalsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AdditionalDerivativeLiabilityRecorded'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_Closingstockpriceassumed2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ExpectedVolatility'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_Contractuallifeofthenoteinyears2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_Rateofdividendyield2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_Riskfreeinterestrateperannum2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_Fairvalueofthederivativerecorded2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AmountsAdvancedUnderTheNote1Abstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanySRestrictedCommonStockValueScheduleA'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_RestrictedCommonStockSharePerShareValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DiscountOffOfTheTenDayTrailingQuotedPriceOfTheCommonStockInTheOverCounter'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanySRestrictedCommonStockValueScheduleB'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_RestrictedCommonStockSharePerShareValueB'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DiscountOffOfTheTenDayTrailingQuotedPriceOfTheCommonStockInTheOverCounterB1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanySRestrictedCommonStockValueScheduleC'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_RestrictedCommonStockSharePerShareValueC'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DiscountOffOfTheTenDayTrailingQuotedPriceOfTheCommonStockInTheOverCounterC'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanySRestrictedCommonStockValueScheduleD'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_RestrictedCommonStockSharePerShareValueD'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DiscountOffOfTheTenDayTrailingQuotedPriceOfTheCommonStockInTheOverCounterD'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ConvertibleNote2BearsInterestRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FormationsOfSubsidiaryCompanies1Abstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanyHasAbandonedThePatentApplicationsPurchasedAndRecordedALossOnAbandonment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_PercentageOfOwnershipInZivoBiologicForTheEnity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsIssuedAndOutstanding2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_Issued2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_Exercised2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_Cancelled2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_Expired2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsIssuedAndOutstanding4'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SignificantAccountingPoliciesTextBlock'

M;VL-D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%]F.64R86$R-U\W-V-B7S0X8V%?.&$W.5]B9#@P
M-V%D8F)E,&,B#0H-E1H:7
@9&]C=6UE;G0@:7
@82!3:6YG;&4@1FEL92!7



M9#@P-V%D8F)E
&







T0B5V]R:W-H965T
&-E;%=O<FMS:&5E=#X-B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*(`@(#QX.DYA;64^0T].1$5.4T5$7T-/
M3E-/3$E$051%1%]04Q!3D-%/]X.DYA;64^#0H@(`@/'@Z5V]R:W-H965T

&-E;%=O<FMS:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M(`@(#QX.DYA;64^0T].1$5.4T5$7T-/3E-/3$E$051%1%]04Q!3D-%
3PO






#I.86UE/D1%4T-225!424].7T]&7T)54TE.15-3/]X

MB`@(#QX.D5X8V5L5V]R:W-H965T/@T*(`@(#QX.DYA;64^0D%325-?3T9?

M($A2968]
&-E;%=O<FMS:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*(`@(#QX
M.DYA;64^4U5-34%265]/1E]324=.249)0T%.5%]!0T-/54Y4/]X.DYA;64^

#I.86UE


O4VAE970Q
M


15]296QA=&5D

M
#I.86UE/@T*(`@(#QX.E=O<FMS:&5E=%-O

O4VAE970Q

2519/]X.DYA;64^#0H@(`@




O4VAE


1$524U]$149)

M



M:&5E='


3DN:'1M;(O/@T*(`@


O
M4VAE970R
#I.86UE/@T*(`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E='
O4VAE970R


M968]


O4VAE970R
M


#I.



&-E;%=O<FMS:&5E=#X-B`@(`\





O4VAE970S
YH=&UL(B\^#0H@(`\
&-E;%=O<FMS:&5E=#X-B`@

M='
O4VAE970S
#I.86UE/E!R;W!E<G1Y7V%N

M:&5E='
O4VAE970S


&-E;%=O<FMS:&5E




O4VAE970S-BYH=&UL
&-E;%=O<FMS


&-E;%=O<FMS:&5E=#X-B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*(`@(#QX.DYA;64^0V]N=F5R=&EB;&5?1&5B=%]5;F%M;W)T

M


&-E;%=O<FMS:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M(`@(#QX.DYA;64^0V]N=F5R=&EB;&5?9&5B=%]C;VYS:7-T<U]O9E]T
3PO



O4VAE970T
BYH=&UL(B\^
&-E;%=O<FMS:&5E












M968]


O4VAE970U
M


O4VAE970U

#I.86UE/@T*


O4VAE970U
&-E;%=O<FMS:&5E=#X-B`@(`\
#I.86UE



&-E;%=O<FMS:&5E='
^#0H@

B






;V-A=&EO
M;CH@9FEL93HO+R]#.B]F.64R86$R-U\W-V-B7S0X8V%?.&$W.5]B9#@P-V%D
M8F)E
&



]





M/D1E8RX@
S$L(#(P
30\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$
M=&@^36%R+B`S

]
M
T1T:#Y*=6XN(#
P+`R,#$T/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@


]
T1T97AT

]
T1T97AT

]
T1P;!V86QI9VX],T1T
M;W`^16YT:71Y(%)E9VES=')A;G0@3F%M93PO=&0^#0H@(`@(`@(#QT9!C




]

]
T1T






Q+`T*0DR,#$T/'-P86X^/]S









]



BTS
M

]
T1T97AT

]



]


]




M=&5X=#Y997






]


]

]
T1T97AT


T1T
M;W`^1&]C=6UE;G0@1FES8V%L(%EE87(@1F]C=7




]

M1F]C=7






]
T1R97!O





]





]


]
T1N=6UP/B0@
2PS.#

RPQ

M97

]

M

]



T1T;W`^1&5F97)R960@1FEN86YC92!#;W-T

]
T1N=6UP/C0L.#
T/'-P86X^

]



]


]


]
T1N=6UP/C$L
SDR

]








M
T1T;W`^1&5P;W-I='


]


]
T1N=6UP/C$L


($%34T544SPO

]
T1N=6UP/C(L

M

]



L
M




]
T1N=6UP/C$T
2PP



@9&ES8V]U;G0@;V8@)#$Q
2PR.#`@
M86YD(0W-#8L,S$T(&%T($1E8V5M8F5R(#,Q+`R
#$S(&%N9`R,#$T/]T


M






S@L-C@V

]






M3TY'(%1%4DT@3$E!0DE
251)15


]

M-3@@870@1&5C96UB97(@
S$L(#(P
3
@86YD(#(P
30\+W1D/@T*(`@(`@




T1T;W`^5&]T86P@3&]N
M9R!497)M($QI86)I;&ET:65S/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$








2PP


2PW-C@L
C8S





]


T1T;W`^0V]M;6]N('-T;V-K+`D+C`P
M,2!P87(@=F%L=64L(#(P,PP
#`L

M
38L.#4R+#`Y
R!A;F0@


2P@
C`Q
R!A;F0@


M

]
T1N=6UP/C
U+#0R-RPS

BPX.34L
S@P/'-P86X^



]


]


M2TA/3$1%4E


]
T1N=6UP/B0@

M9#@P-V%D8F)E
&




2P@

#$S/&)R/CPO=&@^#0H@







]
T1N=6UP/B0@
3$Q+#(X



]



T1T;W`^





@



#`L
#`P+#`P



]

]


]

]

;V-A=&EO;CH@9FEL93HO+R]#.B]F.64R86$R-U\W-V-B7S0X8V%?
M.&$W.5]B9#@P-V%D8F)E
&

T1#;VYT

]
T13:&]W+FIS









]


]



T1T;W`^4V5L;&EN9SPO=&0^#0H@

]













V

]
M
T1P;!V86QI9VX],T1T;W`^4F5S96%R8V@@86YD($1E=F5L;W!M96YT/]T

M
C


2PS.3$L
C@Q/'-P

#QS



L
3


RPQ
3`L


]

]
T1N=6T^*#4L
34S

M;G5M/B@S+#$Q




M/D]T:&5R($EN8V]M92`M(%-E='1L96UE;G0@06=R965M96YT/]T9#X-B`@




]

]




M

]




]
T1N=6T^*#$L-#8T+#4Q



C(I/'-P




M;G5M/B@Q+#(R-BPP



]
T1N=6T^*#0T

]



M4U



I(%!%4B!32$%213PO


T1T;W`^

]
T1N=6UP/C$R-2PS



3$R+#(Q


]

3U-3*2!015(@4TA!4D4\


T1T;W`^5T5)1TA4
M140@059%4D%'12!$24Q55$5$(%-(05)%4R!/55135$%.1$E.1SPO=&0^#0H@


M
F%A
C=?-S=C8E\T.&-A7SAA-SE?8F0X
#=A9&)B93!C#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T






^+RH@1&\@


$54








]

]
T1N=6UP/C$P-2PS


3`U+#
Q


M87-S/3-$;G5M/B@S
BPU
3`L

]




]



T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N

M;65N='

]
T1N=6UP



]









]







]
T1N=6UP/C$L
C4P+#`P



]








]



]
T1N=6UP/CDV

]
T1N
M=6UP/CDW+#4P


]

]


]
T1N=6UP/C0W.2PT












]



S(S/'-P86X^


C8U+#$Q
M

]

]
T1T97AT/CQS

]
T1T97AT/CQS


S$L(#(P
M
3

]
M
T1N=6UP/C

M/'1D(&-L87-S/3-$;G5M/B@T
BPV
#8L












]


]


]



]



]
T1N=6UP/C@Q+#@X


]
T1N=6UP/C@R+#4P


]

]
T1N=6UP/C
L-#
S
M+#


]

]








M


]


S0W+#`X


]
T1N=6UP/C
U

]
T1R93X-


BPP-#`L



C4U+#`P


]

]


]


]
T1N=6UP/C0P+#4S-SQS

]

P+#@Y


]
T1N=6UP/C@S

]
M

30L

3$T+#`Y


]




]
T1N=6UP/C$R
2PS.#



]


]


]
T1N
M=6UP/B0@-C@P+#@Q

]
T1P






M
S4L-#(W+#

F%A
C=?-S=C8E\T.&-A
M7SAA-SE?8F0X
#=A9&)B93!C#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T



M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@


^+RH@1&\@3F]T(%)E;6]V92!4:&ES

$4V5D%'/@T*(`@(`@/'1R


M/3-$






]

M=&EV:71I97


]

I/]T9#X-B`@(`@(`@/'1D(&-L






@86YD

]


S0L-S4P/'-P86X^






2PR
C8L



T1T;W`^1FEN86YC:6YG(&-O


]


]



T1T;W`^06UO













]


]









]
T1N=6UP
M/C0P+#


]

M1&YU;7`^





M




M

M=&]P/BA$96-R96%S92D@:6X@8W5S=&]M97(@9&5P;W-I='


]
T1N

M;G5M/B@R
S4L

]
T1P


]
T1N=6UP/C$Y


]

]
T1N=6T^*#(L-S

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@R+#DX
M-BPR
3




]
T1T

]


]
M

]

S$L


]

]


T1T;W`^4')O8V5E9'
@9G)O


#$U/'-P86X^

S8Q*3QS

]

]
T1N=6T^*#$L


]

2PS

M1&YU;7`^
BPY





]
T1R;W4^#0H@


BPR-#0L

RPW-C












]











]


]
M

]

]

M+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@
'!T)SX\8CX\9F]N=!L
M86YG/3-$14XM55,^3D]412`Q(8C

M;W)M86P[;6%R9VEN.C!C;2`P8VT@


M9VEN.C!C;2`P8VT@
'!T)SX\9F]N=!L86YG/3-$14XM55,^6FEV;R!:6]S

M96UE;G0@4')O9'5C='







M86YG/3-$14XM55


M;64@;V8@=&AE($-O;7!A;GD@9G)O;2!(96%L=&@@16YH86YC96UE;G0@4')O
M9'5C='
L($EN8RX@=&\@6FEV;R!:6]S8VEE;F-E+!);F

M($]C=&]B97(@
38L(#(P






P@,C`Q-P@=&AE($-O;7!A;GD@8F5G86X@=')A
M9&EN9R!O;B!T:&4@3U1#44(@=6YD97(@=&AE('-Y;6)O;#H@6DE63RX\+V9O

M+W1A8FQE/@T*(`\+V)O9'D^#0H\+VAT;6P^#0H-BTM+2TM+3U?3F5X=%!A

F%A
C=?-S=C8E\T.&-A7SAA-SE?8F0X
#=A9&)B93!C#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T


#@N:'1M;`T*0V]N



^


M1$E$




]



M14XM55
^3D]412`R(8C,34P.R!05-)4R!/1B!04D5314Y4051)3TX\+V9O


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P.SPO




RPQ

C`Q

M;7!A;GD@:&%D(&$@=V]R:VEN9R!C87!I=&%L(&1E9FEC:65N8WD@;V8@)#8L
M


M9B`D-BPS-CDL
38X(&%T($1E8V5M8F5R(#



&-M

T1%3BU54SY4



M=6-H(&%S(&1E8G0@;W(@97%U:71Y(&9I;F%N8VEN9W

M96YT:6%L('-O=7)C97
N(%1H92!L86-K(&]F(&%D9&ET:6]N86P@8V%P:71A


@=V]U;&0@9F]R8V4@=&AE($-O;7!A;GD@

@



M9'

3MM87)G:6XZ,&-M(#!C;2`P<'0[;&EN92UH96EG:'0Z;F]R
M;6%L)SX\9F]N=!L86YG/3-$14XM55

M;VQI9&%T960@9FEN86YC:6%L('-T871E;65N='
@9&\@;F]T(&EN8VQU9&4@
M86YY(&%D:G5S=&UE;G1S(')E;&%T960@=&\@=&AE(')E8V]V97)A8FEL:71Y

@
M;W(@=&AE(&%M;W5N='
@86YD(&-L87-S:69I8V%T:6]N(&]F(&QI86)I;&ET


M8VT@

'!T.VQI


'!T.VQI


'!T.VQI;F4M:&5I9VAT

2P@


M





'!T.VQI;F4M:&5I9VAT

V.2PW
#`@9G)O;2!T:&4@:7-S=6%N8V4@;V8@8V]N=F5R=&EB





M8VT@

M;CX\+W-P86X^/]T9#X-B`@(`@(#PO='(^#0H@(`@/]T86)L93X-B`@








]

T1)1#!%344^#0H@




]
T1T:#Y$96
N(#





]
T1T97AT

M9VEN.C!C;2`P8VT@

'!T.VQI;F4M


'!T.VQI;F4M:&5I9VAT.FYO

T1%

^)FYB



M/3-$14XM55

\+V9O;G0^/]U/CPO8CX\
M8CX\9F]N=!L86YG/3-$14XM55

M/&9O;G0@;&%N9STS1$5.+553/E1H92!#;VUP86YY)B

M9&%T960@9FEN86YC:6%L('-T871E;65N='





L(&%T('1H






\+V9O;G0^/]U/CPO8CX\8CX\
M9F]N=!L86YG/3-$14XM55














2P@









M(S$U




L


M=FEC92!P;W1E;G1I86P@;W(@97AT96YD('1H92!E8V]N;VUI8R!L:69E(&]F



M9VEN.C!C;2`P8VT@


M8VT@







@;V8@:6YP=71S+!O9B!W:&EC:!T

M92!L87-T('5N;V)S97)V86)L92P@=&AA=!M87D@8F4@=7-E9!T;R!M96%S

M8VT@




'!T.VQI;F4M:&5I9VAT.FYO

M9GD[;6%R9VEN.C!C;2`P8VT@






'!T.VQI;F4M:&5I




@)B
Q-3`[(%5N;V)S97)V86)L92!I;G!U='
@=&AA

^5&AE($-O;7!A;GDF(S$T-CMS


'!T


'!T.VQI;F4M:&5I






M(&)E(&$@3&5V96P@


&-M





M(&9O;&QO=W
@875T:&]R:71A=&EV92!G=6ED86YC92!F;W(@86-C;W5N=&EN

@=&\@8V]N=F5R




#$T

&-M(#!P=#ML:6YE



Q

30X.R`H)B

M


M;&4[(&%N9`H-D@8V]L;&5C=&%B:6QI='D@:7



M(&]F('1H;W-E(&%M;W5N='




3MM87)G:6XZ,&-M(#!C;2`P<'0[;&EN92UH96EG:'0Z;F]R;6%L)SX\
M8CX\=3X\9F]N=!L86YG/3-$14XM55



'!T.VQI;F4M:&5I9VAT.FYO

M9GD[;6%R9VEN.C!C;2`P8VT@



@96YD960@
M1&5C96UB97(@
S$L(#(P
30@86YD(#(P
3


&-M(#!P=#ML

T0G=&5X

^4F5S96%R8V@@86YD(&1E

M($-O;7!A;GD@86-C;W5N='


&-M

&-M(#!P=#ML:6YE





2PP
#`@9F]R

C`Q
RP@





&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF


M;VYS:7-T:6YG(&]F(&9E97
L(&-H87)G97

M;F0@)#DW-RPP

C`Q


&-M(#!C




M/&9O;G0@;&%N9STS1$5.+553/E1H92!#;VUP86YY(&9O;&QO=W
@=&AE(&%U




@87)E(')E8V]G

M=&%B;&4@=&\@9&EF9F5R96YC97
@8F5T=V5E;B!T:&4@9FEN86YC:6%L('-T



@86YD(&QI86)I;&ET:65S(&]F(&$@8VAA;F=E(&EN


&-M



2!D:69F97)E;F-E<R!T:&%T(&=A=F4@

M=&%X(&QI86)I;&ET:65S(&%T($1E8V5M8F5R(#
Q+`R,#$T(&%N9`R
#$S






M=6%T:6]N(&%L;&]W86YC92!H87






M


&-M(#!P=#ML:6YE+6AE:6=H=#IN

T1%3BU54SY3=&]C:R!87-E9!#


34P.R!3=&]C:R!#;VUP96YS

M($%30R`W




M;WEE97








&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P


C`Q





C`Q
R!R97-P96-T:79E;'DN



M($)L86-K+5-C:&]L97


M9&5R/3-$
#X@/'1R(&%L:6=N/3-$;&5F=#X@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$V

#MB;W)D

#MW:61T:#HQ
C(N
C5P=#MB;W)D97(M8F]T=&]M
M.B-F


M861D:6YG+6QE9G0Z




T1B;W1T;VT@=VED=&@]
T0R



&8P.V)O

&8P.W=I9'1H.C$Y



M=&]P.C!C;3MP861D:6YG+6QE9G0Z

&8P9C`[


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF

T1%3BU54SY996%R($5N9&5D($1E8V5M8F5R(#
Q+#PO9F]N


M86YG/3-$14XM55
^


M/3-$14XM55
^
C`Q

^

M+6)O='1O;3HC9C!F


&8P.W!A




&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF;VYT

T1%3BU54SXQ
3
N.3
E('1O(#$S.XP-24\+V9O;G0^/]P/CPO


M9C!F




M;W`Z

#MP






\+V9O;G0^
M/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q

M;&4]
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD


M96EG:'0Z;F]R;6%L)SX\9F]N=!L86YG/3-$14XM55,^,4\+V9O;G0^/]P
M/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q-2!S='EL93TS


#MW:61T
M:#HQ

#MP861D:6YG+6)O='1O


M+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O

&-M(#!C;2`P

^

T0G;6%R9VEN
M.C!C;2`P8VT@

^


T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M

M86QI9VX]


M9STS1$5.+553/C

M/3-$14XM55

M86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q

T1B;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z.30N-7!T.V)O


M9RUT;W`Z

M





M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D
M97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3$N
M
C5P=#MB;W)D97(M8F]T=&]M.B-F

&-M


M.B-F

M
T1B;W1T;VT@=VED=&@]
T0Q

T1B;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F

M8F]T=&]M.B-F


M.C!C;3MP861D:6YG+6QE9G0Z



M;6%R9VEN.C!C;2`P8VT@


&-M(#!P=#ML:6YE+6AE

T1%3BU54SY4:&4@0FQA8VLM4V-H

M8VEN9R!M;V1E;'

M8W1I=F4@87-S=6UP=&EO;G

28C
30V
M.W






30V.W
@;W!I;FEO

M=FED92!A(')E;&EA8FQE('-I;F=L92!M96%S=7)E(&]F('1H92!F86ER('9A






M:'0Z;F]R;6%L)SX\8CX\=3X\9F]N=!L86YG/3-$14XM55,^26YC;VUE(A

^0F%S:6



@86YD(&-O


C0L.34V(&-O;6UO;B!S:&%R97
@9G)O;2!C;VYV

M-#(T(&-O;6UO;B!S:&%R97


SD@


C`Q

^061V


M.C!C;2`P8VT@


M

T1%

!F;W(@=&AE('EE87)S(&5N9&5D($1E8V5M
M8F5R(#,Q+`R

M

M;&4]



&-M(#!P=#ML

T1%3BU54SY&:6YA;F-I
M86P@:6YS=')U;65N='







30X.RD@
M;&EM:70@;V8@)#(U

M9GD[;6%R9VEN.C!C;2`P8VT@

M.C!C;2`P8VT@



M:6X@:71E;7


&-M(#!C;2`P




M9'

M86YG/3-$14XM55
^26X@36%Y(#(P
30L('1H92!&:6YA;F-I86P@06-C;W5N
M=&EN9R!3=&%N9&%R9'

30M
#D@*$%3
M52`R
#$T+3`Y*2P@)B








M='
@=&\@8F4@96YT:71L960@=&\@:6X@97AC:&%N9V4@9F]R('1H;W-E(&=O


M97(@1&5C96UB97(@
34L(#(P

M9'

30M
#D@:7
@;F]T

M(&]P97)A=&EO;G


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M


M;W5N=&EN9R!S=&%N9&%R9'
@8F5E;B!A9&]P=&5D(&EN('1H92!C=7)R96YT

M+2TM/5].97AT4&%R=%]F.64R86$R-U\W-V-B7S0X8V%?.&$W.5]B9#@P-V%D
M8F)E
&


M
M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q






]



]


M4D]015)462!!3D0@15%525!-14Y4/]T9#X-B`@(`@(`@/'1D(&-L87-S

T0G;&EN92UH96EG:'0Z;F]R


M;CHP8VT@

M(S$U



M
T1C96YT97(^(#QT86)L92!B;W)D97(]



T1B
M;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D

M:6YG+6QE9G0Z




M=&]P.C!C;3X\+W1D/B`\=&0@=VED=&@]
T0R

C0V


M






M(V8P9C!F



T1%

T1T;W`@
M=VED=&@]
T0R

M86YG/3-$14XM55

^1&5C96UB97(@



#MB
M;W)D97(M;&5F=#HC9C!F


M
35P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R
M9&5R+7)I9VAT.B-F


'!T)SX\9F]N

M:6=N/3-$=&]P('=I9'1H/3-$

M8FQA8VL@


M;W1T;VTZ

M9RUL969T.C!C;3MW:61T:#HX




#MP861D:6YG+71O


'!T

M/'`@86QI9VX]


M;&%N9STS1$5.+553/C(P
3

M=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$

M='1O;3HC9C!F


M;VTZ





#MP861D:6YG+71O

M


M/]P/CPO=&0^(#QT9!V86QI9VX]
T1T;W`@=VED=&@]
T0R



#MB;W)D97(M
M;&5F=#HC9C!F


35P=#MP
M861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F


M+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@

M=&]P('=I9'1H/3-$

&8P


&-M.V)A8VMG

M:#HX


#MB






M/'1R/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

M8F]R9&5R+6)O='1O;3HC9C!F


M9&EN9RUB;W1T;VTZ


M


#MP

M;#MM87)G:6XZ

T1%3BU54SY&=7)N

\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI
M9VX]
T1B;W1T;VT@=VED=&@]
T0R



&-M.W=I9'1H

&8P.V)O


M
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I9VAT.VQI;F4M:&5I9VAT


T1%3BU5
M4SXR

#MB;W)D
M97(M;&5F=#HC9C!F


35P
M=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R
M+7)I9VAT.B-F


M+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q
M

T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z
M(V8P9C!F


#`\+V9O

M9'1H/3-$








#MB;W)D






M86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R


M9G0Z(V8P9C!F

M;6%R9VEN.C!C;2`P8VT@

M

T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z
M(V8P9C!F





M861D:6YG+6QE9G0Z


&-M.W=I9'1H

&8P.V)O


M



M;3HC9C!F


M



M(V8P9C!F



&-M(#!C


T1B;W1T;VT@=VED=&@]
T0Q

T1B
M;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D

M9F]N=#X\+W`^/]T9#X\+W1R/B`\='(^(#QT9!V86QI9VX]
T1B;W1T;VT@
M=VED=&@]

T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R
M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+6)O='1O;3HP8VT[8F%C:V=R;W5N

&8P.V)O


M



M;3HC9C!F


M



M(V8P9C!F



&-M(#!C


T1B;W1T;VT@=VED=&@]
T0Q

T1B
M;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D

M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D
M97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG


#MB;W)D97(M;&5F
M=#HC9C!F


M:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT
M.B-F



M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M8F]T
M=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+6)O='1O

M/]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P.!S='EL93TS
M1=B;W)D97(M8F]T=&]M.F)L86-K(#%P=!S;VQI9#MB;W)D97(M;&5F=#HC
M9C!F


M+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
M

&-M)SX@/'`@86QI9VX]

M:6XZ

T1%3BU54SXH
S$L
C4P*3PO

&-M

M



T0G=&5X=UA;&EG;CIR:6=H=#ML:6YE
M+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N=!L86YG
M/3-$14XM55
^*#8L
C4P*3PO9F]N=#X\+W`^/]T9#X\+W1R/B`\='(^(#QT
M9!V86QI9VX]
T1B;W1T;VT@=VED=&@]

T1B;W)D97(M
M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+6)O






M;CHP8VT@



&8P



M:'0Z


M



T1%3BU54SXF

T1B;W1T;VT@=VED
M=&@]
T0Q

T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R
M+6QE9G0Z(V8P9C!F



M+6QE9G0Z






M8VT@




M:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@
'!T)SX\9F]N=!L86YG/3-$
M14XM55,^)#PO9F]N=#X\+W`^/]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$P.!S='EL93TS1=B;W)D97(M8F]T=&]M.F)L86-K(#(N
C5P

M

M9C!F



T0G=&5X=UA;&EG;CIR:6=H=#ML
M:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N=!L
M86YG/3-$14XM55

&-M

M


M86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I9VAT.VQI;F4M


M


C4L
#`P(&%N












M
S$L(#(P




]
TM/CQP

&EN(#!I;B`P




&EN(#!P=#ML:6YE
M+6AE:6=H=#IN;W)M86PG/D%S(&]F($1E8V5M8F5R(#
Q+`R,#$T+!T:&4@





@86)A;F1O;F5D('1H

Y
2PR.#$@9F]R('1H92!Y
M96%R(&5N9&5D($1E8V5M8F5R(#


;V-A=&EO;CH@9FEL93HO
M+R]#.B]F.64R86$R-U\W-V-B7S0X8V%?.&$W.5]B9#@P-V%D8F)E
&
O5V]R


M(#Q-151!(&AT='`M97%U:78]

]

T0Q(')O=W-P86X]
M


M/3-$
3XQ
B!-;VYT:'

2P@
C`Q-#QB

]



3MM87)G:6XZ,&EN
M(#!I;B`P<'0[;&EN92UH96EG:'0Z;F]R;6%L)SX\8CY.3U1%(#8@)B,Q-3`[
M($Q/04X@4$%904),12U296QA=&5D(%!A<G1Y/]B/CPO<#X@/'`@<W1Y;&4]
M


&EN(#!P=#ML:6YE+6AE:6=H=#IN


2P@
C`Q
M
RP@37(N($UA9V=I;W)E+!A('-I9VYI9FEC86YT('-H87)E:&]L9&5R+!A

#`P+B`F;F)S



M:7
@82!M96UB97(N($%S(&]F($1E8V5M8F5R(#
Q+`R,#$S+!T:&5R92!W
M87

M;&4]

&EN(#!P=#ML:6YE+6AE:6=H




M;6%R9VEN.C!I;B`P:6X@

M960@=&AE($-O;7!A;GD@)#8L
S0T+B9N8G-P.R!4:&5S92!A;6]U;G1S(')E



M-U\W-V-B7S0X8V%?.&$W.5]B9#@P-V%D8F)E
&

M;G1E;G0]


M



]




12!$14)4/]T9#X-B`@(`@(`@/'1D




&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQB

T1%3BU54SY(15`@26YV97-T;65N='
L($Q
0R`F(S$U
M


'!T.VQI;F4M:&5I




L($Q
0RP@82!-:6-H:6=A

L(&5F


2P@
C`Q-#H@*&DI(&$@3&]A;B!!9W)E96UE;G0@

@86=R965D('1O(&%D=F%N8V4@
M=7`@=&\@)#8L
#`P+#`P

M97)T86EN(&-O;F1I=&EO;G

M-BPP
#`L







@

M;65N='
@:6YC;'5D92!A;B!A9W)E96UE;G0@;F]T('1O(&UA:V4@86YY(&-H

30V.W





&-M(#!P=#ML:6YE+6AE

T1%3BU54SY!;6]U;G1S(&%S(&]F
M($1E8V5M8F5R(#
Q+`R,#$T(&%D=F%N8V5D('5N9&5R('1H92!.;W1E(AI

30V.W


M0BD@)#(L-C8P+#`P


!A=`D+C

M*&EI*2!B96%R(&EN=&5R97-T(&%T('1H92!R871E(&]F(#$Q)2!P97(@86YN



2P@
C`Q
M
R!W87
@:6YI=&EA;&QY(&5X=&5N9&5D('1O($IU;F4@
2P@



M('1H92!D871E(&]F('1H:7




@;F]T(&$@



&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF;VYT

T1%3BU54SY!;6]U;G1S(&%S(&]F($1E8V5M8F5R(#

M


M=6YT97(@*$]40RD@;6%R:V5T+`H0BD@)#8T,PP


I(0W-3`L,#`P(&%T('1H92!L97-S97(@;V8@)XS



M(#$L(#(P









T0G


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M


M

96YD97(@:6X@8V]N;F5C


M97(@
3(L(#(P

!I;B`D,C4P
M+#`P,!I;F-R96UE;G1S(AF:6YA;!I;F-R96UE;G0@;V8@)#$U

30V.W
@0T5/+!S=6)J
M96-T('1O('-A=&ES9F%C=&EO;B!O9B!C97)T86EN(&-O;F1I=&EO;G,N(9N


M+#8V-R!S:&%R97
@;V8@8V]M;6]N('-T;V-K(&%T(&%N(&5X97)C:7-E('!R

'!I<FEN9R!397!T96UB97(@,S`L(#(P
M,38@86YD(AI:2D@96YT97(@:6YT;R!A(%)E9VES=')A=&EO;B!2:6=H='
@

M
BPP
#`L

^





@;65T




M8VT@

'!T.VQI

@861V86YC960@=&AE($-O;7!A;GD@86X@




Z('9O;&%T:6QI='D@;V8@
30P+CDS
M)2TQ-#
N


M;B!W:71H('1H92`D-3`P+#`P


&-M(#!P=#ML:6YE+6AE


M=&5R(&]F(#(P






#`P(@D,34L,#`P(&%T($1E8V5M8F5R(#,Q+`R
#$R(&%N




3$@=&\@:6YV97-T('5P('1O(0R
M+#`P,PP
#`@:6X@8V]N=F5R=&EB;&4@;F]T97


@=V5R92!C;VYV97)T


M


&-M(#!P=#ML:6YE+6AE:6=H=#IN







M=!V86QU92!O9B`D+C,R+!A(')E;6%I;FEN9R!T97)M(&]F(#


L('9O;&%T:6QI='D@;V8@
30X+C0T)2P@86YN=6%L(')A=&4@;V8@9&EV

M(#`N


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N


C`Q
RP@=&AE($-O;7!A;GD@86YD($QE

M9F9E8W1I=F4@87
@;V8@07!R:6P@
34L(#(P
3
Z(AI*2!&:7)S=!!;65N
M9&UE;G0@=&\@3&]A;B!!9W)E96UE;G0@86YD(AI:2D@86X@06UE;F1E9!A
M;F0@4F5S=&%T960@4V5N:6]R(%-E8W5R960@0V]N=F5R=&EB;&4@4')O;6ES



@;V8@=&AE(&UO9&EF


@86=R965D('1O(&%D=F%N

M(&1U92!D871E(&]F(&5A8V@@3F]T92P@8F%S960@;VX@82`D
C4P+#`P




'!T.VQI;F4M:&5I






Q-#8[

M




M;6%R9VEN.C!C;2`P8VT@

M;2`P8VT@


T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI


'!T.VQI;F4M:&5I9VAT

M:71H:6X@

C`Q









C@Q+#`P



M(&)E='=E96X@)#
@;6EL;&EO;B!A;F0@)#
N-S4@;6EL;&EO;B!M=7-T(&)E

Q





3


3
@86YD

C`Q


M)#4Y
BPT


M

M;&4]





@9G5N9&5D(&$@=&]T86P@;V8@)#0N
#4@;6EL;&EO;B`H)#(L-S`W
M+#4Y
B!T;R!B92!C;VYV97)T960@870@)XQ,BP@)#4Y,BPT,#@@=&\@8F4@
M8V]N=F5R=&5D(&%T(0N




M;6%R9VEN.C!C;2`P8VT@



M9B!A9W)E96UE;G1S('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!W:71H($A%




M97)M:6YE9!T:&%T('1H92!M;V1I9FEC871I;VX@;V8@=&AE($A%4!);G9E



F(S$T.#LN


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P.SPO


M





M

3(L
M
#`P(')E;&%T:6YG('1O(0Q+#`P,PP
#`@:6X@:6YV97-T;65N='
@=&AA

M=&5R(&]F(#(P
3


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M


M=6YE(#
P+`R,#$S+!(15`@26YV97-T;65N='
@861V86YC960@=&AE($-O


#`P+#`P



@


@



&-M(#!P=#ML:6YE




@:&%S(')E86-H960@
M82`D
RPS
#`L

C`Q
2D@86YD('1H97-E(&%D=F%N8V5S
M(&AA=F4@8F5E;B!C;VYV97)T960@:6YT;R!C;VYV97)T:6)L92!D96)T+B`F



@



@;V8@
XS,RTP+C,T)2X\+V9O;G0^/]P/B`\

M

'!T.VQI;F4M

#$S+!(15`@26YV
M97-T;65N=',@861V86YC960@=&AE($-O;7!A;GD@86X@861D:71I;VYA;`D
M-S4P+#`P




M96UB97(@
S$L(#(P
3


&-M(#!P=#ML:6YE


M

24@0V]N=F5R




M92!#;VUP86YY(&1E=&5R;6EN960@=&AA=!T:&4@;6]D:69I8V%T:6]N(&]F
M('1H92!(15`@26YV97-T;65N=',@;&]A;B!!9W)E96UE;G0@=V%S(&YO=!A

M05-#(#0W



&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF;VYT




S-2PP
#`@=&AR97-H

M-2PP




@;65T:&]D(&]F('9A;'5A=&EO

M9B!D:79I9&5N9'
@


&-M(#!P=#ML:6YE+6AE:6=H=#IN


2P@



M


M9&5D(&$@9&5B=!D:7-C;W5N=!I;B!T:&4@86UO=6YT(&]F(0T,PU

M9'5R:6YG('1H92!Q=6%R=&5R(&5N9&5D($1E8V5M8F5R(#









M





^3VX@

C`Q
BP@=&AE($-O;7!A;GD@86YD(%1H92!696YT=7)E




M('5N9&5R('=H:6-H('1H92!

#`L

38X+#`P

#$R


M8VEP86P@86UO=6YT(&]F(0U,#`L,#`P(@F(S$T-SM.;W1E)B
Q-#@[*3L@





M960@8F%S:7
@8GD@86QL('1H92!#;VUP86YY)B













S$L(#(P
3(L

CDS
M+#(X
B!R96QA=&5D('1O(#4U
RPQ



2P@
C`Q
M


M(&-H87)G97
@;V8@)#
Q
2PT









M86YG/3-$14XM55
^07



3`X+#
Y
M

@



M;F1E;G0Z



C`Q

M=F5R=&5D(0Q-3`L,#`P(&]F('1H92`D-3`P+#`P,!C;VYV97)T:6)L92!D





#`@;V8@=&AE(&-O;G9E


'!T

M87)G:6XZ

T1%3BU54SY/=&AE


M9VEN.C!C;2`P8VT@



M(&EN=&\@.34P+#`P


M97





&-M(#!C



@=V%S(&YO


M1#`@8F]R9&5R/3-$
#X@/'1R(&%L:6=N/3-$;&5F=#X@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#




T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M

M;&4]
T0G;6%R9VEN.C!C;2`P8VT@

M(V8P9C!F

#MW:61T:#HR-C@N-7!T.V)O


M9RUT;W`Z

M






M:6=H=#HC9C!F

&8P

M969T.C!C;3MB;W)D97(M;&5F=#HC9C!F

&-M


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P.SPO




#MW

7!T('-O;&ED.W!A9&1I

M;3MB;W)D97(M;&5F=#HC9C!F

&-M.V)A8VMG




T0G

30\+V9O;G0^/]P
M/CPO=&0^(#QT9!V86QI9VX]
T1T;W`@=VED=&@]
T0R

M1&)O='1O;2!W:61T:#TS1#$Q

M9RUT;W`Z

M

M96YT)SX@/'`@86QI9VX]


M/&9O;G0@;&%N9STS1$5.+553/D1E8V5M8F5R(#
Q+#PO9F]N=#X\+W`^(#QP


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF;VYT(&QA

T1%3BU54SXR

T1B;W1T;VT@=VED=&@]

M;&4]
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[
M=VED=&@Z
C8X+C5P=#MB;W)D97(M8F]T=&]M.B-F

M;W1T;VTZ

&-M.V)O



T1T;W`@=VED=&@]
T0R

M:61T:#TS1#$Q

#MB;W)D97(M


M


M;&5F=#HP8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C

M87)G:6XZ




&8P.W=I9'1H



M=#HC9C!F



&-M(#!P=#ML

M/3-$8F]T=&]M('=I9'1H/3-$

M


M='1O;3HC9C!F


&8P.W!A9&1I



&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M



T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M


#$U(#PO9F]N=#X\


M;F]R;6%L)SX\9F]N=!L86YG/3-$14XM55,^)#PO9F]N=#X\+W`^/]T9#X@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q



#MW:61T:#HX-'!T


M9&EN9RUT;W`Z

M9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O;&]R.G1R86YS

M/&9O;G0@;&%N9STS1$5.+553/C(T
PP,#`\+V9O;G0^/]P/CPO=&0^(#QT

M;W`Z(V8P9C!F

#MW:61T:#HQ-7!T.V)O


M9RUT;W`Z

M


M;G0@;&%N9STS1$5.+553/B0\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
M
T1B;W1T;VT@=VED=&@]
T0Q

T1B;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z.#1P=#MB;W)D97(M8F]T
M=&]M.B-F


M;3MP861D:6YG+6QE9G0Z




T0G;6%R9VEN.C!C;2`P
M8VT@


M;W`Z(V8P9C!F

#MW:61T:#HQ-7!T.V)O


M9RUT;W`Z

M







&8P



M97(M;&5F=#HC9C!F



&-M

M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$




M9&5R+6)O='1O;3HC9C!F


&8P



&-M(#!P=#ML:6YE+6AE:6=H



T0G;6%R9VEN.C!C;2`P8VT@
'!T


2PW.30L

BPR
S4L

M;VT@07!R:6P@



T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M

M9VX]

M8VT@

T1%
M3BU54SXS+#8R-2PT
C@\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B
M;W1T;VT@=VED=&@]
T0R


M


M9C!F

#MP861D:6YG


M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O

SPO

M9&5R+6)O='1O;3HC9C!F


&8P



&-M(#!P=#ML:6YE+6AE:6=H

M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R
M+7)I9VAT.B-F
&8P9C`[=VED=&@Z
35P=#MB;W)D97(M8F]T=&]M.B-F
&8P


M+6QE9G0Z



M/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q

M;&4]
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[
M=VED=&@Z.#1P=#MB;W)D97(M8F]T=&]M.B-F

M;VTZ




M86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R

M:61T:#TS1#$Q

#MB;W)D97(M


M


M;&5F=#HP8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C

M87)G:6XZ


M='1O;3HC9C!F


&8P.W!A9&1I



&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M

T1%3BU54SXQ
24@0V]N=F5R=&EB;&4@;F]T92!P





M9&5R+6)O='1O;3HC9C!F


&8P



&-M(#!P=#ML:6YE+6AE:6=H

M('=I9'1H/3-$

#MB;W)D


M8VL@


&8P.W!A9&1I



M9STS1$5.+553/BT\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T
M;VT@=VED=&@]
T0R


B!S
M='EL93TS1=B;W)D97(M=&]P.B-F,&8P9C`[8F]R9&5R+7)I9VAT.B-F,&8P
M9C`[=VED=&@Z.#1P=#MB;W)D97(M8F]T=&]M.F)L86-K(#%P=!S;VQI9#MP


M=#HP8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB

T1R:6=H

&-M(#!P

T1%3BU54SXS
C`L
M

T1B;W1T;VT@=VED=&@]

T1B;W)D97(M
M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
C8X+C5P
M=#MB;W)D97(M8F]T=&]M.B-F

&-M.W!A


M

T1B
M;W1T;VT@=VED=&@]
T0R


M


M9C!F

#MP861D:6YG


M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O

L.#8U+#0R.#PO

M:6=H=#MM87)G:6XZ



T0G
M;6%R9VEN.C!C;2`P8VT@



'!T.VQI;F4M:&5I9VAT.FYO



&8P.W=I9'1H



M=#HC9C!F



&-M(#!P=#ML

M/3-$8F]T=&]M('=I9'1H/3-$

M9C!F


M;W1T;VTZ8FQA8VL@


M



M/&9O;G0@;&%N9STS1$5.+553/C$L-C$Y+#

M

M9RUL969T.C!C;3MB;W)D97(M;&5F=#HC9C!F

M


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P


M;&4]
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[
M=VED=&@Z
35P=#MB;W)D97(M8F]T=&]M.B-F

M;VTZ




M86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q

T1B;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z.#1P=#MB;W)D
M97(M8F]T=&]M.B-F


M=&]P.C!C;3MP861D:6YG+6QE9G0Z

&8P9C`[

T1B;W1T;VT@
M=VED=&@]
T0R

B!S='EL


#MW

#MP861D:6YG+6)O='1O


M+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O

&-M(#!C;2`P

&8P.W!A

M.C!C;3MB;W)D97(M;&5F=#HC9C!F

&-M.V)A

M;CHP8VT@

M




&-M(#!C;2`P

M
B!S='EL93TS1=B;W)D97(M=&]P.B-F,&8P9C`[8F]R9&5R+7)I9VAT.B-F
M,&8P9C`[=VED=&@Z.#1P=#MB;W)D97(M8F]T=&]M.F)L86-K(#(N,C5P=!D


M:6YG+6QE9G0Z





M55
^
C
W+#`T

&-M(#!C

M1#$Q


M861D:6YG+6QE9G0Z





M14XM55
^.#DP+#@Q
3PO9F]N=#X\+W`^/]T9#X\+W1R/CPO=&%B;&4^/]D

&-M(#!P=#ML:6YE+6AE:6=H


2PW
M
S4@86YD(0Q+#0V-PU

C`Q


&-M(#!C


M7S0X8V%?.&$W.5]B9#@P-V%D8F)E
&



M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-

T1T

M(%1H:7


]

T0Q


#$T/&)R/CPO


M=F%L:6=N/3-$=&]P/D1%4DE6051)5D4@3$E!0DE

T0G=&5X


'!T.VQI;F4M:&5I





3$@=VET



@9&5R:79A=&EV92!L:6%B:6QI='D@=V%S('9A


M:6QI='D@;V8@


M9'
@


2P@
C`Q

@;65T


M9B`N




M:6XZ

C`Q
BP@:6X@8V]N;F5C=&EO;B!W:71H
M('1H92!(15`@26YV97-T;65N='





M)#0Y-BPS-S4@=71I;&EZ:6YG('1H92!;&%C:RU38VAO;&5S(&UE=&AO9!O





@;V8@




&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF;VYT



M97


M8W1E9!V;VQA=&EL:71Y(&]F(#$T,XY



@;V8@




&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF


2P@
C`Q
BP@=&AE($-O
FEN9R!T:&4@0FQA8VLM4V-H;VQE<R!M971H;V0@;V8@
M=F%L=6%T:6]N('5S:6YG('1H92!F;VQL;W=I;F<@87-S=6UP=&EO;G,Z(9N

M92!O9B`N

M96-R96%S960@8GD@)#4P-BPW


2P@
C`Q








38P+CDV)2!O=F5R









34Q+C
W

BXP











M.C!C;2`P8VT@


M

#$S+!I;B!C;VYN96-T:6]N('=I=&@@=&AE($A%4!)





@;65T:&]D(&]F('9A;'5A=&EO



M;6%R9VEN.C!C;2`P8VT@

M;2`P8VT@





@;65T:&]D(&]F('9A;'5A


M




M

M=&QE9!(15`@26YV97-T;65N=',@=&\@861D:71I;VYA;!S:&%R97
@;V8@




M;&%T:6QI='D@;V8@

BXP
!Y
M96%R(&-O;G1R86-T=6%L(&QI9F4@;V8@=&AE(&YO=&4L(&%N(&%N;G5A;!R

M;V8@+C


M9STS1$5.+553/D]N($IU;'D@
C4L(#(P
3
L(&EN(&-O;FYE8W1I;VX@=VET

@82!R97-U;'0@

@=VAI8V@@





Z




&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M



M86EN:6YG(#(N

@;V8@
4L(&%N9!A(')I

T0G


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M

T1%3BU54SY/;B!/8W1O8F5R(#(X+`R,#$S+!I





M+5-C:&]L97




S
E+CPO9F]N=#X\+W`^(#QP('-T





M:'0Z;F]R;6%L)SX\9F]N=!L86YG/3-$14XM55,^3VX@1&5C96UB97(@,3@L
M(#(P,3,L(&EN(&-O;FYE8W1I;VX@=VET:!T:&4@2$50($EN=F5S=&UE;G1S






&-M(#!P=#ML

T1%3BU54SY/;B!$96-E


@;V8@8V]M;6]N('-T

#$@=71I
M;&EZ:6YG('1H92!;&%C:RU38VAO;&5S(&UE=&AO9!O9B!V86QU871I;VX@


M;V8@
3

BXP
!Y96%R(&-O;G1R
M86-T=6%L(&QI9F4@;V8@=&AE(&YO=&4L(&%N(&%N;G5A;!R871E(&]F(&1I

Y)2X\

M/D]N($1E8V5M8F5R(#


M(')A=&4@;V8@+C




2P@
C`Q
RX\+V9O;G0^




M=F4@;&EA8FEL:71Y(&%T(0R+#8W,2PU,CD@=71I;&EZ:6YG('1H92!;&%C

M92!O9B!T:&4@9&5R:79A=&EV92!D96-R96%S960@8GD@)#8L
3
U+#0U.!W
M:&EC:!H87

M/3-$14XM55
^3VX@2G5N92`S
P@,C`Q-P@=&AE($-O;7!A;GD@=F%L=65D

M9B`Q


@8V]N=')A
M8W1U86P@;&EF92!O9B!T:&4@;F]T92P@86X@86YN=6%L(')A=&4@;V8@9&EV




&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF

T1%3BU54SY/;B!*=6QY(#$T+`R,#$T+!I;B!C;VYN96-T




@


T0G=&5X


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG

T1%3BU54SY/;B!397!T96UB97(@
3DL(#(P
30L(&EN



@=VAI8V@@96YT:71L960@2$50($EN=F5S=&UE;G1S('1O(&%D







BXP



P@
M,C`Q-P@=&AE($-O;7!A;GD@=F%L=65D('1H92!D97)I=F%T:79E(&QI86)I



M=6UP=&EO;G


M9&5R:79A=&EV92!D96-R96%S960@8GD@)#0L-#@Q+#0W.!W:&EC:!H87
@

S`L(#(P
30N


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P.SPO




M;65N9&UE;G0@=&\@3&]A;B!!9W)E96UE;G0@86YD('1H92!&:69T:!!;65N
M9&5D(&%N9!297-T871E9!396YI;W(@4V5C=7)E9!#;VYV97)T:6)L92!0






M-24@9&ES8V]U;G0@;V9F(&]F('1H92!T96X@9&%Y('1R86EL:6YG('%U;W1E

2P@
C`Q



M4&%R=%]F.64R86$R-U\W-V-B7S0X8V%?.&$W.5]B9#@P-V%D8F)E
&






544\


]
T1R







M8VT@

T1%




2P@
C`Q


M86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R

T1B;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z

M;W)D97(M8F]T=&]M.B-F

&-M.W!A9&1I


&8P

T1B;W1T
M;VT@=VED=&@]

M;W`Z

#MP


T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M:&5I9VAT

M86YG/3-$14XM55
^3&5V96P@



M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O


M;&4]

M9VX]
T1B;W1T;VT@=VED=&@]
T0R

T1B;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z

M97(M8F]T=&]M.B-F


M=&]P.C!C;3MP861D:6YG+6QE9G0Z

&8P9C`[






M9&5R+6)O='1O;3HC9C!F


&8P



&-M(#!P=#ML:6YE+6AE:6=H

M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R
M+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3@N-S5P=#MB;W)D97(M8F]T=&]M.B-F
M


M:6YG+6QE9G0Z




T1B;W1T;VT@=VED=&@]

T1B;W1T;VT@=VED
M=&@]
T0R

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F
&8P9C`[=VED=&@Z

&8P


M+6QE9G0Z




\+V9O
M;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R-2!S
M='EL93TS1=B;W)D97(M=&]P.B-F,&8P9C`[8F]R9&5R+7)I9VAT.B-F,&8P
M9C`[=VED=&@Z,3@N-S5P=#MB;W)D97(M8F]T=&]M.F)L86-K(#(N,C5P=!D


M:6YG+6QE9G0Z




&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF


M;VTZ




T0G

^




M;2`P8VT@



#MW:61T:#HQ-S4N

#MP861D:6YG+6)O='1O;3HP8VT[


M(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O;&]R.G1R



M8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[
M8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3@N-S5P=#MB;W)D97(M8F]T
M=&]M.B-F


M;3MP861D:6YG+6QE9G0Z



T1B;W1T;VT@=VED=&@]
M


T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI

M;W1T;VTZ(V8P9C!F

M

#MP861D




T0G;6%R
M9VEN.C!C;2`P8VT@


#MB


M;VTZ(V8P9C!F

&-M

#MP861D:6YG





M:'0Z(V8P9C!F

T1B;W1T;VT@=VED=&@]
T0W-!S='EL93TS1=B
M;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z

BXR-7!T(&1O=6)L93MP861D


M8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K


&-M(#!P=#ML

T1%3BU54SXX+#`S-BPR
M
SD\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
M


M(V8P9C!F
#MW:61T:#HQ

#MP861D


M8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K

M

BXR-7!T(&1O=6)L93MP861D


M8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K

T0G;6%R9VEN
M.C!C;2`P8VT@


^3&5V96P@
R!F
M:6YA;F-I86P@:6YS=')U;65N='


@87)E(&5S




M=&AE('%U87)T97(@96YD960@36%R8V@@
S$L(#(P

&-M

M

#$T

M9&EN9STS1#`@8F]R9&5R/3-$
#X@/'1R(&%L:6=N/3-$;&5F=#X@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#



M:6=H=#HC9C!F

M

M9RUL969T.C!C;3MB;W)D97(M;&5F=#HC9C!F

M


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P

T0Y-2!S='EL93TS
M1=B;W)D97(M=&]P.B-F,&8P9C`[8F]R9&5R+7)I9VAT.B-F,&8P9C`[=VED
M=&@Z-S$N,C5P=#MB;W)D97(M8F]T=&]M.F)L86-K(#%P=!S;VQI9#MP861D


M8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K

T1C96YT97(@


M8V5M8F5R(#

T0G;6%R
M9VEN.C!C;2`P8VT@



^1&5C96UB97(@
M
S$L(#(P
3

T1B;W1T;VT@=VED=&@]

M
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED
M=&@Z
3!C;3MB;W)D97(M8F]T=&]M.B-F

M


M969T.B-F

M9VX]
T1B;W1T;VT@=VED=&@]

M9C!F




M:6=H=#HC9C!F

&8P

M969T.C!C;3MB;W)D97(M;&5F=#HC9C!F

&-M


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P.SPO


M
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED
M=&@Z
3@N-S5P=#MB;W)D97(M8F]T=&]M.B-F

M;VTZ




M/'1R(&%L:6=N/3-$;&5F=#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#

M14XM55

T1B;W1T;VT@=VED=&@]




^)#PO9F]N=#X\


M:'0Z;F]R;6%L)SX\9F]N=!L86YG/3-$14XM55,^.PP
S8L
C


T0G;6%R9VEN.C!C;2`P8VT@
M



M9RUT;W`Z

M



M:'0Z;F]R;6%L)SX\9F]N=!L86YG/3-$14XM55,^)#PO9F]N=#X\+W`^/]T







M9C!F




^
2PP
C8L

T1B;W1T;VT@


T1B;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3!C;3MB;W)D97(M
M8F]T=&]M.B-F


M.C!C;3MP861D:6YG+6QE9G0Z






M;&4]
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[
M=VED=&@Z
3@N-S5P=#MB;W)D97(M8F]T=&]M.B-F

M;W1T;VTZ

&-M.V)O



T1B;W1T;VT@=VED=&@]

M;W`Z(V8P9C!F

#MW:61T:#HW
2XR-7!T


M9&EN9RUT;W`Z

M9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O;&]R.G1R86YS



T0G;6%R9VEN.C!C
M;2`P8VT@


M
T1L969T/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

M
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED
M=&@Z
3@N-S5P=#MB;W)D97(M8F]T=&]M.B-F

M;VTZ




M86QI9VX]
T1B;W1T;VT@=VED=&@]

M(V8P9C!F

#MW:61T:#HW
2XR-7!T.V)O


M9RUT;W`Z

M


M;G0@;&%N9STS1$5.+553/C$L

M
T0G;6%R9VEN.C!C;2`P8VT@


'!T.VQI;F4M:&5I

T1L969T/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$

M

&8P.W=I9'1H.C$P8VT[8F]R9&5R+6)O
M='1O;3HC9C!F


&8P.W!A9&1I



&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M




T1R:6=H=!S='EL93TS1=T

&-M(#!P=#ML:6YE+6AE:6=H

T1%3BU54SXH.PT,3@L.3@R*3PO9F]N
M=#X\+W`^/]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$V('-T


&8P



M97(M;&5F=#HC9C!F



&-M

M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3@N-S5P=#MB
M;W)D97(M8F]T=&]M.B-F

&-M.W!A9&1I


&8P

T1B;W1T
M;VT@=VED=&@]

#MB;W)D

#MW:61T:#HW

M9C!F

&-M.W!A9&1I

#MP861D:6YG+7)I9VAT



M;&EN92UH96EG:'0Z;F]R;6%L)SX\9F]N=!L86YG/3-$14XM55,^*#@S,PX

T0G;6%R9VEN
M.C!C;2`P8VT@

M=&0^(#QT9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R-2!S='EL93TS1=B
M;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
M

T1B;W1T;VT@=VED=&@]
T0Y-B!S='EL93TS1=B;W)D
M97(M=&]P.B-F,&8P9C`[8F]R9&5R+7)I9VAT.B-F,&8P9C`[=VED=&@Z-S)P
M=#MB;W)D97(M8F]T=&]M.F)L86-K(#%P=!S;VQI9#MP861D:6YG+6)O='1O


M+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O

T1R:6=H=!S='EL93TS1=T

&-M(#!P=#ML:6YE+6AE:6=H


T1B;W1T;VT@
M=VED=&@]

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R
M+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3!C;3MB;W)D97(M8F]T=&]M.B-F
&8P


M+6QE9G0Z




M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T0G


&8P.W=I9'1H


M.C!C;3MB;W)D97(M;&5F=#HC9C!F

&-M.V)A

M:6XZ


#MB;W)D

#MW:61T:#HW

M8FQA8VL@

M9RUT;W`Z

M

M96YT)SX@/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I

&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF



T0G;6%R9VEN.C!C;2`P8VT@


&8P9C`[8F]R9&5R+7)I9VAT
M.B-F
&8P9C`[=VED=&@Z
3@N-S5P=#MB;W)D97(M8F]T=&]M.F)L86-K(#(N
M


T0G8F]R9&5R+71O





M;&5F=#HC9C!F



#
V+#(S.3PO9F]N=#X\

M;CHP8VT@



M;'5E(&]F('1H92!#;VUP86YY)B

979E;`S(&9I;F%N8VEA;!I




M($%S(&YO=&5D(&EN($YO=&4@-R`F(S$U
#L@0V]N=F5R=&EB;&4@1&5B=!A
M;F0@3F]T92`X(8C

M8V5M8F5R(#$L(#(P
30@86UE;F1M96YT('=I=&@@2$50($EN=F5S=&UE;G1S


&-M



M-V-B7S0X8V%?.&$W.5]B9#@P-V%D8F)E
&

M;G0]

2!R





3XQ
B!-;VYT:'


2P@
C`Q

]


]


]

&-M

T1%3BU5


M

T1%





@;V8@8V]M;6]N('-T;V-K('1O(%!H:6QI

M
3


3(L-3`P('9E


3`L
S@Q('5S


M96EV92`D
3`L




&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF;VYT


@



M(&]F(&-O;6UO;B!S=&]C:R!T;R!4:&]M87
@2RX@0V]X(&EN($IU;F4L(#(P
M
3


3(L-3`P('9E









@

C`Q
M

BPU
#`@=F5S

W+#4P
M




Z('9O;&%T:6QI='D@
30S+C
W


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M




BPU
#`@

W
M+#4P



@


M871E(#`N
S

M(')E8V5I=F4@)#$P+#`P
!F;W(@96%C:!A;FYU86P@=&5R;2!S97)V960L

3DL(#(P
30L($UR


M87)G:6XZ


&-M

L('1H92!#;VUP86YY(&=R86YT960@







M;W=S.B`Q
BPU


W+#4P

3(L-3`P


Z('9O
M;&%T:6QI='D@
3(Q+C
S)3L@86YN=6%L(')A=&4@;V8@9&EV:61E;F1S(#`E
M.R!D:7-C;W5N=!R871E(#`N-#0E+B9N8G-P.R!);B!A9&1I=&EO;BP@37(N
M(%)I8V4@=VEL;!R96-E:79E(0Q,PP
#`@9F]R(&5A8V@@86YN=6%L('1E

'!T.VQI


'!T.VQI;F4M:&5I9VAT

M(#4P+#`P

M;W=S.B`Q
BPU


W+#4P

3(L-3`P





3`L

M


&-M(#!P=#ML:6YE+6AE:6=H=#IN






M(&EN($IU;'DL(#(P

@9F]L;&]W






M87EN92!W:6QL(')E8V5I=F4@)#$P+#`P
!F;W(@96%C:!A;FYU86P@=&5R










M-3`L






M;VYS.B!V;VQA=&EL:71Y(#$Q
RXY

#`@9F]R(&5A

M;2`P8VT@

'!T

M:6YG('1H92!T=V5L=F4@;6]N=&AS(&5N9&5D($1E8V5M8F5R(#

@97AP96YS960@86YD('1H92!V86QU

M.C!C;2`P8VT@


M


'!T.VQI;F4M:&5I





M
2PQ

M9B`S-2PP


T0G


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M






#`P(&9R;VT@=&AE(&5X97)C
M:7-E(&]F(#8X
BPP


&-M





M;7!A;GD@:7-S=65D(#8P



M


P+`R,#$S+!T




M9B`N







@;V8@
4L(&%N9!A


M

'!T.VQI;F4M





Z)FYB

M;VQA=&EL:71Y(&]F(#$Y
XQ-24@82!F:79E('EE87(@=&5R;2P@86X@86YN
M=6%L(')A=&4@;V8@9&EV:61E;F1S(&]F(#`E+!A;F0@82!R:7-K(&9R964@








#`L(#

L



65A<B!T97)M+!A;B!A;FYU86P@<F%T92!O9B!D:79I9&5N
M9'
@;V8@



&-M(#!P

T1%3BU54SY$=7)I

#`P(&9R


R!S:&%R97
@;V8@8V]M;6]N




M;6%R9VEN.C!C;2`P8VT@

C`Q
RP@=&AE($-O;7!A;GD@:7-S=65D(#$L
#`P+#`P
M

^1'5R:6YG('1H92!T:')E92!M;VYT:'
@96YD960@
M4V5P=&5M8F5R(#

C$W

@8V]M;6]N('-T;V-K('9A;'5E9!A=`D-#`L.#`R



@;V8@

M;2`P8VT@

'!T

C`Q
RP@

@;V8@:71S(&-O
M;6UO;B!S=&]C:R!V86QU960@870@)#$L


M;CHP8VT@

M

2P@
C`Q
RP@=&AE($-O;7!A;GD@9W)A
M;G1E9!A(&-O;G-U;'1A;G0@=&\@=&AE($-O;7!A;GD@-38L,C4V+`U('EE

Y

@=V5R92!V86QU960@870@)#8T
M+#DT






M9&5D($1E8V5M8F5R(#

C(Y
M+#4Y-R!S:&%R97


#`P(&-O;6UO;B!S=&]C:R!W



M;CHP8VT@

M




'!T.VQI;F4M:&5I9VAT.FYO

M9GD[;6%R9VEN.C!C;2`P8VT@





'!T.VQI;F4M:&5I9VAT






M=F%L=6%T:6]N(AS964@3F]T92`W(8C
34P.R!#;VYV97)T:6)L92!$96)T
M*2X@5V4@=F%L=65D('1H:7


BXX
M.4M,30S+C0T)2P@86YN=6%L(')A=&4@;V8@9&EV:61E;F1S(#`E(&%N9!A
3MM87)G:6XZ,&-M(#!C;2`P
M<'0[;&EN92UH96EG:'0Z;F]R;6%L)SX\9F]N=!L86YG/3-$14XM55
^1'5R
M:6YG('1H92!T:')E92!M;VYT:'
@96YD960@1&5C96UB97(@
S$L(#(P
3
L




&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG



#`@;V8@
M



Q+`R,#$T+!T


#`L



&-M(#!P=#ML:6YE







S`L
M(#(P

M(#
Y

^1'5R:6YG('1H92!T:')E
M92!M;VYT:'
@96YD960@4V5P=&5M8F5R(#

#`L

M(&%T(0V-PU



&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF;VYT


3
L-S8P


@;65T:&]D(&]F('9A



M87-S=6UP=&EO;G



M;2`P8VT@

'!T

#$T('1H

#`@86YD(#4P





@

'!T.VQI;F4M


'!T.VQI;F4M:&5I9VAT.FYO








M+5-C:&]L97



'!T


'!T.VQI;F4M:&5I

M14XM55
^3VX@07!R:6P@
34L(#(P
3


Q-#@[*2!E;G1E




M)#(L
#`P+#`P


M)B




2PQ
#`L



Q

Q-#@[*2!P;'5S(&$@
C`E('!R96UI=6T@86UO




M


P@,C`Q,RDL('1H92!#;VUP86YY(&-O;7!L971E9!T:&4@86-Q=6ES


@86YD('-E8W5R






&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG






BPX
M.#0@:6X@=')A;G-A8W1I;VX@8V]S='






2PS.3$L
C@Q


M9STS1$5.+553/D%S(&]F($1E8V5M8F5R(#






@86)A;F1O;F5D('1H92!P871E

Y
2PR.#$@9F]R('1H92!Y96%R(&5N
M9&5D($1E8V5M8F5R(#

T1%3BU5


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P

T0G;6%R9VEN.C!C;2`P8VT@
'!T)SX\8CX\9F]N

M.C!C;2`P8VT@



T1%

@0VAI968@1FEN


@=V]U;&0@

@;V8@8V]M


M.B!V;VQA=&EL:71Y(#$R.XS-24[(&%N;G5A;!R871E(&]F(&1I=FED96YD

M1$5.+553/B9N8G-P.R!/;B!-87D@
30L(#(P
30L('1H92!#;VUP86YY(&ES




M.B!V;VQA=&EL:71Y(#$R





38N-S(E.R!A

@

M






M9B!D:79I9&5N9'

&-M

M9GD[;6%R9VEN.C!C;2`P8VT@


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N

T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M

T0G;6%R
M9VEN.C!C;2`P8VT@


T0P
M(&-E;&QP861D:6YG/3-$


&8P


M='1O;3HC9C!F


&8P.W!A9&1I



&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M

M/3-$
C`Q(&-O;'-P86X]

M

#MW:61T:#HQ-3`N-S5P=#MB;W)D97(M

M;CIC96YT97([;6%R9VEN.C!C;2`P8VT@


#$T/]F
M;VYT/CPO8CX\+W`^/]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS


M9C!F

&8P.W!A

M.C!C;3MB;W)D97(M;&5F=#HC9C!F

&-M.V)A

M;CHP8VT@

M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
C`X(&-O;'-P86X]
M


M(V8P9C!F

M;2`P8VT@

#$S/]F;VYT/CPO8CX\+W`^/]T9#X\
M+W1R/B`\='(@86QI9VX]
T1L969T/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$


M:6=H=#HC9C!F
&8P.W=I9'1H.C$T

M


M;&5F=#HP8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C

M87)G:6XZ






M86QI9VX]



M



&8P.W=I



M97(M;&5F=#HC9C!F




&-M(#!P=#ML:6YE+6AE

T1%3BU54SY.=6UB97(@;V8\+V9O
M;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R
2!S


M

#MP861D:6YG


M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O

&-M



T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M

&8P9C`[
M8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-C`N-S5P=#MB;W)D97(M8F]T

M96YT97([;6%R9VEN.C!C;2`P8VT@

M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M
M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
34N-S5P
M=#MB;W)D97(M8F]T=&]M.B-F

&-M.W!A


M

T1B
M;W1T;VT@=VED=&@]

M9RUT;W`Z

M

M96YT)SX@/'`@86QI9VX]




T0G;6%R9VEN.C!C;2`P8VT@
'!T

M
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-C`N-S5P=#MB;W)D

M;&EG;CIC96YT97([;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M:&5I9VAT.FYO

M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B
M;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
M
34N-S5P=#MB;W)D97(M8F]T=&]M.B-F

M


M969T.B-F

M9VX]
T1B;W1T;VT@=VED=&@]
T0Q


M9C!F



M;&EG;CIC96YT97([;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M:&5I9VAT.FYO




&8P.W=I



M97(M;&5F=#HC9C!F



T0G

^
38L.3`P+#4S.3PO9F]N





&8P.W=I9'1H



M;&5F=#HC9C!F



T0G=&5X

^
XQ-SPO9F]N=#X\+W`^/]T



&8P.W=I9'1H.C$U



M=#HC9C!F




M;&EN92UH96EG:'0Z;F]R;6%L)SX\9F]N=!L86YG/3-$14XM55,^,38L,S8U
M+#(P.3PO9F]N=#X\+W`^/]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T


M=#HC9C!F

&8P

M969T.C!C;3MB;W)D97(M;&5F=#HC9C!F

&-M



^)#PO


M92UH96EG:'0Z;F]R;6%L)SX\9F]N=!L86YG/3-$14XM55,^,XQ-SPO9F]N



T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M

M;VTZ(V8P9C!F

&-M

#MP861D:6YG

M1$5.+553/C
L


T1R:6=H

&-M(#!P

T1%3BU54SXP+C$V

T0G;6%R9VEN
M.C!C;2`P8VT@


#MP861D:6YG+6)O='1O;3HP


M9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O;&]R

S
#PO9F]N=#X\+W`^

M=#X@/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I9VAT

&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF;VYT


T1B;W1T;VT@=VED=&@]
T0Q.#@@

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P
M9C`[=VED=&@Z



M;W)D97(M;&5F=#HC9C!F



M

T1%3BU5

T1T;W`@
M=VED=&@]
T0R

#MB;W)D97(M


M9C!F

&-M.W!A9&1I

#MP861D:6YG+7)I9VAT




M96EG:'0Z;F]R;6%L)SX\9F]N=!L86YG/3-$14XM55,^*#(L,#0P+#`P,D\
M+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R
M


M9C!F

#MP861D


M8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K

M

M;&EG;CIR:6=H=#MM87)G:6XZ

M;6%L)SX\9F]N=!L86YG/3-$14XM55,^,XQ

M86QI9VX]

M;CHP8VT@

M
T1%3BU54SXH
BPW.#4L

T1R

&-M

T1%3BU54SXP

T1B;W1T;VT@=VED=&@]

T1B;W)D97(M
M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z

M8F]R9&5R+6)O='1O;3HC9C!F


M



&-M(#!P=#ML:6YE+6AE

T1%3BU54SY#86YC96QL960\+V9O
M;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1T;W`@=VED=&@]
T0R
2!S='EL


#MW

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD

&-M(#!C

M:6=H=#MM87)G:6XZ

M9F]N=!L86YG/3-$14XM55,^*#$Q,PQ


T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M

M;VTZ(V8P9C!F

&-M

#MP861D:6YG

M1$5.+553/C`N
S$\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T
M;VT@=VED=&@]
T0R

#MB;W)D


M(V8P9C!F

&-M.W!A

#MP861D:6YG+7)I







&8P.W=I



M97(M;&5F=#HC9C!F



&-M

M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$




M;W)D97(M8F]T=&]M.B-F

&-M.W!A9&1I


&8P


M9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F
&8P9C`[=VED=&@Z
34N-S5P=#MB;W)D97(M8F]T=&]M.B-F
&8P


M+6QE9G0Z



M/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0X
2!S='EL
M93TS1=B;W)D97(M=&]P.B-F,&8P9C`[8F]R9&5R+7)I9VAT.B-F,&8P9C`[
M=VED=&@Z-C`N-S5P=#MB;W)D97(M8F]T=&]M.F)L86-K(#%P=!S;VQI9#MP


M=#HP8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB

T1R:6=H

&-M(#!P




M:6=H=#HC9C!F

M

M9RUL969T.C!C;3MB;W)D97(M;&5F=#HC9C!F

M


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P

M;&4]


&8P



M9G0Z





^
XQ
M-SPO9F]N=#X\+W`^/]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS


M9C!F

&8P.W!A

M.C!C;3MB;W)D97(M;&5F=#HC9C!F

&-M.V)A

M;CHP8VT@


T0G


&8P.W=I9'1H

M9RUB;W1T;VTZ

&-M



M;&4]

^*#$L-3`P+#`P
M



'!T.VQI

M9C!F

#MW:61T:#HQ-#%P=#MB;W)D97(M
M8F]T=&]M.B-F


M.C!C;3MP861D:6YG+6QE9G0Z



T1T;W`@=VED=&@]
M
T0R


M(V8P9C!F

#MP


M=#HP8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB

M:6XZ




T0G;6%R9VEN.C!C;2`P
M8VT@



&8P.V)O


M;3HC9C!F










&8P.W=I9'1H.C$U



M=#HC9C!F



&-M(#!P=#ML

M/3-$8F]T=&]M('=I9'1H/3-$

M


M8F]T=&]M.B-F


M.C!C;3MP861D:6YG+6QE9G0Z





T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M

M;&4]
T0G;6%R9VEN.C!C;2`P8VT@

&8P9C`[8F]R9&5R+7)I9VAT.B-F
M
&8P9C`[=VED=&@Z-C`N-S5P=#MB;W)D97(M8F]T=&]M.F)L86-K(#(N
C5P

M

M8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[
M8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
34N-S5P=#MB;W)D97(M8F]T
M=&]M.B-F


M;3MP861D:6YG+6QE9G0Z










&8P



M;G0@;&%N9STS1$5.+553/C`N
38\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI
M9VX]
T1B;W1T;VT@=VED=&@]
T0R

M9C!F




M;W`Z

#MP

M/CPO=&0^(#QT9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X,2!S='EL93TS
M1=B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED
M=&@Z-C`N-S5P=#MB;W)D97(M8F]T=&]M.F)L86-K(#(N

&-M(#!C;2`P



M:6=H=#HC9C!F

M

M9RUL969T.C!C;3MB;W)D97(M;&5F=#HC9C!F

M



^
M)#PO9F]N=#X\+W`^/]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$P-B!S='EL93TS1=B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT
M.B-F

BXR

&-M

#MP861D:6YG

M86QI9VX]

M;CHP8VT@

M


T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M:&5I9VAT

&-M(#!C


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF



@;V8@1&5C96UB97(@
S$L(#(P
M


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P.SPO

M



M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD


M



&8P

&8P.W=I9'1H.C$Y+C5P=#MB;W)D97(M8F]T
M=&]M.B-F


M;3MP861D:6YG+6QE9G0Z



T1B;W1T;VT@=VED=&@]
M


&8P



M
T0G;6%R9VEN.C!C;2`P8VT@




&8P.W=I9'1H.C4V+C(U



M9C!F



&-M(#!P=#ML:6YE

M8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[
M8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3$N
C5P=#MB;W)D97(M8F]T
M=&]M.B-F


M;3MP861D:6YG+6QE9G0Z



T1B;W1T;VT@=VED=&@]
M


M(V8P9C!F
#MW:61T:#HW

#MP


M=#HP8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB

&-M(#!C;2`P



M=#HC9C!F
&8P.W=I9'1H.C$Y+C5P=#MB;W)D97(M8F]T=&]M.B-F
&8P9C`[


M9G0Z



T1B;W1T;VT@=VED=&@]
T0V-B!S='EL93TS


#MW:61T



M;&5F=#HC9C!F



&-M(#!P

M:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3(N-S5P=#MB;W)D
M97(M8F]T=&]M.B-F


M=&]P.C!C;3MP861D:6YG+6QE9G0Z

&8P9C`[

T1B;W1T;VT@
M=VED=&@]

#MB;W)D97(M


M9C!F

&-M.W!A9&1I

#MP861D:6YG+7)I9VAT




T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M


T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M:&5I9VAT




&8P



M;W)D97(M;&5F=#HC9C!F



M

M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M
M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3$N
C5P
M=#MB;W)D97(M8F]T=&]M.B-F

&-M.W!A


M

T1B
M;W1T;VT@=VED=&@]

#MB

#MW:61T:#HW

M;VTZ(V8P9C!F

&-M

#MP861D:6YG

M:6XZ



&8P.W=I9'1H



M;&5F=#HC9C!F



&-M(#!P


T1B;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-38N
C5P=#MB;W)D
M97(M8F]T=&]M.B-F


M=&]P.C!C;3MP861D:6YG+6QE9G0Z

&8P9C`[

T1B;W1T;VT@
M=VED=&@]
T0R

#MB;W)D97(M


M9C!F

&-M.W!A9&1I

#MP861D:6YG+7)I9VAT



T1L969T/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
34N-S5P=#MB;W)D
M97(M8F]T=&]M.B-F


M=&]P.C!C;3MP861D:6YG+6QE9G0Z

&8P9C`[

T1B;W1T;VT@
M=VED=&@]



&8P.W=I



M97(M;&5F=#HC9C!F



&-M


T1B;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-38N
C5P=#MB
M;W)D97(M8F]T=&]M.B-F

&-M.W!A9&1I


&8P

T1B;W1T
M;VT@=VED=&@]

#MB;W)D

#MW:61T:#HQ

M(V8P9C!F

&-M.W!A

#MP861D:6YG+7)I




M


M+6)O='1O;3HC9C!F


&8P.W!A



&-M(#!P=#ML:6YE+6AE:6=H=#IN


T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F
&8P9C`[=VED=&@Z-38N
C5P=#MB;W)D97(M8F]T=&]M.B-F
&8P


M+6QE9G0Z



M/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R
2!S='EL


#MW

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD

&-M(#!C




#MW
M:61T:#HV

7!T('-O;&ED.W!A9&1I

M;3MB;W)D97(M;&5F=#HC9C!F

&-M.V)A8VMG





#MW:61T

7!T('-O;&ED.W!A9&1I

M;3MB;W)D97(M;&5F=#HC9C!F

&-M.V)A8VMG



M

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
M
&8P9C`[=VED=&@Z
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F

M9&EN9RUB;W1T;VTZ

M



T1B;W1T;VT@=VED=&@]
T0Y-2!S='EL93TS1=B
M;W)D97(M=&]P.B-F,&8P9C`[8F]R9&5R+7)I9VAT.B-F,&8P9C`[=VED=&@Z
M-S$N,C5P=#MB;W)D97(M8F]T=&]M.F)L86-K(#%P=!S;VQI9#MP861D:6YG


M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O


M;&4]


\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
M
T1B;W1T;VT@=VED=&@]

M


M='1O;3HC9C!F


&8P.W!A9&1I



&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M




M=#HC9C!F
&8P.W=I9'1H.C0Y+C5P=#MB;W)D97(M8F]T=&]M.F)L86-K(#%P

M.C!C;2`P8VT@

M:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3(N-S5P=#MB;W)D
M97(M8F]T=&]M.B-F


M=&]P.C!C;3MP861D:6YG+6QE9G0Z

&8P9C`[

T1B;W1T;VT@
M=VED=&@]

M

#MP861D

M/'`@86QI9VX]



M/B`\='(@86QI9VX]
T1L969T/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$
M

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
M
&8P9C`[=VED=&@Z
34N-S5P=#MB;W)D97(M8F]T=&]M.B-F

M9&EN9RUB;W1T;VTZ

M



&8P


M;3HC9C!F






&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG

34@

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P
M9C`[=VED=&@Z
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F

M9RUB;W1T;VTZ

&-M



T1T;W`@=VED=&@]

M;W`Z(V8P9C!F

#MW:61T:#HU-BXR-7!T


M9&EN9RUT;W`Z

M9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O;&]R.G1R86YS






M9C!F

M9&EN9RUL969T.C!C;3MB;W)D97(M;&5F=#HC9C!F

M:'0Z


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N

M;&4]
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[
M=VED=&@Z-S$N
C5P=#MB;W)D97(M8F]T=&]M.B-F

M;W1T;VTZ

&-M.V)O



T1B;W1T;VT@=VED=&@]

M;W`Z(V8P9C!F


M8F]R9&5R+6)O='1O;3HC9C!F


M



&-M(#!P=#ML:6YE+6AE


T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R
M+7)I9VAT.B-F

M9C!F

&-M.W!A9&1I

#MP861D:6YG+7)I9VAT





&8P.W=I



M97(M;&5F=#HC9C!F



&-M


T1B;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-38N
C5P=#MB;W)D
M97(M8F]T=&]M.B-F


M=&]P.C!C;3MP861D:6YG+6QE9G0Z

&8P9C`[

T1T;W`@=VED
M=&@]
T0R


M:'0Z(V8P9C!F

M


M;&5F=#HP8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C

M87)G:6XZ




&8P.W=I9'1H



M;&5F=#HC9C!F



&-M(#!P



'!T.VQI



#MW
M:61T:#HV

#MP861D:6YG+6)O='1O


M+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O

#D\+V9O;G0^/]P/CPO
M=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q-2!S='EL93TS1&)O


#MW:61T:#HQ
M

#MP861D:6YG+6)O='1O;3HP


M9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O;&]R



M87)G:6XZ

M/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3$N
C5P=#MB;W)D97(M
M8F]T=&]M.B-F


M.C!C;3MP861D:6YG+6QE9G0Z



T1B;W1T;VT@=VED
M=&@]


M:'0Z(V8P9C!F
#MW:61T:#HW

M


M;&5F=#HP8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C


T1B;W1T;VT@=VED=&@]
M


M(V8P9C!F

&8P.W!A

M.C!C;3MB;W)D97(M;&5F=#HC9C!F

&-M.V)A



^)#PO9F]N


&-M(#!P=#ML:6YE+6AE



T0G;6%R9VEN.C!C;2`P8VT@
M

M:'0[;6%R9VEN.C!C;2`P8VT@


M9C!F


M9&5R+6)O='1O;3HC9C!F


&8P





M:6XZ


T0G;6%R9VEN.C!C;2`P8VT@
M

M(V8P9C!F

#MW:61T:#HV



M;W`Z

#MP


M;&%N9STS1$5.+553/C`N
3`\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
M
T1B;W1T;VT@=VED=&@]

M

#MW:61T:#HQ

M;W1T;VTZ(V8P9C!F

M

#MP861D




&-M(#!C;2`P

M/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT
M.B-F
&8P9C`[=VED=&@Z
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F
&8P9C`[


M9G0Z



T1B;W1T;VT@=VED=&@]
T0Y-2!S='EL93TS


#MW:61T
M:#HW

#MP861D:6YG+6)O='1O


M+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O

T1B;W1T;VT@=VED=&@]
T0R-B!S='EL93TS1&)O


#MW:61T:#HQ



M=#HC9C!F






M=#HC9C!F
&8P.W=I9'1H.C0Y+C5P=#MB;W)D97(M8F]T=&]M.B-F
&8P9C`[


M9G0Z



M

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
M
&8P9C`[=VED=&@Z
3(N-S5P=#MB;W)D97(M8F]T=&]M.B-F

M9&EN9RUB;W1T;VTZ

M



T1B;W1T;VT@=VED=&@]
T0W-2!S='EL93TS1&)O


#MW:61T:#HU

#MP861D:6YG+6)O='1O;3HP


M9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O;&]R


M;&EG;CIR:6=H=#MM87)G:6XZ


&-M(#!C;2`P

M


T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M:&5I

#MB;W)D

#MW:61T:#HV

M9C!F

&-M.W!A9&1I

#MP861D:6YG+7)I9VAT

M/C`N
3(\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED
M=&@]


M:'0Z(V8P9C!F
#MW:61T:#HQ

M


M;&5F=#HP8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C

M87)G:6XZ



M:'0Z;F]R;6%L)SX\9F]N=!L86YG/3-$14XM55,^,RPT.#DL-#,Y/]F;VYT


M;&4]
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[
M=VED=&@Z
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F

M;W1T;VTZ

&-M.V)O



T1B;W1T;VT@=VED=&@]

M;W`Z(V8P9C!F

#MW:61T:#HW
2XR-7!T


M9&EN9RUT;W`Z

M9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O;&]R.G1R86YS


M=#X@/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I9VAT

&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P

M;&4]
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD

3(\+V9O;G0^/]P
M/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q-R!S='EL93TS


#MW:61T
M:#HQ

#MP861D:6YG+6)O='1O


M+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O

&-M(#!C;2`P

M=#MM87)G:6XZ


M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
34N-S5P=#MB
M;W)D97(M8F]T=&]M.B-F

&-M.W!A9&1I


&8P


T1B;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-3`N
C5P=#MB;W)D97(M
M8F]T=&]M.B-F


M.C!C;3MP861D:6YG+6QE9G0Z



M=#X@/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I9VAT

&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF;VYT


T1R

&-M

T1%3BU54SXT
M-#`L

T0G
M;6%R9VEN.C!C;2`P8VT@


'!T.VQI;F4M:&5I



&8P.W=I9'1H
M.C$Y+C5P=#MB;W)D97(M8F]T=&]M.B-F

M


M969T.B-F

M9VX]
T1B;W1T;VT@=VED=&@]

M9C!F


M+6)O='1O;3HC9C!F


&8P.W!A




M86YG/3-$14XM55
^



M=#HC9C!F

&8P

M969T.C!C;3MB;W)D97(M;&5F=#HC9C!F

&-M



^-#0P
M+#`P


T1R:6=H=!S='EL93TS1=T

&-M(#!P=#ML:6YE+6AE:6=H

T1%3BU54SXP+C$R-3PO9F]N=#X\+W`^

M;&4]
T0G;6%R9VEN.C!C;2`P8VT@


M9C!F
#MW:61T:#HV

#MP861D:6YG


M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O

30\+V9O;G0^
M/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q-2!S='EL


#MW
M:61T:#HQ

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD

&-M(#!C

M:6=H=#MM87)G:6XZ


M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3$N
C5P=#MB
M;W)D97(M8F]T=&]M.B-F

&-M.W!A9&1I


&8P

T1B;W1T
M;VT@=VED=&@]

#MB;W)D

#MW:61T:#HW

M(V8P9C!F

&-M.W!A

#MP861D:6YG+7)I

M+553/C0N-C(\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@
M=VED=&@]

#MB;W)D97(M


M

M9RUL969T.C!C;3MB;W)D97(M;&5F=#HC9C!F

M


&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P

M;&4]
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD

30\+V9O;G0^/]P
M/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q-R!S='EL93TS


#MW:61T
M:#HQ

#MP861D:6YG+6)O='1O


M+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O

&-M(#!C;2`P

M=#MM87)G:6XZ


M:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
34N-S5P=#MB;W)D
M97(M8F]T=&]M.B-F


M=&]P.C!C;3MP861D:6YG+6QE9G0Z

&8P9C`[

T1B;W1T;VT@
M=VED=&@]

#MB;W)D97(M

#MW:61T:#HU


M8VT@

M9VX]

M8VT@

T1%

M
T0G;6%R9VEN.C!C;2`P8VT@


'!T.VQI;F4M



M

&8P.W!A9&1I

M;3MB;W)D97(M;&5F=#HC9C!F

&-M.V)A8VMG

M8VT@


T1B;W)D
M97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-S$N
M
C5P=#MB;W)D97(M8F]T=&]M.B-F

&-M


M.B-F

M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M
M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3DN-7!T


M9&EN9RUT;W`Z

M9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O;&]R.G1R86YS



M9VX]

M8VT@

T1%

M
T0G;6%R9VEN.C!C;2`P8VT@


'!T.VQI;F4M



M

&8P.W!A9&1I

M;3MB;W)D97(M;&5F=#HC9C!F

&-M.V)A8VMG

M8VT@


T1B;W)D
M97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-3`N
M
C5P=#MB;W)D97(M8F]T=&]M.B-F

&-M


M.B-F




&8P.W=I



M;&5F=#HC9C!F



T0G=&5X

^
XQ-SPO9F]N=#X\+W`^/]T



&8P.W=I9'1H.C$Q



M=#HC9C!F



&-M(#!P=#ML


T1B;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-38N
C5P=#MB;W)D97(M
M8F]T=&]M.B-F


M.C!C;3MP861D:6YG+6QE9G0Z



#`\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
M
T1B;W1T;VT@=VED=&@]

M

#MW:61T:#HQ

M;W1T;VTZ(V8P9C!F

M

#MP861D




&-M(#!C;2`P


T0G;6%R9VEN
M.C!C;2`P8VT@


M;&EG;CIR:6=H=#MM87)G:6XZ


M86QI9VX]

M;CHP8VT@

M
T1%3BU54SXU




M9C!F

&8P.W!A

M.C!C;3MB;W)D97(M;&5F=#HC9C!F

&-M.V)A



^
XQ-SPO
M9F]N=#X\+W`^/]T9#X\+W1R/B`\='(@86QI9VX]
T1L969T/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
34N-S5P=#MB;W)D
M97(M8F]T=&]M.B-F


M=&]P.C!C;3MP861D:6YG+6QE9G0Z

&8P9C`[

T1B;W1T;VT@
M=VED=&@]


M



&8P.W=I9'1H



M;&5F=#HC9C!F



T0G=&5X

^
3`P+#`P
#PO9F]N=#X\+W`^

M=#X@/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I9VAT

&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF;VYT




M=#HC9C!F
&8P.W=I9'1H.C0Y+C5P=#MB;W)D97(M8F]T=&]M.B-F
&8P9C`[


M9G0Z



M

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
M
&8P9C`[=VED=&@Z
3(N-S5P=#MB;W)D97(M8F]T=&]M.B-F

M9&EN9RUB;W1T;VTZ

M



T1B;W1T;VT@=VED=&@]
T0W-2!S='EL93TS1&)O


#MW:61T:#HU

#MP861D:6YG+6)O='1O;3HP


M9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O;&]R


M/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I9VAT.VUA

&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF;VYT(&QA


T1B;W1T;VT@=VED=&@]
T0R
2!S='EL


#MW

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD

&-M(#!C

M=#MM87)G:6XZ

M=!L86YG/3-$14XM55,^,XR

T1R

&-M

T1%3BU54SXR
M-3`L

T0G
M;6%R9VEN.C!C;2`P8VT@


'!T.VQI;F4M:&5I


M;6%R9VEN.C!C;2`P8VT@



M=#HC9C!F

&8P

M969T.C!C;3MB;W)D97(M;&5F=#HC9C!F

&-M



^
C4P
M+#`P


T1R:6=H=!S='EL93TS1=T

&-M(#!P=#ML:6YE+6AE:6=H


T1B;W1T
M;VT@=VED=&@]
T0R

#MB;W)D


M(V8P9C!F

&-M.W!A

#MP861D:6YG+7)I




M96EG:'0Z;F]R;6%L)SX\9F]N=!L86YG/3-$14XM55,^,XR
CPO9F]N=#X\


T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I

&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF




T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M:&5I


M;2`P8VT@


'!T.VQI;F4M:&5I



M9C!F


M9&5R+6)O='1O;3HC9C!F


&8P





M

M

T1%3BU5

T1B;W1T;VT@=VED=&@]
T0R



#MW:61T:#HQ-2XW

#MP861D:6YG+6)O='1O;3HP8VT[


M(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O;&]R.G1R



M


&-M(#!P=#ML:6YE

T1%3BU54SXW


T0G;6%R9VEN.C!C
M;2`P8VT@







M;2`P8VT@




&8P



M;W)D97(M;&5F=#HC9C!F



M

^-S`W+#`P
#PO9F]N


T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N

&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG


T1B;W1T;VT@=VED=&@]
M
T0R


M(V8P9C!F

#MP


M=#HP8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB

M:6XZ


M;&EG;CIR:6=H=#MM87)G:6XZ

M;6%L)SX\9F]N=!L86YG/3-$14XM55,^,XS

M86QI9VX]

M;CHP8VT@

M
T1%3BU54SXR-3`L


T0G;6%R9VEN.C!C;2`P8VT@



'!T






&8P.V)O


M;3HC9C!F







M14XM55
^
C4P+#`P


&-M(#!P=#ML

T1%3BU54SXP+C

M9VX]
T1B;W1T;VT@=VED=&@]
T0R

M9C!F




M;W`Z

#MP




&-M(#!C;2`P

M


T1R:6=H=!S='EL93TS1=T97AT

&-M(#!P=#ML:6YE+6AE:6=H=#IN

T1%3BU54SXR-3`L


T0G;6%R9VEN.C!C;2`P8VT@
'!T

M;6%R9VEN.C!C;2`P8VT@


'!T




&8P.W=I9'1H.C4V



M=#HC9C!F




^
C4P+#`P

M/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I9VAT.VUA

&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/CQF;VYT(&QA

T1%3BU54SXP+C

T1B;W1T;VT@=VED=&@]
T0R
2!S='EL


#MW

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD

&-M(#!C

M=#MM87)G:6XZ


T1R

&-M

T1%3BU54SXS
M.2PX-C
\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED
M=&@]


M:'0Z(V8P9C!F
#MW:61T:#HQ

M


M;&5F=#HP8VT[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C

M87)G:6XZ






&8P.W=I9'1H
M.C$Y+C5P=#MB;W)D97(M8F]T=&]M.B-F

M


M969T.B-F

M9VX]
T1B;W1T;VT@=VED=&@]

M9C!F


M+6)O='1O;3HC9C!F


&8P.W!A




M86YG/3-$14XM55
^
XS-CPO9F]N=#X\+W`^/]T9#X@/'1D('9A;&EG;CTS

&8P


M='1O;3HC9C!F


&8P.W!A9&1I



&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M


T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT
M.B-F
&8P9C`[=VED=&@Z-38N
C5P=#MB;W)D97(M8F]T=&]M.B-F
&8P9C`[


M9G0Z





&8P.W=I9'1H



M;&5F=#HC9C!F



T0G=&5X

^
XS-CPO9F]N=#X\+W`^/]T
M9#X\+W1R/B`\='(@86QI9VX]
T1L969T/B`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R
M+7)I9VAT.B-F
&8P9C`[=VED=&@Z
34N-S5P=#MB;W)D97(M8F]T=&]M.B-F
M


M:6YG+6QE9G0Z




T1B;W1T;VT@=VED=&@]


'!T.VQI;F4M:&5I



M9C!F


M9&5R+6)O='1O;3HC9C!F


&8P




^
3`P+#`P

M

M

T1%3BU5



&8P.W=I
M9'1H.C0Y+C5P=#MB;W)D97(M8F]T=&]M.B-F

M;VTZ




M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B
M;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
M
3(N-S5P=#MB;W)D97(M8F]T=&]M.B-F

M


M969T.B-F

M9VX]
T1B;W1T;VT@=VED=&@]

M9C!F




M;W`Z

#MP


M;&%N9STS1$5.+553/C$P



M:6=H=#HC9C!F

M

M9RUL969T.C!C;3MB;W)D97(M;&5F=#HC9C!F

M



^
M
XS.#PO9F]N=#X\+W`^/]T9#X\+W1R/B`\='(@86QI9VX]
T1L969T/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M
M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
34N-S5P
M=#MB;W)D97(M8F]T=&]M.B-F

&-M.W!A


M

T1B
M;W1T;VT@=VED=&@]


M;2`P8VT@




M

7!T('-O;&ED

M969T.C!C;3MB;W)D97(M;&5F=#HC9C!F

&-M

M+#`P


M;&EN92UH96EG:'0Z;F]R;6%L)SX\9F]N=!L86YG/3-$14XM55,^,2XY-#PO
M9F]N=#X\+W`^/]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(V


M
&8P.W=I9'1H.C$Y+C5P=#MB;W)D97(M8F]T=&]M.B-F

M9RUB;W1T;VTZ

&-M



T1B;W1T;VT@=VED=&@]



#MW:61T:#HT.2XU



M9C!F




^
XT,#PO9F]N=#X\+W`^/]T9#X@/'1D




M8F]R9&5R+6)O='1O;3HC9C!F


M



&-M(#!P=#ML:6YE+6AE



&8P.V)O




M=&]P.C!C;3MP861D:6YG+6QE9G0Z

&8P9C`[


^-3`L


T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M:&5I9VAT

&8P9C`[8F]R9&5R
M+7)I9VAT.B-F
&8P9C`[=VED=&@Z-3`N
C5P=#MB;W)D97(M8F]T=&]M.F)L






M9&5R+6)O='1O;3HC9C!F


&8P



&-M(#!P=#ML:6YE+6AE:6=H

M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R
M+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F
M


M:6YG+6QE9G0Z




T1B;W1T;VT@=VED=&@]
T0W-2!S


M

#MP861D:6YG


M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O

&-M


T0G;6%R9VEN.C!C;2`P8VT@



M


M+6)O='1O;3HC9C!F


&8P.W!A



&-M(#!P=#ML:6YE+6AE:6=H=#IN


T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F
&8P9C`[=VED=&@Z-38N
C5P=#MB;W)D97(M8F]T=&]M.B-F
&8P


M+6QE9G0Z



M/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R
2!S='EL


#MW

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD

&-M(#!C

T1B;W1T;VT@=VED=&@]
T0R
2!S='EL93TS


#MW:61T

#MP861D:6YG+6)O='1O


M+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!C;3MB86-K9W)O=6YD+6-O

&-M(#!C;2`P

T0G
M;6%R9VEN.C!C;2`P8VT@

&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[
M=VED=&@Z-38N
C5P=#MB;W)D97(M8F]T=&]M.F)L86-K(#(N

&-M(#!C

M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R
M+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F
M


M:6YG+6QE9G0Z




T1B;W1T;VT@=VED=&@]
T0Y-2!S
M='EL93TS1=B;W)D97(M=&]P.B-F,&8P9C`[8F]R9&5R+7)I9VAT.B-F,&8P
M9C`[=VED=&@Z-S$N,C5P=#MB;W)D97(M8F]T=&]M.F)L86-K(#(N,C5P=!D


M:6YG+6QE9G0Z





M55
^
2XW

T0G
M;6%R9VEN.C!C;2`P8VT@


T0G;6%R9VEN.C!C;2`P8VT@
'!T.VQI;F4M:&5I

&8P9C`[8F]R
M9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-38N
C5P=#MB;W)D97(M8F]T=&]M
M.F)L86-K(#(N


M:6=H=#MM87)G:6XZ



T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N

&-M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG



'!T.VQI;F4M:&5I9VAT


M(&9I;&4Z+R\O0SHO9CEE
F%A
C=?-S=C8E\T.&-A7SAA-SE?8F0X
#=A9&)B

O4VAE970Q-RYH=&UL#0I#;VYT96YT+51R86YS9F5R


M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A

M

M;W9E(%1H:7



]

M;CTS1#$^
3(@36]N=&AS($5N9&5D/]T:#X-B`@(`@(#PO='(^#0H@(`@

S$L(#(P
30\



M;&4]

M/&(^/&9O;G0@;&%N9STS1$5.+553/DY/5$4@
3$M($]42$52($E.0T]-12`H



'!T




M:&4@)B



M(&]B;&EG871I;VYS('1H97)E=6YD97(N(9N8G-P.TYO(&UO;F5T87)Y(&-O
M;G-I9&5R871I;VX@=V%S(&5X8VAA;F=E9!I;B!C;VYN96-T:6]N('=I=&@@




M;&4]


M9VEN.C!C;2`P8VT@







@86UO=6YT(')E8V]R9&5D(&]N('1H92!#;VUP86YY)B
Q





^3VX@36%Y(#$L(#(P
3
L('1H92!#


C`Q





M(&-L87-S:69I960@87

M8V4@=&AE('-E8V]N9!Q=6%R=&5R(&]F(#(P,3,N(9N8G-P.T]N($IU;'D@
M
C0L(#(P
30L('1H92!#;VUP86YY('-E='1L960@=&AE(&]U='-T86YD:6YG
M(&-O;7!L86EN='
@86YD('1H92`D
3$X+#0V-B!-:7-C96QL86YE;W5S(%)E


P@,C`Q-X\+V9O;G0^


M9CEE
F%A
C=?-S=C8E\T.&-A7SAA-SE?8F0X
#=A9&)B93!C#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T


3@N:'1M;`T*0V]N=&5N



^+RH@


M
$5


]


M9VX]

M4R![


T1T
M;W`^0V]M;6ET;65N='
@86YD($-O;G1I;F=E;F-I97





&-M

T1%3BU54SY%;7!L;WEM96YT($%G


38L(#(P
3$N(%5N9&5R('1H92!A9W)E96UE;G0@37(N

L('-U8FIE


F(S$T-CLF



M861D:71I;VXL($UR+B!$86AL(&ES(&5N=&ET;&5D('1O(&UO;G1H;'D@8F]N
M=7

Q




Z(#$I

#`L

M:6]N(&]F(&)I;RUA8W1I=F4@86=E;G1S(&EN('1H92!#;VUP86YY)B
Q-#8[


#`L



2PP
#`L
#`P('-H87)E



M


@9F]R(#$L
#`P+#`P

M;G


P+`R,#$T+!N;VYE(&]F('1H

@8F5E;B!N;R!N;W1I8V4@;V8@8V]N=')A8W0@=&5R;6EN



M;CHP8VT@


M.C!C;2`P8VT@


M


M;CX\+W-P86X^/]T9#X-B`@(`@(#PO='(^#0H@(`@/]T86)L93X-B`@








]

T1)1#!%3$4^#0H@

]



T1T;W`^/'-T

RT@1D]234%424].($]&(%-50E-)1$E!

&EN(#!P=#ML

T0G;6%R
M9VEN.C!I;B`P:6X@


M;CHP:6X@



M8GD@6FEV;R!:6]S8VEE;F-E+!);F


30V.W
@1&5F:6-I96YC



@;V8@1&5C96UB97(@
S$L(#(P
30L('1H


M=!T:&4@;F5W('!A=&5N=',@87!P;&EC871I;VYS(')E9&5F:6YE(&%N9!P


@86)A;F1O;F5D('1H92!P

Y
2PR.#$@9F]R('1H92!Y96%R
M(&5N9&5D($1E8V5M8F5R(#

&EN(#!P=#ML:6YE+6AE:6=H



'!T.VQI;F4M:&5I





M=V%R92!#;W)P;W)A=&EO;BP@9F]R('1H92!P=7)P;W-E(&]F(&UA;G5F86-T


M;R!:6]S8VEE;F-E+!);F


F%A
C=?-S=C8E\T.&-A7SAA-SE?8F0X
M
#=A9&)B93!C#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+V8Y93)A

M965T

M(G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@/$U%5$$@:'1T


^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@


]







M96EG:'0Z;F]R;6%L)SX\8CX\9F]N=!L86YG/3-$14XM55,^3D]412`Q-`M



&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/E-E92!.;W1E

M87)G:6XZ


&EN




&EN


&-M(#!P=#ML:6YE+6AE:6=H

T1%


S`L(#(P
3
L($UR+B!-86=G:6]R92!A
M('-I9VYI9FEC86YT('-H87)E:&]L9&5R+!S=6)S8W)I8F5D('1O(&%N9!P





@

;V-A=&EO;CH@9FEL93HO+R]#.B]F.64R86$R-U\W-V-B7S0X8V%?
M.&$W.5]B9#@P-V%D8F)E
&

T1#;VYT

]
T13:&]W+FIS


M(&-O;'-P86X]
T0Q(')O=W-P86X]


]
T1T:#Y$96
N(#




&-M(#!P=#ML:6YE+6AE








T1%3BU54SXL-C`P+#`P
#PO
M9F]N=#X\9F]N=!L86YG/3-$14XM55,^+!W:&EC:!M87D@8F4@87!P;&EE
M9!A9V%I;G-T(&9U='5R92!T87AA8FQE(&EN8V]M92P@:68@86YY+!A=!V
M87)I;W5S(&1A=&5S(&9R;VT@

M;&4]

&-M(#!P=#ML:6YE+6AE:6=H


M14XM55




M8W1I=F4@=&%X(')A=&4@;V8@

^+#0P


M+R\O0SHO9CEE
F%A
C=?-S=C8E\T.&-A7SAA-SE?8F0X
#=A9&)B93!C+U=O

O4VAE970R
BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D



T1T97AT

M:7

]

T0Q/C$R($UO

#$T/&)R/CPO=&@^#0H@



M=&]P/E-50E-%455%3E0@159%3E13/]T9#X-B`@(`@(`@/'1D(&-L87-S


34P.R!354)315%514Y4



!S:&%R97,@;V8@
M8V]M;6]N('-T;V-K(&%T(&%N(&5X97)C:7-E('!R:6-E(&]F(0N



M
BPU

3`L
M



M;G0@=&\@1&5C96UB97(@
S$L(#(P
30L('1H92!#;VUP86YY(')E8V5I=F5D
M('!R;V-E961S(&]F(0T.PU

M+#`P

T0G;6%R9VEN.C!I;B`P:6X@
M


M
RP@


M96UB97(@
C`Q
2D@86YD('1H97-E(&%D=F%N8V5S(&AA=F4@8F5E;B!C;VYV










]
T1T

]



]
T1R



'!T)SX\








T1%3BU54SXF;F)S

^5&AE($-O

@:6X@=&AE(%5N




@86YD


M+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@
'!T)SX\8CX\=3X\9F]N





M;&5N='









]



M;VYT/CPO=3X\+V(^/&(^/&9O;G0@;&%N9STS1$5.+553/B9N8G-P.R8C
34P



M;&]W86YC97









M


M8VT@


'!T)SX\




M:6QL:6YG('1O('1R86YS86-T+B!4:&4@9W5I9&%N8V4@9&5S8W)I8F5S(&$@

M;G!U='



&-M(#!P





T1B86-K
M9W)O=6YD.G=H:71E/DQE=F5L(#(@)B







M

R`F(S$U
#L@56YO8G-E



@;W(@;&EA8FEL:71I97









M:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@


M=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@






@







@4&]L:6-Y/]T9#X-B`@(`@(`@







@87




M='5R97


@86UO=6YT960@=&\@)#0L.#


&-M(#!P

]
T1P
M;!V86QI9VX],T1T;W`^4F5V96YU92!296-O9VYI=&EO;CPO=&0^#0H@(`@


M;2`P8VT@

T0G=&5X






L('1H92!#;VUP86YY(')E8V]G;FEZ92!R979E;G5E(&EN(&%C8V]R
M9&%N8V4@=VET:!3=&%F9B!!8V-O=6YT:6YG($)U;&QE=&EN($YO+B`Q,#0L
M(8C

M:6YG($)U;&QE=&EN($YO+B`Q
#$L(8C,30W.U)E=F5N=64@4F5C;V=N:71I
M;VX@:6X@1FEN86YC:6%L(%-T871E;65N=',F(S$T.#L@*8C
30W.U-!0B!.
M;RX@
3`Q)B





@;V-C=7)R

M:6YA8FQE.R!A;F0@*#0I(&-O;&QE8W1A8FEL:71Y(&ES(')E87-O;F%B;'D@




M='
@86YD(')E8F%T97



M8VT@


]



M


^

C`Q

@=V5R


]

M:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@

M9F]N=!L86YG/3-$14XM55,^4F5S96%R8V@@86YD($1E=F5L;W!M96YT/]F



M96YS960@87



&-M


T1M87)G

M:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@








T1M87)G:6XM=&]P.C!C;3X@/&QI('-T

M;6%R9VEN.C!C;2`P8VT@



@8GD@:6YD97!E;F1E;G0@97AT97)N86P@96YT:71I97
N
M($5X=&5R;F%L(&-L:6YI8V%L('-T=61I97
@97AP96YS97




@96YD960@1&5C96UB97(@
S$L(#(P
30@86YD(#(P
3





]


M8VT@







M97

!C;VYS97%U96YC97


N


@:6X@=VAI8V@@=&AO





M;CHP8VT@



C`Q
R!W97)E


@82!H:7-T



M=V%R9'
@87)E('-U8FIE8W0@=&\@82!S=6)S=&%N=&EA;!A;FYU86P@;&EM
M:71A=&EO;B!D=64@=&\@=&AE(8C







T1%3BU54SY3=&]C:R!87-E9!#;VUP96YS871I;VX\

M/3-$14XM55


3@L('-T




L(&-O;G-U



M($)L86-K(%-C:&]L97



M;&4]

C`Q





C`Q




M97





M1=L:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N
M=!L86YG/3-$14XM55



&8P.W!A9&1I
'0M

&-M(#!C

T1%3BU54SXR

M:6YG+6QE9G0Z



&8P.W!A9&1I

T0G;&EN92UH96EG:'0Z;F]R;6%L.VUA


M-R!S='EL93TS1=B;W)D97(M8F]T=&]M.F)L86-K(#%P=!S;VQI9#MB;W)D
M97(M;&5F=#HC9C!F


M-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R
M9&5R+7)I9VAT.B-F

&-M)SX@/'`@86QI9VX]
M


M+553/C(P
3

M/3-$8F]T=&]M('=I9'1H/3-$

M9C!F


&-M

M;3MW:61T:#HQ
C(N
C5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

&-M

M8VT@


#MB;W)D97(M;&5F
M=#HC9C!F





M:'0Z(V8P9C!F


M;#MM87)G:6XZ

T1%3BU54SXQ
3
N
M.3

M='EL93TS1=L:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T
M)SX\9F]N=!L86YG/3-$14XM55

M1=L:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N
M=!L86YG/3-$14XM55



&8P.W!A


T0G=&5X

M:6YG+6QE9G0Z



&8P.W!A9&1I

T0G;&EN92UH96EG:'0Z;F]R;6%L.VUA



#MB;W)D97(M;&5F=#HC
M9C!F


M:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT
M.B-F


M;6%R9VEN.C!C;2`P8VT@
'!T)SX\9F]N=!L86YG/3-$14XM55,^,4\+V9O

M9'1H/3-$






C(N
M
C5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R
M9&5R+7)I9VAT.B-F


'!T)SX\9F]N
M=!L86YG/3-$14XM55,^17AP96-T960@=&5R;3PO9F]N=#X\+W`^/]T9#X@


#MB;W)D97(M;&5F=#HC9C!F



&-M.V)O


#MP861D:6YG


&-M(#!C;2`P


\+V9O;G0^/]P
M/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q-2!S='EL93TS

#MB;W)D97(M;&5F=#HC9C!F
&8P.W!A


3$N
C5P=#MP861D:6YG+7)I9VAT
M.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[


M86P[;6%R9VEN.C!C;2`P8VT@

M/3-$


M969T.B-F





#MB;W)D97(M





T1%3BU54SXS


M:6=N/3-$8F]T=&]M('=I9'1H/3-$

M;3HC9C!F


M

M.C!C;3MW:61T:#HQ
C(N
C5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M
M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

M

M;2`P8VT@


&-M.W=I9'1H.CDT+C5P=#MP861D
M:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT
M.B-F


M;6%R9VEN.C!C;2`P8VT@

M9'1H/3-$

T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R
M+6QE9G0Z(V8P9C!F


^+C(U)2!T;R`N

T0G;&EN92UH96EG:'0Z;F]R


M;CHP8VT@




Q















30V.W
@;F5T(&EN

M(&-O;6UO;B!S:&%R97



M9&5S('1H92!E9F9E8W0@9G)O;2!P;W1E;G1I86P@:7-S=6%N8V4@;V8@8V]M
M;6]N('-T;V-K('-U8V@@87


@;V8@


2P@

C0@8V]M;6]N('-H

@86YD(')E;&%T960@











'!T




3$V+#`P
!A;F0@)#(W
M+#`P,!F;W(@=&AE('EE87)S(&5N9&5D($1E8V5M8F5R(#
Q+`R,#$T(&%N
M9`R






'!T


M;2`P8VT@

M/3-$;&EN92UH96EG:'0Z
3`W)3Y&:6YA;F-I86P@:6YS=')U;65N='
@=&AA



M8F%L86YC97

M;W)A=&EO;B`H)B

30X.RD@;&EM:70@;V8@)#(U









M=&%T96UE;G1S(&AA=F4@8F5E;B!R96-L87-S:69I960@=&\@8V]N9F]R;2!T







M87)G:6XZ

T0G=&5X


30M

M96-O9VYI=&EO;B!R97%U:7)E;65N='
@:6X@)B

M9VYI=&EO;B`H5&]P:6
@-C`U*28C

M:65S('1O(')E8V]G;FEZ92!R979E;G5E('=H96X@:70@=')A;G-F97)S('!R





M


C`Q-BP@:6YC;'5D


30V.W













]

T1)1#!%3$4^#0H@(`@(`\


3(@36]N=&AS($5N9&5D/]T:#X-B`@

M/D1E8RX@
S$L(#(P



]

M86)L97
I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#X\(2TM96=X



T0G;6%R9VEN.C!I;B`P:6X@
'!T.VQI


T0P(&-E;&QP861D:6YG/3-$
!B
M;W)D97(],T0P/B`\='(^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q
M-C

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
M
&8P9C`[=VED=&@Z

&8P.W!A

M.C!I;CMB;W)D97(M;&5F=#HC9C!F

&EN.V)A

M;CHP:6X@

M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
C4X(&-O;'-P86X]
M


M(V8P9C!F
#MW:61T:#HQ.3

7!T

M9&EN9RUL969T.C!I;CMB;W)D97(M;&5F=#HC9C!F

M:'0Z

M

M8V5M8F5R(#

M='1O;2!W:61T:#TS1#$V

#MB

#MW:61T:#HQ
C(N
C5P=#MB;W)D97(M8F]T
M=&]M.B-F


M;CMP861D:6YG+6QE9G0Z



T1B;W1T;VT@=VED=&@]
M
T0Q



M=#HC9C!F
&8P.W=I9'1H.CDT+C5P=#MB;W)D97(M8F]T=&]M.F)L86-K(#%P

M.C!I;B`P:6X@


T0G;6%R9VEN.C!I;B`P:6X@
'!T.VQI



#MB


T0G;6%R9VEN
M.C!I;B`P:6X@




T0G=&5X

3
Q+CDW)2!T;R`Q.30N

M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$



&8P.W=I9'1H.C$R
M

#MP861D:6YG+6)O='1O;3HP


M9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O;&]R



M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R-B!S='EL93TS1&)O


#MW:61T:#HY



#MW:61T

#MP861D:6YG+6)O='1O


M+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O




M1&)O='1O;2!W:61T:#TS1#$V

M

#MW:61T:#HQ
C(N
C5P=#MB;W)D97(M
M8F]T=&]M.B-F


M.C!I;CMP861D:6YG+6QE9G0Z



M=&]M('=I9'1H/3-$

&8P.V)O

&8P.W=I9'1H.CDT+C5P=#MB;W)D97(M8F]T=&]M
M.B-F


M861D:6YG+6QE9G0Z



M.C!I;B`P:6X@


M;W`Z(V8P9C!F

#MW:61T:#HX-RXW-7!T


M9&EN9RUT;W`Z

M9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O;&]R.G1R86YS




\+W`^/]T9#X\+W1R/B`\='(^(#QT9!V86QI9VX]
M
T1B;W1T;VT@=VED=&@]
T0Q-C

T1B;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z

M+6)O='1O;3HC9C!F


&8P.W!A



&EN(#!P=#ML:6YE+6AE:6=H=#IN

T1B
M;W1T;VT@=VED=&@]
T0Q

T1B;W)D97(M=&]P.B-F
&8P9C`[
M8F]R9&5R+7)I9VAT.B-F

M;VTZ(V8P9C!F

&EN

#MP861D:6YG

M:6XZ



&8P



M;W)D97(M;&5F=#HC9C!F



M

M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$







M9C!F




&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M
M86PG/BXR-24@=&\@+C



F%A
C=?-S=C8E\T.&-A7SAA-SE?8F0X
#=A9&)B
M93!C#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T


C4N



^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C

$5



]
T1R93X-B`@(`@



]

M05
@1D]


M14XM55

2P@
M



T0P(&-E;&QP861D:6YG/3-$
#X@/'1R/B`\=&0@=VED
M=&@]

T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R
M+6QE9G0Z(V8P9C!F





M=&@]
T0R




M






M9C!F

&-M.W=I

M='1O;3HC9C!F


M;VTZ



M;W`Z(V8P9C!F



&-M


T1T;W`@=VED=&@]
T0Q

T0G

M9C!F


M8VT@
'!T)SX\9F]N=!L86YG/3-$14XM55,^,C`Q-#PO9F]N=#X\+W`^/]T





M9C!F


M87)G:6XZ

T1%3BU54SY$96-E;6)E


^
C`Q
SPO9F]N=#X\+W`^
M/]T9#X\+W1R/B`\='(^(#QT9!V86QI9VX]
T1T;W`@=VED=&@]
T0R-#8@

T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P
M9C!F



M9C!F

T0G;&EN92UH96EG


&-M.W=I

&8P


M;&4]




M:6YG+6QE9G0Z






M;CHP8VT@





M8VT@
'!T)SX\9F]N=!L86YG/3-$14XM55,^)#PO9F]N=#X\+W`^/]T9#X@




M='1O;3HC9C!F


M;VTZ



M;W`Z(V8P9C!F



T0G=&5X=UA;&EG;CIR:6=H
M=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N
M=!L86YG/3-$14XM55

M9C!F
#MB;W)D97(M;&5F=#HC9C!F


M=VED=&@Z.#%P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F


M1$5.+553/C(P+#`P
#PO9F]N=#X\+W`^/]T9#X\+W1R/B`\='(^(#QT9!V
M86QI9VX]
T1B;W1T;VT@=VED=&@]

T1B;W)D97(M8F]T
M=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+6)O='1O






M8VT@



&8P



M:'0Z


M



T1%3BU54SXF

T1B;W1T;VT@=VED
M=&@]
T0Q

T0G8F]R9&5R+6)O='1O;3IW:6YD;W=T97AT(#%P

#`\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
M
T1B;W1T;VT@=VED=&@]
T0R

M='EL93TS1=L:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T
M)SX\9F]N=!L86YG/3-$14XM55

M9C!F

M.C!C;2`P8VT@
'!T)SX\9F]N=!L86YG/3-$14XM55,^.#`L,#`P/]F;VYT


#MB;W)D97(M
M;&5F=#HC9C!F


3@T+C5P
M=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R
M+7)I9VAT.B-F


M:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@

M/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M8F]T=&]M.B-F
M
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+6)O='1O;3HP8VT[


#MB;W)D97(M;&5F=#HC9C!F



M97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

M;W`Z

M.C!C;2`P8VT@



M;&4]
T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
M


#MB;W)D97(M
M;&5F=#HC9C!F


M861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F


M+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@


M;W1T;VTZ(V8P9C!F
#MB;W)D97(M;&5F=#HC9C!F


M;&5F=#HP8VT[=VED=&@Z
3@T+C5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D
M97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

M;W`Z

M.C!C;2`P8VT@



M;&4]
T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
M


#MB;W)D97(M
M;&5F=#HC9C!F


M861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F



#MB;W)D97(M;&5F
M=#HC9C!F


35P=#MP861D
M:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT
M.B-F


M:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@

M/3-$8F]T=&]M('=I9'1H/3-$

M9C!F


&-M

M;3MW:61T:#HX


M9C!F



T0G=&5X=UA;&EG;CIR:6=H=#ML:6YE
M+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N=!L86YG
M/3-$14XM55
^
3`P+#`P
9N8G-P.SPO9F]N=#X\+W`^/]T9#X\+W1R/B`\

M861D:6YG+6QE9G0Z

@


#MB;W)D97(M;&5F=#HC9C!F
M


35P=#MP861D:6YG+7)I
M9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P


M;W)M86P[;6%R9VEN.C!C;2`P8VT@

M9'1H/3-$

7!T('-O


&-M.V)A

M:61T:#HX


M


M1$5.+553/B@S

&-M.W=I

&8P


M;&4]


M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P.!S='EL93TS1=B;W)D97(M



#MB;W)D97(M;&5F=#HC
M9C!F


3@T+C5P=#MP861D
M:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT
M.B-F


M:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@

M=&]M('=I9'1H/3-$

T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[
M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+6)O='1O;3HP8VT[8F%C:V=R


M;VTZ(V8P9C!F
#MB;W)D97(M;&5F=#HC9C!F


M=#HP8VT[=VED=&@Z.#%P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

&-M

M8VT@

M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B
M;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D


#MB;W)D97(M;&5F=#HC
M9C!F


M+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
M


M=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@


M(V8P9C!F
#MB;W)D97(M;&5F=#HC9C!F


M8VT[=VED=&@Z
3@T+C5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

&-M

M8VT@

M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B
M;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D

M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

M;W1T;VTZ8FQA8VL@
BXR-7!T(&1O=6)L93MB;W)D97(M;&5F=#HC9C!F
&8P


M.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[

&-M)SX@/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T

&-M

T1%3BU54SXV.PW-3`\+V9O;G0^/]P
M/CPO=&0^(#QT9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R,!S='EL93TS

#MB;W)D97(M;&5F=#HC9C!F
&8P.W!A


35P=#MP861D:6YG+7)I9VAT.C!C
M;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

M9&EN9RUT;W`Z

T1B;W1T;VT@=VED=&@]
T0Q

T0G8F]R9&5R

&8P




M:'0Z


M

#PO9F]N=#X\


M8VT@

M+2TM/5].97AT4&%R=%]F.64R86$R-U\W-V-B7S0X8V%?.&$W.5]B9#@P-V%D
M8F)E
&







@;V8@=&AE(&9O;&QO=VEN9R`H5&%B

3XQ
B!-;VYT:'

M
2P@

]




^5&AE($-O;7!A;GD@9&5T

M;F-E('=I=&@@05-#(#0W
TU,P@)B

M17AT:6YG=6ES:&UE;G1S+B8C
30X.SPO9F]N=#X\+W`^(#QP(&%L:6=N/3-$




M
T0P(&-E;&QP861D:6YG/3-$
#X@/'1R/B`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$

&8P.V)O






#MB







&-M.W=I9'1H

&8P.V)O


M


M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q

M;VTZ(V8P9C!F
#MB;W)D97(M;&5F=#HC9C!F


M=#HP8VT[=VED=&@Z.#1P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

&-M

M8VT@

M+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$

T1B;W)D
M97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG


^

M9C!F
#MB;W)D97(M;&5F=#HC9C!F


M=VED=&@Z
C8X+C5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F

&-M/B`\

M

M/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$

T1B;W)D97(M
M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+6)O






T1B
M;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D





M:61T:#TS1#

M1=L:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N
M=!L86YG/3-$14XM55

&-M

M




&-M(#!P

M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q


#MB;W)D97(M;&5F=#HC9C!F



M97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

M;W`Z

M.C!C;2`P8VT@



M
T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP


M14XM55

M;VTZ(V8P9C!F
#MB;W)D97(M;&5F=#HC9C!F


M=#HP8VT[=VED=&@Z
C8X+C5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M
M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

M

M;2`P8VT@

M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B
M;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D

M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

M='1O;3HC9C!F


M;VTZ



M;W`Z(V8P9C!F



T0G=&5X=UA;&EG;CIR:6=H
M=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N
M=!L86YG/3-$14XM55
^
C0P+#`P

M:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@
'!T)SX\9F]N=!L
M86YG/3-$14XM55,^)#PO9F]N=#X\+W`^/]T9#X@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$Q

M
#MB;W)D97(M;&5F=#HC9C!F


M=&@Z.#1P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[
M8F]R9&5R+7)I9VAT.B-F


M+553/C

M:6=N/3-$8F]T=&]M('=I9'1H/3-$

M;3HC9C!F


M



M;W`Z(V8P9C!F



&-M


T1B;W1T;VT@=VED=&@]
T0R



#MB
M;W)D97(M;&5F=#HC9C!F


M
35P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R
M9&5R+7)I9VAT.B-F


'!T)SX\9F]N

M:6=N/3-$8F]T=&]M('=I9'1H/3-$

M;3HC9C!F


M



M(V8P9C!F



&-M(#!C


S4X


M






M(V8P9C!F



T1%
M3BU54SXQ

M;6]R=&EZ960@9&ES8V]U;G0@;V8@)#$L-SDT+#(W

M
C

@9&%T97
@

34@=&\@1&5C96UB97(@
C`Q-CPO9F]N





M:6=H=#HC9C!F

T1R:6=H

M;#MM87)G:6XZ

T1%3BU54SXS+#8R
M-2PT
C@\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED
M=&@]
T0R

M/3-$14XM55

M:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@

M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#






&8P

T0G;&EN92UH96EG:'0Z;F]R


M:#TS1#$Q

#MB;W)D97(M
M;&5F=#HC9C!F


M861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F


M+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@

M8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M8F]T=&]M.B-F
&8P
M9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+6)O='1O;3HP8VT[8F%C



#MB;W)D97(M;&5F
M=#HC9C!F


C8X+C5P=#MP
M861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F


M+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@


@;V8@1&5C96UB
M97(@
S$L(#(P
3
\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T
M;VT@=VED=&@]
T0R

M1=L:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N
M=!L86YG/3-$14XM55


&-M(#!P

M;VTZ(V8P9C!F
#MB;W)D97(M;&5F=#HC9C!F


M=#HP8VT[=VED=&@Z
35P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

&-M

M8VT@

M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$



M






M9C!F

R

M(V8P9C!F
#MB;W)D97(M;&5F=#HC9C!F


M8VT[=VED=&@Z
35P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F

&-M/B`\

M

M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

M9&5R+6)O='1O;3HC9C!F


M9RUB;W1T;VTZ


&-M.V)O


#MP861D:6YG

T0G=&5X=UA;&EG
M;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T
M)SX\9F]N=!L86YG/3-$14XM55
^

M:6YG+6QE9G0Z






M;CHP8VT@

B!S

#MB;W)D97(M;&5F=#HC9C!F
M


M9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P


#PO9F]N
M=#X\+W`^/]T9#X\+W1R/B`\='(^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED
M=&@]

T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R
M+6QE9G0Z(V8P9C!F





T0G



&-M.W=I

&8P



T0G=&5X=UA;&EG;CIR:6=H=#ML:6YE+6AE
M:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N=!L86YG/3-$
M14XM55
^
RPV
C@L

&-M.W=I

&8P


M;&4]


M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q
B!S='EL93TS1=B;W)D97(M
M8F]T=&]M.F)L86-K(#%P=!S;VQI9#MB;W)D97(M;&5F=#HC9C!F
&8P.W!A


M;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

M9&EN9RUT;W`Z
&-M)SX@/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT

&-M(#!C

T1%3BU54SXQ+#8Q.2PS

M


M.B-F






M:'0Z(V8P9C!F



M

T1B
M;W1T;VT@=VED=&@]
T0R

M93TS1=L:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\
M9F]N=!L86YG/3-$14XM55

M/CPO=&0^(#QT9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R,!S='EL93TS

#MB;W)D97(M;&5F=#HC9C!F
&8P.W!A


35P=#MP861D:6YG+7)I9VAT.C!C
M;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

M9&EN9RUT;W`Z

M;6%R9VEN.C!C;2`P8VT@

M


M.B-F






M(V8P9C!F



T1%

M:6=N/3-$8F]T=&]M('=I9'1H/3-$

M;3HC9C!F


M



M;W`Z(V8P9C!F



&-M





M:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@
'!T)SX\
M9F]N=!L86YG/3-$14XM55,^)#PO9F]N=#X\+W`^/]T9#X@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$Q
B!S='EL93TS1=B;W)D97(M8F]T=&]M
M.F)L86-K(#(N,C5P=!D;W5B;&4[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D

M;&EG;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@
M
'!T)SX\9F]N=!L86YG/3-$14XM55,^,C,W+#`T,CPO9F]N=#X\+W`^/]T

M9&5R+6)O='1O;3HC9C!F


M9RUB;W1T;VTZ


&-M.V)O


#MP861D:6YG

T0G=&5X=UA;&EG
M;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T
M)SX\9F]N=!L86YG/3-$14XM55
^)#PO9F]N=#X\+W`^/]T9#X@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q,B!S='EL93TS1=B;W)D97(M8F]T
M=&]M.F)L86-K(#(N

M=#MP861D:6YG+6QE9G0Z



&8P.W!A

T0G=&5X
M=UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P
M8VT@,'!T)SX\9F]N=!L86YG/3-$14XM55
^.#DP+#@Q
3PO9F]N=#X\+W`^



M;CX\+W-P86X^/]T9#X-B`@(`@(#PO='(^#0H@(`@/]T86)L93X-B`@








]

T1)1#!%6D8^#0H@




]
T1T:#Y$96
N(#





]



@86YD(&QI86)I

M8F%S:7
@87
@;V8@1&5C96UB97(@
S$L(#(P
30@86YD($1E8V5M8F5R(#
Q





M

T0G;&EN92UH96EG:'0Z



7!T('-O


&-M.V)A


M86YG/3-$14XM55

M+6QE9G0Z
&-M.W=I9'1H.C4U+C5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D
M97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

M;W`Z
&-M)SX@/'`@86QI9VX]



#MB;W)D97(M;&5F=#HC9C!F
&8P



M9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P


M;W)M86P[;6%R9VEN.C!C;2`P8VT@

M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M8F]T
M=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+6)O='1O



M='EL93TS1=L:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T
M)SX\9F]N=!L86YG/3-$14XM55

M+6QE9G0Z
&-M.W=I9'1H.C4U+C5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D
M97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

M;W`Z

M.C!C;2`P8VT@



M86YG/3-$14XM55


M;G0@;&%N9STS1$5.+553/B9N8G-P.R0\+V9O;G0^/]P/CPO=&0^(#QT9!V
M86QI9VX]
T1B;W1T;VT@=VED=&@]
T0W-!S='EL93TS1=B;W)D97(M8F]T
M=&]M.F)L86-K(#(N

M=#MP861D:6YG+6QE9G0Z
&-M.W=I9'1H.C4U+C5P=#MP861D:6YG+7)I9VAT
M.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[

&-M)SX@/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T

&-M


M:6YG+6QE9G0Z






M;CHP8VT@


BXR-7!T(&1O=6)L93MB;W)D
M97(M;&5F=#HC9C!F


3@N
M-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R
M9&5R+7)I9VAT.B-F


M


#MP


M14XM55
^1&5C96UB97(@
S$L(#(P
3

M+6QE9G0Z






M;CHP8VT@



&8P





M

T0G;&EN92UH96EG:'0Z








G!T


#MB;W)D97(M






M
T1B;W1T;VT@=VED=&@]

M9C!F
#MB;W)D97(M;&5F=#HC9C!F


M=VED=&@Z
3@N-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F

&-M/B`\

M


T1B;W)D
M97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG


#MB;W)D
M97(M;&5F=#HC9C!F



M+C5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R
M9&5R+7)I9VAT.B-F


'!T)SX\9F]N


BXR-7!T(&1O=6)L93MB
M;W)D97(M;&5F=#HC9C!F


M
3@N-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[
M8F]R9&5R+7)I9VAT.B-F


M;&4]


M9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-!S='EL93TS1=B;W)D97(M
M8F]T=&]M.F)L86-K(#(N,C5P=!D;W5B;&4[8F]R9&5R+6QE9G0Z(V8P9C!F
M


^


M(V8P9C!F



M8VT@


BXR-7!T(&1O=6)L93MB;W)D97(M;&5F
M=#HC9C!F





M:'0Z(V8P9C!F

#
V
M+#(S.3PO9F]N=#X\+W`^/]T9#X\+W1R/CPO=&%B;&4^/]D:78^(#QP('-T



M=F%L:6=N/3-$=&]P/D9A:7(@5F%L=64@;V8@3&5V96P@
R!$97)I=F%T:79E





M97
@=&AE(&-H86YG97

M
30V.W
@3&5V96P@
R!F:6YA;F-I86P@:6YS=')U;65N='
@9F]R('1H92!Y
M96%R(&5N9&5D($1E8V5M8F5R(#
Q+`R,#$T(&%N9`R
#$S+CPO9F]N=#X\

&-M


T0P(&-E;&QP861D:6YG/3-$
M
#X@/'1R/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

M/3-$8F]R9&5R+6)O='1O;3HC9C!F

&8P9C`[




M


#MP

M;#MM87)G:6XZ

T1%3BU54SXF;F)S

T1B;W1T;VT@=VED=&@]
M

#MB;W)D97(M;&5F
M=#HC9C!F


3@N-S5P=#MP
M861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F


M+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@

M1#(@=VED=&@]
T0Y-2!S='EL93TS1=B;W)D97(M8F]T=&]M.F)L86-K(#%P
M=!S;VQI9#MB;W)D97(M;&5F=#HC9C!F


M8VT[=VED=&@Z-S$N
C5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

&-M
M)SX@/'`@86QI9VX]


M/&9O;G0@;&%N9STS1$5.+553/D1E8V5M8F5R(#
Q+`R,#$T/]F;VYT/CPO

M86YG/3-$14XM55






&-M.W=I9'1H.C$P8VT[


M:6=H=#HC9C!F

T0G;&EN



M


&-M.V)A








M

T0G;&EN92UH96EG:'0Z


&-M

M




&-M(#!P






M=#HC9C!F

T0G;&EN92UH






&8P.V)O




M


#MB;W)D






M9VX]
T1B;W1T;VT@=VED=&@]

M(V8P9C!F
#MB;W)D97(M;&5F=#HC9C!F


M8VT[=VED=&@Z
3@N-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

&-M

M8VT@
'!T)SX\9F]N=!L86YG/3-$14XM55,^)#PO9F]N=#X\+W`^/]T9#X@

M+6)O='1O;3HC9C!F


M;W1T;VTZ

M9RUL969T.C!C;3MW:61T:#HW




#MP861D:6YG+71O

T0G=&5X=UA;&EG;CIR
M:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\
M9F]N=!L86YG/3-$14XM55
^
2PP
C8L

#MB;W)D97(M
M;&5F=#HC9C!F


3!C;3MP
M861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F


M+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@


M9B!T:&4@0V]N=F5R=&EB;&4@3F]T97
\+V9O;G0^/]P/CPO=&0^(#QT9!V
M86QI9VX]
T1B;W1T;VT@=VED=&@]

M;VTZ(V8P9C!F
#MB;W)D97(M;&5F=#HC9C!F


M=#HP8VT[=VED=&@Z
3@N-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M
M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

M

M;2`P8VT@


M
T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP


M='EL93TS1=L:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T
M)SX\9F]N=!L86YG/3-$14XM55

M+6QE9G0Z






M8VT@

M/3-$14XM55

&-M.W=I

M


M86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I9VAT.VQI;F4M


M
T1%3BU54SXQ+#(Q
RPV
S0\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
M
T1B;W1T;VT@=VED=&@]

M9C!F
#MB;W)D97(M;&5F=#HC9C!F


M=VED=&@Z
3)P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F


'!T

M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M
M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+6)O


M;2`P8VT@


M:#TS1#

M/3-$14XM55

T1B;W1T;VT@=VED=&@]
T0R-2!S='EL93TS

#MB;W)D97(M;&5F=#HC9C!F
&8P.W!A


3@N-S5P=#MP861D:6YG+7)I9VAT
M.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[


M86P[;6%R9VEN.C!C;2`P8VT@


T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE
M9G0Z(V8P9C!F

M


M:6YG+6QE9G0Z




M=&]P.C!C;3X@/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N



T1%3BU54SXQ+#8W-PQ,S4\+V9O;G0^/]P/CPO=&0^


&-M.W=I9'1H.C$X

&8P.V)O







M+6QE9G0Z(V8P9C!F

M;W)M86P[;6%R9VEN.C!C;2`P8VT@

&-M.W=I9'1H.C$R




T0G


T1B;W1T;VT@=VED=&@]
T0Y-B!S='EL93TS
M1=B;W)D97(M8F]T=&]M.F)L86-K(#%P=!S;VQI9#MB;W)D97(M;&5F=#HC
M9C!F


M+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
M

&-M)SX@/'`@86QI9VX]

M:6XZ


#MB;W)D97(M;&5F
M=#HC9C!F


3!C;3MP861D
M:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT
M.B-F


M:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@

M9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R-2!S='EL93TS1=B;W)D97(M
M8F]T=&]M.F)L86-K(#(N





M



T1%3BU5



M1=L:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N
M=!L86YG/3-$14XM55

M


#MP

M86P[;6%R9VEN.C!C;2`P8VT@
'!T)SX\9F]N=!L86YG/3-$14XM55,^)#PO
M9F]N=#X\+W`^/]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DV

BXR-7!T(&1O=6)L93MB
M;W)D97(M;&5F=#HC9C!F


M-S)P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R
M9&5R+7)I9VAT.B-F

&-M)SX@/'`@86QI9VX]
M
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I9VAT.VQI;F4M:&5I9VAT


T1%3BU5
M4SXX+#`S-BPR


M8VT@

M+2TM/5].97AT4&%R=%]F.64R86$R-U\W-V-B7S0X8V%?.&$W.5]B9#@P-V%D
M8F)E
&


M
M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q






]

]




@
M5T%24D%.5%


M

M='5S(&]F('1H92!#;VUP86YY)B




&-M.W=I9'1H.C$T
M


#MB;W)D






M9VX]
T1B;W1T;VT@=VED=&@]
T0R

M(V8P9C!F
#MB;W)D97(M;&5F=#HC9C!F


M8VT[=VED=&@Z
34N-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

&-M

M8VT@

M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
C`Q(&-O;'-P86X]
M

7!T('-O;&ED.V)O




M-3`N-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[
M8F]R9&5R+7)I9VAT.B-F

&-M)SX@/'`@86QI
M9VX]


M9STS1$5.+553/D1E8V5M8F5R(#

M


M(V8P9C!F




'!T)SX\8CX\
M9F]N=!L86YG/3-$14XM55,^1&5C96UB97(@,S$L(#(P,3,\+V9O;G0^/]B





M861D:6YG+6QE9G0Z



&8P.W!A

T0G;&EN92UH96EG:'0Z;F]R;6%L




M.B-F





M
T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP




#MB;W)D97(M





T1%3BU54SY.
M=6UB97(@;V8\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@
M=VED=&@]
T0R

#MB;W)D
M97(M;&5F=#HC9C!F


34N
M-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R
M9&5R+7)I9VAT.B-F


'!T)SX\9F]N

M:6=N/3-$8F]T=&]M('=I9'1H/3-$

M;3HC9C!F


M





M;3X@/'`@86QI9VX]






M861D:6YG+6QE9G0Z



&8P.W!A

T0G;&EN92UH96EG:'0Z;F]R;6%L



7!T('-O;&ED.V)O




M


M14XM55

\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B
M;W1T;VT@=VED=&@]
T0R

M
#MB;W)D97(M;&5F=#HC9C!F


M=&@Z
34N-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F


'!T


T0G8F]R9&5R

#MP



M.B-F






M:'0Z(V8P9C!F



M

T1B
M;W1T;VT@=VED=&@]
T0X
2!S='EL93TS1=B;W)D97(M8F]T=&]M.F)L86-K
M(#%P=!S;VQI9#MB;W)D97(M;&5F=#HC9C!F


M=#HP8VT[=VED=&@Z-C`N-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M
M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

M
&-M)SX@/'`@86QI9VX]



M+6QE9G0Z






M;CHP8VT@

M='EL93TS1=B;W)D97(M8F]T=&]M.F)L86-K(#%P=!S;VQI9#MB;W)D97(M
M;&5F=#HC9C!F




#MB;W)D97(M


M;W)M86P[;6%R9VEN.C!C;2`P8VT@



&-M.W=I9'1H

&8P


M;&4]



M='1O;3HC9C!F


M;VTZ

M969T.C!C;3MW:61T:#HV

M:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@
'!T)SX\
M9F]N=!L86YG/3-$14XM55,^,38L.3`P+#4S.3PO9F]N=#X\+W`^/]T9#X@

M+6)O='1O;3HC9C!F


M;W1T;VTZ


&-M.V)O


#MP861D:6YG

T0G=&5X=UA;&EG
M;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T
M)SX\9F]N=!L86YG/3-$14XM55


M;W`Z(V8P9C!F



T0G=&5X=UA;&EG;CIR:6=H
M=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N
M=!L86YG/3-$14XM55
^
XQ-SPO9F]N=#X\+W`^/]T9#X@/'1D('9A;&EG

M9C!F


&-M



M(V8P9C!F



M


#MP

T0G=&5X
M=UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P
M8VT@,'!T)SX\9F]N=!L86YG/3-$14XM55
^
38L
S8U+#(P.3PO9F]N=#X\

M;2`P8VT@
'!T)SX\9F]N=!L86YG/3-$14XM55,^)#PO9F]N=#X\+W`^/]T
M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P-B!S='EL93TS1&)O

#MB;W)D97(M;&5F=#HC9C!F
&8P.W!A9&1I


&-M


#MP861D

T0G=&5X=UA
M;&EG;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@
M,'!T)SX\9F]N=!L86YG/3-$14XM55
^
XQ-SPO9F]N=#X\+W`^/]T9#X\


&-M.W=I9'1H.C$T

M:'0Z


M



T1%3BU54SY)

T1T;W`@=VED=&@]
M
T0R

#MB;W)D97(M;&5F
M=#HC9C!F


34N-S5P=#MP
M861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F


M+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@


T1B;W)D97(M8F]T=&]M.B-F
&8P
M9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+6)O='1O;3HP8VT[8F%C


M:6YG+6QE9G0Z



&8P.W!A9&1I

T1R:6=H=!S='EL93TS1=T97AT+6%L

&-M(#!C;2`P


M+6QE9G0Z






M;CHP8VT@



&8P




M.C!C;2`P8VT@
'!T)SX\9F]N=!L86YG/3-$14XM55,^-PX
C`L
S





M9C!F

T0G;&EN92UH96EG



#MB
M;W)D97(M;&5F=#HC9C!F




#MB



T0G=&5X=UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H
M=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N=!L86YG/3-$14XM
M55
^

&-M
M.W=I9'1H.C$T


M9C!F



&-M(#!C;2`P


T1T;W`@=VED=&@]
T0R


#MB;W)D97(M;&5F=#HC9C!F



34N-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB
M;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

M9RUT;W`Z

M9VEN.C!C;2`P8VT@



T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P
M9C!F




M.B-F






M:'0Z(V8P9C!F



M

T1B
M;W1T;VT@=VED=&@]

M
#MB;W)D97(M;&5F=#HC9C!F


M=&@Z-S0N
C5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F


M1$5.+553/C`N
3
\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T
M;VT@=VED=&@]
T0R

#MB
M;W)D97(M;&5F=#HC9C!F


M
34N-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[
M8F]R9&5R+7)I9VAT.B-F


'!T)SX\


T1B;W)D97(M8F]T
M=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+6)O='1O


M+6)O='1O;3HC9C!F


M;W1T;VTZ


&-M.V)O


#MP861D:6YG

M:6XZ


M;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q
#8@

T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P
M9C!F


M;CHP8VT@

M/3-$14XM55

&-M.W=I

M




&-M(#!P






M969T.B-F





#MB;W)D97(M





M
T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP

M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B
M;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D

M9VX]
T1B;W1T;VT@=VED=&@]
T0X

M(V8P9C!F
#MB;W)D97(M;&5F=#HC9C!F


M8VT[=VED=&@Z-C`N-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F

&-M

M;&%N9STS1$5.+553/BT\+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B
M;W1T;VT@=VED=&@]
T0R

M
#MB;W)D97(M;&5F=#HC9C!F


M=&@Z
34N-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F


'!T

M;6%R9VEN.C!C;2`P8VT@


&-M.W=I9'1H.C$T
7!T


#MB;W)D97(M






&-M.W=I

M




&-M(#!P




&8P9C`[





M8VT@


C$@

T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P
M9C!F



M(V8P9C!F



M;&%N9STS1$5.+553/C`N

M
T1B;W1T;VT@=VED=&@]
T0R

M9C!F
#MB;W)D97(M;&5F=#HC9C!F


M=VED=&@Z
34N-S5P=#MP861D:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F

&-M/B`\

M


T0G8F]R

M

M.C!C;2`P8VT@
'!T)SX\9F]N=!L86YG/3-$14XM55,^*#$L-3`P+#`P,D\
M+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R
M

#MB;W)D97(M;&5F=#HC
M9C!F


34N-S5P=#MP861D
M:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT
M.B-F


M:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@

M=&]M('=I9'1H/3-$

M


M






T0G=&5X=UA;&EG;CIR:6=H
M=#ML:6YE+6AE:6=H=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N
M=!L86YG/3-$14XM55
^
XS,CPO9F]N=#X\+W`^/]T9#X\+W1R/B`\='(^

M:6YG+6QE9G0Z
&-M.W=I9'1H.C$T

&-M.V)O


#MP861D:6YG

M:6XZ


M;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1T;W`@=VED=&@]
T0R
2!S='EL

#MB;W)D97(M;&5F=#HC9C!F
&8P


34N-S5P=#MP861D:6YG+7)I
M9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P


M;W)M86P[;6%R9VEN.C!C;2`P8VT@


T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R
M+6QE9G0Z(V8P9C!F

M86YG/3-$14XM55

&-M

M9C!F




&-M


M9&5R+6)O='1O;3HC9C!F


M9RUB;W1T;VTZ


&-M


#MP861D

M87)G:6XZ


M+V9O;G0^/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0X
M

#MB;W)D97(M;&5F=#HC
M9C!F


M:6YG+7)I9VAT.C!C;3MB;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT
M.B-F



&-M.W=I9'1H

&8P9C`[
M8F]R9&5R+7)I9VAT.B-F


'!T)SX\



M:6=N/3-$=&]P('=I9'1H/3-$

T1B;W)D97(M8F]T=&]M.B-F
M
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+6)O='1O;3HP8VT[








&8P.V)O



T0G=&5X=UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H
M=#IN;W)M86P[;6%R9VEN.C!C;2`P8VT@,'!T)SX\9F]N=!L86YG/3-$14XM
M55
^
XQ-CPO9F]N=#X\+W`^/]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W








#MB;W)D




M;&4]
T1B;W)D97(M8F]T=&]M.B-F
&8P9C`[8F]R9&5R+6QE9G0Z(V8P9C!F
M


M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$


BXR-7!T(&1O=6)L93MB;W)D97(M;&5F
M=#HC9C!F





M:'0Z(V8P9C!F



'!T)SXF;F)S

M





M










&8P9C`[

M;CIC96YT97([;6%R9VEN.C!I;B`P:6X@


M.B`C9C!F



&EN.R!B;W)D
M97(M;&5F=#H@(V8P9C!F

&EN.R!B86-K9W)O

M





M9C!F


M+6)O='1O;3HC9C!F


&8P.W!A



&EN(#!P=#ML:6YE+6AE:6=H=#IN

M9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F
&8P9C`[=VED=&@Z
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F
&8P


M+6QE9G0Z



M/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0W-2!S='EL


#MW

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD

&EN(#!I

M9VX]


M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B
M;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
M

#MP861D:6YG+6)O='1O;3HP


M9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O;&]R




T0G;6%R9VEN.C!I;B`P:6X@
'!T.VQI;F4M:&5I9VAT.FYO



&8P.W=I



M97(M;&5F=#HC9C!F



&EN

M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
34N-S5P=#MB
M;W)D97(M8F]T=&]M.B-F

&EN.W!A9&1I


&8P

T1B;W1T
M;VT@=VED=&@]

#MB;W)D

#MW:61T:#HU





&8P



M97(M;&5F=#HC9C!F



&EN

M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3$N
C5P=#MB
M;W)D97(M8F]T=&]M.B-F

&EN.W!A9&1I


&8P

T1B;W1T
M;VT@=VED=&@]

#MB;W)D


M(V8P9C!F

&EN.W!A

#MP861D:6YG+7)I






T0G
M;6%R9VEN.C!I;B`P:6X@


T0G;6%R9VEN.C!I;B`P:6X@
'!T.VQI;F4M:&5I




M

&8P.W!A9&1I

M;CMB;W)D97(M;&5F=#HC9C!F

&EN.V)A8VMG

M:6X@


T1B;W)D
M97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-3`N
M
C5P=#MB;W)D97(M8F]T=&]M.B-F

&EN


M.B-F

M;&EG;CIC96YT97([;6%R9VEN.C!I;B`P:6X@
'!T.VQI;F4M:&5I9VAT.FYO



M=#HC9C!F

&8P.W!A

M.C!I;CMB;W)D97(M;&5F=#HC9C!F

&EN.V)A

M;CHP:6X@

M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B
M;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
M
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F

M


M969T.B-F

M9VX]
T1B;W1T;VT@=VED=&@]

M9C!F




M;W`Z

#MP





M

M
T1B;W1T;VT@=VED=&@]

M


M='1O;3HC9C!F


&8P.W!A9&1I



&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M


T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT
M.B-F

#MP


M=#HP:6X[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB

M:6XZ



T0G;6%R9VEN.C!I;B`P:6X@
'!T.VQI;F4M:&5I9VAT




&8P



M;W)D97(M;&5F=#HC9C!F




&EN(#!P=#ML:6YE
M+6AE:6=H=#IN;W)M86PG/D%V97)A9V4\+W`^/]T9#X\+W1R/B`\='(^(#QT
M9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R

M;W`Z(V8P9C!F

#MW:61T:#HQ-2XW-7!T


M9&EN9RUT;W`Z

M9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O;&]R.G1R86YS



T0G;6%R9VEN.C!I
M;B`P:6X@

M(#QT9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-2!S='EL93TS1=B;W)D
M97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-38N
M

'!T.VQI;F4M




M(V8P9C!F
#MW:61T:#HW

7!T

M9&EN9RUL969T.C!I;CMB;W)D97(M;&5F=#HC9C!F

M:'0Z

M



M:6X[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K

T1C96YT97(@



T0G;6%R9VEN
M.C!I;B`P:6X@

M=&0^(#QT9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-R!S='EL93TS1=B
M;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
M-3`N

'!T.VQI



T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT
M.B-F
&8P9C`[=VED=&@Z-C-P=#MB;W)D97(M8F]T=&]M.B-F

M9&EN9RUB;W1T;VTZ

M



T1T;W`@=VED=&@]



#MW:61T:#HQ
2XR

#MP861D:6YG+6)O='1O;3HP:6X[


M(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O;&]R.G1R



&8P.V)O


M;3HC9C!F






&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG

34@

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P
M9C`[=VED=&@Z
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F

M9RUB;W1T;VTZ

&EN



T1T;W`@=VED=&@]

M;W`Z(V8P9C!F

#MW:61T:#HW
2XR-7!T


M9&EN9RUT;W`Z

M9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O;&]R.G1R86YS



M;&4]
T0G;6%R9VEN.C!I;B`P:6X@


T0G;6%R9VEN.C!I;B`P:6X@
'!T.VQI;F4M:&5I



T0G;6%R9VEN.C!I;B`P:6X@
'!T.VQI;F4M:&5I9VAT

M/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I9VAT.VUA


M;CIR:6=H=#MM87)G:6XZ

M)SXP+C`Y/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q


M9C!F
#MW:61T:#HQ

#MP861D


M:6X[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K

M

M;&EG;CIR:6=H=#MM87)G:6XZ

M;6%L)SXU
PP,#`\+W`^/]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T


M=#HC9C!F

&8P

M969T.C!I;CMB;W)D97(M;&5F=#HC9C!F

&EN


&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P.SPO

M
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED
M=&@Z-S$N
C5P=#MB;W)D97(M8F]T=&]M.B-F

M;VTZ






M:6=H=#HC9C!F
&8P.W=I9'1H.C$Y+C5P=#MB;W)D97(M8F]T=&]M.B-F
&8P


M+6QE9G0Z




M

&8P.W=I9'1H.C0Y+C5P=#MB;W)D97(M
M8F]T=&]M.B-F


M.C!I;CMP861D:6YG+6QE9G0Z





&8P.W=I9'1H



M;&5F=#HC9C!F



&EN(#!P


T1B;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-38N
C5P=#MB;W)D
M97(M8F]T=&]M.B-F


M=&]P.C!I;CMP861D:6YG+6QE9G0Z

&8P9C`[


&EN(#!P=#ML:6YE+6AE

&EN(#!I

M/'1R/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B
M;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
M
34N-S5P=#MB;W)D97(M8F]T=&]M.B-F

M


M969T.B-F

M9VX]
T1B;W1T;VT@=VED=&@]

M9VEN.C!I;B`P:6X@


M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B
M;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
M
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F

M


M969T.B-F

M9VX]
T1B;W1T;VT@=VED=&@]

M9C!F




M;W`Z

#MP


M/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q-2!S='EL


#MW
M:61T:#HQ

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD

&EN(#!I

M:6=H=#MM87)G:6XZ

M+CDT/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R-B!S


M



M;W)D97(M;&5F=#HC9C!F



M


&8P.V)O

&8P.W=I9'1H.C0Y+C5P=#MB;W)D97(M8F]T=&]M
M.B-F


M861D:6YG+6QE9G0Z










M9C!F



&EN(#!P=#ML:6YE


T1B;W)D97(M=&]P.B-F
&8P9C`[
M8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-38N
C5P=#MB;W)D97(M8F]T
M=&]M.B-F


M;CMP861D:6YG+6QE9G0Z




T1R:6=H=!S='EL93TS1=T97AT

&EN(#!P=#ML:6YE+6AE:6=H=#IN


T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F
&8P9C`[=VED=&@Z-3`N
C5P=#MB;W)D97(M8F]T=&]M.B-F
&8P


M+6QE9G0Z





M


M='1O;3HC9C!F


&8P.W!A9&1I






M


M+6)O='1O;3HC9C!F


&8P.W!A






&8P



M;W)D97(M;&5F=#HC9C!F



M


T1B;W)D97(M
M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-S$N
C5P
M=#MB;W)D97(M8F]T=&]M.B-F

&EN.W!A


M


'!T.VQI;F4M

M

T1B;W1T;VT@=VED=&@]



#MW:61T:#HQ
BXW

#MP861D:6YG+6)O='1O;3HP:6X[


M(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O;&]R.G1R



M:6XZ



&8P.W=I



M97(M;&5F=#HC9C!F



T0G

M


M;&5F=#HP:6X[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I

M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D
M97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
34N
M-S5P=#MB;W)D97(M8F]T=&]M.B-F

&EN


M.B-F

M
T1B;W1T;VT@=VED=&@]


M.C!I;B`P:6X@


M/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I9VAT.VUA

&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/C0T



&8P.W=I



M97(M;&5F=#HC9C!F



&EN


T1B;W)D97(M=&]P
M.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-S$N
C5P=#MB
M;W)D97(M8F]T=&]M.B-F

&EN.W!A9&1I


&8P




&8P.W=I9'1H.C0Y+C5P=#MB
M;W)D97(M8F]T=&]M.B-F

&EN.W!A9&1I


&8P




&8P.W=I9'1H.C4V+C(U



M9C!F






&8P.W=I9'1H



M;&5F=#HC9C!F



T0G=&5X


&EN(#!P=#ML
M:6YE+6AE:6=H=#IN;W)M86PG/C`N

T1R:6=H

&EN(#!P
M=#ML:6YE+6AE:6=H=#IN;W)M86PG/C4P+#`P

M:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
M
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3$N
C5P=#MB;W)D
M97(M8F]T=&]M.B-F


M=&]P.C!I;CMP861D:6YG+6QE9G0Z

&8P9C`[

T1B;W1T;VT@
M=VED=&@]

#MB;W)D97(M

#MW:61T:#HW

M9C!F

&EN.W!A9&1I

#MP861D:6YG+7)I9VAT




&8P.W=I9'1H.C0Y+C5P=#MB;W)D97(M8F]T=&]M.B-F
M


M:6YG+6QE9G0Z







M8F]R9&5R+6)O='1O;3HC9C!F


M



&EN(#!P=#ML:6YE+6AE


T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R
M9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-38N
C5P=#MB;W)D97(M8F]T=&]M
M.B-F


M861D:6YG+6QE9G0Z




T0G;6%R9VEN.C!I;B`P:6X@
'!T.VQI

M;W1T;VTZ(V8P9C!F

M

#MP861D




T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N

&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG
M/C`N


T1R:6=H=!S='EL93TS1=T97AT+6%L

&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M
M86PG/C(L-C8U+#`P

M9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I
M9VAT.B-F
&8P9C`[=VED=&@Z
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F
&8P


M+6QE9G0Z



M/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Y-2!S='EL


#MW
M:61T:#HW

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD


M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R
M+7)I9VAT.B-F
&8P9C`[=VED=&@Z

M9C!F

&EN.W!A9&1I

#MP861D:6YG+7)I9VAT




&EN(#!P=#ML:6YE+6AE
M:6=H=#IN;W)M86PG/C`N


&EN(#!P=#ML:6YE
M+6AE:6=H=#IN;W)M86PG/C(L-C0P+#`P

M/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
34N-S5P=#MB;W)D97(M
M8F]T=&]M.B-F


M.C!I;CMP861D:6YG+6QE9G0Z



T1B;W1T;VT@=VED
M=&@]


M:'0Z(V8P9C!F
#MW:61T:#HU


M




&8P.W=I9'1H.C$U



M=#HC9C!F



&EN(#!P=#ML


T1B;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-C-P=#MB;W)D97(M8F]T
M=&]M.B-F


M;CMP861D:6YG+6QE9G0Z






&8P.W=I9'1H.C$Q



M=#HC9C!F



&EN(#!P=#ML


T1B;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-38N
C5P=#MB;W)D97(M
M8F]T=&]M.B-F


M.C!I;CMP861D:6YG+6QE9G0Z




T0G;6%R9VEN.C!I;B`P:6X@
M

M:'0[;6%R9VEN.C!I;B`P:6X@



M;&4]
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[
M=VED=&@Z

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD

&EN(#!I


T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I

&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/C`N
M


T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N

&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG
M/C4P+#`P

M

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
M
&8P9C`[=VED=&@Z
34N-S5P=#MB;W)D97(M8F]T=&]M.B-F

M9&EN9RUB;W1T;VTZ

M



T1B;W1T;VT@=VED=&@]
T0V-R!S='EL93TS1&)O


#MW:61T:#HU
M


'!T.VQI;F4M:&5I9VAT.FYO


&8P.V)O


M;3HC9C!F






&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG


T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
M
&8P9C`[=VED=&@Z-C-P=#MB;W)D97(M8F]T=&]M.B-F

M9RUB;W1T;VTZ

&EN





&8P.V)O


M;3HC9C!F






&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG


T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
M
&8P9C`[=VED=&@Z-38N
C5P=#MB;W)D97(M8F]T=&]M.B-F

M9&EN9RUB;W1T;VTZ

M





T1R

&EN
M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/C
N


T0G;6%R9VEN.C!I;B`P:6X@
'!T.VQI;F4M:&5I9VAT

&EN(#!I

M86QI9VX]
T1B;W1T;VT@=VED=&@]

M(V8P9C!F

#MW:61T:#HQ
BXW-7!T.V)O


M9RUT;W`Z

M




&EN


M86QI9VX]

M;CHP:6X@
&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/C`N
3D\+W`^/]T
M9#X\+W1R/B`\='(^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R
2!S


M

#MP861D:6YG


M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O

&EN

M:6=H=#MM87)G:6XZ

M+C(P/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q-2!S


M
#MW:61T:#HQ

#MP861D:6YG


M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O

&EN

M;CIR:6=H=#MM87)G:6XZ

M)SXR-3`L
#`P/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
M


M(V8P9C!F
#MW:61T:#HQ

#MP


M=#HP:6X[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB

M:6XZ



M;F]R;6%L)SXR+C
S/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED
M=&@]


M:'0Z(V8P9C!F

&8P

M969T.C!I;CMB;W)D97(M;&5F=#HC9C!F

&EN


&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P.SPO

M
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED

#MP861D:6YG+6)O='1O


M+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O


T0G
M;6%R9VEN.C!I;B`P:6X@


'!T.VQI;F4M:&5I

M;&4]
T0G;6%R9VEN.C!I;B`P:6X@

#MP861D


M:6X[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K


M

M
&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/C`N

M9VX]

M:6X@
&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/C0W-RPP

M/'`@86QI9VX]
T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N.G)I9VAT.VUA

&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/C$N-C$\+W`^


T0G;6%R9VEN.C!I;B`P:6X@
'!T

M87)G:6XZ

T1B;W1T;VT@=VED=&@]
T0Q-R!S='EL93TS


#MW:61T
M:#HQ

#MP861D:6YG+6)O='1O


M+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O

&EN(#!I;B`P

M=#MM87)G:6XZ

M
#`T/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R
2!S


M

#MP861D:6YG


M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O

&EN

M;CIR:6=H=#MM87)G:6XZ


M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R
M+7)I9VAT.B-F
&8P9C`[=VED=&@Z
34N-S5P=#MB;W)D97(M8F]T=&]M.B-F
M


M:6YG+6QE9G0Z




T1B;W1T;VT@=VED=&@]


'!T.VQI;F4M:&5I

M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R
M+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F
M


M:6YG+6QE9G0Z




T1B;W1T;VT@=VED=&@]
T0W-2!S


M

#MP861D:6YG


M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O


M8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[
M8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3$N
C5P=#MB;W)D97(M8F]T
M=&]M.B-F


M;CMP861D:6YG+6QE9G0Z



T1B;W1T;VT@=VED=&@]
M


M(V8P9C!F
#MW:61T:#HW

#MP


M=#HP:6X[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB

RXU

M/3-$8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P
M9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z

M;W1T;VTZ(V8P9C!F

M

#MP861D




T1R:6=H

&EN(#!P
M=#ML:6YE+6AE:6=H=#IN;W)M86PG/C`N

T1R

&EN


M9VX]

M:6X@
&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/C`N
C4\+W`^/]T9#X\
M+W1R/B`\='(^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R
2!S='EL


#MW

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD

&EN(#!I

M=#MM87)G:6XZ

P
M/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q-2!S='EL


#MW
M:61T:#HQ

#MP861D:6YG+6)O


M9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD

&EN(#!I

M:6=H=#MM87)G:6XZ

M-3`L
#`P/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q


M9C!F
#MW:61T:#HQ

#MP861D


M:6X[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K

M

M;&EG;CIR:6=H=#MM87)G:6XZ

M;6%L)SXS+CDQ/]P/CPO=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
M


M(V8P9C!F

&8P.W!A

M.C!I;CMB;W)D97(M;&5F=#HC9C!F

&EN.V)A

M;CHP:6X@


T1B
M;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z

#MP861D:6YG+6)O='1O;3HP


M9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O;&]R


T0G;6%R
M9VEN.C!I;B`P:6X@



'!T.VQI;F4M:&5I9VAT

M
T0G;6%R9VEN.C!I;B`P:6X@

#MP861D:6YG


M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O


T1R

&EN
M(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/C`N
S

M

M
&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/C(U
PP,#`\+W`^/]T9#X@



&8P.W=I9'1H.C$Q+C(U



M9C!F



&EN(#!P=#ML:6YE


T1B;W)D97(M=&]P.B-F
&8P9C`[
M8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-S$N
C5P=#MB;W)D97(M8F]T
M=&]M.B-F


M;CMP861D:6YG+6QE9G0Z






&8P.W=I9'1H.C$Y
M+C5P=#MB;W)D97(M8F]T=&]M.B-F

&EN


M.B-F

M
T1B;W1T;VT@=VED=&@]

M


M='1O;3HC9C!F


&8P.W!A9&1I






M


M+6)O='1O;3HC9C!F


&8P.W!A








M8F]R9&5R+6)O='1O;3HC9C!F


M




T0G
M;6%R9VEN.C!I;B`P:6X@



#MW
M:61T:#HV

#MP861D:6YG+6)O='1O


M+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O


T0G
M;6%R9VEN.C!I;B`P:6X@


'!T.VQI;F4M:&5I




M

&8P.W!A9&1I

M;CMB;W)D97(M;&5F=#HC9C!F

&EN.V)A8VMG

M;&4]


'!T.VQI

M8F]T=&]M('=I9'1H/3-$

T1B;W)D97(M=&]P.B-F
&8P9C`[
M8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
3(N-S5P=#MB;W)D97(M8F]T
M=&]M.B-F


M;CMP861D:6YG+6QE9G0Z



T1B;W1T;VT@=VED=&@]
M


M(V8P9C!F

#MP


M=#HP:6X[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB

SDL.#8S/]P/CPO=&0^(#QT9!V86QI
M9VX]
T1B;W1T;VT@=VED=&@]
T0R

M9C!F




M;W`Z

#MP




&EN(#!I


M/'1R/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B
M;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
M
34N-S5P=#MB;W)D97(M8F]T=&]M.B-F

M


M969T.B-F

M9VX]
T1B;W1T;VT@=VED=&@]

M9VEN.C!I;B`P:6X@

M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T1B
M;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z
M
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F

M


M969T.B-F

M9VX]
T1B;W1T;VT@=VED=&@]

M9C!F




M;W`Z

#MP


3`P+#`P
M


M;&4]
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[
M=VED=&@Z
3$N
C5P=#MB;W)D97(M8F]T=&]M.B-F

M;W1T;VTZ

&EN.V)O



T1B;W1T;VT@=VED=&@]

M;W`Z(V8P9C!F

#MW:61T:#HW
2XR-7!T


M9&EN9RUT;W`Z

M9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O;&]R.G1R86YS

M

C8@

T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P
M9C`[=VED=&@Z

#MP861D:6YG


M8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O

&EN


T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N

&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG
M/C`N


T1R:6=H=!S='EL93TS1=T97AT+6%L

&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M
M86PG/C$P
PP,#`\+W`^/]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T


M=#HC9C!F

&8P

M969T.C!I;CMB;W)D97(M;&5F=#HC9C!F

&EN


&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N8G-P.SPO

M
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED
M=&@Z-3`N
C5P=#MB;W)D97(M8F]T=&]M.B-F

M;VTZ






M=#HC9C!F

&8P.W!A

M.C!I;CMB;W)D97(M;&5F=#HC9C!F

&EN.V)A





M:'0Z(V8P9C!F

M





#`P/]P/CPO
M=&0^(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q-2!S='EL93TS1&)O


#MW:61T:#HQ
M

#MP861D:6YG+6)O='1O;3HP


M9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O;&]R









&8P.W=I9'1H.C0Y
M+C5P=#MB;W)D97(M8F]T=&]M.B-F

&EN


M.B-F



M9C!F

&8P.W!A

M.C!I;CMB;W)D97(M;&5F=#HC9C!F

&EN.V)A

M;CHP:6X@


T0G


&8P.W=I9'1H

M9RUB;W1T;VTZ

&EN



M;&4]


M


M;&4]
T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[
M=VED=&@Z
34N-S5P=#MB;W)D97(M8F]T=&]M.B-F

M;W1T;VTZ

&EN.V)O



T1B;W1T;VT@=VED=&@]





M9C!F

M9&EN9RUL969T.C!I;CMB;W)D97(M;&5F=#HC9C!F

M:'0Z


&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/B9N


T1B;W)D97(M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P
M9C`[=VED=&@Z-38N
C5P=#MB;W)D97(M8F]T=&]M.B-F

M9RUB;W1T;VTZ

&EN



T1B;W1T;VT@=VED=&@]



#MW:61T:#HQ
2XR

#MP861D:6YG+6)O='1O;3HP:6X[


M(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O;&]R.G1R





&8P.W=I9'1H
M.C0Y+C5P=#MB;W)D97(M8F]T=&]M.B-F

M


M969T.B-F

M9VX]
T1B;W1T;VT@=VED=&@]

M9C!F

#MW:61T:#HQ



M;W`Z

#MP




T0G;6%R9VEN.C!I;B`P
M:6X@




M9&EN9RUT;W`Z

M9C!F
#MP861D:6YG+7)I9VAT.C!I;CMB86-K9W)O=6YD+6-O;&]R.G1R86YS



M86QI9VX]
T1B;W1T;VT@=VED=&@]
T0R

M(V8P9C!F

#MW:61T:#HQ-2XW-7!T.V)O


M9RUT;W`Z

M




T0G;6%R9VEN.C!I;B`P
M:6X@

M9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-2!S='EL93TS1=B;W)D97(M
M=&]P.B-F
&8P9C`[8F]R9&5R+7)I9VAT.B-F
&8P9C`[=VED=&@Z-38N
C5P
M=#MB;W)D97(M8F]T=&]M.F)L86-K(#(N


M96EG:'0Z;F]R;6%L)SXY+#`U
RPP

M9VEN.C!I;B`P:6X@


M

&8P.W=I9'1H.C0Y+C5P=#MB;W)D97(M
M8F]T=&]M.B-F


M.C!I;CMP861D:6YG+6QE9G0Z



T1B;W1T;VT@=VED
M=&@]


M:'0Z(V8P9C!F
#MW:61T:#HQ

M


M;&5F=#HP:6X[8F]R9&5R+6QE9G0Z(V8P9C!F
#MP861D:6YG+7)I9VAT.C!I

M87)G:6XZ



T1R:6=H=!S='EL93TS1=T97AT+6%L:6=N

&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG

BXR-7!T(&1O

&EN.W!A9&1I

#MP861D:6YG+7)I9VAT

M

M
&EN(#!P=#ML:6YE+6AE:6=H=#IN;W)M86PG/C`N

M/5].97AT4&%R=%]F.64R86$R-U\W-V-B7S0X8V%?.&$W.5]B9#@P-V%D8F)E
M
&



M;W)T(&ED/3-$240P14)*04

T0R


#$T/&)R/CPO

]



]
M
T1N=6UP/B0@-2PQ-3
L
3












]
T1R93X-

]
T1N=6UP/B0@
30Q+#`Q-#QS


F%A
M
C=?-S=C8E\T.&-A7SAA-SE?8F0X
#=A9&)B93!C#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T




^+RH@1&\@3F]T


$5714%%

M/3-$




]
M

]
T1T:#Y$
M96
N(#







]
M
T1N=6UP/B0@
S`L






M;7`^

M86QI9VX]

L
M(&-H87)G97
@86YD(')E;&%T960@97AP96YS97

]
T1N=6UP/CDW-RPP





]

3@X+#@X
#QS


]





]
T1N=6UP/CDL






]
T1R


M('1O(&]P97)A=&EO;G



]
T1N=6UP/C(W+#`P


]



M871I;VX@*)&1$E#(BD@;&EM:70@+CPO=&0^#0H@(`@(`@(#QT9!C;&%S



M+2TM+2TM/5].97AT4&%R=%]F.64R86$R-U\W-V-B7S0X8V%?.&$W.5]B9#@P
M-V%D8F)E
&




04
^#0H@(`@(`\='(^#0H@(`@(`@


M

S$L(#(P
30\8G(^/]T
M:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q



]





]
T1N=6UP/C$S
2XY-R4\




]




T1T
M;W`^17AP96-T960@=&5R;2!M:6YI;75M/]T9#X-B`@(`@(`@/'1D(&-L



]
T1P







]




F%A
C=?-S=C8E\T.&-A7SAA-SE?8F0X
M
#=A9&)B93!C#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+V8Y93)A

M965T

M(G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@/$U%5$$@:'1T


^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@

$4Q1T%#/@T*(`@(`@/'1R/@T*(`@(`@





#$T/&)R/CPO=&@^


]
T1R93X-B`@(`@

]
T1R

]
T1N
M=6UP/B0@
C`L









M1&YU;3XH
S$L


@

#QS

M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9CEE
F%A
C=?-S=C8E\T.&-A7SAA
M-SE?8F0X

O4VAE970S
RYH=&UL#0I#;VYT


M87-C:6DB#0H-CQH
M=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q=6EV/3-$0V]N=&5N



M*B!$;R!.;W0@4F5M;W9E(%1H:7

]



]
T1T:#Y$96
N(#

S$L(#(P
3
\


]



M(&%N9!A;6]R=&EZ871I;VX@97AP96YS97,\+W1D/@T*(`@(`@(`\=&0@

]
T1N=6UP/B0@
C4L



;V-A=&EO;CH@9FEL93HO+R]#
M.B]F.64R86$R-U\W-V-B7S0X8V%?.&$W.5]B9#@P-V%D8F)E
&
O5V]R:W-H



M151!(&AT='`M97%U:78]

]

T0Q(')O=W-P86X]
T0R

3(@36]N=&AS($5N9&5D
M/]T:#X-B`@(`@(#PO='(^#0H@(`@(`\='(^#0H@(`@(`@(#QT:!C

S$L(#(P




]

]
T1P



;V-A=&EO;CH@9FEL93HO
M+R]#.B]F.64R86$R-U\W-V-B7S0X8V%?.&$W.5]B9#@P-V%D8F)E
&
O5V]R



M(#Q-151!(&AT='`M97%U:78]

]



]
T1T:#Y$96
N(#

#(L(#(P
3$\8G(^



]



T1T;W`^061V86YC92!A


]
T1N=6UP/B0@-BPP
#`L


#`\


;V-A=&EO;CH@9FEL93HO+R]#.B]F.64R86$R-U\W-V-B7S0X8V%?
M.&$W.5]B9#@P-V%D8F)E
&


T1#;VYT

]
T13:&]W+FIS





]
T1T:#Y$96
N(#

M;VYG/E)E;&%T960@4&%R='D@861V86YC97


]


T1T;W`^06UO=6YT(&]F(&%D=F%N8V5S(&9R

]


]
T1N=6UP/B0@-#8R+#`P
M

]

]



M;CX\+W-P86X^/]T9#X-B`@(`@(#PO='(^#0H@(`@/]T86)L93X-B`@








]

T1)1#!%54]!0SX-


#$T/&)R/CPO=&@^







]




]
T1N=6UP/C$L
C@U+#`P


]




]






]
T1N=6UP/B0@


T1T;W`^1&ES8V]U;G0@;V9F(&]F('1H92!T96X@9&%Y

M1&YU;7`^
C4N








M
F%A
C=?-S=C8E\T.&-A7SAA-SE?8F0X
#=A9&)B93!C#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T






^+RH@1&\@


$5:






]
T1T:#Y/8W0N(#











]

T1T;W`^4W5B;W)D:6YA=&5D



T1T

]
T1T97AT/CQS

]
T1N=6UP/B0@
M


M



M:&%R97

]
T1N=6UP/C$U


]

]
M





]
T1N=6UP/C$L
C4P+#`P



T1T;W`^5F5N='5R





]
T1T


M9CEE
F%A
C=?-S=C8E\T.&-A7SAA-SE?8F0X
#=A9&)B93!C#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T


SDN:'1M;`T*0V]N=&5N



^+RH@


M




M8G0@56YA;6]R=&EZ960@9&ES8V]U;G0@:6YF;W)M871I;VX@*$1E=&%I;'
I


]
T1T:#Y$96
N(#




]


]


T1T;W`^



]
T1N=6UP/C$L-SDT
M+#(W


T1T;W`^



]
T1N=6UP/B0@

M+2TM/5].97AT4&%R=%]F.64R86$R-U\W-V-B7S0X8V%?.&$W.5]B9#@P-V%D
M8F)E
&


M
M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q





^#0H@(`@(`\='(^#0H@(`@(`@(#QT

]


30\8G(^






@;V8@
24@8V]N=F5R=&EB;&4@9&5B96YT



T1T
M;W`^0V]N=F5R=&EB;&4@9&5B96YT=7)E(&%M;W5N=!W87,\+W1D/@T*(`@

]










]



2P@
C`Q

M
#$S/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R(&-L87-S/3-$






]




]




M+#@V-2PT




]




]
T1N=6UP/B0@.#DP+#@Q








]

L($Q
0R!087)E;G1H

]
T1T:#Y397`N(#

M:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^2G5L+B`Q-P@


#$T/&)R

]
T1T:#Y$96
N(#

3@L
M(#(P
3
\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^3V-T+B`R

]
T1T:#Y397`N
M(#


]
T1T
M:#Y-87D@

3
\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$
M=&@^07!R+B`R.2P@
C`Q


C`Q

#$R/&)R/CPO=&@^#0H@(`@(`@(#QT

C`Q

#$R/&)R/CPO=&@^#0H@(`@(`\

L($Q


]
M
T1N=6UP/B0@

]



]
T1N=6UP/B0@


]
T1N=6UP/B0@


]
T1N



]


]
T1N=6UP/B0@-3$X


]
T1N=6UP/B0@

]



M

3

3




38\

M(#`N





S





M











S4N-C`E/'-P86X^

30U+C0U



]



]
T1N=6UP/C$T








]
T1N=6UP/C$U
2XW




30S+C

]
M

CQS

]
T1N
M=6UP/C$N





]




]




]
T1R;SX-

]
T1N=6UP
M/C`N

M1&YU;7`^




]
T1N=6UP/C`N






]
T1N=6UP/C`N






]
T1N=6UP
M/C`N

M1&YU;7`^













R)3QS




]
T1N=6UP/C`N



T1T;W`^























]








]

@86YD(&QI86)I;&ET

I(A54T0@)D\

]
T1T:#Y$
M96
N(#




]

]
M





]
M

]











]




S$L(#(P
M
30\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
M
C`Q

]

]
M


M9VX]

S8L
C

]
T1R93X-


RPV


S

M/3-$=&]P/D-H86YG92!I;B!F86ER('9A;'5E/]T9#X-B`@(`@(`@/'1D




M(`@(`@/'1D(&-L87-S/3-$;G5M/B@X


T1T;W`^16YD:6YG($)A;&%N

]

M871I;VXZ(&9I;&4Z+R\O0SHO9CEE
F%A
C=?-S=C8E\T.&-A7SAA-SE?8F0X
M

O4VAE970T-2YH=&UL#0I#;VYT96YT+51R





M;W0@4F5M;W9E(%1H:7


M86X]
T0Q(')O=W-P86X]

M(&9E97
@*$1E=&%I;'



#$T/&)R/CPO=&@^


]
T1T:#Y.;W8N(#

C`Q
M

M
#$S/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R(&-L87-S/3-$

















]
T1N=6UP/B0@

]
T1N=6UP/B0@
M

]
T1N
M=6UP/B0@


]
T1N=6UP/B0@


]
T1N=6UP/B0@


]
T1N=6UP/B0@

]
T1N=6UP/B0@








3(L-3`P/'-P86X^

3(L-3`P

M

M1&YU;7`^




N
S$L(#(P



]
T1R;SX-

]
T1N=6UP






M-S


X


]

]
T1N=6UP/C




]
T1N=6UP/C




]
T1N=6UP/C$R
2XS



30S+C



]
T1N=6UP/C`N




]
T1N
M=6UP/C`N












M;7`^)`Q,PP






]
T1N=6UP/B0@
M
3`L

M1&YU;7`^)`Q,PP




'0O:'1M;#L@


]



R!-;VYT:'

M
2P@


]
T1T
M:#Y$96
N(#


C`Q

#$S/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*

]
T1T97AT

]
T1T97AT

]
T1T97AT

]
T1T97AT


T1T





]


]


]
T1N=6UP/C0U





#`\










]


]
T1N=6UP/C4P


]


]
T1N=6UP/B0@-#`R+#4P


]
T1N=6UP/B0@
M
C4V+#4P


]




]
T1N=6UP
M/C(L
#0P+#`P


]
T1N=6UP/C4P+#`P


]


]

]
M

]
M
T1N=6UP/C$L
#@X+#`P

]
T1N=6UP/C@P








]


]
T1N=6UP/C0Y
M





@

24@8V]N





@;V8@

M97


]







]
T1R;SX-


M-RPU


3




S(L

M='

#`L
M



]







]







]


]


]


]



]


]
T1T

]
T1T

]
T1N
M=6UP/C$L


]

]
T1P









]

]




]
T1N=6UP/B0@-C0L-3`P/'-P86X^








M-V-B7S0X8V%?.&$W.5]B9#@P-V%D8F)E
&

M;G0]


2P@
C`Q




38L


]




]


]


T1T

]
M
T1N=6UP/C`N


M;7`^


;V-A=&EO;CH@9FEL93HO+R]#.B]F.64R86$R-U\W
M-V-B7S0X8V%?.&$W.5]B9#@P-V%D8F)E
&




M:78]

]
M



Q




N(#
Q+`R,#$S/]T9#X-



]

RPQ-#DL-S`P

M


M


]
T1N=6UP/C`N
3





]
T1N=6UP/C`N


M;G1S($]U='-T86YD:6YG(&%T($1E8RX@
S$L(#(P
30\+W1D/@T*(`@(`@

]
T1N=6UP/C`N








]

T1)1#!%-$5!23X-B`@(`@(#QT


@4F%N9V4@;V8\8G(^/]T:#X-B`@(`@(`@

@3G5M8F5R/&)R



M:6-E/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R(&-L87-S/3-$


#$S/]T9#X-B`@(`@(`@/'1D


#D\




M

]
T1N
M=6UP/C4P+#`P


]




M1&YU;7`^

]
T1N=6UP/C`N





]
T1N=6UP
M/C


]

C4\


]
T1N=6UP/C`N






]





M

]
T1N=6UP/C`N



M;V8@


]
T1N=6UP/C4P
M+#`P



]

]
T1N
M=6UP/C
N






@:6X@82!R86YG92!O

]
T1N=6UP/C(U


C4P+#`P


@:6X@82!R86YG92!O9B`P




]
T1N=6UP/C`N


M


]

M


M1&YU;7`^


]





M(#`N


C4P+#`P
M



M
S






M


]
T1N=6UP/C`N




]
T1N=6UP/C$P






#`P/'-P

2XY

]
T1N
M=6UP/C4P+#`P



@870@1&5C+B`S
2P@
C`Q


]
T1T97AT


]
T1N=6UP/C`N





]
T1R97!O


M



T1T;W`^

M965M96YT(&%N9!-=71U86P@4F5L96%S92!O9B!A;&P@0VQA:6US/]S=')O









]


]



T1T;W`^5&AE('-E='1L96UE;G0@


]



]




]



3`L








3@L-#8V/'-P86X^



M97)E;F-E(&]F86UO=6YT(&ES(')E8V]G;FEZ960@87
@;W1H97(@:6YC;VUE




]


F%A
C=?-S=C8E\T.&-A7SAA-SE?8F0X
#=A9&)B93!C#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T




M:G


M9#TS1$E$



M;G1S($%N9!#;VYT:6YG96YC:65S($%S($9O;&QO=W,@*$1E=&%I;',I(A5

M=&@^1&5C+B`Q-BP@
C`Q

]







M-3`P+#`P

]




]





#`P+#`P

]
M



F%A
C=?-S=C8E\T.&-A7SAA-SE?8F0X
#=A9&)B
M93!C#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T





^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C



M(&-O;'-P86X]


#$T/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R(&-L87-S

]


]

SDQ+#(X


]


#`N
#`E/'-P


M-U\W-V-B7S0X8V%?.&$W.5]B9#@P-V%D8F)E
&

M;G1E;G0]

^


]

]
T1T:#Y397`N(#


\+W-T


T1T;W`^37(N($UA






M=F%L=64@;V8@8V]M;6]N('-T;V-K/]T9#X-B`@(`@(`@/'1D(&-L87-S



M=&@@;V8@;VYE('-H87)E(&]F($-O;6UO;B!3=&]C:SPO=&0^#0H@(`@(`@




C(\


#`L

M.&$W.5]B9#@P-V%D8F)E
&



M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\

T1T97AT+VIA

@

]

@
M*$1E=&%I;'


@+2!$





@9F]R($9E9&5R86P@=&%X('!U




C`L
3`P+#`P



]










]

T1)1#!%5T)!0SX-B`@(`@(#QT

#$U/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*







]
T1N=6UP/B0@
3`L


BPU



M97
@;V8@8V]M;6]N('-T;V-K/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$







M8F]O:RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
#$N:'1M;(O
M/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#`R+FAT;6PB+SX-B`\;SI&:6QE
M($A2968],T0B4VAE970P,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,#0N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#`U+FAT;6PB
M+SX-B`\;SI&:6QE($A2968]
T0B4VAE970P-BYH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T

M:&5E=#`X+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970P.2YH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3`N:'1M;(O/@T*(#QO.D9I
M;&4@2%)E9CTS1)3:&5E=#$Q+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B
M4VAE970Q
BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
3
N:'1M
M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#$T+FAT;6PB+SX-B`\;SI&
M:6QE($A2968],T0B4VAE970Q-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,38N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#$W+FAT
M;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970Q.YH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T,3DN:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS
M1)3:&5E=#(P+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970R
2YH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
C(N:'1M;(O/@T*(#QO
M.D9I;&4@2%)E9CTS1)3:&5E=#(S+FAT;6PB+SX-B`\;SI&:6QE($A2968]
M,T0B4VAE970R-YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
C4N
M:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#(V+FAT;6PB+SX-B`\
M;SI&:6QE($A2968],T0B4VAE970R-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,C@N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#(Y
M+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970S
YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,S$N:'1M;(O/@T*(#QO.D9I;&4@2%)E
M9CTS1)3:&5E=#,R+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970S
M
RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
S0N:'1M;(O/@T*
M(#QO.D9I;&4@2%)E9CTS1)3:&5E=#

T0B4VAE970S.2YH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T-#`N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E
M=#0Q+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970T,BYH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#,N:'1M;(O/@T*(#QO.D9I;&4@
M2%)E9CTS1)3:&5E=#0T+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE
M970T-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#8N:'1M;(O
M/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#0W+FAT;6PB+SX-B`\;SI&:6QE
M($A2968],T0B4VAE970T.YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T-#DN:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#4P+FAT;6PB
M+SX-B`\;SI&:6QE($A2968],T0B4VAE970U,2YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T-3(N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3
M:&5E=#4S+FAT;6PB+SX-B`\;SI&:6QE($A2968]

 'defref_fil_Level3Abstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DerivativeInstruments2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_TotalAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_TotalDerivativeInstruments1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_BASISOFPRESENTATIONCONSISTSOFAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanyincurredOperatingNetLosses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WorkingCapitalDeficiency'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_StockholdersDeficiency'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ReceivedProceedsThroughTheSaleOfCommonStockAndExerciseOfCommonStockWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ReceivedProceedsThroughTheIssuanceOfConvertibleDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ReceivedProceedsThroughLoansFromToRelatedParties'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_STOCKHOLDERSWARRANTSAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsOutstandingAndExercisableTableTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_SummaryOfTheChangesInFairValueOfTheCompanyAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_BeginningbalanceOfFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_InitialRecognitionDerivativeLiabilityOfEmbeddedConversionFeatureOfTheConvertibleNotes'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ChangeInFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ReclassificationToAdditionalPaidInCapital'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_EndingbalanceOfFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DeferredFinancingCostsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AmortizationOfDeferredFinancingCostsRelatedToConvertibleDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ResearchAndDevelopmentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ResearchExpensesSalariesAndEquipmentRelatedExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ClinicalStudiesExpensesFeesChargesAndRelatedExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_StockBasedCompensationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompensationExpensesRecorded'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CommonSharesFromOutstandingWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AdvertisingPublicRelationsCostsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AdvertisingAndPublicRelationsCostsAreChargedToOperationsWhenIncurred'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ConcentrationsOfCreditRiskAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FairValueAssumptionsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ExpectedVolatilityMinimum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ExpectedVolatilityMaximum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ExpectedDividends'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ExpectedTermMinimum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ExpectedTermMaximum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_RiskFreeRateMinimum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_RiskFreeRateMaximum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_BasisOfAccounting'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_PropertyAndEquipmentConsistsOfTheFollowingAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FurnitureAndFixtures'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_Equipment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_PropertyAndEquipmentGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_LessAccumulatedDepreciationAndAmortization'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_PropertyAndEquipmentsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_OtherDebtDetailsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_HoldersOf1ConvertibleDebenturesConvertedTheirDebenturesIntoShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ConvertibleDebentureAmountWas'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_RelatedPartyStockSubscriptionAgreementsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_MrMaggioreASignificantShareholderSubscribedToTheAcquisitionForUnits'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ShareOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_PerShareValueOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsToPurchaseOneTenthOfOneShareOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_PerUnitPriceOfWarrant'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AggregatePurchasePriceOfUnits'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsCurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Cash'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PrepaidExpenseCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredFinanceCostsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAssetsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DepositsAssetsNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesCurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsPayableCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LoansPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConvertibleDebtCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccruedLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesNoncurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConvertibleDebtNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Liabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingencies'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdditionalPaidInCapital'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RetainedEarningsAccumulatedDeficit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesAndStockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_BoardOfDirectorsFeesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsGrantedPurchaseCommonStockShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsExercisePricePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsGrantedVestedOnGrant'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsGrantedVestedOnSept30Dec312012AndMarch31Of2013'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsValued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_TermOfTheWarrantsInYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_VolatilityRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AnnualrateofdividendsForDirectors'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DiscountRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ProceedsFromAnnualTermServedPaidQuarterly'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProfitLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_StocksAndWarrantsIssuedForServicesRendered1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsIssuedForDirectorsFees'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_StocksAndWarrantsIssuedForFinancingCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PaymentsOfFinancingCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AmortizationOfFinancingCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AmortizationOfBondDiscount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AmortizationOfIntangibles'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DepreciationAmortizationAndAccretionNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AbandonmentOfPatentApplicationsPending1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FairValueAdjustmentOfDerivativeLiability'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DecreaseInDeferredRent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesSubjectToCompromisePeriodIncreaseDecrease'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInSecurityDeposits'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInAccountsPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInCustomerDeposits'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PaymentsToAcquireIntangibleAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FinanceChargesPaidOnIssuanceOf11ConvertibleDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromConvertibleDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromSaleOfTreasuryStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashPeriodIncreaseDecrease'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CashPaidDuringThePeriodForAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestPaidNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxesPaid'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ConvertibleDebtConsistsOfTheFollowingAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AdvanceAgreedUnderLoanAgreement1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AdvancedAmountOfConvertibleSecuredPromissoryNote'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SubsequentEventsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SubsequentEventsTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_RelatedPartyAdvancesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AmountOfAdvancesFromASignificantShareholderMrMaggiore'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_OfficersAdvancedTheCompanyInTheAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FairValueOfWarrantsEstimatedTablesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FairValueOfWarrantsEstimatedTablesTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NatureOfOperations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockTransactionsParentheticalDisclosuresAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DiscountOfConvertibleDebenturePayableCurrent1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DiscountOfLongTermConvertibleDebenturePayable1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockParOrStatedValuePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_OtherIncomeAndExpensesAbstract1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DocumentAndEntityInformationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityRegistrantName'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_TradingSymbol'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentType'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentPeriodEndDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_AmendmentFlag'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCentralIndexKey'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_CurrentFiscalYearEndDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityFilerCategory'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCurrentReportingStatus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityVoluntaryFilers'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityWellKnownSeasonedIssuer'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentFiscalYearFocus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentFiscalPeriodFocus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityPublicFloat'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CommitmentAndContingenciesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RevenuesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Revenues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingExpensesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SellingExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GeneralAndAdministrativeExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProfessionalFees'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ResearchAndDevelopmentExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AbandonmentOfPatentApplicationsPending'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostsAndExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NonoperatingIncomeExpenseAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherIncome'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_OtherIncomeCancellationOfAccountsPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FairValueAdjustmentOfDerivativeLiability1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AmortizationOfBondDiscount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_Amortizationofdeferredfinancecosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FinancingCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FinanceCostsPaidInStocksAndWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherOperatingIncomeExpenseNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerShareBasicAndDiluted'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_LoanPayableAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_LoanPayableTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_IntangibleAssetsGoodwillAndOtherAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AccountingPolicies1Abstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConsolidationPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_UseOfEstimates'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredChargesPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RevenueRecognitionPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShippingAndHandlingCostPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerSharePolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdvertisingCostsPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ConcentrationRiskCreditRisk'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FormationOfSubsidiariesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_idr_DisclosureFORMATIONOFSUBSIDIARIESTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FairValueMeasuresAndDisclosuresAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueDisclosuresTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CONVERTIBLEDEBTAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ConvertibleDebtDisclosureTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DERIVATIVELIABILITYAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativesAndFairValueTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_STOCKHOLDERSDEFICIENCYAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AbandonmentOfThePatentApplicationsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_PatentApplicationsPurchasedAndRecordedALossOnAbandonment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CommitmentsAndContingenciesAsFollowsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AnnualBaseSalary'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsExercisePrice1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsToPurchaseSharesUponIdentificationOfBioActiveAgentsAndUponTheEnteringIntoContract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ReceiptsFromWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsToPurchaseSharesUponCoDevelopmentAgreement'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_AmountProvidedByPartner'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsToPurchaseUnderEmploymentAgreement'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_IncomeTaxesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ConvertibleDebtConsistsOfTheFollowingAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ConvertibleDebtConsistsOfTheFollowingTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_TotalWarrants2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf009'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf01'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf012'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf01251'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf014'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf015'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf017'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf019'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf021'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf022'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf025'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf03'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf0331'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf0361'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf0381'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsInARangeOf04'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_TotalWarrants3'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ConvertibleDebtConsistsOfTheFollowing1Abstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_N1ConvertibleNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_N11ConvertibleNotesPayableHepInvestmentsLlc1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_N11ConvertibleNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_TotalConvertibleNotesPayable1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_LessCurrentPortionOfConvertibleNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_LongTermPortionOfConvertibleNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_IssuanceOfWarrantsToBoardOfDirectors'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_IssuanceOfWarrantsForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CashlessExerciseOfCommonStockWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CommonStockIssuedOnConversionOf1ConvertibleDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CommonStockIssuedOnConversionOf11ConvertibleDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CommonStockIssuedForPurchaseOfAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ExerciseOfCommonStockWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DiscountsOnConvertibleDebentures'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsIssuedForFinancingCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_SharesIssuedForFinancingCosts'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_NetLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_IssuanceOfWarrantsToBoardOfDirectors1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_IssuanceOfWarrantsForServices1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_IssuanceOfCommonStockForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CommonStockIssuedOnConversionOf1ConvertibleDebt1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_CommonStockIssuedOnConversionOf11ConvertibleDebt1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ExerciseOfCommonStockWarrants1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_DiscountsOnConvertibleDebentures1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_ReclassificationOfDerivativeLiability'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_WarrantsIssuedForFinancingCosts1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_SharesIssuedForFinancingCosts1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_NetIncome'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FairValueOfWarrantsEstimatedAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_FairValueOfWarrantsEstimatedTextBlock'

#$T
3(S
2YX
2F-JO?[W4&]
M^?)OO_S7?_[\EWJ=70IUDG=&U9G\EPF@EWG
A


*@.HX26T4L[;_6$

*ZA



S'[0'(]\$.2%RDL1A)


M]K0:_:W6?:=XZM]ON\T.G%1@ZT)0.ZZQM*/&!N!/5`JQ6X9ZY%0



[(ZK+S/VH-%O-K==


5`PT%&N/1.UZ
N!X_X2X/!RE;83,2:'I])0
CT!MW^(GZ;K/15$%S!<]U!$P/V'1%<8;6NN/Z@KS-44F3`KH2^GG]

M(ORGP:/]E?&X

M

ZZRH[/+^N=K^Q.'7'[X=,9:[<^G1W]



T`SEQP;9A(8U!M
MIR(2TZ'0K-VL


%9U;I;^0=!8A
M(08G$

@8.G).D'I'!PMSX)@I`;:@_%L&=4]!E0Q

M[67):RD@2@S'E
8'6O!1!F=(!54`.Q8I
B]






MH2

-=#W+.*
@VM%9'(ZSZA$QE8DK=0@4V(D0SE:T*ET#+%=@5!Y\UCQ-^



UPP1(J04CDOY[PGH9LIE4D!+`C^K^]


J^KVQ3@7D



MGOV4?X'PWY/;

!
VUB;GPV(:@



4)$![TDTUF



M%$B@/Y#!?D\6-X3&0QK2957B2HC9?+*0Z
K3)=+.UQ$6+``:FUQ'$VY$3/MX

2N.SVBA_Q6G&_[RMIC+(^_A0^3`5UX5'W;$B2.LHU




B4S]BB)?ON?&LO@=F`(`3!^

$_#^62WRAH3
M-$!`=9P^1+U)B'*G*!
.0_.T?%
KJYA8JS0V\G$'$.)FU\
5;$$-S1-L\GG4





MRV;N:K94(

PCF3P53=N
MP?E6/90BA6XS!7<;7T<K&N<1QEU69JE9E<DX1^BF$%9`S3U)(Y4TKK.^&C$

1BT`]XB44
M-H731;
+\5ZW7H(6P7J+QRAKXHY$M-<K]FOKXPF;)[0976E\I0+;/YSKCS[GD<TL

U9E5[9DW`KSSWO?8E58WTE`AFNI?








M#I#I`O9%S

SNZ9/&2B7
4VPOK`H


M$N3)&C;W87








M3$1Q


MQ/*&$=$=O2*!KF!)

T.7=^G-D.X.51^68'5E
MZ42
]/JEW]ZZB!__6/-%')/R1(
MA\U6:Z_5G65^C%VL&.0VZ!\#U8M'+AU;_(T[H0<.$OV]


H^=\=3QZP3;%#C]XW

VGF'6F=E=RO?.T11T`4=$3F0]$+T@LDS[&Y$`C%?\*B<9+7L57


MA25M3$;FWBTJ
3&F#PY5IEPK,C'$1R1'UH7*F`(G26V=W=%GK@CBL#1F
MK


3(RR='.LD[&DR)
MI
U!F'&-:1_\9G


MU4-
IW/P)6+
P\FK<73?H`H\*M=VJD'&V<YUPC3=W,7LPV/
M03-:%LLTB^BV



M:4OW





Z`M6-/*&E8HJGS(YD!4Y#+

A

2PNHSOL#



M4)3.
\!Q/OGZ#';Q*78







M
M#C;-`4.)+P$&=&`63X:3DJDA&3/AX(

MLBN`*95D^/1;B+

MM4\T%+YUF@RG08%VP4^
$1S'P3$*9.G'_@7SP$9W!`\X+2;&[




[

MZ&4

[G?P$V`G4:;4Z0[$=
[\


M
Z4+4`O


M3L;)%ZT

M3O9.7@D_O[Z]!VL&Y/C=B1/;Q]BM
H3*T2$D5NZJ:#G+4+)V]!A0GJW[=[MB

N?^JT


^Y:K

M$J$:SQ:NDJ&-7XD[C`'(!QS*;%W\CS!-U
TB3M18DC`NC`\O#$I?FTVEDV8Q
%2Z:_YX14)3I5-@W,
MW]#$/-5`-K#([!F


SNV2HS-HS$

S8B5Q!V8\@+5%
0VB&4(VDIK!YECEATAD(5T1QY;%ON\^==I

74QO^!/(T'Z@98!*$;_2[,@'US-RO]]D@Q?VBL
MQ+)!W--D*C`H%LSW(D43=0@K


M7\F&J)NZ

V9Y6P-5R(PE.PDJOYC:8=Q$N7L+$:R(HGZ6&$5UF4Y@U9@:CL_


M655#B6P#!3/[D


V^


K8IKU(



M%-&4S')PS(3):9'+FF(6U`I1(LL0AJ0G!Q7'-K0L/*DTW+L&IG_U+$Q)9/
Z




P9;/O
V!V]`[8N`*F_RFZDJ3)RXI(?3IUN




0Q-Y-O45\[-!GK-(3EA;N7A(\30T
M2S0

Z#L:S6%T-5]JCY
MO?

[*33SAI1#!8QN282
Y7`M&(')60UFJ1=X\@UV9(:8.J&LC-1
M&OL5](.1*)U2JCVIH#?37@KEK-F*)LHR1
RZ!9&IQTRYU5&-NM@UD^2UFTGB

([@:H^DJP63*-F




$X-&XTU:S)&^MK36_R$I2Q5A4A6W:_E

V@(-CYC37&_Z5%`(2QDE*!
M(.L:3:N
\C*!])G7]@



MIJ2&NC3]@R3'\(+?3X+2:(OJ%EN4)4M4QQ*[126M
TFV6&HDOJ%7V)J-JS(V
;_;&#N2X6C


M=%ICBM@YVA.2S%\_2)M^I[6S7'`J:T'(OD2&90L3Q_.BA3UQ
^Y.)];C)\F\

G5M1LA/=.1Z)04!




4%8F*;%9X
M4M2K2S]5#DFGPVCI/54`/G[9G-B017.LB8JIE!


`

M7K\KZK(DRFJ#E[N`_0]'_'1B:*W3.7!U3)$*(0%YA\GVM%KA5Y?+1MT8`E
MJA:OL^&BPT5GR^(!0QZ+JCSFCL4YR1I7;
-7;!S;G+6/C6S.VKQX8

M58TQ/

MC



&M7(0W0T&WN+



=)S^Q[$ZY7::/5%]-KAR&:X.@I3PE



M2W%F4PZU=(:Z6ZU*2[HQ5ZDB
BP[KSAT[
D3TFXLI&QD^T
$ZJCW#27B1\

L&([(3$(OB^8V(YQ]+-TPFZ1%%71K.5ZNR

M$@-\4O3QRBYC`9U39P(:)0+@'UY04@W15

M:B])&IDR-P8'!DZ9QEPY`-4=*DH\B&JF^R9:I9*1O*2)(ZEPV-RP;HIW.6
M#1W

M


[:L5(TB#ND







Z2#MQO62.15ENW_EN

MB&!L2J)IM%_RU$ADUZ=:]='QPF7-.NN`(#^(D



MS
VN`U\.:BPB*AQ\&)0%O:8Y8(P30`'.:#/K`#6U#T']BYA+/TF1C6G-HO
R=<WET)E@)F
\&;9OZ$?`01A`^@?T&-DCB!N!EAC72!ZR?
MQ)*O0_JIE7L4):Y7^I3Q4\1Z#T\NV/EP\O1-+0+S\Q`ND'3HJ(%NY4LGWIH

MGM#Z1&[9V%^
%*ZSN



M(.8WFHNWG_
[S_-@ZGCE5=/KUO8T6







M0T#IU
'!N'(]+7OOC:X\XQM31W7MZ*Q/[M@-67BXTCHE!Z^G2.^)QKK@#EZO





0B4F\










`7Y+:;K
JCL?G#3[`C'PUL
MB+LCG/#L3L&J1(($'V+?5O!08_JQ-%+


M2#7IO(14%RU3[4Q(-7UD;^D^GHA17IR&3T%&?WOX,D7WHV$+_:+[U`9]1H8
M4M4Z+QDU1=DRNY-1=:2V+J.4HEQ*3T9*_X:;\&EBX)DLWD!.C?.24TV4]`YM
MJ3S2U6WE5%77RVEUOT%-4\BW?KY?(11$.0QS3/4U@*F`QD!U`VX-Y#?=R

`-3!W60KZ@#5=0
J3-UH
@HW%NJ`TW[@86?Q[^G*[WU

HS
1
ME2U
F\IHH*^049Y^'LZ4OH9N$6X'@F?;)%
`I($'SG+.(\EXOKLJ9B:MD
M:MV)JSH:;^WUZN,UTAJQE.42NZ/$WI-Z%RINV*LRQZ4T\+I-I$&RQ!E2Q*8


44XG(-
\BQ^2DDY:Y#AU'L#@+$.GZ$ZZH^!5H94
M]AQ=
O*8(0B;#1Q3@J&ADD7#



MNM'OH/.`A=
ODL/F4OA102
0PL!;DGVZ_L1;(KWRF$:7]B=.8:2/I32#*C
M73HI6O$A3E!#ZJ1J\5

MS#)%?8U!ZYZ#U?4*3`)/K1
%=N:
JB@LITZ*NE.Q$LY3M^.\8DGU!LZ3)4M4



3=(GQ)J+
MDFF*BJG6Y9/3/!4;R^EK@DI.NIU(E[ID:6RW+DA+(L3L)A\A
GT*I;(F)$RB

WAM*J;HBJ5'\TL3Z47GL3





MB#0TZ@S01J(E5RXI95



#2(N51N-VXBX





$P(V5(5C:K.8/?TF\#Z/$JAL!L
M.PG.

M3K[U1+38C9.#W12D
FJ

Q701B:$P-D.H
M%$R/`)[G5'E

E


MN`O






Z];GXQ_RU86%I





45N


M$??!C%R?V%%-`GJXCCRZCCS'3#UYQ7K52+[2@23)!IEQK:MC[EP



,EW(V?)()3^H2*6/&/761FSL56]7:



MQ33&M[D_OG6#XYOS=T_Q/=X?W^80\'TX#VJ#XW3Y[(3V8X-IQCPNZ;'8&/NC

L]








M\LQX_


&+XT-!!BXU
M/+]VV*+/D2'S_-J@)8;GUP;OF?'\&O?
3E=D.O+


M&O?
3E=D.O+

&9`N[%G;#(\/S:24@-SZ\=NGZM_<'Y]=X?NU4!:83SXSGU[AG
M=KHBP_-K)R$U/+_60T/#\VLG(U\\OW90X3)XIF#8\L*]N
-FL:B9?D]
%
MAJ?7#MQ^S6J_+PY/K_'TVJD*3>.&4^O


PZ6.!Y+HMZ^@W4N$7A/Z/BJ;?IU7*'$97)=E1(8H&VJ


M\


^W
[\TAXC6\D&_Q/63-_JGI)



P?X

M%\1GY

M9DZ(#!XZSXZ_))S[2E%U+





$3.**.!YMP`C#!7YV)XSZC@RU$+@I+3%\6@-K_8PFF
M#8W8C!T!=E`)T5;IP+Q;Z`_HMBFDC1)<1\E%I3!1RU8:`:_P=9B!_EAE@NM
M0QWKO:4V]_FW\MX+?C_L?.[&1



6(


(X4'2V*$#V!SPSLLTC\7#N.P8)1+ID)$3@NU+;.
MP;^`*

LEXY\$-+NP)$3UP)/!9


06.\X)%2=4D20EX:@)@'&2AT_)`PP#S9VI.P%MX`D`Q`*6
MGML3!]0?1&"O5AX7DBX?4WQ&*6.?!1G83!



C:2D#*U%RVY3@=+#.V`J.8.
MEC`-@.


0G_O@%?O@J:M8IJMD\)!IX?P!?

M&EHR@3W7*1[Q%`G?P%X3H1+NE@_1)'071$ZRC4:KAKK$







M;-H\(E!6(;[MY


M
VG:#L\5B
VC#]F8D


/CDS6_32691CLW4;1$#5L1


M'9





M$P






/-YZ^7PNL\
+_QIT`U3)@YCTNP



M9H2\/4\JLDGFA

#;I#]2&4D
\GMV?HY\DE1SSYR5(J]!F0))<*13`3T@/GHY
M&NF(;0GH657J5X





UO+@16D:&/S!;ZK/9



M!-C#)Z`%:C/A5=-:=8-#X+#)5V5MF\(W4=R.6B.GEN6=Z*G,N1B6H1W8/.
M8?&

38J(BFPL-+X;CY?;*E

4
MUL2P.VO

I!R+9EQZP#L)HIAR


M=



M^V`$RW6.[TSW'N.%.U\W1&22S`?PNB^0+^4;DW/-P(I%TL.&5BRB.]%]+?


)2?46*!=[*'#N6X'KLMA5EGV^X71





MF(Y+&^
2-EY1(]E=`7R@=/

MJE.'GDS65$&#





A)RX1``P



G=X&%]I?^]._8YA]^1!]ON


MO-:

MRSBR\HB\NIS

^?&8D76
-SH#
MU:T1A^L








];'E?@<C_3^.C(=PW#3K`,MJ;]D
MV*_8BJ<TD:XXJQSK4BA+KYYMD_*Y:D;?JR6)5I6FB4S%7%LZFQ?@(;'$#M6
MA_26XCUBK54)SMG*9K5NHET+&JDLO1=%Z;TH2&]12^?M$K^1[:`J!LUC/SJ%




?HD
MF&/M7.02?;[6B:GW0MID+FPU])'-/@F;98[
\Y&VU3E?W.3U6`JO5UK)5XQ.
MZ-[V'8!4YV/S9%D=C572N!\'`DCZ#]P]E'VCFL!#T@
[)\LBJ/QB:5.=`T

M


.7_R=76!;;OP

O(X)
+UDFBP9/8/

!

MSLEFJSM^%KI=I/V;R5Q5G)V('XY%25=%2=*K7LI2
]WV2-AM.VII.ZHA*F-)





JC

M_^M[


S[`CD-R

3*


X+Y*6X93


MNC:A





C5=.WXKL&O:3Z


N8[L
7'.(TP;*G6XZ/28









M!P=9I=4WCJ9

``S&<[=(-E).#4Y$@`S`+8CSA[]G(1NAY.PM2%M@7[++1N3\HP
MVB^H.0NMW!/J*1IO,C!P$G(!'#+U5%,7);U![I4[3[UQGGA5_ED2YSSTXEI
MPT6GQ\3AHL
S+6?J+


2YB7

2M_



M*G7K1B
=MMWRJ4SV4E2M%];
U$\E\FC;V]#[=%0@6R.3TZF*3N9F.3H@G?2N

9Q1X:
MDFXE7EHEX\/A%.XA*

A+XQU



M


MN]


[MJ=3'*)




M


Y@8KHQJZ






M)



34XFM+M#13E





V_


MCXL+Y_'[Q46*U.*.T^VYOD#^652Q0K[C%(AR$$2X#^DP




M2U@3[&O&821
MK0*JG`9PQ\8GZ.IC+5Q.-+4N'%KUM+];VUO?!NK9HHCNSHV
M;:C!UC&W3%.9'-\-\&WNCV_=X/CF_-U3?(_WQ[

J;9Z'

MJ6?X/H0(Z)(H21(7@L$)P;ED:@XA!-K(


]
Q-GDF

M`(6`IYG:3#.--9YFZA-%!G%#[`SITI;'Q/--W&
:J`BTYC&=2]@\/'O!$T_=


M;=Z+


T6]\X5XIHC[
M0@



*VI.*5L;&\A9NT<#%0'--








M2W]Z_=T))VZ$C]V3?P&D[[Q@\OM?__W?_O3S
KIXM.W%VR]A


M((P^.
ZVS*&-#4DJ







M?Y5`=\YD&8*(@JD((G=K_]#2]'7D+[^]16`V!A%CV6P1-+7Z%A%X(!CF-+
M-)F:IICJ.G!*[V\/F@TLINFZIBKM078%=B8.^&._2M@Z3\[A9!V8`EQ;34










MP0]Y!CX$


M;N#;W@[51H:E66.UX.P47K?S6NNW/)84U5`:+OO5B1P[G*#*?0^
[P4+C(%V
MY7-3EDV=%:4U+V\'C`W4EV0+L+$-1
V/?[L_^&X1H!:/O8LN`1;8D*I.@L*M





/


MNBJ;ELS$FMKM0:)O?@%UH_JP+`.`,/E=$J=-`F`@[%TC3+9
L7.X/DJQ/;
MKN]

4W+8FN;UZ;DGJZ]\&[P`ZG$`FGMVZ;


QZZ;9)U`WL;*LFZIR?(BK01N/




454-C^F*:%FOZ@S9,`QSS9E#XW.[W8K




U$6#




M&;`;VFZ:9DM@@]6%OQ`)2#\$381SQ+?M`RQ;\']Y=K'VM7NOO:G\4AF;^G9@
MH*DB?MAJU_PD)9.C




M(Q.7^)=YTZZK;-C9M@ONQJ)ZQ2HU7-%PE0W;:K#@5S?Z_4/H.%_!?]N16L@6






M&68:J.^R7G?0;DA&XB%C*X#?SN!;3A@E3Y
8D@:A-S[\3%^^`:W_J#B0U!*O

K_F4!#4^2^'Q$UGW(X.K\D0-<'0NJ/8O#K5^M1_1TNIWSB)6I??.!$)[

MR=6[ZM7CP;RK+MX68C)6=FW1UTI(1^_?FJ40BKYHA_=7!&NT.MXT6EIA)0RC

A@5::H]@*;3!V&6$[D]O998L38



MK3%C3=J`?:W56WMAJ4XG


'(4![ZTR




M@

Q#]&W[`4M[#FHK#G3SU?(Z].G411/!MK?+
MAL$VF2)3?4G8-QUG'C1C99H#Z`;,LYUO'(\KE6.C+N!9%?-43
DTCH.C

E25E!2)%UG3E.%2[KDR)F6


\/AI$$!RO*&O9`-XZ&D2:LF+0+-W0Y.-1#;RZ%:H!'^G'
OH(

M&ZJYD_VX\@+

MEUEWM/ZFOJU&YZNO*\$W.UY]#=]E`Q:[HON*?UOJB:ITOWY16Y?VWS7?K_BN

!VN7_(P2_COEOLJ
M_
D2_@^P?WE=?^KN^5]=IWV4;OFOY!E6]RKO;.\K?F!I[]VO7_+Z=EU_=0#E
M+LVKE&Q$S^K[=EQJU:O+%C.M+A8KNG!9;R-=;GNQVLY9NM'%4I5=IW2M=@3J


XQ.30

%1HU4/#4.4_'58JJMRJ`V.A
MTMLZ.`P53MBA8:CRS0X-0Y7+=G`8*CRYP\-P=`U5Z?=)(U
^J(*HZB@Y/BPF

O0U[YZ?P#6N3=IJ_T#@%#G\&B'P<*:=OWFP0!8W\Z_


O4R<F6WA$UK=`+::KM0/2W_.01T?W<6
M-_#=*)X[?AQ]]9;(E(VQYJ25O7LM_)!-K;D51]:Q98FL;.`#G[L8:W?&M
M@A?\.P%N2PPI3-OOVG?NN^IJSRQ3EW2M^:IU7UGAJFT9!'2^KJ7J=IMU.@!N

MKWUU.P`HJYTM3+;A51






MM24_&-HNBN%J6W;8!JSJ-@Y-%VJ?';:`O4-NN-J!&=YOR0SF:@OK)JMLRPS;
M@%7=TZ3I0NTSPQ:P=\@


GB+3-O;;@R)5S.=NL$QNL9U)Z`MB-+





M2CD'^/[2]MZAH;0].]S0B@?\XM6VYFSY3/EU*Y)8L-N;O?!U32^5DM`57[U&
M!U#!Q6%`-U-`&5&E]-P9
7:\8$$\X#2<VPV+LM00C=6+

NW.(;XZ\3+TR29(W@1V
MU)3K(+1=`4VV-*/4Q6[S0BSK)8#??B
.RT=P03S8U8U__7WB1-%&=!D5X5PQ
M@;%A@3R(L^?@?$0W?CH$@H0A)=3&6OD(U/$-C&F[FK`D86;[LOS*2
9Z!O




K:\'A78.JEU)3



0

M;F



JBH$BR)@KQDR
DW58$YYDTIW2FY*\3-YPL
MYU&


M7[`SX1$(*H0%@3(2;!9


MA2DX#;`:^[K1;+*.F54Y)!J+G@EJYIHF%+1&.0D#DE\#0\M_05X;&#=*JWM
M*:(6'8'X2?B#]F_';5.DWLY`QB(J)&K5X:H:EK)N$9.@M!H!XQ2W[7*
F1F

Y=

X^3-TVVG@?I6)*F\T(*(PM_WE#!-\![TWF!'OSO$$[=!\_L7KO]L
M1Q#W_@5;+[\+?7`(::/1PQ8:%AD2?I!+ZA)#Z\-C867CG!M'$Q1:(IBH






*LGJ]9(TG_@%H1;D+XB_$`R

Q
(OQ`TJ#H5!K4S3DI^B


M^;BK?
&V8-@!&48M+%=8Y>UY7>(C042^4EN+;XV(6DNOR^P\+M#GI!UIH-4
MNEP[ZV_/#ZI2`\






MG__T
Y;VQ-C#)!2BR9
/


E?5:P]GQ4)%ERE

7U32R

OI`
BPB5UWHE'M\<DQ%-VM


=[*R+U#[8
_`I=K-GU_+1$S7*[@GC&UD!/71T_M$
M#^WH3V#/S:-[U0H):7?RJC$N4(YOP!\96=;`!10^K`#L`4[[Z`'?C6AP1Y^

MH#S
3LL@
=5CZZ-M5)+FE';0HT





M1-


M]$WEIW[^






:4S]@T.
MB:1

U=OG9W7:\U/!NZSW=UB+S&S<WE;:-5

M$=SJ\*


R&K88&8NG4`@XGW90O%Z<Q.*)'A/
MM`TH:#&'

/&.A\FT??]Q2EX#X-K`CM02_.+M%
1I
M9SCH:@-#Z^(_C&%?[ZH3K7NO]M5!1S
^:=KD4$+3!4MB

/FD

M9W/8

P!D'9B84P=$

MYH12[NH(/)





THZ5/&@03;^3#[]B:D6-:H4G)KL@NK3*..H`H

M
S@7F%VO
GI^QI/;EYSO%&
9;`O

M6/@I]-Z@K
H/^[:@P#PVL1S1_]6A\KQOFTN@W!.2NUK
%;;V-TJ0SI+)
9
MM`O

9=QO$Y@(IR7C-

MP')
A.`


M_VCH`\TXF

`2&&/N/Q


;R/QF2O

M7DH$(8:^GJJ/G]3^HY:?M'=1TJFBJA84#^V]I$`;=`0




10^58ZY
RR4C%4?YD
MK`X






M38'\\AD_($'QYO:3/O@C@BA`P]GD!?0\Q_%^X*M*%-U9E


ME




=8T-!6#K#LY'0H)0#+(


D.[&;G:1K[WYPG3?Q-3?

M#T*N


X/
+SG#5[\`WGT'T
MSJ&1#RW`9IJG5_E9Y[*]=

M:(+^BXQD7U29[`M)1PP!FS:&HU]*3N#&@



M.I?MI_(=NZ+$64BJ8OV(IVQ40(TNIO:2C]'+C)Z*:T0UV86XMIEYVUC@+Q


MMEE:25$,#7?$23=W4CS148YE?%05G[XBCS_7S=_)EY@.A&)E&T_7O)ZWD[

MQFV?S4..KKK.)L_/;Q-NU&ZW*SF;#.


M93^V*3?HBF^YIT*KBLY%5RSIX)B$ZT6;Z!5R3B+&6:ULZT;GF'ZVTEA^LM
F6<LXY7$G#ZO$:FL<@MN!\B[.
U:IB&:O%+&.U

!G.?&\8I71*]V='D839^

XDB?Z\UW$^Q_P
M]G9GJB+LZG+5]

M`J!(BE]`)B2Q[WHC=KILD\A$

MQVV4.D$_;O=O2F[E

W/^;O

M.5_S
$U&3TD:.VZJA\2Y_



3&ITOQ1
6:

83&


MT+?73`V1$G

]_9T)7$E_H'@[-EN+O#GO:)N)$ER3P
MM)
D/&6.^\O6CX40V(
:R$^8QY?B
1Q?[&QA(C8W
8;X_3:&5=MA&W2A6;IR
MQ`C+)7=3%G

A((_=)S_P4Y\G@G8J7_`BP22\D&R#%P*R8KW

ILHQID+







M:4JV#
+JC-J
`HC]`
2F2[$5WF;$'C6Q(1F%L63RAM%1__H;Q_CK1IR%N'?K


M-!Q)WVU



B^%!FNC?E!-D
MU*__73M9-RLG?N;)+`I\=[?@7]-K0?3GD@(9OM1;.;LQ1=%(38%ESB5#[Y))

M

M

ME&UOD2W1DV*^6D2##XZ2P21@XPZ2(/*$CMRZ;)#4U1#:96UL]-7)1XH+9S
M?;AR?&\:0J(5_'*ZO+IJOQSL.@(M^:


M28;63)P6M)(C0]YJ=G4




1FLOCST+2K71!EW3+]+*?3K*G86N(1EHS7J%+^;+N
M5)C*(NL=,5!F1S59OB_)[.-\?UN')]#JRMF75;C6I4X%NB.!*Z9;9\W[T+



A2N


MX^(@NT8
%BQ0OF#;9.L$088ID4;/'%?P5U\(W(WB310#+Q!K'U0@K_=WJCI\


M)G&&:K(F090*Q=JUJ+\ZBW5+U0U
7[DG?KH7A\I`R&(2CK^Z/*F
9QJ\1%)R


141BM8N'UF\$`


@=
MN3?5Y*%@2MQ3@8M6GR@/R1((,!7K8+%ROY$!0`J$!%!^58%L%^.K/6\[9;


M'*


1W]99=8=^$P4@F3I\$

4+






M9$-K8X1J67I\QA4!Z^TZ;


*+!Y!TL5N



MK^:`1;-D7TCLU4A5MN(`UF9B6+0JVU;M?8;]L1X+R3$Q6![OWXQFDYNWN:3A
M+!;@5PCG'8#X0:/X!#K/@U+M6VG)^`M:WE

MR8A+5JL^-#QEX\^6]\T[&



NB)IXE52AF+
MYH/*)&B==P/7)7

4Z;63^*XX(-[ZP38]N(LT?8NL0(9L

4RE$=9S3I]IY

M-EK5')*DJ





MJI\8R=_*=NX;F9E5M#_YW`1Y5_=8)M`+YF`/T,W,MD+YAGN6!Q6&+QO(:R




N`[I1R&$D
J0SV$9?=+9BL\20RC_'2NB=:J)5S2S16KJUU6XD4-:
;L/0JON[<TT


M*)1WW9$NDV?NSA6?P%^R0`B





'43LS
M1F:XZB=1O(/E`9/69K$XY_L;)Y#UWU77N83!B*=!ZB1HI\(]]8*OL:?/'I2W

@X=D



ZX=%@[PHL?$S\!2##!UET$=2MP1\6_IM=B
MT)_;S^YM`]@\M!LR:^NTCF!4KJ*I8TQ+39:]66!QJA6`@^-.MO7RW'G:!DZ

'@7=QDX?4:-[
M


Z4PU#2UBJ:AE


M)D6(&.YQN
+V0^PS*29^P;;)%A














1!NPDA;$EI:7R)619DP10RU(`8TQ1\


M__+Y\^CQI^G=?/+I87(WN1D]+$8W-]
O#XO)PZ?9]'YR



MQ0R&HMUF$C@
F[.%D7=;_9=;I

M(85C

0:0?K'_;;Z$&)/6O;VP<@!


LD=
M_]DET[3@%VHM&XJJ=)5*?KGI_KT(Z:@\!G@]E0*K+O
J=*CZ.5HB:1-I4I8H
MC]D6


OOJ^/Z[^OG]_
M3`WNQ'Q_%6Z<PQ!T^+VI$K^WI<6(WMG4&*GT`!TGUVKC(PF-JW=8:P6A_1DU
M@)$;*,\-.'&#X[CU@K+`LFFW5F`=AL[*C49GR6;K\*=+#U@S^:M($N6/J[%


3!E

3L47F!0](*4V'D]:3;Y[&%5'P7Q8L5_XD[\1BJM&ZYB\0^7L%[





MK761L


V6S\

I:+R2U/L+FRW'B60[&T'E(J5^AT5M/3V5X^TEJ
4]2!23:]0;8U`W9(

M'*OM\**%U=Z4.8HBZM$1-$&-#Z=1)#`TK3


X?:'F)O;
47/T$8Z3-7]
MOE$4WMKTL^W-)`6.ZUSLOM










4^C4:S0:5_=-;(
M4J?C/BN#5422JV\KEJSJYVPCDNQ)'P61Y.K;(P*2=..]-R!)\QP&`$BRET
+


MT:D0F[:G24KT$L`EI;N.^7N*TU]//;D;ABW@B^5`9(H`[CZIQXI(;\@;6#


JDY=[5I&



MB[E@


EUE;EHJ-I.EITM9AP`9EL\B&9]=R?%O[



?5


MJG/M!5Z
01@:7@G\M2]SDRZ8F)T'?_4#./4F%VP-Z3\AC^67XEJ0P/428@.Y



#2]
Q%[=(W(``XY3U=OAN
MD4MG


+K_
K9M4=98
M;[2A/?]#LQFC^==Z0^WJ=%*`8(Q)0K97/1!9^2D;P+]59&FNS;`BSRU3K0R
MK1?QZ?3AQDE6H]#_T`4[

M*=NG\P&H#];=V5Q

M


A11Y@SFF`$CE)<42Z%ASANGI
MODJQ3#%1OP9?HF00SK#/
QP[MY#L#I4Z&5HNXK:MG!<NT763*/``94+CR8B%$M]2@!/LC:\!)XICXCO

M);JP3'S7NJ
Q




5A:<$#$IA?[+X*P\#STWW;2\P!,#828.GA@0(%OLX]0*IXWTN939F[*
MVJ18(6_\#:B!5!E03DFA^QT)VI@%+5NKC8!?(D1B*7G42Q&&&HO''.9V6


M+UO!F3=GDJ(X&4I[&C$=%%?8=SRCR!Q-TC8(O=U)&D/2TR=[ZO-\=X%5X=5W
MU5U,T

6'+1LZC2!
MNK+EL/U#&6.^8&(*$!T`T'TG60&O4Q$D7UF,;;*8VC1ML/=2/XUZT8@!MG&
MNJ&!8!I:L^*/ZJ99W9+30SZ'J1:Q&+(M8IAOPHAI#S$^^48








M3RK_A1OKY8W%WB_6IVC0\

#]9








-__]6^5L8851+1(!X;4=^:'+FW;6
M%C/V2`O+X+H]]1!`Y:K1Y0
1RHO&CY

MVMD@50!EP[-L_'IB\'TY4?II_AA*@T_G
H#D`N^%8N5@KYX3/V:_7;6^89

%
ML7EY69_A)PPQ-]3LNQ4.&!V




D2;U9DC:F\!]DWQO338A5&%FC+KHVAJ$

M&+38[?A
8ONM%_*OJ1?RD-;6X^ALJ0GRT18V0B&BD_)HZ?D`AAYZ.U]\IJJX

M7_JK[#U/=!.KF5RUA5U+8AO7=XF*7@/-BEZ#^3^S&Z*J&E@$?'BCO21']#
*5A'PB$E*0]'/
MOH(IU\#T^X2GT]`O$+379E/.D*IYB*QMU40I.K6O<^6NL&DR33/NJPP3;(^



4;3NC1[^+9;M*PJZ.?;@5C!S



[QY$IG(J




M
[490'K.`Z_3_




M-O4V
GF-=D'3@3&27Z'HR(1&J4PY4D/1GZXB*5Q9=/Y8!

E]`%


TA
M*5



!)WF_O-*G+%&


MU$1:25@WV5HAE=1*M]RIMQ(:DV\:2*50M=E,YPB4FC]=XA[%W@*U;64/




*T`FM%**[!
MY9:8W5T[LO;004

M=6&3F

M34#7YP%@-D/
=C?R7J!LOBE]JO%Q&MZ^`2
4NU+C
R3`'$5A2



2$[%SNU@6\\A=
M03#8
7G+QW+PZ'-(_G9B3^C_
!'W^PJP7$!+^_0GA+?9/B7\ERU`H;Q@$G&U
MY]/Z.!W4IH414DW*E^OY^*]?Q@\+-OY!_.]\:%K7-OD#_!JCS]#?Z9G&ST[H
M_P=N;@7P=K%$SV2EB2-;0M[I0K8
4B=CIBI#U=+`)


M0'IT8I0$[Z%H


+X0^)ZJ5=)3RXE

MG;Y8


&6

MY_LH26[$!KR[B^)7N#85_[WC'F#^+9ROLVTLCDH\F2Y'&^&^?
6FS4%5I.\H



M3BKI^DMXV'2[_7E:D;8)*Z0;4U@?TS,JA60B+5*;5LS:;5KRHQ.7J5M(I5



M'!K#9C=N0PSO5L^Y`
?08'&$_
#]VJC'?L#;MJM:V+/65V@Y?88
D6*VN0TA
MVR4D%5LZ;'
7-KL@C:G4QN#F5SRIM!%XPB0
M5F*U1,TA@E7FD`-0_2H`P:B9-@?:Y;KFAK2$*D/EN+4N#H`^FM<CPG)/A



6?\?K\@KVN

;5#=:1S$QV(*NC&$

M4=ER*FT(X^MR#EN;GYTIM&V`
OL+-@H$U)--V'CK.&P#J1%(JT]7Z)H!NM
MVZ7#7F
_!9RBC;`*V




MXH
;!?'8V?8I\%V


;\!S
]CN3$@.:27H**72SM?=^$BP(-Q_`4QC6=FX6`DG


=)T

GW5IP1O0K#Q$R(5KOS-1JC%
M*/2^%Q]3C/\
RZ89$J?ARW04PTY



M(

$0Z*ND1
MF0M##B=PU$4`924S_R0$3!RAO(`[U%BH4G'R-GN/AEK3A342#(TBM(^EUE4C


'80*(M5/6D:
M2-7Z75
MZW9DD'0ZQML%28Q=P@U%1@]43E/4H&?6:GF/





%TN5GZR




&






M])UZ?_'^2COC



JBMZ1B2S:\HQS

%
M[L
H]#X+(:X^7DV7L.`U;)`=![*R1?9CWLHFJ9MVJX;90J^!.OOX_@)VR7=J
@GTRI'@F(9A-[<$MKR41YVX/-5



P3/.W%UQ



M&__U




M`7Y_$_




M6F4JB$




*VD2=`P.S-3(#(=F
M8NRA:$OKY+62&`K^6+IQJP[;


M#\
*6VP@G`@M^NO6B5

'C-=2FQ1RQ/*J+P\S?)E:&=6:35A8F*[(E
M/81D^$525%!+V%P:;[\$681[L5@6=I2IFE_WZ5G+LO1!H4[TD$VQ]JNGNM(Q

@LD_R-#+28EW5




M*O*F2WA7F^%!R
?*N+1@D

MOVBFK
603BVA5L2A4TKJY%$IF](NQ*OLVQJYA84


0KAD1`2




1<*D2+J8I5Z$WXE/Y



M@7\(


6_P91L?


*8%)
MUFM?!C9'(;2&`_^7AZ[/DSV7;6M6QT$L0)CT89J&:Y)1Q
-+@2;;$QV*DM(D
M=8A6TO_[]E_\[B
.GZG$QXZG1TN<(MHY/ZR]6


MW4ZGB)/0!51I?LOE?R?A2`8F]75TC2*VOT=61&/6*(JHB;`WFLQ;';\%2CI!


MXC#874

S+/UX

)RXQ%GFZZB&(`
WC'9
M&$-KC[X-UD+
=0[!.V[YZ\J6(96*5^K].:ALL][*6]'FL^\JVW^+`&I.6*JK


?

66:0P`43$OBA9
Q4.+H)MFKD=MPQ;5]+05$VU@







M;
8(N]Z@$

YFXX?;

M$/+JQW_]



SR






M-K$&*/'6Z%#;6V25


9^;%:ST


M03



^#


/[8RIR-^Z[
MYGUUG
P0-'HOD#:5+BN37=CS[PQU&AZT#GK^W7%U6HQ_3*SP;MR;ZG21PL#5

CO
MO_R%BUY]M9KWMZJL82D22WV
FUJ$6/P$LD*S9DB9?(@.F-&)J]0@\I4-9=&

MK:K5D\ZK99

M#R+L,
M15VX^KJNT&KC5VFX?AT9I&C^GE8%%'GN?A/O.R^OK:$`'F&*K=`]J9Z<MC`

MZW:H$D
ZYB\\!.2#$)N?1&LN?N4$T!M%2BMQ`E4%*%_(']/9&_XU@[W._QX#

M+6NGL]]Z#


MK0/-6G`0)FPQH1

-*

(K7V2F+CP#]RM(:JF5T$4U6XU?'C
MD=HOKWV$(P22XA`A%FGA%-?#Q1J^1&V7;
@4#;'B\^?)`D#$)6[%S?1A
7GX
M-'ZXF8SG-EN\VYV..*XE_+[/G(9B)=UD4FJ&VTGQ!H#.?^LG;A`EVYBW+=J=


MZ.D\AG2QUN6437D1-[TV6&:EM5%FKV'JV#4!?6*)HVR?J/YL)P&+T6Q!#M
M6Y.SZ6A9GU[CLF\^Q\'.S_SZPU=FA&O'/C=MX_CRKE&:$GLSFDUNWN;2T_'Z

CC7`IO_IKL4D&5<E5'5ZF1K8[
M


M7V5^*AXN#F123KCRN+=U4Q]_RK*G/'\I7N0X#
107.&7[Y91+(X=7C*H[*CN

D@QX#TM

M[R9TG=$0D$.

9T.-
JJ8K__SDROQ7.VU7I/^BA:_?Z[(RIU-]Y[(Y
USV$`

*`QQ8]@ZP;V_Y)
0


1JK!P5*X
MW-W&N[?OV&+%$Z['$6^)_T#$6]_P^JHEJH8D7OKQ6M;#)476L(@U5^*V=G9B


M(V!KF;


M[=W88`C.5A#!9\7]?1/[+@?$^G4U3&G]LS1GJ(T%DG




(-5:)NXT+T`CJ1^5KB@W&U=N:;('3MJOMNVIL
PA'(/#$K$1^DL?G/<L)Q-(B#^NHYCG$R3?Y'J0Y(YC;P%+0O&0
M][G1G\XV2.F]#V\7;-.B@WW0S#()NW;I\2-?13E2#=9^1(*L?P(WU&<HNXY
M_/2]D^?O46D\&4JUA+8#3\%_(D:

MTI%L6$.2.8D@N@`@WO+4\8.LKFU(!DD75@&4Q9+N4R*(V5*!_8*X-\-U/HEB
M1



MQ2ZN?OB
4FO)26YZF@;TW
X&15_VPS



MMF:&(4SW1&)Y7T+TUN5!D-6=*


M;;X))

Z/1!$@.I5+7Y--`U&LRE&CK;J68J'W*ZQ'K&FOS?]M?(


1QV`S!6M]/9C2Y=4I5,#[A$3I<'8773N*[-7;4;0RR7?5BF52%
M.YY\^GXQOF6C'\:/HT]C=CV:3V[8_/O1XWC.IE\6\\7HX7;R\&EH:MI+4F6U
M)7S=_FXKP.K*WF3W4?@

/?J]R[6_7;Y6CFFNL?_L
MAY@:&G

Q@=*)^ZVY^W`%_9P@HIOY#
M:$#A\F<@P30-)HD,14V,I7$(5VGT96BE(_R7+8`UY]HX-R21M+Q`+@%I9X9:
MYB$I%-I6#T5/S(50KEHP_23]-67?;KJF'[4JGGBJ@AQ+ABYOVS]!

K=U'\
55Q7K18Q`K.(+=
MF2:%-W,M7+*+*W7#I9

HB_*DB?1?39^9E?O9\Y.\3WF[KRQ'I8]*P#&Q-
MB73:AK[P&1=[W650)B]SUF##TM!FP@36@AEV]1[*_58#5QA6ZU0/*E@3&+*





M2!U)TO*!@\)G7XIA)1Z=M66#PG`K=D%'QD^NKG63+ZAILX:0




N=\1C_6[=WF+Y)
K^.[%%



M

T-R@DH23&_




(3IHU68_'HW4T8!\K(C@J_H]?X!`LZLF/F(-




D!H!3DA-$U#)@0Y95F5333Z(A]9C]\?
M59%_T^.B'%K5V)H6%QN9%%SCJ\J4*M.W:!INSA9)WQ49INBP[/2$E`:E+N82

.2%)`.Y.A

<UY_



HKZU^`D`2_Y/^%-A_0(

!(



M%NS-5AA.;GP
!T7+]%7LXX.*_;2J4QN46X5-6L!N&R7)=KUI@Z)L?-P.4EL#


M&S%#\GZ+4`/6(33LS:#5&VVD-2U-Y-)P6?LH&/T%*SI_KX$=A29XP@2@A(

@O`TH,KK-*'KWN*7!Q90Y:B.9,<+.!0=*5E
MNN4BR48Q]U]%(!T`8@2%5`Q?.E%;;:-X8%T$<T0
(G/`L?%QJM)52B9-!QI


M
C`Q-#$R



L!1H7'S]^?)U]6TV-




MQEY9)/XUH_


M6`KBM:\M`[RN&AWORZ)QMX;S%
0PPCKX0S?A`5Y/9RGR!\K2*;AJBP('B^03

MFASAJP*V'V#E\DR?F1@H#/U8[M,$;=/




%$ZU9V+EAN?LIQ44UK-1LUI1E\M&9RYSI

M@.EI+
.?HB0#]YW]_8_71\K=X@_T[&X
)O?#T?U\-


M!R&0(


MNS4'V9E=PA`FX!8^`G^



M9


COZPJCS1<8'HG7VG[#/NKY?X%-+4/<8=&G^5BYI?



38=IN;[=-G=GH?O%YM!@/G-NYL;MN!]7TY^;;@6`=
M#JR+V`T1;IX8!S3-&OL:)-!S@R%$7AA%`
E8P8HE:



DZBN%_



Q/F

3J!$[H._X&AMGS`^08+)\142Z;
M*!(BT+M.


X1E&$&N_QBUGB(?E(
I)?`[
M#C^/300)M-=I^%(]BLX#7NQ'(:ETLIRZ3E^M=T&
'_B4T!S3Q2R&@#%RHX
M]-J1=E)J5)!IB5[D
P&8M@ZGM$Q]QT2XQ#;B.`V0LQ;_924-M%(U90=&-\Z
M)N^C
*JK6*`B
)/$^2PPER24[]W2(XM\D`O+ZG*5%!V3(-VZCL)JE!H:WYZL

3#:3P
)!Y[-?]#$JJPZ+/&``

GJIEH\S/92?T`B0
/=AU2I#-


MD*S`?;IYP*/*\N@T6*8)@SBU
BR@41$40\_P&B(U/Z#9F

M


L9YL$D
#+:/]TZN9DO)H-_?I[
QZ
3WG43K:&

MWAWWVPF8ZS*(-KCA9R%KGB#+/.'GZ?PR`:U=43FAJ]P[BBHW&^X`F1&8!V
.

MOMARG0?$/0QAPR69D=@V=EDZZW.R=4[K`13#:(

ML`D%QOA7X9IPG[`OG(@7@A7ESNAQ+=FKP3V\#\QJ=#7V9&_Y-G[P#LL1)W92
M^'OGYZ8:DO@[-W9)V^\64ETQQ-5*-OXGRW*;?Q%=1V[L3Y9#&`
/%T
[`B&5



M07%V$B8-%H/






M!$W92%5GVVK
$*/S5AQ]'7486FRWPB@]P#

M8?(S9UD


MD4D.U6)PVZ@HJ_EN!E[O0A





SX+N2Y-Y
MF._







MEGK_M3



?M%`HE1$QWXZ
M:?X.-M45

K[-9Q%BG36[AS%-?GDAQ29G!TN3%0Y.W`KBT&Q






BFN
M:CMB\K#8/@Y
%I_QDN=^


M

NK(M./



.7/@IPD




W:Q?F=7'QF
M!Q3GM(=`*1SH['WL0=1&N6['3&X/3VR-&8;VFPY-O6A#FD^&9+'11@8%66-/
M


M$LM$P_ZM1!U=''`62Z7YXC.S(IF[S^+



N5_
=4T&G+([CF1U
M((W^:%9E!9*QK(Z2=S[0TX



M-'-DT-/X*14
)O?XLP7^E#
RR^739G5OMF[X#$
O)0=S=R]PWX.$+/..KN#(



VCJ_
XFP@WV/T5L/GJ=

NX9&.`49*J9)ZF/







M



&W5EG0L0;\2#0S659:#6%#1^[*16JW`HJ*:R$59^]]=Y

M6X0XWGI)LVV\X8`H^?!'+O0KYX=H_AD-EJ@E1`
FY*T-1!]T!V4LJ26LT&
M&P!O='ZJ[:4`RLVVC%=[I:HPEDKM'7NJ':RHR:55/_Y(P.G&-Q
KEZUFMY
M^)=]50J

PCR1Y\I'N##Q-EN@R(6[:F['?(5M-9UY472=+)`


MY(F?Q=:@?V(LVCBP5

M!%+9]!X$GU

M7$[+Z)$&Q+CQ0$+=YE/N
EM!+T`X=)\7
1Y'\#+ZES0BDP
6%63?5J3-AOP)

MZ:R6




M
='TQ`G[J)S6)N.CFC7=0SHHEC.7


`^-6E/Q?$2V\!*0*%N[S3)G7AV4C$C:XCGI)
MU6+




[%VPQ4YY+







^*(-XV=ODH3^
MAQ%&3V!V(



:UKRV!


TFBBMBZ

[2
MK2):*ZQM/=#)&V'R394OY$(UGN.O`]?[8^ZM
73H#B3KR)\L28J
D&8CMTH%

MS158U0IT@\MH#CH?7*NN^'*Y3Z/_Q`*MHOM4\!CT:O0N-3'&C3HXSL%:T@DJ
MHPEH=''=
;P?P:!`DJ/\F4
M??7FXE6A;O$Q[HJXQY`H(PM*2&Y&H@Y'CE
8(F

M!N

UGN#KS=9:V)9N8P4O8%8EZ;V5DS


7KB!G[;H1N84W</W<`<


]E2\.K\F7O(:LJ\I?+ML\N6WI+*[[J/6)[)5IS
MV3:8\BV=7MZ=AU^VHI$Q_ZM4':W[6:6D








M5?Q6=H!]:^D`^Y8YP.H

M5KMS?RUL\D.)G9RPC[^KW&7@U;QC[)#R8^6#B4_LH


M;&@TD!T


:[*K,EU=26Y@4)K43VBGUDS:S5=?5!$MD/=@+[@8FK69/KZKULDWUO

@4<0
B16Q@!L0/,]`DL9AUI3FP$MCW*XX$Z9YG/D
M404[XX%4]^UG\@WX^*];-_0#7


MX?N05+.(CEL.U@F;Z'[VU32.L

?3T$$%E%QS#2SJKILY<^<^N[@]NZ$?A9E_<.HFI*%NMT&Q


)-F-QF=.N`KUM+:P*\HERX;3JI2SCR@6H*FKG\7W[FK%8QBX
SA
M*LS





C`Q-#$R
M


1

2(QS&NCUB[/S




WN)H




M^$17@3S[:E^!*`KV=)3%L;U]9:$H3N)]Y^$&-%94!@3_^+0P*_3DYB/ECKCA
M[R
'H&2+NAV?[H:1<9FR6`_4?

M]@PS`VGJDZH;C@U/4N0LI]R77T'_4TM8S8WOAH7T_$4UZP.[=I;\KTU@2J
MT-?@[+2N+Z
OJJKC1%P9JJ*.%UI16

)/6;&E-S9&Q
M&H^6*_K?R_%L94V6*VOXWQ^MZ6B\6([&$W-HKCCCV!U'H;I3074\75001M8$

Y61^@J_A$&RFTZ'PE1K!E$M7V_JNJ)D4$8'
M


3\;*_/S

MC*6


FC[]B



M801]S:?#/0HUU5':SW75%\&3M$GJ]X?
_[^CK2(
S:*\770^^`E!T^580/_B



M04VU[`H)M_?8R+SL-S(/3H5?6A-K/EZD!W\M*?!56)7I%K8Q\M1W=B92DNS5
MU;0*7RS'OWZB'3;^#+TF7V]K



^E?$QT!P'P.1U6O8;NWPCAF^



M5=$!(0NNN589$$2
8J\I^1JU&$^AV^;&8O5UM3!F2V-8.U[O`*LZOQ6#J!D9



U?+9M3-Q70JJ5&W`CQA%!.Z2^8E/G^A'M9


MCH97
$[V9:#^.`@T_Q::'[SNU+SPN
@#.`C\V4.9X%Z)V9L1[DT58.!54]/2
M1U@JK8DXRB=G&IAC[4@13[`71_DOQR6IE.





MOL6A0R)H

M;N@EV2ZPOI:VD.T

MV@_IX'I5UFJMJ[

M0SNZGMO$'25`&JZC

MP])J




MIQA/L@7V&




MXV
EUCI_XF2/A(/,R2B9B^_O%_;BA9K^8-HZ.BUR)HT0P+!Z+B=RVDJ6\8


]ZYZ%3/=CO


*V$


M_PDOADFVS+_(Y&`
WXMF];^
X!NL\'EZX]6]O[





L\L(*^R/[+M5:--5
MRM_\F@1P$PE2)_/GI7(YV

M2J6Q*H?[JW+X)%0YW%.5^TFEK;$:/KJU^HMTS(6D6

M!
;HB.=OD74`U



M50A6.HF?:!.8HZM]7A[A5TWWT1$%&R;5BSZEXG2UG-^^



=:C]8:\/SAIY-MK*[QX]%


K



MK0ZOA[C=JW64;VFI0#25JM.
&^PW0;65MFM=MGWKN&DK;U97
'W+$BH+6CY

B/%U`
MM=1+.9+*\MSU6M:%[]D)]LF*.=A'3FVL:JN@7)769@$K0$]/
(7JJE`'C8V7

2K8

_\953LPGNH&+`



MS?
WC[+J6LK;22*




M8G.D8OL)/WWU0AAA!`V31
WI*@4;Z1-#.ZS*5C.`V%G$N?UQ1R+/8ZKK
C









))I<QC5IQO

2UND\
5QJ4K42]=H5H!TS#:
M`BX0W@S<9OFU6;;VF1XCSZCT39]P73I;(!L:X&B8%NYTPE2J&USV`;W_*?F




MD:3'\MK8@0`%P[68:Q/\FR







(

`

30Q
C
Q7V1E9BYX;6Q55`4`


#$T
3(S

M``

30Q
C
Q+GAS9%54!0`#

 'defref_fil_VentureGroupDetailsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_SubscriptionAgreementUnderWhichTheLenderHasAgreedToAdvance'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_SubordinatedConvertiblePromissoryNoteInThePrincipalAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_VentureGroupRestrictedCommonStockPerShareValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_VentureGroupBearInterestRatePerAnnum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_VentureGroupConvertedDebentureAmountIntoShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_VentureGroupConvertedConvertibleDebentureAmountIntoShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_VentureGroupSharesWere'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_VentureGroupConvertedTheRemainingOfTheConvertibleDebentureAmountIntoShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_VentureGroupConvertibleDebentureAmountIntoCommonStockShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_fil_RelatedPartyDisclosuresAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock'

